Section 1 SE Tables - Results from the 2024 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

250520

Table 1.1C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	1,128	1,156	918	1,015	829	845
Marijuana	1,113	1,157	876	974	787	795
Cocaine	838	865	264	221	170	152
Crack	403	460	139	117	104	93
Heroin	329	324	84	86	65	68
Hallucinogens	861	900	294	388	152	179
LSD	707	732	126	138	45	59
PCP	343	331	45	27	10	22
Ecstasy	579	558	170	136	65	69
Psilocybin	--	747	--	328	--	147
Inhalants³	--	650	--	163	--	96
Methamphetamine	547	525	212	184	168	150
Misuse of Prescription Psychotherapeutics	nr	nr	422	416	239	254
Pain Relievers	nr	nr	334	326	174	185
Prescription Opioids	--	--	324	312	169	181
Stimulants	nr	nr	193	209	111	118
Tranquilizers or Sedatives	nr	nr	259	248	124	146
Tranquilizers	nr	nr	225	221	112	132
Sedatives	nr	nr	148	127	72	61
Benzodiazepines	--	--	230	207	--	--
Opioids^2,4	--	--	329	318	177	190
Central Nervous System Stimulants	nr	nr	355	327	255	220
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	573	--	368
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	331	322	179	196
Illegally Made Fentanyl	119	158	69	88	51	74
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.1D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	0.40	0.40	0.32	0.35	0.29	0.29
Marijuana	0.39	0.40	0.31	0.34	0.28	0.28
Cocaine	0.30	0.30	0.09	0.08	0.06	0.05
Crack	0.14	0.16	0.05	0.04	0.04	0.03
Heroin	0.12	0.11	0.03	0.03	0.02	0.02
Hallucinogens	0.30	0.31	0.10	0.13	0.05	0.06
LSD	0.25	0.25	0.04	0.05	0.02	0.02
PCP	0.12	0.11	0.02	0.01	<0.01	0.01
Ecstasy	0.20	0.19	0.06	0.05	0.02	0.02
Psilocybin	--	0.26	--	0.11	--	0.05
Inhalants³	--	0.23	--	0.06	--	0.03
Methamphetamine	0.19	0.18	0.07	0.06	0.06	0.05
Misuse of Prescription Psychotherapeutics	nr	nr	0.15	0.14	0.08	0.09
Pain Relievers	nr	nr	0.12	0.11	0.06	0.06
Prescription Opioids	--	--	0.11	0.11	0.06	0.06
Stimulants	nr	nr	0.07	0.07	0.04	0.04
Tranquilizers or Sedatives	nr	nr	0.09	0.09	0.04	0.05
Tranquilizers	nr	nr	0.08	0.08	0.04	0.05
Sedatives	nr	nr	0.05	0.04	0.03	0.02
Benzodiazepines	--	--	0.08	0.07	--	--
Opioids^2,4	--	--	0.12	0.11	0.06	0.07
Central Nervous System Stimulants	nr	nr	0.13	0.11	0.09	0.08
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	0.20	--	0.13
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	0.12	0.11	0.06	0.07
Illegally Made Fentanyl	0.04	0.05	0.02	0.03	0.02	0.03
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.1P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug	Lifetime (2023)	Past Year (2023)	Past Month (2023)
ILLICIT DRUGS^1,2	0.1254	0.1562	0.8364
Marijuana	0.4193	0.3021	0.9146
Cocaine	0.6216	0.0126	0.4306
Crack	0.3257	0.1502	0.3761
Heroin	0.6597	0.3138	0.1952
Hallucinogens	0.0625	0.0020	0.6739
LSD	0.8627	0.5376	0.4133
PCP	0.7454	0.4922	0.3208
Ecstasy	0.4420	0.4286	0.5897
Psilocybin	--	--	--
Inhalants³	--	--	--
Methamphetamine	0.1360	0.3028	0.3680
Misuse of Prescription Psychotherapeutics	nr	0.1285	0.7296
Pain Relievers	nr	0.1107	0.7084
Prescription Opioids	--	0.0779	0.6524
Stimulants	nr	0.7588	0.7269
Tranquilizers or Sedatives	nr	0.5200	0.2527
Tranquilizers	nr	0.4557	0.2823
Sedatives	nr	0.3990	0.7101
Benzodiazepines	--	0.1913	--
Opioids^2,4	--	0.0490	0.4007
Central Nervous System Stimulants	nr	0.0928	0.3449
Illicit Drugs Other Than Marijuana^2,3,5	nr	--	--
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	0.0642	0.5522
Illegally Made Fentanyl	0.0209	0.7846	0.2529
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.2C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	138	161	119	131	91	95
Marijuana	115	116	107	107	83	83
Cocaine	18	21	17	18	12	5
Crack	5	13	4	4	4	<1
Heroin	10	10	4	6	4	1
Hallucinogens	47	51	41	43	21	27
LSD	33	33	26	24	11	7
PCP	14	12	12	1	4	<1
Ecstasy	22	24	17	16	8	5
Psilocybin	--	46	--	37	--	17
Inhalants³	--	115	--	67	--	35
Methamphetamine	23	27	17	24	16	22
Misuse of Prescription Psychotherapeutics	nr	nr	58	53	34	26
Pain Relievers	nr	nr	53	44	30	20
Prescription Opioids	--	--	50	39	29	19
Stimulants	nr	nr	32	31	10	11
Tranquilizers or Sedatives	nr	nr	25	26	14	13
Tranquilizers	nr	nr	18	23	13	11
Sedatives	nr	nr	18	17	6	6
Benzodiazepines	--	--	18	20	--	--
Opioids^2,4	--	--	50	39	29	19
Central Nervous System Stimulants	nr	nr	36	41	20	26
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	101	--	56
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	50	42	29	22
Illegally Made Fentanyl	13	17	13	15	3	13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.2D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Standard Errors of Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	0.53	0.62	0.46	0.51	0.35	0.37
Marijuana	0.44	0.45	0.41	0.41	0.32	0.32
Cocaine	0.07	0.08	0.06	0.07	0.04	0.02
Crack	0.02	0.05	0.02	0.02	0.02	<0.01
Heroin	0.04	0.04	0.02	0.02	0.02	<0.01
Hallucinogens	0.18	0.20	0.16	0.16	0.08	0.11
LSD	0.13	0.13	0.10	0.09	0.04	0.03
PCP	0.05	0.05	0.05	<0.01	0.02	<0.01
Ecstasy	0.08	0.09	0.06	0.06	0.03	0.02
Psilocybin	--	0.18	--	0.14	--	0.07
Inhalants³	--	0.44	--	0.26	--	0.14
Methamphetamine	0.09	0.11	0.07	0.09	0.06	0.09
Misuse of Prescription Psychotherapeutics	nr	nr	0.23	0.20	0.13	0.10
Pain Relievers	nr	nr	0.21	0.17	0.12	0.08
Prescription Opioids	--	--	0.19	0.15	0.11	0.07
Stimulants	nr	nr	0.12	0.12	0.04	0.04
Tranquilizers or Sedatives	nr	nr	0.10	0.10	0.05	0.05
Tranquilizers	nr	nr	0.07	0.09	0.05	0.04
Sedatives	nr	nr	0.07	0.07	0.02	0.02
Benzodiazepines	--	--	0.07	0.08	--	--
Opioids^2,4	--	--	0.19	0.15	0.11	0.07
Central Nervous System Stimulants	nr	nr	0.14	0.16	0.08	0.10
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	0.39	--	0.22
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	0.19	0.16	0.11	0.09
Illegally Made Fentanyl	0.05	0.06	0.05	0.06	0.01	0.05
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.2P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug	Lifetime (2023)	Past Year (2023)	Past Month (2023)
ILLICIT DRUGS^1,2	0.0000	0.5930	0.5241
Marijuana	0.5252	0.1858	0.9247
Cocaine	0.3670	0.7084	0.4242
Crack	0.2664	0.5212	0.3432
Heroin	0.7876	0.3907	0.4872
Hallucinogens	0.3054	0.7584	0.7198
LSD	0.5384	0.3770	0.1868
PCP	0.7776	0.0752	0.3056
Ecstasy	0.9091	0.4279	0.2587
Psilocybin	--	--	--
Inhalants³	--	--	--
Methamphetamine	0.9213	0.5656	0.8273
Misuse of Prescription Psychotherapeutics	nr	0.0773	0.4904
Pain Relievers	nr	0.0328	0.4143
Prescription Opioids	--	0.0659	0.5385
Stimulants	nr	0.5309	0.9028
Tranquilizers or Sedatives	nr	0.9519	0.7264
Tranquilizers	nr	0.8285	0.5782
Sedatives	nr	0.8652	0.7117
Benzodiazepines	--	0.8607	--
Opioids^2,4	--	0.0697	0.4847
Central Nervous System Stimulants	nr	0.8924	0.8006
Illicit Drugs Other Than Marijuana^2,3,5	nr	--	--
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	0.1521	0.7639
Illegally Made Fentanyl	0.5651	0.9000	0.2676
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.3C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	1,110	1,108	908	1,003	813	832
Marijuana	1,093	1,112	866	957	774	781
Cocaine	828	857	264	220	170	152
Crack	403	459	139	117	104	93
Heroin	328	324	84	86	65	67
Hallucinogens	849	890	289	385	152	177
LSD	700	725	124	139	43	58
PCP	343	330	44	27	9	22
Ecstasy	576	556	169	134	64	69
Psilocybin	--	744	--	325	--	147
Inhalants³	--	633	--	147	--	88
Methamphetamine	546	525	212	181	168	149
Misuse of Prescription Psychotherapeutics	nr	nr	421	411	237	253
Pain Relievers	nr	nr	333	322	173	186
Prescription Opioids	--	--	324	309	168	181
Stimulants	nr	nr	190	206	111	117
Tranquilizers or Sedatives	nr	nr	258	245	123	145
Tranquilizers	nr	nr	225	219	110	131
Sedatives	nr	nr	147	125	72	61
Benzodiazepines	--	--	230	205	--	--
Opioids^2,4	--	--	328	315	176	190
Central Nervous System Stimulants	nr	nr	351	325	254	222
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	568	--	368
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	330	319	178	196
Illegally Made Fentanyl	119	157	68	87	51	73
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.3D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Standard Errors of Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	0.43	0.42	0.35	0.38	0.32	0.32
Marijuana	0.42	0.42	0.34	0.36	0.30	0.30
Cocaine	0.32	0.33	0.10	0.08	0.07	0.06
Crack	0.16	0.17	0.05	0.04	0.04	0.04
Heroin	0.13	0.12	0.03	0.03	0.03	0.03
Hallucinogens	0.33	0.34	0.11	0.15	0.06	0.07
LSD	0.27	0.28	0.05	0.05	0.02	0.02
PCP	0.13	0.13	0.02	0.01	<0.01	0.01
Ecstasy	0.22	0.21	0.07	0.05	0.02	0.03
Psilocybin	--	0.28	--	0.12	--	0.06
Inhalants³	--	0.24	--	0.06	--	0.03
Methamphetamine	0.21	0.20	0.08	0.07	0.07	0.06
Misuse of Prescription Psychotherapeutics	nr	nr	0.16	0.16	0.09	0.10
Pain Relievers	nr	nr	0.13	0.12	0.07	0.07
Prescription Opioids	--	--	0.13	0.12	0.07	0.07
Stimulants	nr	nr	0.07	0.08	0.04	0.04
Tranquilizers or Sedatives	nr	nr	0.10	0.09	0.05	0.06
Tranquilizers	nr	nr	0.09	0.08	0.04	0.05
Sedatives	nr	nr	0.06	0.05	0.03	0.02
Benzodiazepines	--	--	0.09	0.08	--	--
Opioids^2,4	--	--	0.13	0.12	0.07	0.07
Central Nervous System Stimulants	nr	nr	0.14	0.12	0.10	0.08
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	0.22	--	0.14
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	0.13	0.12	0.07	0.07
Illegally Made Fentanyl	0.05	0.06	0.03	0.03	0.02	0.03
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.3P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug	Lifetime (2023)	Past Year (2023)	Past Month (2023)
ILLICIT DRUGS^1,2	0.3839	0.1820	0.7476
Marijuana	0.4225	0.2393	0.8908
Cocaine	0.5651	0.0110	0.4499
Crack	0.3508	0.1428	0.3883
Heroin	0.6808	0.2844	0.2035
Hallucinogens	0.0756	0.0021	0.7158
LSD	0.8717	0.6573	0.5518
PCP	0.7395	0.7899	0.2368
Ecstasy	0.4181	0.4653	0.5170
Psilocybin	--	--	--
Inhalants³	--	--	--
Methamphetamine	0.1274	0.2684	0.3486
Misuse of Prescription Psychotherapeutics	nr	0.1908	0.6711
Pain Relievers	nr	0.1976	0.7956
Prescription Opioids	--	0.1320	0.7149
Stimulants	nr	0.8241	0.7411
Tranquilizers or Sedatives	nr	0.5145	0.2409
Tranquilizers	nr	0.4346	0.2601
Sedatives	nr	0.4114	0.7323
Benzodiazepines	--	0.1927	--
Opioids^2,4	--	0.0844	0.4545
Central Nervous System Stimulants	nr	0.0842	0.3273
Illicit Drugs Other Than Marijuana^2,3,5	nr	--	--
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	0.0972	0.5783
Illegally Made Fentanyl	0.0236	0.8006	0.3236
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.4C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	239	234	235	227	200	198
Marijuana	241	238	238	224	198	196
Cocaine	127	110	84	63	30	33
Crack	30	25	21	15	3	6
Heroin	31	27	8	14	6	5
Hallucinogens	163	178	111	117	55	50
LSD	127	135	47	46	16	15
PCP	22	28	1	10	<1	6
Ecstasy	106	106	60	49	22	23
Psilocybin	--	158	--	106	--	42
Inhalants³	--	129	--	60	--	33
Methamphetamine	47	51	19	29	14	19
Misuse of Prescription Psychotherapeutics	nr	nr	103	107	59	56
Pain Relievers	nr	nr	63	84	28	40
Prescription Opioids	--	--	59	82	28	38
Stimulants	nr	nr	79	73	48	31
Tranquilizers or Sedatives	nr	nr	48	55	24	32
Tranquilizers	nr	nr	45	53	23	30
Sedatives	nr	nr	19	19	8	12
Benzodiazepines	--	--	43	51	--	--
Opioids^2,4	--	--	59	82	28	38
Central Nervous System Stimulants	nr	nr	113	89	60	46
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	155	--	76
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	60	84	28	43
Illegally Made Fentanyl	29	31	17	25	8	22
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.4D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Standard Errors of Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	0.70	0.67	0.69	0.65	0.59	0.57
Marijuana	0.71	0.68	0.70	0.64	0.58	0.56
Cocaine	0.37	0.31	0.25	0.18	0.09	0.09
Crack	0.09	0.07	0.06	0.04	0.01	0.02
Heroin	0.09	0.08	0.02	0.04	0.02	0.01
Hallucinogens	0.48	0.51	0.33	0.33	0.16	0.14
LSD	0.37	0.39	0.14	0.13	0.05	0.04
PCP	0.06	0.08	<0.01	0.03	<0.01	0.02
Ecstasy	0.31	0.30	0.18	0.14	0.06	0.07
Psilocybin	--	0.45	--	0.30	--	0.12
Inhalants³	--	0.37	--	0.17	--	0.10
Methamphetamine	0.14	0.15	0.06	0.08	0.04	0.06
Misuse of Prescription Psychotherapeutics	nr	nr	0.30	0.31	0.17	0.16
Pain Relievers	nr	nr	0.19	0.24	0.08	0.12
Prescription Opioids	--	--	0.17	0.23	0.08	0.11
Stimulants	nr	nr	0.23	0.21	0.14	0.09
Tranquilizers or Sedatives	nr	nr	0.14	0.16	0.07	0.09
Tranquilizers	nr	nr	0.13	0.15	0.07	0.09
Sedatives	nr	nr	0.06	0.05	0.02	0.03
Benzodiazepines	--	--	0.13	0.14	--	--
Opioids^2,4	--	--	0.17	0.23	0.08	0.11
Central Nervous System Stimulants	nr	nr	0.33	0.26	0.18	0.13
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	0.44	--	0.22
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	0.18	0.24	0.08	0.12
Illegally Made Fentanyl	0.08	0.09	0.05	0.07	0.02	0.06
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.4P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug	Lifetime (2023)	Past Year (2023)	Past Month (2023)
ILLICIT DRUGS^1,2	0.8213	0.3422	0.3685
Marijuana	0.2251	0.0961	0.2109
Cocaine	0.0013	0.0138	0.9302
Crack	0.0125	0.3880	0.1967
Heroin	0.2222	0.1509	0.8773
Hallucinogens	0.3072	0.8694	0.0970
LSD	0.1530	0.0235	0.6139
PCP	0.6843	0.0105	0.1458
Ecstasy	0.0615	0.0946	0.9495
Psilocybin	--	--	--
Inhalants³	--	--	--
Methamphetamine	0.0989	0.1454	0.2774
Misuse of Prescription Psychotherapeutics	nr	0.6904	0.4822
Pain Relievers	nr	0.3842	0.1762
Prescription Opioids	--	0.4572	0.3989
Stimulants	nr	0.2681	0.0733
Tranquilizers or Sedatives	nr	0.7767	0.9516
Tranquilizers	nr	0.8296	0.8005
Sedatives	nr	0.5379	0.4511
Benzodiazepines	--	0.9374	--
Opioids^2,4	--	0.3265	0.3751
Central Nervous System Stimulants	nr	0.0476	0.2296
Illicit Drugs Other Than Marijuana^2,3,5	nr	--	--
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	0.2126	0.1823
Illegally Made Fentanyl	0.7996	0.5273	0.1071
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.5C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	1,065	1,060	834	954	750	791
Marijuana	1,050	1,057	792	909	714	742
Cocaine	802	831	245	208	167	147
Crack	400	456	137	116	104	93
Heroin	327	320	84	85	65	67
Hallucinogens	829	851	263	370	143	168
LSD	681	692	110	129	40	56
PCP	343	329	44	25	9	21
Ecstasy	567	537	152	124	60	64
Psilocybin	--	711	--	308	--	139
Inhalants³	--	624	--	133	--	88
Methamphetamine	544	517	211	178	167	147
Misuse of Prescription Psychotherapeutics	nr	nr	398	395	220	245
Pain Relievers	nr	nr	322	309	170	182
Prescription Opioids	--	--	314	295	165	178
Stimulants	nr	nr	170	193	95	111
Tranquilizers or Sedatives	nr	nr	252	238	119	142
Tranquilizers	nr	nr	217	210	107	128
Sedatives	nr	nr	146	124	71	60
Benzodiazepines	--	--	223	197	--	--
Opioids^2,4	--	--	318	300	173	186
Central Nervous System Stimulants	nr	nr	329	314	244	215
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	545	--	357
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	320	304	175	192
Illegally Made Fentanyl	117	153	68	84	50	70
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.5D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Standard Errors of Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	0.48	0.47	0.37	0.42	0.34	0.35
Marijuana	0.47	0.46	0.35	0.40	0.32	0.33
Cocaine	0.36	0.37	0.11	0.09	0.07	0.06
Crack	0.18	0.20	0.06	0.05	0.05	0.04
Heroin	0.15	0.14	0.04	0.04	0.03	0.03
Hallucinogens	0.37	0.37	0.12	0.16	0.06	0.07
LSD	0.30	0.30	0.05	0.06	0.02	0.02
PCP	0.15	0.14	0.02	0.01	<0.01	0.01
Ecstasy	0.25	0.24	0.07	0.05	0.03	0.03
Psilocybin	--	0.31	--	0.14	--	0.06
Inhalants³	--	0.27	--	0.06	--	0.04
Methamphetamine	0.24	0.23	0.09	0.08	0.07	0.06
Misuse of Prescription Psychotherapeutics	nr	nr	0.18	0.17	0.10	0.11
Pain Relievers	nr	nr	0.14	0.14	0.08	0.08
Prescription Opioids	--	--	0.14	0.13	0.07	0.08
Stimulants	nr	nr	0.08	0.08	0.04	0.05
Tranquilizers or Sedatives	nr	nr	0.11	0.10	0.05	0.06
Tranquilizers	nr	nr	0.10	0.09	0.05	0.06
Sedatives	nr	nr	0.07	0.05	0.03	0.03
Benzodiazepines	--	--	0.10	0.09	--	--
Opioids^2,4	--	--	0.14	0.13	0.08	0.08
Central Nervous System Stimulants	nr	nr	0.15	0.14	0.11	0.09
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	0.24	--	0.16
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	0.14	0.13	0.08	0.08
Illegally Made Fentanyl	0.05	0.07	0.03	0.04	0.02	0.03
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.5P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug	Lifetime (2023)	Past Year (2023)	Past Month (2023)
ILLICIT DRUGS^1,2	0.3323	0.0999	0.8987
Marijuana	0.2583	0.0927	0.8621
Cocaine	0.9281	0.0509	0.4512
Crack	0.2605	0.1753	0.3576
Heroin	0.5890	0.1994	0.1979
Hallucinogens	0.1045	0.0015	0.3463
LSD	0.6566	0.6643	0.6415
PCP	0.7255	0.4507	0.3861
Ecstasy	0.6648	0.8732	0.4794
Psilocybin	--	--	--
Inhalants³	--	--	--
Methamphetamine	0.1751	0.1930	0.2891
Misuse of Prescription Psychotherapeutics	nr	0.2101	0.5307
Pain Relievers	nr	0.1273	0.5971
Prescription Opioids	--	0.0867	0.5926
Stimulants	nr	0.8425	0.2855
Tranquilizers or Sedatives	nr	0.5454	0.2176
Tranquilizers	nr	0.4481	0.2157
Sedatives	nr	0.4661	0.6412
Benzodiazepines	--	0.1861	--
Opioids^2,4	--	0.0471	0.3537
Central Nervous System Stimulants	nr	0.2441	0.4721
Illicit Drugs Other Than Marijuana^2,3,5	nr	--	--
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	0.0480	0.4068
Illegally Made Fentanyl	0.0175	0.9348	0.5642
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.6C – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	1,128	1,156	918	1,015	829	845
12-20	296	279	255	225	187	168
21 or Older	2,113	2,079	1,196	1,286	959	991
12-17	138	161	119	131	91	95
12-13	60	76	48	53	23	30
14-15	102	97	91	73	62	46
16-17	114	123	95	103	65	78
18 or Older	1,110	1,108	908	1,003	813	832
18-25	239	234	235	227	200	198
18-20	213	187	182	161	141	129
21-25	352	352	285	283	210	218
26 or Older	1,065	1,060	834	954	750	791
26-49	554	632	504	583	450	479
26-29	367	360	294	296	253	235
30-34	374	428	278	308	237	232
35-39	454	431	309	317	233	271
40-44	374	377	259	274	199	224
45-49	360	360	264	239	224	191
50 or Older	860	813	617	646	549	530
50-54	483	542	300	350	242	282
55-59	525	563	293	328	246	285
60-64	609	560	359	307	325	248
65 or Older	577	532	341	383	305	282
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.6D – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.40	0.40	0.32	0.35	0.29	0.29
12-20	0.55	0.58	0.50	0.51	0.41	0.39
21 or Older	0.44	0.44	0.36	0.40	0.32	0.33
12-17	0.53	0.62	0.46	0.51	0.35	0.37
12-13	0.71	0.85	0.57	0.63	0.28	0.37
14-15	0.95	0.95	0.87	0.79	0.64	0.52
16-17	1.05	1.12	0.91	0.97	0.69	0.78
18 or Older	0.43	0.42	0.35	0.38	0.32	0.32
18-25	0.70	0.67	0.69	0.65	0.59	0.57
18-20	1.11	1.09	1.03	1.00	0.92	0.88
21-25	0.82	0.78	0.85	0.84	0.72	0.73
26 or Older	0.48	0.47	0.37	0.42	0.34	0.35
26-49	0.54	0.60	0.49	0.55	0.43	0.45
26-29	1.14	1.19	1.21	1.20	1.15	1.07
30-34	0.97	1.05	0.90	0.98	0.85	0.81
35-39	1.08	1.15	0.96	1.08	0.82	1.00
40-44	1.14	1.19	1.02	1.04	0.85	0.90
45-49	1.29	1.18	1.19	1.03	1.06	0.90
50 or Older	0.72	0.67	0.51	0.53	0.46	0.44
50-54	1.81	1.81	1.41	1.52	1.19	1.31
55-59	1.68	1.73	1.29	1.52	1.13	1.36
60-64	1.63	1.54	1.33	1.20	1.26	1.00
65 or Older	1.00	0.89	0.59	0.64	0.53	0.47
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.6P – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.1254	0.1562	0.8364
12-20	0.0012	0.5541	0.4378
21 or Older	0.3619	0.1115	0.9427
12-17	0.0000	0.5930	0.5241
12-13	0.0000	0.0539	0.1097
14-15	0.1266	0.1588	0.1359
16-17	0.0212	0.3580	0.1606
18 or Older	0.3839	0.1820	0.7476
18-25	0.8213	0.3422	0.3685
18-20	0.9381	0.0837	0.0625
21-25	0.8433	0.9864	0.8502
26 or Older	0.3323	0.0999	0.8987
26-49	0.4025	0.7801	0.4832
26-29	0.9823	0.8091	0.2605
30-34	0.3578	0.1978	0.0573
35-39	0.8757	0.9434	0.4034
40-44	0.8654	0.4895	0.5050
45-49	0.0028	0.2592	0.9611
50 or Older	0.5717	0.0465	0.7155
50-54	0.4843	0.5601	0.8376
55-59	0.2221	0.0135	0.0534
60-64	0.9047	0.8405	0.3212
65 or Older	0.3999	0.1742	0.9090
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.7C – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	1,113	1,157	876	974	787	795
12-20	262	220	235	194	179	153
21 or Older	2,019	2,004	1,100	1,200	904	930
12-17	115	116	107	107	83	83
12-13	26	29	21	27	16	20
14-15	78	61	73	54	53	41
16-17	100	102	89	93	63	71
18 or Older	1,093	1,112	866	957	774	781
18-25	241	238	238	224	198	196
18-20	201	174	178	153	139	124
21-25	335	331	275	267	203	213
26 or Older	1,050	1,057	792	909	714	742
26-49	553	608	493	562	425	462
26-29	359	348	276	285	236	228
30-34	358	398	261	281	223	222
35-39	434	411	289	296	220	263
40-44	365	368	244	255	189	212
45-49	349	345	248	222	219	178
50 or Older	847	824	580	600	525	509
50-54	445	528	281	333	231	277
55-59	492	538	266	313	237	270
60-64	596	556	337	290	301	244
65 or Older	565	541	308	334	281	263
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.7D – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.39	0.40	0.31	0.34	0.28	0.28
12-20	0.52	0.50	0.48	0.45	0.40	0.36
21 or Older	0.43	0.44	0.34	0.38	0.30	0.31
12-17	0.44	0.45	0.41	0.41	0.32	0.32
12-13	0.32	0.36	0.27	0.34	0.20	0.25
14-15	0.77	0.68	0.72	0.61	0.56	0.46
16-17	0.96	0.98	0.87	0.90	0.66	0.73
18 or Older	0.42	0.42	0.34	0.36	0.30	0.30
18-25	0.71	0.68	0.70	0.64	0.58	0.56
18-20	1.09	1.07	1.02	0.99	0.91	0.86
21-25	0.84	0.79	0.85	0.81	0.70	0.73
26 or Older	0.47	0.46	0.35	0.40	0.32	0.33
26-49	0.53	0.57	0.48	0.53	0.41	0.44
26-29	1.16	1.19	1.17	1.19	1.09	1.06
30-34	0.99	1.04	0.90	0.93	0.82	0.78
35-39	1.09	1.12	0.94	1.05	0.78	0.98
40-44	1.14	1.18	0.98	1.00	0.82	0.86
45-49	1.29	1.18	1.15	0.98	1.04	0.85
50 or Older	0.71	0.68	0.48	0.49	0.44	0.42
50-54	1.81	1.80	1.36	1.47	1.15	1.29
55-59	1.66	1.74	1.20	1.48	1.09	1.30
60-64	1.65	1.56	1.28	1.16	1.19	0.99
65 or Older	0.98	0.90	0.53	0.56	0.49	0.44
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.7P – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.4193	0.3021	0.9146
12-20	0.2804	0.0130	0.1330
21 or Older	0.3095	0.1099	0.8576
12-17	0.5252	0.1858	0.9247
12-13	0.5825	0.3363	0.6805
14-15	0.0165	0.0014	0.0492
16-17	0.4778	0.7929	0.2480
18 or Older	0.4225	0.2393	0.8908
18-25	0.2251	0.0961	0.2109
18-20	0.1630	0.0057	0.0280
21-25	0.6106	0.8829	0.9974
26 or Older	0.2583	0.0927	0.8621
26-49	0.6977	0.9221	0.6249
26-29	0.7345	0.7221	0.7397
30-34	0.2738	0.3087	0.0974
35-39	0.9895	0.8879	0.2902
40-44	0.8299	0.9588	0.7543
45-49	0.0309	0.3688	0.6124
50 or Older	0.2860	0.0251	0.5424
50-54	0.6331	0.3259	0.6366
55-59	0.1154	0.0170	0.0961
60-64	0.7460	0.9755	0.5135
65 or Older	0.4469	0.1468	0.9941
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.8C – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	838	865	264	221	170	152
12-20	60	42	42	34	21	15
21 or Older	1,034	1,012	260	222	169	151
12-17	18	21	17	18	12	5
12-13	6	6	5	5	5	1
14-15	7	14	7	12	*	1
16-17	15	16	14	12	11	5
18 or Older	828	857	264	220	170	152
18-25	127	110	84	63	30	33
18-20	57	36	38	28	18	14
21-25	122	107	75	58	25	30
26 or Older	802	831	245	208	167	147
26-49	415	471	180	162	96	99
26-29	170	186	81	85	47	44
30-34	209	195	102	77	56	40
35-39	228	243	84	74	34	47
40-44	193	215	63	64	33	38
45-49	200	199	66	67	42	49
50 or Older	662	658	165	120	128	103
50-54	267	293	96	67	46	55
55-59	329	320	86	75	74	73
60-64	421	377	70	46	57	26
65 or Older	386	400	78	45	73	38
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.8D – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.30	0.30	0.09	0.08	0.06	0.05
12-20	0.16	0.11	0.11	0.09	0.06	0.04
21 or Older	0.33	0.34	0.10	0.09	0.07	0.06
12-17	0.07	0.08	0.06	0.07	0.04	0.02
12-13	0.07	0.07	0.06	0.06	0.06	0.01
14-15	0.08	0.16	0.07	0.14	*	0.01
16-17	0.17	0.18	0.16	0.14	0.12	0.05
18 or Older	0.32	0.33	0.10	0.08	0.07	0.06
18-25	0.37	0.31	0.25	0.18	0.09	0.09
18-20	0.45	0.28	0.30	0.22	0.14	0.11
21-25	0.49	0.45	0.32	0.26	0.11	0.13
26 or Older	0.36	0.37	0.11	0.09	0.07	0.06
26-49	0.40	0.45	0.17	0.15	0.09	0.09
26-29	0.86	0.92	0.45	0.47	0.26	0.25
30-34	0.80	0.71	0.44	0.32	0.25	0.17
35-39	0.85	0.92	0.35	0.31	0.15	0.20
40-44	0.83	0.88	0.29	0.28	0.16	0.17
45-49	0.93	0.93	0.35	0.34	0.22	0.25
50 or Older	0.55	0.54	0.14	0.10	0.11	0.08
50-54	1.33	1.34	0.51	0.34	0.25	0.28
55-59	1.40	1.42	0.41	0.38	0.36	0.37
60-64	1.47	1.35	0.30	0.21	0.24	0.11
65 or Older	0.67	0.67	0.13	0.07	0.13	0.06
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.8P – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.6216	0.0126	0.4306
12-20	0.0191	0.1884	0.3580
21 or Older	0.7025	0.0187	0.4885
12-17	0.3670	0.7084	0.4242
12-13	0.9230	0.9021	0.2541
14-15	0.2912	0.4013	*
16-17	0.7316	0.9072	0.6469
18 or Older	0.5651	0.0110	0.4499
18-25	0.0013	0.0138	0.9302
18-20	0.0020	0.0745	0.5154
21-25	0.0266	0.0615	0.7869
26 or Older	0.9281	0.0509	0.4512
26-49	0.6857	0.5028	0.9749
26-29	0.4930	0.7621	0.8428
30-34	0.0990	0.2158	0.4182
35-39	0.4143	0.9189	0.1471
40-44	0.5499	0.8359	0.9231
45-49	0.6666	0.8834	0.9837
50 or Older	0.7163	0.0291	0.3054
50-54	0.4136	0.2713	0.6244
55-59	0.8606	0.6853	0.8936
60-64	0.6526	0.0959	0.0611
65 or Older	0.6336	0.1621	0.2545
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.9C – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	403	460	139	117	104	93
12-20	15	17	13	9	4	1
21 or Older	435	480	139	118	104	93
12-17	5	13	4	4	4	<1
12-13	4	1	4	1	4	<1
14-15	<1	11	*	4	*	*
16-17	4	7	<1	<1	*	*
18 or Older	403	459	139	117	104	93
18-25	30	25	21	15	3	6
18-20	14	11	12	8	<1	1
21-25	30	22	17	13	3	6
26 or Older	400	456	137	116	104	93
26-49	211	214	58	60	41	48
26-29	47	57	8	11	6	3
30-34	78	70	20	22	12	7
35-39	116	108	21	20	18	11
40-44	109	105	37	24	17	16
45-49	122	126	33	46	31	43
50 or Older	334	398	124	86	95	73
50-54	158	210	67	36	38	35
55-59	165	207	81	59	68	58
60-64	194	224	53	46	44	26
65 or Older	178	173	33	21	27	9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.9D – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.14	0.16	0.05	0.04	0.04	0.03
12-20	0.04	0.04	0.03	0.02	0.01	<0.01
21 or Older	0.16	0.18	0.06	0.05	0.04	0.04
12-17	0.02	0.05	0.02	0.02	0.02	<0.01
12-13	0.05	0.01	0.05	0.01	0.05	<0.01
14-15	<0.01	0.13	*	0.05	*	*
16-17	0.04	0.08	<0.01	<0.01	*	*
18 or Older	0.16	0.17	0.05	0.04	0.04	0.04
18-25	0.09	0.07	0.06	0.04	0.01	0.02
18-20	0.12	0.09	0.10	0.06	<0.01	<0.01
21-25	0.14	0.10	0.08	0.06	0.01	0.03
26 or Older	0.18	0.20	0.06	0.05	0.05	0.04
26-49	0.20	0.20	0.06	0.06	0.04	0.05
26-29	0.27	0.32	0.04	0.06	0.03	0.02
30-34	0.34	0.29	0.09	0.09	0.05	0.03
35-39	0.49	0.45	0.09	0.09	0.08	0.05
40-44	0.50	0.46	0.18	0.11	0.08	0.07
45-49	0.61	0.64	0.18	0.24	0.16	0.22
50 or Older	0.28	0.33	0.10	0.07	0.08	0.06
50-54	0.83	1.02	0.36	0.18	0.20	0.18
55-59	0.78	1.01	0.39	0.30	0.33	0.30
60-64	0.80	0.94	0.23	0.21	0.19	0.11
65 or Older	0.31	0.29	0.06	0.04	0.05	0.02
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.9P – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.3257	0.1502	0.3761
12-20	0.9767	0.8290	0.4493
21 or Older	0.3306	0.1534	0.3868
12-17	0.2664	0.5212	0.3432
12-13	0.4228	0.4228	0.3433
14-15	0.1382	*	*
16-17	0.7750	0.6918	*
18 or Older	0.3508	0.1428	0.3883
18-25	0.0125	0.3880	0.1967
18-20	0.3851	0.6154	0.2020
21-25	0.0290	0.4835	0.2366
26 or Older	0.2605	0.1753	0.3576
26-49	0.7834	0.9777	0.5396
26-29	0.2628	0.9800	0.4032
30-34	0.6727	0.6044	0.4057
35-39	0.5285	0.7698	0.4242
40-44	0.7632	0.6828	0.9670
45-49	0.8622	0.6491	0.9638
50 or Older	0.2469	0.0998	0.4539
50-54	0.7510	0.3031	0.9680
55-59	0.0850	0.4147	0.9451
60-64	0.6516	0.5308	0.3842
65 or Older	0.4678	0.3676	0.2263
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.10C – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	861	900	294	388	152	179
12-20	98	98	77	71	34	36
21 or Older	1,092	1,096	291	405	152	178
12-17	47	51	41	43	21	27
12-13	14	14	11	9	5	4
14-15	27	28	23	21	5	13
16-17	35	42	32	36	20	24
18 or Older	849	890	289	385	152	177
18-25	163	178	111	117	55	50
18-20	80	83	63	55	27	24
21-25	171	177	98	105	47	46
26 or Older	829	851	263	370	143	168
26-49	452	535	216	298	135	145
26-29	219	229	127	155	68	66
30-34	232	242	129	122	62	63
35-39	257	277	114	131	67	75
40-44	230	247	68	115	53	64
45-49	238	241	86	107	63	54
50 or Older	619	656	133	201	47	84
50-54	290	332	88	161	27	59
55-59	280	308	75	57	22	44
60-64	375	353	55	83	17	35
65 or Older	375	367	43	71	26	22
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.10D – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.30	0.31	0.10	0.13	0.05	0.06
12-20	0.25	0.25	0.20	0.18	0.09	0.09
21 or Older	0.34	0.35	0.11	0.15	0.06	0.07
12-17	0.18	0.20	0.16	0.16	0.08	0.11
12-13	0.18	0.18	0.14	0.11	0.07	0.05
14-15	0.29	0.32	0.25	0.24	0.05	0.15
16-17	0.40	0.46	0.35	0.39	0.22	0.26
18 or Older	0.33	0.34	0.11	0.15	0.06	0.07
18-25	0.48	0.51	0.33	0.33	0.16	0.14
18-20	0.61	0.62	0.49	0.43	0.22	0.18
21-25	0.64	0.68	0.42	0.46	0.21	0.20
26 or Older	0.37	0.37	0.12	0.16	0.06	0.07
26-49	0.44	0.51	0.21	0.28	0.13	0.14
26-29	1.03	1.04	0.68	0.81	0.38	0.37
30-34	0.87	0.84	0.54	0.49	0.27	0.26
35-39	0.90	0.99	0.46	0.54	0.28	0.32
40-44	0.94	0.98	0.32	0.49	0.25	0.28
45-49	1.08	1.06	0.44	0.54	0.33	0.28
50 or Older	0.52	0.54	0.11	0.17	0.04	0.07
50-54	1.38	1.49	0.46	0.79	0.15	0.30
55-59	1.23	1.42	0.36	0.29	0.11	0.23
60-64	1.38	1.33	0.24	0.37	0.08	0.16
65 or Older	0.65	0.61	0.07	0.12	0.04	0.04
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.10P – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.0625	0.0020	0.6739
12-20	0.1763	0.9467	0.3592
21 or Older	0.0822	0.0016	0.5307
12-17	0.3054	0.7584	0.7198
12-13	0.7515	0.5951	0.5835
14-15	0.7181	0.6184	0.3332
16-17	0.2445	0.4123	0.9737
18 or Older	0.0756	0.0021	0.7158
18-25	0.3072	0.8694	0.0970
18-20	0.4214	0.7940	0.0982
21-25	0.4169	0.7258	0.3193
26 or Older	0.1045	0.0015	0.3463
26-49	0.1050	0.0018	0.8805
26-29	0.1773	0.0250	0.5438
30-34	0.9357	0.4404	0.6592
35-39	0.5154	0.1856	0.5684
40-44	0.5180	0.0003	0.5443
45-49	0.2531	0.1498	0.2874
50 or Older	0.3932	0.2531	0.0736
50-54	0.6669	0.3774	0.1136
55-59	0.0341	0.6613	0.3691
60-64	1.0000	0.2066	0.2288
65 or Older	0.6665	0.6971	0.5169
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.11C – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	650	--	163	--	96
12-20	--	154	--	82	--	42
21 or Older	--	726	--	139	--	85
12-17	--	115	--	67	--	35
12-13	--	69	--	44	--	24
14-15	--	72	--	40	--	17
16-17	--	69	--	34	--	19
18 or Older	--	633	--	147	--	88
18-25	--	129	--	60	--	33
18-20	--	85	--	41	--	20
21-25	--	116	--	45	--	26
26 or Older	--	624	--	133	--	88
26-49	--	368	--	114	--	70
26-29	--	158	--	59	--	21
30-34	--	161	--	56	--	40
35-39	--	170	--	61	--	44
40-44	--	186	--	24	--	10
45-49	--	186	--	45	--	22
50 or Older	--	517	--	71	--	57
50-54	--	286	--	45	--	34
55-59	--	279	--	18	--	1
60-64	--	262	--	24	--	24
65 or Older	--	270	--	46	--	40
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.11D – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	0.23	--	0.06	--	0.03
12-20	--	0.37	--	0.21	--	0.11
21 or Older	--	0.25	--	0.05	--	0.03
12-17	--	0.44	--	0.26	--	0.14
12-13	--	0.78	--	0.52	--	0.29
14-15	--	0.74	--	0.45	--	0.20
16-17	--	0.73	--	0.37	--	0.21
18 or Older	--	0.24	--	0.06	--	0.03
18-25	--	0.37	--	0.17	--	0.10
18-20	--	0.64	--	0.32	--	0.15
21-25	--	0.47	--	0.20	--	0.12
26 or Older	--	0.27	--	0.06	--	0.04
26-49	--	0.35	--	0.11	--	0.07
26-29	--	0.82	--	0.33	--	0.12
30-34	--	0.63	--	0.23	--	0.17
35-39	--	0.67	--	0.26	--	0.19
40-44	--	0.78	--	0.11	--	0.05
45-49	--	0.88	--	0.23	--	0.12
50 or Older	--	0.43	--	0.06	--	0.05
50-54	--	1.35	--	0.23	--	0.17
55-59	--	1.26	--	0.09	--	0.01
60-64	--	1.02	--	0.11	--	0.10
65 or Older	--	0.45	--	0.08	--	0.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.12C – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	547	525	212	184	168	150
12-20	32	33	20	27	17	24
21 or Older	609	555	216	183	169	149
12-17	23	27	17	24	16	22
12-13	6	9	5	9	4	4
14-15	11	10	1	6	<1	3
16-17	20	24	16	22	16	22
18 or Older	546	525	212	181	168	149
18-25	47	51	19	29	14	19
18-20	23	23	11	10	7	8
21-25	41	45	15	27	12	18
26 or Older	544	517	211	178	167	147
26-49	290	293	146	123	118	95
26-29	74	82	44	42	28	30
30-34	119	94	67	49	52	31
35-39	172	145	84	63	76	43
40-44	133	168	63	49	38	45
45-49	150	133	70	68	63	53
50 or Older	424	425	149	133	114	99
50-54	184	152	82	71	43	53
55-59	197	208	81	77	69	74
60-64	246	228	58	57	33	24
65 or Older	236	235	74	54	74	24
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.12D – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.19	0.18	0.07	0.06	0.06	0.05
12-20	0.08	0.08	0.05	0.07	0.05	0.06
21 or Older	0.22	0.21	0.09	0.07	0.07	0.06
12-17	0.09	0.11	0.07	0.09	0.06	0.09
12-13	0.07	0.11	0.06	0.11	0.05	0.05
14-15	0.12	0.11	0.01	0.06	<0.01	0.03
16-17	0.22	0.27	0.19	0.24	0.18	0.24
18 or Older	0.21	0.20	0.08	0.07	0.07	0.06
18-25	0.14	0.15	0.06	0.08	0.04	0.06
18-20	0.19	0.18	0.09	0.08	0.06	0.06
21-25	0.19	0.20	0.07	0.12	0.05	0.08
26 or Older	0.24	0.23	0.09	0.08	0.07	0.06
26-49	0.28	0.28	0.14	0.12	0.11	0.09
26-29	0.41	0.46	0.25	0.24	0.16	0.17
30-34	0.51	0.40	0.29	0.21	0.23	0.13
35-39	0.68	0.59	0.35	0.27	0.32	0.19
40-44	0.59	0.72	0.29	0.22	0.18	0.20
45-49	0.74	0.66	0.37	0.35	0.33	0.27
50 or Older	0.35	0.35	0.12	0.11	0.10	0.08
50-54	0.96	0.76	0.44	0.36	0.23	0.27
55-59	0.93	1.02	0.40	0.39	0.34	0.38
60-64	1.00	0.95	0.25	0.25	0.15	0.11
65 or Older	0.41	0.39	0.13	0.09	0.13	0.04
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.12P – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.1360	0.3028	0.3680
12-20	0.6328	0.8359	0.9041
21 or Older	0.1398	0.2867	0.3556
12-17	0.9213	0.5656	0.8273
12-13	0.5930	0.3952	0.6151
14-15	0.5341	0.0142	0.0400
16-17	0.7082	0.8166	0.9157
18 or Older	0.1274	0.2684	0.3486
18-25	0.0989	0.1454	0.2774
18-20	0.4202	0.4818	0.8147
21-25	0.1602	0.0463	0.1754
26 or Older	0.1751	0.1930	0.2891
26-49	0.8315	0.1363	0.0503
26-29	0.1156	0.9260	0.4564
30-34	0.1436	0.3507	0.1986
35-39	0.4463	0.2515	0.0664
40-44	0.1089	0.7402	0.4660
45-49	0.7843	0.5753	0.3986
50 or Older	0.0656	0.7180	0.7028
50-54	0.0964	0.8216	0.3872
55-59	0.7556	0.9450	0.5226
60-64	0.3280	0.7805	0.7913
65 or Older	0.2128	0.9446	0.5269
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.13C – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	843	913	324	312	169	181
12-20	162	177	60	63	34	28
21 or Older	1,182	1,187	334	309	168	182
12-17	102	110	50	39	29	19
12-13	54	54	26	18	14	8
14-15	75	70	30	24	23	12
16-17	67	74	30	25	11	11
18 or Older	829	901	324	309	168	181
18-25	150	155	59	82	28	38
18-20	100	114	32	47	17	21
21-25	135	134	51	63	22	32
26 or Older	817	877	314	295	165	178
26-49	443	432	196	188	97	89
26-29	161	176	72	69	38	36
30-34	206	198	98	66	46	23
35-39	250	247	98	95	47	46
40-44	229	250	78	102	36	53
45-49	245	226	106	83	49	35
50 or Older	690	738	257	242	138	152
50-54	340	355	113	141	65	124
55-59	357	310	106	113	61	47
60-64	383	369	135	104	88	57
65 or Older	486	498	148	133	55	57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.13D – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.30	0.32	0.11	0.11	0.06	0.06
12-20	0.35	0.40	0.15	0.16	0.09	0.07
21 or Older	0.34	0.35	0.13	0.12	0.07	0.07
12-17	0.39	0.42	0.19	0.15	0.11	0.07
12-13	0.64	0.63	0.33	0.22	0.18	0.10
14-15	0.76	0.74	0.33	0.28	0.25	0.14
16-17	0.70	0.75	0.34	0.28	0.12	0.12
18 or Older	0.32	0.34	0.13	0.12	0.07	0.07
18-25	0.44	0.44	0.17	0.23	0.08	0.11
18-20	0.71	0.80	0.26	0.36	0.14	0.16
21-25	0.56	0.51	0.22	0.27	0.10	0.14
26 or Older	0.37	0.39	0.14	0.13	0.07	0.08
26-49	0.43	0.41	0.19	0.18	0.09	0.08
26-29	0.81	0.91	0.40	0.39	0.21	0.20
30-34	0.79	0.74	0.42	0.28	0.20	0.10
35-39	0.90	0.90	0.41	0.40	0.20	0.20
40-44	0.96	0.96	0.36	0.44	0.17	0.23
45-49	1.10	1.00	0.54	0.42	0.26	0.18
50 or Older	0.57	0.61	0.21	0.20	0.11	0.12
50-54	1.56	1.54	0.60	0.70	0.35	0.62
55-59	1.45	1.40	0.51	0.56	0.30	0.24
60-64	1.42	1.36	0.58	0.46	0.38	0.25
65 or Older	0.84	0.83	0.26	0.22	0.09	0.09
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.13P – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.2751	0.0779	0.6524
12-20	0.0856	0.2700	0.6544
21 or Older	0.4218	0.1157	0.7078
12-17	0.0364	0.0659	0.5385
12-13	0.5421	0.1485	0.7386
14-15	0.2239	0.6551	0.5223
16-17	0.0969	0.1604	0.9675
18 or Older	0.4234	0.1320	0.7149
18-25	0.1945	0.4572	0.3989
18-20	0.8173	0.6979	0.9340
21-25	0.0654	0.4986	0.3307
26 or Older	0.2749	0.0867	0.5926
26-49	0.6534	0.0795	0.3676
26-29	0.5336	0.9112	0.4892
30-34	0.1561	0.0003	0.0057
35-39	0.6043	0.6658	0.9926
40-44	0.3466	0.2610	0.2881
45-49	0.4882	0.3581	0.8392
50 or Older	0.1131	0.4842	0.9698
50-54	0.6392	0.8451	0.4065
55-59	0.5390	0.4798	0.6808
60-64	0.9457	0.0409	0.1908
65 or Older	0.1071	0.8260	0.8514
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.14C – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	467	466	193	209	111	118
12-20	135	131	50	51	22	24
21 or Older	480	496	192	208	109	114
12-17	89	89	32	31	10	11
12-13	40	37	12	5	2	2
14-15	58	58	23	13	7	5
16-17	56	64	21	27	7	10
18 or Older	453	455	190	206	111	117
18-25	150	150	79	73	48	31
18-20	88	89	38	40	20	21
21-25	131	126	76	63	45	22
26 or Older	416	438	170	193	95	111
26-49	299	299	144	159	79	102
26-29	155	133	92	72	53	38
30-34	156	144	81	69	34	51
35-39	165	151	73	83	34	41
40-44	126	145	39	60	23	44
45-49	114	126	34	62	18	45
50 or Older	284	298	83	105	55	50
50-54	155	168	71	49	51	31
55-59	151	163	33	80	12	7
60-64	121	120	23	35	18	26
65 or Older	150	138	14	28	1	28
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.14D – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.16	0.16	0.07	0.07	0.04	0.04
12-20	0.32	0.32	0.13	0.13	0.06	0.06
21 or Older	0.18	0.18	0.08	0.08	0.04	0.05
12-17	0.34	0.34	0.12	0.12	0.04	0.04
12-13	0.49	0.45	0.15	0.06	0.03	0.02
14-15	0.61	0.63	0.25	0.15	0.07	0.05
16-17	0.60	0.68	0.23	0.30	0.07	0.11
18 or Older	0.18	0.17	0.07	0.08	0.04	0.04
18-25	0.44	0.43	0.23	0.21	0.14	0.09
18-20	0.65	0.66	0.30	0.32	0.16	0.17
21-25	0.55	0.51	0.34	0.27	0.20	0.10
26 or Older	0.19	0.19	0.08	0.08	0.04	0.05
26-49	0.29	0.28	0.14	0.15	0.08	0.10
26-29	0.79	0.71	0.50	0.40	0.29	0.22
30-34	0.64	0.55	0.35	0.28	0.15	0.22
35-39	0.64	0.61	0.31	0.35	0.15	0.18
40-44	0.57	0.62	0.19	0.26	0.11	0.20
45-49	0.59	0.62	0.18	0.32	0.10	0.23
50 or Older	0.24	0.25	0.07	0.09	0.05	0.04
50-54	0.81	0.80	0.38	0.25	0.27	0.16
55-59	0.70	0.81	0.16	0.41	0.06	0.03
60-64	0.53	0.52	0.10	0.16	0.08	0.12
65 or Older	0.26	0.23	0.02	0.05	<0.01	0.05
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.14P – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.5938	0.7588	0.7269
12-20	0.5445	0.9102	0.8167
21 or Older	0.6935	0.7742	0.7568
12-17	0.8733	0.5309	0.9028
12-13	0.1006	0.0737	0.6166
14-15	0.6604	0.0652	0.4444
16-17	0.3552	0.1936	0.4108
18 or Older	0.6068	0.8241	0.7411
18-25	0.5848	0.2681	0.0733
18-20	0.4956	0.7691	0.8763
21-25	0.2608	0.1584	0.0282
26 or Older	0.4718	0.8425	0.2855
26-49	0.9882	0.8477	0.3857
26-29	0.1691	0.1293	0.0816
30-34	0.4165	0.6459	0.3303
35-39	0.3946	0.9040	0.7142
40-44	0.1308	0.2422	0.1041
45-49	0.0591	0.1321	0.1493
50 or Older	0.3091	0.5279	0.5751
50-54	0.7058	0.7251	0.6597
55-59	0.7882	0.6675	0.7066
60-64	0.1633	0.2465	0.4075
65 or Older	0.7876	0.3438	0.0948
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.15C – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	750	752	259	248	124	146
12-20	101	97	34	41	21	21
21 or Older	887	920	265	245	121	145
12-17	79	66	25	26	14	13
12-13	34	31	5	7	*	6
14-15	49	40	9	16	2	3
16-17	49	39	24	20	14	11
18 or Older	738	747	258	245	123	145
18-25	105	106	48	55	24	32
18-20	59	65	23	32	16	16
21-25	101	97	42	48	19	28
26 or Older	731	734	252	238	119	142
26-49	363	351	162	140	71	79
26-29	139	122	62	60	29	31
30-34	165	156	88	54	29	34
35-39	196	177	88	63	31	36
40-44	178	194	69	78	48	48
45-49	195	177	68	56	10	25
50 or Older	624	633	187	196	95	120
50-54	289	295	74	66	53	50
55-59	265	307	53	105	42	54
60-64	304	295	98	91	47	58
65 or Older	411	415	129	119	48	75
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.15D – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.26	0.26	0.09	0.09	0.04	0.05
12-20	0.25	0.24	0.09	0.11	0.06	0.05
21 or Older	0.30	0.30	0.11	0.10	0.05	0.06
12-17	0.31	0.25	0.10	0.10	0.05	0.05
12-13	0.42	0.37	0.07	0.09	*	0.08
14-15	0.53	0.45	0.10	0.19	0.03	0.03
16-17	0.54	0.44	0.27	0.22	0.15	0.12
18 or Older	0.29	0.28	0.10	0.09	0.05	0.06
18-25	0.31	0.30	0.14	0.16	0.07	0.09
18-20	0.46	0.49	0.19	0.25	0.13	0.13
21-25	0.41	0.41	0.19	0.21	0.09	0.12
26 or Older	0.33	0.32	0.11	0.10	0.05	0.06
26-49	0.35	0.33	0.16	0.13	0.07	0.07
26-29	0.74	0.64	0.35	0.33	0.17	0.18
30-34	0.66	0.61	0.38	0.22	0.13	0.15
35-39	0.74	0.71	0.37	0.27	0.14	0.16
40-44	0.78	0.79	0.32	0.34	0.23	0.21
45-49	0.92	0.85	0.36	0.29	0.05	0.13
50 or Older	0.52	0.52	0.16	0.16	0.08	0.10
50-54	1.39	1.36	0.39	0.34	0.28	0.25
55-59	1.20	1.36	0.26	0.53	0.20	0.27
60-64	1.19	1.16	0.43	0.40	0.21	0.26
65 or Older	0.71	0.69	0.22	0.20	0.08	0.13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.15P – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.5370	0.5200	0.2527
12-20	0.1363	0.6808	0.5867
21 or Older	0.6581	0.4749	0.2163
12-17	0.0278	0.9519	0.7264
12-13	0.4508	0.5325	*
14-15	0.1651	0.2488	0.7036
16-17	0.0800	0.3279	0.3416
18 or Older	0.6676	0.5145	0.2409
18-25	0.0287	0.7767	0.9516
18-20	0.7277	0.5776	0.6581
21-25	0.0062	0.4940	0.8294
26 or Older	0.9237	0.5454	0.2176
26-49	0.0917	0.0286	0.4305
26-29	0.5232	0.7863	0.6341
30-34	0.0584	0.0204	0.7317
35-39	0.3905	0.1249	0.4297
40-44	0.4953	0.8506	0.5467
45-49	0.9910	0.4137	0.0478
50 or Older	0.3754	0.3468	0.3564
50-54	0.7138	0.3027	0.7647
55-59	0.2201	0.0220	0.7073
60-64	0.8287	0.9200	0.4991
65 or Older	0.6352	0.6670	0.3239
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.16C – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	652	630	225	221	112	132
12-20	83	73	29	38	20	17
21 or Older	754	754	229	217	109	131
12-17	62	46	18	23	13	11
12-13	29	19	3	5	*	5
14-15	35	27	9	14	2	2
16-17	38	30	18	18	13	10
18 or Older	645	628	225	219	110	131
18-25	98	95	45	53	23	30
18-20	54	55	22	30	14	13
21-25	91	86	40	46	19	27
26 or Older	638	622	217	210	107	128
26-49	330	331	153	134	70	73
26-29	128	111	58	58	29	28
30-34	149	145	85	51	29	32
35-39	170	157	77	58	30	33
40-44	159	178	66	73	47	46
45-49	174	164	68	55	9	25
50 or Older	527	535	149	160	81	108
50-54	265	270	70	55	20	47
55-59	213	270	53	91	42	25
60-64	234	252	81	57	47	58
65 or Older	357	359	87	103	47	74
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.16D – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.23	0.22	0.08	0.08	0.04	0.05
12-20	0.21	0.18	0.08	0.10	0.05	0.04
21 or Older	0.26	0.25	0.09	0.09	0.04	0.05
12-17	0.24	0.18	0.07	0.09	0.05	0.04
12-13	0.36	0.23	0.04	0.06	*	0.06
14-15	0.38	0.30	0.10	0.16	0.02	0.03
16-17	0.43	0.33	0.21	0.20	0.15	0.11
18 or Older	0.25	0.24	0.09	0.08	0.04	0.05
18-25	0.29	0.27	0.13	0.15	0.07	0.09
18-20	0.43	0.43	0.18	0.24	0.12	0.10
21-25	0.38	0.37	0.18	0.20	0.08	0.12
26 or Older	0.29	0.27	0.10	0.09	0.05	0.06
26-49	0.32	0.31	0.15	0.13	0.07	0.07
26-29	0.68	0.59	0.32	0.32	0.16	0.16
30-34	0.62	0.57	0.37	0.21	0.13	0.13
35-39	0.66	0.64	0.32	0.25	0.13	0.14
40-44	0.70	0.74	0.31	0.32	0.22	0.20
45-49	0.85	0.81	0.36	0.28	0.05	0.13
50 or Older	0.44	0.44	0.12	0.13	0.07	0.09
50-54	1.29	1.26	0.37	0.28	0.11	0.24
55-59	0.98	1.25	0.26	0.47	0.20	0.13
60-64	0.96	1.03	0.35	0.25	0.20	0.26
65 or Older	0.62	0.60	0.15	0.17	0.08	0.12
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.16P – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.6118	0.4557	0.2823
12-20	0.0280	0.5194	0.3418
21 or Older	0.7897	0.3916	0.2205
12-17	0.0033	0.8285	0.5782
12-13	0.0983	0.7736	*
14-15	0.0748	0.5070	0.8813
16-17	0.0518	0.7892	0.3509
18 or Older	0.7682	0.4346	0.2601
18-25	0.0110	0.8296	0.8005
18-20	0.8768	0.5529	0.4242
21-25	0.0044	0.5364	0.8746
26 or Older	0.9160	0.4481	0.2157
26-49	0.1385	0.0290	0.7426
26-29	0.5239	0.7524	0.9529
30-34	0.1883	0.0194	0.9199
35-39	0.5934	0.2274	0.4485
40-44	0.4752	0.7174	0.5235
45-49	0.7622	0.3402	0.0597
50 or Older	0.2921	0.3467	0.2058
50-54	0.8048	0.2294	0.2828
55-59	0.2551	0.0587	0.5979
60-64	0.8014	0.7964	0.4474
65 or Older	0.6316	0.2789	0.3248
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.17C – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	497	500	148	127	72	61
12-20	61	66	23	20	9	12
21 or Older	522	532	148	125	71	60
12-17	50	51	18	17	6	6
12-13	21	28	4	5	*	4
14-15	30	33	6	14	1	1
16-17	35	30	16	9	6	4
18 or Older	493	496	147	125	72	61
18-25	62	65	19	19	8	12
18-20	36	39	14	11	7	11
21-25	53	53	13	15	5	6
26 or Older	488	495	146	124	71	60
26-49	209	199	68	53	27	31
26-29	70	61	29	17	19	15
30-34	98	77	47	23	13	14
35-39	96	98	34	32	12	17
40-44	108	105	23	27	7	15
45-49	104	99	7	14	5	7
50 or Older	434	422	130	112	66	51
50-54	169	173	52	38	49	15
55-59	164	171	3	52	2	47
60-64	225	170	70	71	42	3
65 or Older	282	281	96	59	11	9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.17D – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.18	0.17	0.05	0.04	0.03	0.02
12-20	0.16	0.17	0.06	0.05	0.02	0.03
21 or Older	0.20	0.20	0.06	0.05	0.03	0.02
12-17	0.19	0.20	0.07	0.07	0.02	0.02
12-13	0.27	0.34	0.05	0.06	*	0.05
14-15	0.32	0.38	0.07	0.16	0.02	0.01
16-17	0.39	0.33	0.19	0.10	0.07	0.04
18 or Older	0.19	0.19	0.06	0.05	0.03	0.02
18-25	0.18	0.18	0.06	0.05	0.02	0.03
18-20	0.29	0.30	0.11	0.09	0.05	0.08
21-25	0.23	0.23	0.06	0.07	0.02	0.03
26 or Older	0.22	0.22	0.07	0.05	0.03	0.03
26-49	0.20	0.19	0.07	0.05	0.03	0.03
26-29	0.39	0.34	0.16	0.10	0.11	0.08
30-34	0.41	0.32	0.21	0.10	0.06	0.06
35-39	0.39	0.41	0.15	0.14	0.05	0.07
40-44	0.51	0.46	0.11	0.12	0.03	0.07
45-49	0.52	0.50	0.04	0.07	0.03	0.04
50 or Older	0.36	0.35	0.11	0.09	0.05	0.04
50-54	0.88	0.86	0.28	0.19	0.26	0.08
55-59	0.77	0.84	0.02	0.26	0.01	0.24
60-64	0.94	0.72	0.31	0.31	0.19	0.02
65 or Older	0.49	0.47	0.17	0.10	0.02	0.01
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.17P – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.0931	0.3990	0.7101
12-20	0.8858	0.5215	0.8340
21 or Older	0.0941	0.4581	0.6811
12-17	0.6045	0.8652	0.7117
12-13	0.8419	0.4585	*
14-15	0.9272	0.2828	0.6148
16-17	0.3775	0.1740	0.2533
18 or Older	0.1000	0.4114	0.7323
18-25	0.4459	0.5379	0.4511
18-20	0.6181	0.3945	0.6237
21-25	0.2038	0.9397	0.5308
26 or Older	0.1236	0.4661	0.6412
26-49	0.0309	0.4298	0.5007
26-29	0.4547	0.4739	0.8414
30-34	0.0066	0.2466	0.5831
35-39	0.3469	0.7917	0.8736
40-44	0.3962	0.6048	0.7301
45-49	0.9341	0.4397	0.6458
50 or Older	0.4838	0.6832	0.3931
50-54	0.9691	0.3882	0.1467
55-59	0.9872	0.1822	0.2970
60-64	0.1230	0.9361	0.2606
65 or Older	1.0000	0.4901	0.9243
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.18C – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)
TOTAL	577	577	230	207
12-20	60	66	28	34
21 or Older	646	646	233	205
12-17	42	43	18	20
12-13	14	18	3	7
14-15	26	23	8	13
16-17	32	26	18	14
18 or Older	574	575	230	205
18-25	85	91	43	51
18-20	42	48	22	27
21-25	82	84	37	45
26 or Older	560	568	223	197
26-49	293	290	144	126
26-29	118	108	57	57
30-34	133	124	81	50
35-39	151	145	75	52
40-44	134	154	65	72
45-49	147	143	61	43
50 or Older	478	485	163	149
50-54	226	223	68	53
55-59	175	220	52	89
60-64	206	223	80	60
65 or Older	320	332	110	88
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.18D – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)
TOTAL	0.20	0.20	0.08	0.07
12-20	0.15	0.17	0.07	0.09
21 or Older	0.23	0.23	0.09	0.08
12-17	0.16	0.17	0.07	0.08
12-13	0.17	0.22	0.04	0.08
14-15	0.28	0.26	0.08	0.15
16-17	0.36	0.29	0.21	0.16
18 or Older	0.22	0.22	0.09	0.08
18-25	0.25	0.26	0.13	0.14
18-20	0.34	0.37	0.18	0.22
21-25	0.35	0.36	0.17	0.20
26 or Older	0.25	0.25	0.10	0.09
26-49	0.28	0.27	0.14	0.12
26-29	0.63	0.58	0.32	0.32
30-34	0.55	0.50	0.35	0.21
35-39	0.59	0.60	0.32	0.22
40-44	0.61	0.66	0.30	0.32
45-49	0.74	0.71	0.32	0.22
50 or Older	0.40	0.40	0.14	0.12
50-54	1.12	1.07	0.36	0.27
55-59	0.82	1.05	0.25	0.45
60-64	0.86	0.94	0.35	0.27
65 or Older	0.55	0.55	0.19	0.15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.18P – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year (2023)	Misuse in Past Year (2023)
TOTAL	0.9110	0.1913
12-20	0.6427	0.9371
21 or Older	0.9375	0.1843
12-17	0.1585	0.8607
12-13	0.4125	0.1512
14-15	0.3169	0.4981
16-17	0.0860	0.2679
18 or Older	0.9663	0.1927
18-25	0.1977	0.9374
18-20	0.5222	0.8490
21-25	0.0763	0.8424
26 or Older	0.8634	0.1861
26-49	0.1782	0.0257
26-29	0.9232	0.6222
30-34	0.1823	0.0421
35-39	0.9723	0.1202
40-44	0.5163	0.7502
45-49	0.2846	0.2010
50 or Older	0.3085	0.8863
50-54	0.7323	0.2455
55-59	0.2934	0.0751
60-64	0.4284	0.5069
65 or Older	0.5713	0.8885
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.19C – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	840	914	329	318	177	190
12-20	162	177	60	63	34	28
21 or Older	1,180	1,189	338	316	177	191
12-17	102	110	50	39	29	19
12-13	54	54	26	18	15	8
14-15	75	70	30	25	23	12
16-17	67	74	30	25	11	11
18 or Older	827	902	328	315	176	190
18-25	150	155	59	82	28	38
18-20	100	114	32	47	17	21
21-25	135	134	51	62	22	32
26 or Older	815	878	318	300	173	186
26-49	444	433	203	190	107	96
26-29	161	176	74	69	41	36
30-34	206	198	99	65	47	23
35-39	251	247	108	96	60	50
40-44	229	251	80	103	41	54
45-49	246	226	108	83	52	37
50 or Older	689	738	256	246	140	153
50-54	340	355	115	141	65	125
55-59	357	310	106	117	65	47
60-64	383	369	135	107	88	57
65 or Older	485	498	149	133	57	57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Any use of opioids includes the use of heroin or any use of prescription opioids. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.19D – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.30	0.32	0.12	0.11	0.06	0.07
12-20	0.35	0.40	0.15	0.16	0.09	0.07
21 or Older	0.34	0.35	0.13	0.12	0.07	0.08
12-17	0.40	0.42	0.19	0.15	0.11	0.07
12-13	0.64	0.63	0.33	0.22	0.18	0.10
14-15	0.76	0.74	0.33	0.28	0.25	0.14
16-17	0.70	0.75	0.34	0.28	0.12	0.12
18 or Older	0.32	0.34	0.13	0.12	0.07	0.07
18-25	0.44	0.44	0.17	0.23	0.08	0.11
18-20	0.71	0.80	0.26	0.37	0.14	0.16
21-25	0.56	0.51	0.22	0.27	0.10	0.14
26 or Older	0.36	0.39	0.14	0.13	0.08	0.08
26-49	0.43	0.41	0.20	0.18	0.10	0.09
26-29	0.81	0.91	0.41	0.39	0.23	0.21
30-34	0.79	0.74	0.42	0.28	0.20	0.10
35-39	0.90	0.90	0.45	0.40	0.26	0.21
40-44	0.96	0.96	0.37	0.45	0.19	0.24
45-49	1.10	1.00	0.55	0.43	0.27	0.19
50 or Older	0.57	0.61	0.21	0.20	0.12	0.13
50-54	1.56	1.54	0.61	0.71	0.35	0.63
55-59	1.45	1.40	0.51	0.58	0.31	0.24
60-64	1.42	1.36	0.58	0.47	0.38	0.25
65 or Older	0.84	0.83	0.26	0.22	0.10	0.09
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Any use of opioids includes the use of heroin or any use of prescription opioids. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.19P – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year¹ (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.3166	0.0490	0.4007
12-20	0.0846	0.2959	0.6271
21 or Older	0.4780	0.0712	0.4443
12-17	0.0383	0.0697	0.4847
12-13	0.5796	0.1193	0.5975
14-15	0.2208	0.7527	0.5223
16-17	0.0969	0.1623	0.9562
18 or Older	0.4765	0.0844	0.4545
18-25	0.2084	0.3265	0.3751
18-20	0.7934	0.6448	0.8924
21-25	0.0693	0.3543	0.3234
26 or Older	0.3204	0.0471	0.3537
26-49	0.5814	0.0261	0.1502
26-29	0.5484	0.7253	0.2815
30-34	0.1716	0.0003	0.0027
35-39	0.5107	0.3419	0.6760
40-44	0.3751	0.4053	0.4592
45-49	0.4568	0.2987	0.8287
50 or Older	0.1249	0.5215	0.9025
50-54	0.6726	0.8110	0.3253
55-59	0.5428	0.3721	0.9016
60-64	0.9471	0.0604	0.1919
65 or Older	0.1161	0.9357	0.6832
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Any use of opioids includes the use of heroin or any use of prescription opioids. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.20C – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	536	521	355	327	255	220
12-20	140	134	66	59	34	29
21 or Older	576	571	363	339	256	222
12-17	90	89	36	41	20	26
12-13	40	38	13	11	5	4
14-15	58	58	24	15	7	6
16-17	56	65	25	36	18	24
18 or Older	525	511	351	325	254	222
18-25	165	157	113	89	60	46
18-20	94	94	54	46	28	26
21-25	149	137	104	84	52	38
26 or Older	490	498	329	314	244	215
26-49	335	336	244	239	162	163
26-29	174	163	124	115	81	64
30-34	185	161	131	105	78	65
35-39	192	172	124	123	84	75
40-44	153	157	91	89	51	70
45-49	148	145	94	102	73	82
50 or Older	349	343	212	201	171	142
50-54	183	192	124	107	74	80
55-59	192	191	115	128	99	96
60-64	147	137	85	81	68	43
65 or Older	183	154	107	72	103	50
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.20D – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	0.19	0.18	0.13	0.11	0.09	0.08
12-20	0.33	0.33	0.17	0.15	0.09	0.07
21 or Older	0.21	0.20	0.14	0.13	0.10	0.09
12-17	0.35	0.34	0.14	0.16	0.08	0.10
12-13	0.49	0.46	0.17	0.14	0.06	0.05
14-15	0.61	0.63	0.26	0.17	0.07	0.06
16-17	0.60	0.68	0.28	0.40	0.21	0.27
18 or Older	0.20	0.19	0.14	0.12	0.10	0.08
18-25	0.48	0.45	0.33	0.26	0.18	0.13
18-20	0.69	0.69	0.42	0.36	0.22	0.21
21-25	0.61	0.55	0.44	0.36	0.23	0.17
26 or Older	0.22	0.22	0.15	0.14	0.11	0.09
26-49	0.32	0.32	0.24	0.23	0.16	0.15
26-29	0.87	0.84	0.66	0.62	0.44	0.36
30-34	0.74	0.61	0.55	0.43	0.34	0.27
35-39	0.72	0.68	0.50	0.51	0.36	0.32
40-44	0.68	0.67	0.42	0.39	0.24	0.31
45-49	0.75	0.71	0.48	0.52	0.38	0.42
50 or Older	0.29	0.28	0.18	0.17	0.14	0.12
50-54	0.95	0.92	0.66	0.54	0.39	0.41
55-59	0.88	0.93	0.55	0.65	0.48	0.48
60-64	0.63	0.59	0.37	0.36	0.29	0.19
65 or Older	0.32	0.26	0.19	0.12	0.18	0.08
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.20P – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Age Category	Any Use in Past Year¹ (2023)	Misuse in Past Year (2023)	Misuse in Past Month (2023)
TOTAL	0.7955	0.0928	0.3449
12-20	0.7380	0.3215	0.8679
21 or Older	0.7221	0.1264	0.3522
12-17	0.6866	0.8924	0.8006
12-13	0.1624	0.4558	0.9002
14-15	0.6145	0.1225	0.9871
16-17	0.2751	0.1509	0.7743
18 or Older	0.7305	0.0842	0.3273
18-25	0.3411	0.0476	0.2296
18-20	0.9847	0.1515	0.6412
21-25	0.2460	0.1314	0.2463
26 or Older	0.9500	0.2441	0.4721
26-49	0.7477	0.4460	0.6514
26-29	0.5133	0.7439	0.0887
30-34	0.1120	0.1339	0.5699
35-39	0.5367	0.9565	0.8658
40-44	0.2330	0.7314	0.1228
45-49	0.2145	0.9490	0.8604
50 or Older	0.8810	0.3379	0.5444
50-54	0.7529	0.7285	0.4647
55-59	0.9228	0.9361	0.9597
60-64	0.5698	0.5622	0.2614
65 or Older	0.6174	0.3361	0.2922
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.21C – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2023 and 2024
Age Category	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	573	--	368
12-20	--	140	--	71
21 or Older	--	617	--	373
12-17	--	101	--	56
12-13	--	48	--	26
14-15	--	52	--	26
16-17	--	65	--	41
18 or Older	--	568	--	368
18-25	--	155	--	76
18-20	--	83	--	43
21-25	--	147	--	67
26 or Older	--	545	--	357
26-49	--	392	--	247
26-29	--	187	--	99
30-34	--	163	--	96
35-39	--	197	--	125
40-44	--	174	--	111
45-49	--	155	--	101
50 or Older	--	368	--	247
50-54	--	211	--	157
55-59	--	173	--	122
60-64	--	150	--	91
65 or Older	--	193	--	109
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.21D – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Standard Errors of Percentages, 2023 and 2024
Age Category	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	0.20	--	0.13
12-20	--	0.35	--	0.18
21 or Older	--	0.23	--	0.14
12-17	--	0.39	--	0.22
12-13	--	0.57	--	0.31
14-15	--	0.57	--	0.30
16-17	--	0.70	--	0.45
18 or Older	--	0.22	--	0.14
18-25	--	0.44	--	0.22
18-20	--	0.62	--	0.33
21-25	--	0.59	--	0.29
26 or Older	--	0.24	--	0.16
26-49	--	0.37	--	0.23
26-29	--	0.94	--	0.53
30-34	--	0.62	--	0.39
35-39	--	0.78	--	0.52
40-44	--	0.73	--	0.49
45-49	--	0.75	--	0.51
50 or Older	--	0.30	--	0.20
50-54	--	1.02	--	0.78
55-59	--	0.85	--	0.62
60-64	--	0.65	--	0.40
65 or Older	--	0.32	--	0.18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.22C – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Prescription Drug/Age Group	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Misuse in Past Year among Past Year Any Users (2023)	Misuse in Past Year among Past Year Any Users (2024)
PRESCRIPTION PSYCHOTHERAPEUTICS	--	1,013	422	416	--	439
12-17	--	132	58	53	--	54
18 or Older	--	992	421	411	--	432
18-25	--	197	103	107	--	114
26 or Older	--	964	398	395	--	410
PAIN RELIEVERS	--	929	334	326	--	337
12-17	--	112	53	44	--	44
18 or Older	--	916	333	322	--	332
18-25	--	163	63	84	--	86
26 or Older	--	892	322	309	--	316
PRESCRIPTION OPIOIDS	843	913	324	312	341	321
12-17	102	110	50	39	51	39
18 or Older	829	901	324	309	338	317
18-25	150	155	59	82	60	84
26 or Older	817	877	314	295	325	301
STIMULANTS	467	466	193	209	197	213
12-17	89	89	32	31	32	31
18 or Older	453	455	190	206	194	211
18-25	150	150	79	73	82	74
26 or Older	416	438	170	193	173	197
TRANQUILIZERS OR SEDATIVES	750	752	259	248	266	251
12-17	79	66	25	26	25	26
18 or Older	738	747	258	245	265	248
18-25	105	106	48	55	48	56
26 or Older	731	734	252	238	258	239
TRANQUILIZERS	652	630	225	221	230	223
12-17	62	46	18	23	18	23
18 or Older	645	628	225	219	230	220
18-25	98	95	45	53	46	54
26 or Older	638	622	217	210	222	211
SEDATIVES	497	500	148	127	149	127
12-17	50	51	18	17	18	17
18 or Older	493	496	147	125	148	126
18-25	62	65	19	19	19	19
26 or Older	488	495	146	124	147	124
BENZODIAZEPINES	577	577	230	207	233	208
12-17	42	43	18	20	18	20
18 or Older	574	575	230	205	234	207
18-25	85	91	43	51	43	51
26 or Older	560	568	223	197	226	198
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.22D – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2023 and 2024
Prescription Drug/Age Group	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Misuse in Past Year among Past Year Any Users (2023)	Misuse in Past Year among Past Year Any Users (2024)
PRESCRIPTION PSYCHOTHERAPEUTICS	--	0.35	0.15	0.14	--	0.40
12-17	--	0.51	0.23	0.20	--	1.01
18 or Older	--	0.38	0.16	0.16	--	0.41
18-25	--	0.56	0.30	0.31	--	1.07
26 or Older	--	0.42	0.18	0.17	--	0.44
PAIN RELIEVERS	--	0.32	0.12	0.11	--	0.44
12-17	--	0.43	0.21	0.17	--	1.28
18 or Older	--	0.35	0.13	0.12	--	0.46
18-25	--	0.47	0.19	0.24	--	1.43
26 or Older	--	0.39	0.14	0.14	--	0.48
PRESCRIPTION OPIOIDS	0.30	0.32	0.11	0.11	0.50	0.47
12-17	0.39	0.42	0.19	0.15	1.68	1.25
18 or Older	0.32	0.34	0.13	0.12	0.53	0.49
18-25	0.44	0.44	0.17	0.23	1.13	1.55
26 or Older	0.37	0.39	0.14	0.13	0.56	0.51
STIMULANTS	0.16	0.16	0.07	0.07	0.87	0.88
12-17	0.34	0.34	0.12	0.12	1.62	1.52
18 or Older	0.18	0.17	0.07	0.08	0.96	0.94
18-25	0.44	0.43	0.23	0.21	1.80	1.68
26 or Older	0.19	0.19	0.08	0.08	1.08	1.11
TRANQUILIZERS OR SEDATIVES	0.26	0.26	0.09	0.09	0.60	0.60
12-17	0.31	0.25	0.10	0.10	2.09	2.48
18 or Older	0.29	0.28	0.10	0.09	0.61	0.61
18-25	0.31	0.30	0.14	0.16	1.58	1.94
26 or Older	0.33	0.32	0.11	0.10	0.65	0.63
TRANQUILIZERS	0.23	0.22	0.08	0.08	0.66	0.67
12-17	0.24	0.18	0.07	0.09	2.53	3.71
18 or Older	0.25	0.24	0.09	0.08	0.68	0.68
18-25	0.29	0.27	0.13	0.15	1.81	2.23
26 or Older	0.29	0.27	0.10	0.09	0.71	0.69
SEDATIVES	0.18	0.17	0.05	0.04	0.95	0.88
12-17	0.19	0.20	0.07	0.07	2.96	2.96
18 or Older	0.19	0.19	0.06	0.05	0.99	0.91
18-25	0.18	0.18	0.06	0.05	2.11	2.20
26 or Older	0.22	0.22	0.07	0.05	1.05	0.95
BENZODIAZEPINES	0.20	0.20	0.08	0.07	0.89	0.81
12-17	0.16	0.17	0.07	0.08	3.68	4.37
18 or Older	0.22	0.22	0.09	0.08	0.90	0.82
18-25	0.25	0.26	0.13	0.14	2.14	2.53
26 or Older	0.25	0.25	0.10	0.09	0.95	0.85
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.22P – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Prescription Drug/Age Group	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Past Year Any Users (2023)
PRESCRIPTION PSYCHOTHERAPEUTICS	--	0.1285	--
12-17	--	0.0773	--
18 or Older	--	0.1908	--
18-25	--	0.6904	--
26 or Older	--	0.2101	--
PAIN RELIEVERS	--	0.1107	--
12-17	--	0.0328	--
18 or Older	--	0.1976	--
18-25	--	0.3842	--
26 or Older	--	0.1273	--
PRESCRIPTION OPIOIDS	0.2751	0.0779	0.0238
12-17	0.0364	0.0659	0.0065
18 or Older	0.4234	0.1320	0.0622
18-25	0.1945	0.4572	0.1744
26 or Older	0.2749	0.0867	0.0306
STIMULANTS	0.5938	0.7588	0.5356
12-17	0.8733	0.5309	0.4624
18 or Older	0.6068	0.8241	0.6024
18-25	0.5848	0.2681	0.3331
26 or Older	0.4718	0.8425	0.9024
TRANQUILIZERS OR SEDATIVES	0.5370	0.5200	0.6479
12-17	0.0278	0.9519	0.2702
18 or Older	0.6676	0.5145	0.5926
18-25	0.0287	0.7767	0.4212
26 or Older	0.9237	0.5454	0.5442
TRANQUILIZERS	0.6118	0.4557	0.5577
12-17	0.0033	0.8285	0.0411
18 or Older	0.7682	0.4346	0.4808
18-25	0.0110	0.8296	0.2232
26 or Older	0.9160	0.4481	0.4074
SEDATIVES	0.0931	0.3990	0.6585
12-17	0.6045	0.8652	0.9899
18 or Older	0.1000	0.4114	0.6578
18-25	0.4459	0.5379	0.6983
26 or Older	0.1236	0.4661	0.6987
BENZODIAZEPINES	0.9110	0.1913	0.1819
12-17	0.1585	0.8607	0.4473
18 or Older	0.9663	0.1927	0.1733
18-25	0.1977	0.9374	0.4791
26 or Older	0.8634	0.1861	0.1444
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.23C – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,128	1,156	138	161	1,110	1,108	239	234	1,065	1,060
SEX
Male	768	803	95	111	747	777	167	167	717	737
Female	732	761	99	108	725	739	157	157	694	725
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	993	973	105	128	977	947	202	201	943	912
AIAN	73	74	13	9	73	74	13	14	71	70
Asian	279	323	31	37	278	315	68	91	269	284
Black or African American	633	654	60	71	615	633	131	133	575	596
NHPI	*	*	*	*	*	*	*	*	*	*
White	822	770	110	126	1,729	1,691	315	308	1,614	1,593
Two or More Races	219	232	27	31	212	232	53	60	204	224
Hispanic or Latino	483	482	82	93	471	459	120	125	445	433
EDUCATION LEVEL
< High School	da	da	da	da	310	327	95	84	383	420
High School Graduate	da	da	da	da	577	585	196	206	854	832
Some College/Associate’s Degree	da	da	da	da	586	540	294	268	966	911
College Graduate	da	da	da	da	571	587	167	161	1,035	1,124
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,335	1,301	256	258	1,257	1,244
Part-Time	da	da	da	da	535	535	186	199	491	494
Unemployed	da	da	da	da	294	320	94	109	267	290
Other¹	da	da	da	da	1,014	1,060	178	152	994	1,038
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.23D – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.40	0.40	0.53	0.62	0.43	0.42	0.70	0.67	0.48	0.47
SEX
Male	0.55	0.57	0.71	0.84	0.60	0.61	0.98	0.95	0.66	0.67
Female	0.51	0.52	0.78	0.85	0.55	0.55	0.93	0.90	0.60	0.62
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.43	0.42	0.55	0.67	0.46	0.44	0.78	0.77	0.51	0.48
AIAN	3.06	3.27	4.49	3.83	3.38	3.70	6.20	5.97	3.62	4.15
Asian	1.43	1.37	1.81	2.17	1.55	1.44	2.53	2.89	1.76	1.59
Black or African American	1.02	1.04	1.36	1.55	1.11	1.14	1.65	1.61	1.28	1.30
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.48	0.45	0.69	0.83	0.52	0.47	0.93	0.90	0.57	0.52
Two or More Races	1.96	1.92	2.48	2.51	2.21	2.22	2.64	2.80	2.71	2.75
Hispanic or Latino	0.92	0.88	1.20	1.34	1.04	0.96	1.46	1.42	1.20	1.11
EDUCATION LEVEL
< High School	da	da	da	da	1.27	1.36	1.84	1.78	1.44	1.55
High School Graduate	da	da	da	da	0.83	0.83	1.09	1.08	0.97	0.97
Some College/Associate’s Degree	da	da	da	da	0.76	0.69	1.15	1.16	0.87	0.81
College Graduate	da	da	da	da	0.66	0.65	1.64	1.53	0.69	0.69
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.59	0.59	1.04	0.99	0.64	0.64
Part-Time	da	da	da	da	1.00	1.02	1.25	1.39	1.29	1.31
Unemployed	da	da	da	da	1.70	1.51	2.11	1.88	2.17	2.01
Other¹	da	da	da	da	0.71	0.67	1.37	1.31	0.76	0.72
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.23P – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1254	0.0000	0.3839	0.8213	0.3323
SEX
Male	0.7726	0.0002	0.7581	0.7029	0.8264
Female	0.0505	0.0071	0.1177	0.9469	0.1110
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2539	0.0000	0.5726	0.3779	0.6994
AIAN	0.5920	0.6658	0.3799	0.9595	0.3510
Asian	0.1181	0.0819	0.1734	0.1396	0.3093
Black or African American	0.8264	0.0031	0.8141	0.6447	0.7335
NHPI	*	*	*	*	*
White	0.2596	0.0037	0.4656	0.5588	0.5311
Two or More Races	0.9321	0.2377	0.9853	0.9059	0.9957
Hispanic or Latino	0.1164	0.0715	0.2311	0.0671	0.0667
EDUCATION LEVEL
< High School	da	da	0.5622	0.3673	0.4358
High School Graduate	da	da	0.8969	0.9637	0.8891
Some College/Associate’s Degree	da	da	0.4170	0.7699	0.3526
College Graduate	da	da	0.6265	0.6326	0.6754
EMPLOYMENT STATUS
Full-Time	da	da	0.6245	0.8524	0.6387
Part-Time	da	da	0.8349	0.2933	0.8336
Unemployed	da	da	0.1408	0.1282	0.3086
Other¹	da	da	0.0855	0.8582	0.0759
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.24C – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	918	1,015	119	131	908	1,003	235	227	834	954
SEX
Male	658	723	86	85	653	715	168	158	609	688
Female	546	603	86	91	538	595	150	155	500	567
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	831	906	95	110	820	901	202	192	762	859
AIAN	65	52	12	7	66	51	11	12	64	47
Asian	192	191	20	26	190	188	61	70	189	170
Black or African American	432	419	51	56	421	408	113	111	384	373
NHPI	*	54	*	*	*	52	*	*	*	51
White	685	749	98	102	919	991	259	248	825	918
Two or More Races	133	149	24	23	129	150	49	52	119	138
Hispanic or Latino	376	390	70	67	369	376	119	118	336	352
EDUCATION LEVEL
< High School	da	da	da	da	241	244	78	73	239	250
High School Graduate	da	da	da	da	475	463	163	168	548	530
Some College/Associate’s Degree	da	da	da	da	520	501	245	221	548	605
College Graduate	da	da	da	da	459	521	135	132	554	635
EMPLOYMENT STATUS
Full-Time	da	da	da	da	816	827	206	208	753	790
Part-Time	da	da	da	da	336	355	150	169	283	304
Unemployed	da	da	da	da	242	248	85	89	216	229
Other¹	da	da	da	da	575	635	146	127	550	615
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.24D – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.32	0.35	0.46	0.51	0.35	0.38	0.69	0.65	0.37	0.42
SEX
Male	0.47	0.51	0.65	0.64	0.52	0.56	0.98	0.90	0.56	0.62
Female	0.38	0.41	0.68	0.72	0.41	0.44	0.89	0.89	0.43	0.48
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.36	0.39	0.50	0.58	0.39	0.42	0.78	0.73	0.41	0.46
AIAN	3.54	2.97	4.43	3.15	4.29	3.44	6.13	5.59	4.96	3.76
Asian	1.05	0.97	1.32	1.67	1.14	1.03	2.36	2.48	1.33	1.12
Black or African American	0.93	0.87	1.26	1.34	1.03	0.96	1.64	1.61	1.16	1.07
NHPI	*	4.21	*	*	*	4.39	*	*	*	4.94
White	0.40	0.44	0.63	0.71	0.43	0.47	0.93	0.86	0.46	0.51
Two or More Races	1.85	1.81	2.32	2.02	2.18	2.16	3.09	2.81	2.56	2.56
Hispanic or Latino	0.72	0.71	1.03	0.96	0.81	0.79	1.44	1.34	0.90	0.90
EDUCATION LEVEL
< High School	da	da	da	da	0.98	1.02	1.69	1.69	1.08	1.13
High School Graduate	da	da	da	da	0.68	0.66	1.03	1.00	0.78	0.76
Some College/Associate’s Degree	da	da	da	da	0.67	0.64	1.19	1.15	0.73	0.75
College Graduate	da	da	da	da	0.53	0.58	1.61	1.63	0.55	0.59
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.51	0.55	1.03	0.98	0.55	0.60
Part-Time	da	da	da	da	0.88	0.91	1.19	1.33	1.08	1.10
Unemployed	da	da	da	da	1.68	1.44	2.06	1.80	2.15	1.93
Other¹	da	da	da	da	0.54	0.55	1.28	1.25	0.57	0.59
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.24P – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1562	0.5930	0.1820	0.3422	0.0999
SEX
Male	0.2119	0.3791	0.2622	0.1878	0.1382
Female	0.3899	0.9254	0.3814	0.9534	0.3617
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1471	0.2969	0.1873	0.6324	0.1323
AIAN	0.0993	0.9424	0.0777	0.9909	0.0708
Asian	0.7846	0.5672	0.7222	0.7316	0.6215
Black or African American	0.6443	0.2243	0.5003	0.5731	0.5815
NHPI	*	*	*	*	*
White	0.0174	0.5457	0.0212	0.7322	0.0129
Two or More Races	0.9792	0.6098	0.8448	0.8085	0.8994
Hispanic or Latino	0.7206	0.5552	0.6525	0.3410	0.4155
EDUCATION LEVEL
< High School	da	da	0.7497	0.7444	0.6811
High School Graduate	da	da	0.1540	0.4675	0.1173
Some College/Associate’s Degree	da	da	0.4168	0.3797	0.2450
College Graduate	da	da	0.8214	0.8259	0.8507
EMPLOYMENT STATUS
Full-Time	da	da	0.8047	0.5864	0.7262
Part-Time	da	da	0.8927	0.1551	0.4992
Unemployed	da	da	0.8508	0.5784	0.6851
Other¹	da	da	0.0558	0.7443	0.0502
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.25C – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	829	845	91	95	813	832	200	198	750	791
SEX
Male	612	634	65	63	600	625	146	141	557	605
Female	480	507	62	70	470	499	134	142	439	466
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	742	769	69	77	732	763	180	170	674	723
AIAN	60	39	3	6	60	38	9	11	59	33
Asian	131	147	10	15	131	146	45	51	121	134
Black or African American	343	320	33	38	337	311	94	95	310	280
NHPI	*	38	*	1	*	38	*	*	*	37
White	607	649	65	69	740	787	196	185	675	738
Two or More Races	109	136	17	17	107	135	45	45	96	125
Hispanic or Latino	333	309	53	53	326	298	103	106	301	275
EDUCATION LEVEL
< High School	da	da	da	da	211	208	67	64	212	203
High School Graduate	da	da	da	da	437	407	133	132	482	443
Some College/Associate’s Degree	da	da	da	da	453	432	188	172	453	489
College Graduate	da	da	da	da	378	408	88	102	424	456
EMPLOYMENT STATUS
Full-Time	da	da	da	da	636	630	157	166	590	598
Part-Time	da	da	da	da	281	281	115	123	245	244
Unemployed	da	da	da	da	186	198	73	71	165	183
Other¹	da	da	da	da	493	506	105	101	474	495
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.25D – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.29	0.29	0.35	0.37	0.32	0.32	0.59	0.57	0.34	0.35
SEX
Male	0.44	0.45	0.49	0.48	0.48	0.49	0.85	0.80	0.51	0.55
Female	0.33	0.34	0.49	0.55	0.36	0.37	0.79	0.81	0.38	0.40
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.32	0.33	0.36	0.41	0.35	0.36	0.70	0.65	0.36	0.38
AIAN	3.56	2.48	1.30	2.84	4.24	2.89	5.60	5.47	4.84	2.97
Asian	0.74	0.76	0.72	1.01	0.80	0.82	1.92	1.98	0.86	0.88
Black or African American	0.80	0.72	0.85	0.97	0.88	0.78	1.58	1.50	0.99	0.86
NHPI	*	3.05	*	1.16	*	3.28	*	*	*	3.59
White	0.36	0.38	0.47	0.50	0.38	0.41	0.82	0.76	0.40	0.44
Two or More Races	1.64	1.73	1.77	1.58	1.91	2.04	3.08	2.81	2.20	2.41
Hispanic or Latino	0.64	0.57	0.79	0.77	0.72	0.62	1.24	1.21	0.81	0.71
EDUCATION LEVEL
< High School	da	da	da	da	0.86	0.86	1.56	1.56	0.95	0.95
High School Graduate	da	da	da	da	0.63	0.58	0.93	0.89	0.72	0.67
Some College/Associate’s Degree	da	da	da	da	0.59	0.55	1.06	1.01	0.63	0.64
College Graduate	da	da	da	da	0.44	0.45	1.26	1.37	0.45	0.46
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.43	0.44	0.89	0.88	0.46	0.48
Part-Time	da	da	da	da	0.78	0.77	1.07	1.14	0.97	0.93
Unemployed	da	da	da	da	1.46	1.29	1.89	1.64	1.86	1.70
Other¹	da	da	da	da	0.49	0.46	1.01	1.08	0.51	0.50
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.25P – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.8364	0.5241	0.7476	0.3685	0.8987
SEX
Male	0.9761	0.6961	0.9136	0.2390	0.8729
Female	0.7555	0.6051	0.6817	0.8994	0.6776
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6667	0.1837	0.7830	0.4593	0.6380
AIAN	0.1270	0.1074	0.0683	0.6515	0.0453
Asian	0.8955	0.8725	0.9152	0.7427	0.9920
Black or African American	0.3082	0.1585	0.2170	0.3337	0.3058
NHPI	*	*	*	*	*
White	0.2327	0.2305	0.2899	0.6209	0.2212
Two or More Races	0.5406	0.0664	0.3287	0.9166	0.3168
Hispanic or Latino	0.1482	0.4821	0.1643	0.7276	0.1625
EDUCATION LEVEL
< High School	da	da	0.6956	0.7999	0.7228
High School Graduate	da	da	0.7151	0.2283	0.5266
Some College/Associate’s Degree	da	da	0.5449	0.4142	0.3520
College Graduate	da	da	0.1716	0.3295	0.1037
EMPLOYMENT STATUS
Full-Time	da	da	0.4087	0.7085	0.4231
Part-Time	da	da	0.3126	0.1469	0.5723
Unemployed	da	da	0.7468	0.1449	0.8183
Other¹	da	da	0.3312	0.3545	0.3947
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.26C – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,113	1,157	115	116	1,093	1,112	241	238	1,050	1,057
SEX
Male	777	803	80	80	754	777	169	160	729	740
Female	725	763	82	80	719	745	158	161	689	722
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	983	972	93	97	964	943	204	209	929	903
AIAN	66	63	12	6	65	63	*	14	64	58
Asian	255	284	19	18	254	284	64	73	246	260
Black or African American	613	615	48	52	602	602	122	128	562	569
NHPI	*	100	*	1	*	*	*	*	*	*
White	827	798	88	87	1,640	1,632	302	295	1,533	1,542
Two or More Races	215	228	23	24	208	228	52	58	200	221
Hispanic or Latino	454	490	69	66	443	473	121	123	424	444
EDUCATION LEVEL
< High School	da	da	da	da	300	315	89	78	367	372
High School Graduate	da	da	da	da	578	580	185	197	827	810
Some College/Associate’s Degree	da	da	da	da	580	557	283	252	920	893
College Graduate	da	da	da	da	565	578	159	155	982	1,080
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,247	1,243	244	241	1,177	1,193
Part-Time	da	da	da	da	516	518	172	183	474	480
Unemployed	da	da	da	da	282	308	91	108	257	278
Other¹	da	da	da	da	980	1,024	170	141	958	1,005
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.26D – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.39	0.40	0.44	0.45	0.42	0.42	0.71	0.68	0.47	0.46
SEX
Male	0.56	0.57	0.60	0.61	0.60	0.61	0.99	0.91	0.67	0.67
Female	0.50	0.52	0.65	0.63	0.54	0.55	0.93	0.92	0.60	0.62
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.42	0.42	0.49	0.51	0.45	0.44	0.79	0.80	0.50	0.48
AIAN	3.10	3.30	4.40	2.56	3.67	3.88	*	6.01	4.20	4.27
Asian	1.34	1.27	1.17	1.18	1.45	1.36	2.45	2.62	1.65	1.50
Black or African American	1.02	1.02	1.19	1.31	1.11	1.11	1.68	1.61	1.27	1.27
NHPI	*	6.23	*	1.83	*	*	*	*	*	*
White	0.49	0.47	0.59	0.62	0.52	0.49	0.93	0.94	0.57	0.53
Two or More Races	1.99	1.99	2.20	2.11	2.23	2.26	2.69	2.86	2.72	2.81
Hispanic or Latino	0.87	0.90	1.01	0.95	0.98	0.99	1.46	1.40	1.14	1.14
EDUCATION LEVEL
< High School	da	da	da	da	1.23	1.31	1.82	1.75	1.40	1.49
High School Graduate	da	da	da	da	0.83	0.82	1.08	1.11	0.97	0.96
Some College/Associate’s Degree	da	da	da	da	0.75	0.72	1.16	1.19	0.87	0.83
College Graduate	da	da	da	da	0.65	0.64	1.63	1.62	0.68	0.67
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.58	0.58	1.05	0.98	0.63	0.64
Part-Time	da	da	da	da	1.01	1.03	1.26	1.39	1.30	1.31
Unemployed	da	da	da	da	1.69	1.56	2.06	1.92	2.16	2.06
Other¹	da	da	da	da	0.70	0.68	1.36	1.32	0.75	0.73
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.26P – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4193	0.5252	0.4225	0.2251	0.2583
SEX
Male	0.9156	0.9060	0.9900	0.2844	0.7796
Female	0.2742	0.2985	0.2438	0.4756	0.1725
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5330	1.0000	0.5720	0.7897	0.5118
AIAN	0.7270	0.6147	0.6482	*	0.6339
Asian	0.4555	0.3382	0.4264	0.7803	0.4584
Black or African American	0.8722	0.6001	0.9647	0.9228	0.9807
NHPI	*	*	*	*	*
White	0.3794	0.8148	0.4206	0.7778	0.3720
Two or More Races	0.6890	0.5891	0.9032	0.7472	0.8387
Hispanic or Latino	0.3476	0.2661	0.2972	0.0692	0.0994
EDUCATION LEVEL
< High School	da	da	0.8599	0.1532	0.8965
High School Graduate	da	da	0.9350	0.6709	0.8508
Some College/Associate’s Degree	da	da	0.4180	0.2183	0.2298
College Graduate	da	da	0.5746	0.6559	0.6198
EMPLOYMENT STATUS
Full-Time	da	da	0.7785	0.3237	0.9304
Part-Time	da	da	0.7626	0.1385	0.7895
Unemployed	da	da	0.1398	0.1737	0.2762
Other¹	da	da	0.1515	0.4430	0.1105
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.27C – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	876	974	107	107	866	957	238	224	792	909
SEX
Male	628	688	74	71	619	676	170	152	576	653
Female	510	578	77	74	503	569	149	155	469	538
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	779	863	87	89	769	852	201	191	712	809
AIAN	59	44	12	5	59	44	9	12	58	39
Asian	163	175	16	17	162	175	59	59	162	162
Black or African American	391	389	45	44	384	381	108	110	347	346
NHPI	*	50	*	1	*	50	*	*	*	48
White	647	725	83	81	842	931	252	237	751	861
Two or More Races	124	139	22	21	121	139	48	51	110	127
Hispanic or Latino	356	374	62	58	351	362	119	115	316	336
EDUCATION LEVEL
< High School	da	da	da	da	220	214	78	69	213	213
High School Graduate	da	da	da	da	458	455	159	159	509	510
Some College/Associate’s Degree	da	da	da	da	494	486	241	210	508	577
College Graduate	da	da	da	da	432	496	132	126	507	583
EMPLOYMENT STATUS
Full-Time	da	da	da	da	749	774	202	196	688	740
Part-Time	da	da	da	da	325	332	147	157	272	280
Unemployed	da	da	da	da	229	224	82	85	203	204
Other¹	da	da	da	da	535	589	140	119	507	568
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.27D – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.31	0.34	0.41	0.41	0.34	0.36	0.70	0.64	0.35	0.40
SEX
Male	0.45	0.49	0.56	0.53	0.49	0.53	0.99	0.87	0.53	0.59
Female	0.35	0.39	0.61	0.58	0.38	0.42	0.88	0.89	0.41	0.46
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.34	0.37	0.46	0.47	0.36	0.40	0.78	0.73	0.38	0.43
AIAN	3.51	2.70	4.41	2.48	4.22	3.16	5.80	5.58	4.89	3.31
Asian	0.91	0.90	1.08	1.08	0.99	0.97	2.27	2.24	1.16	1.07
Black or African American	0.87	0.83	1.12	1.16	0.96	0.91	1.60	1.62	1.07	1.01
NHPI	*	3.87	*	1.69	*	4.15	*	*	*	4.63
White	0.38	0.43	0.57	0.59	0.41	0.45	0.92	0.87	0.43	0.49
Two or More Races	1.78	1.73	2.15	1.85	2.10	2.06	3.15	2.81	2.44	2.41
Hispanic or Latino	0.68	0.68	0.92	0.83	0.77	0.76	1.45	1.31	0.85	0.86
EDUCATION LEVEL
< High School	da	da	da	da	0.90	0.89	1.72	1.63	0.97	0.98
High School Graduate	da	da	da	da	0.66	0.65	1.02	0.99	0.75	0.74
Some College/Associate’s Degree	da	da	da	da	0.64	0.62	1.22	1.13	0.69	0.73
College Graduate	da	da	da	da	0.50	0.55	1.63	1.56	0.51	0.56
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.48	0.52	1.05	0.94	0.51	0.57
Part-Time	da	da	da	da	0.86	0.87	1.19	1.29	1.04	1.03
Unemployed	da	da	da	da	1.64	1.35	2.03	1.77	2.10	1.79
Other¹	da	da	da	da	0.51	0.51	1.27	1.20	0.53	0.55
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.27P – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3021	0.1858	0.2393	0.0961	0.0927
SEX
Male	0.3662	0.6055	0.3432	0.1514	0.1835
Female	0.5225	0.1632	0.4032	0.3014	0.2403
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2421	0.5171	0.2173	0.1967	0.0997
AIAN	0.1954	0.5849	0.1937	0.6045	0.1454
Asian	0.6728	0.4680	0.7156	0.5937	0.8327
Black or African American	0.6032	0.8593	0.5644	0.7045	0.6166
NHPI	*	*	*	*	*
White	0.0304	0.8004	0.0275	0.2191	0.0082
Two or More Races	0.6646	0.2280	0.9099	0.5739	0.7429
Hispanic or Latino	0.9311	0.1628	0.7662	0.3359	0.5139
EDUCATION LEVEL
< High School	da	da	0.8181	0.4549	0.9696
High School Graduate	da	da	0.1836	0.2175	0.1062
Some College/Associate’s Degree	da	da	0.4890	0.1409	0.2117
College Graduate	da	da	0.7218	0.7114	0.7703
EMPLOYMENT STATUS
Full-Time	da	da	0.6001	0.3434	0.4598
Part-Time	da	da	0.4030	0.0342	0.9069
Unemployed	da	da	0.8426	0.4606	0.9379
Other¹	da	da	0.0437	0.9202	0.0333
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.28C – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	787	795	83	83	774	781	198	196	714	742
SEX
Male	582	586	58	59	573	575	145	137	528	557
Female	449	488	58	59	441	480	131	141	415	450
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	710	726	66	66	701	718	177	167	648	682
AIAN	58	38	3	5	58	38	9	11	57	33
Asian	115	135	10	14	114	135	44	49	103	123
Black or African American	329	305	27	33	324	298	93	95	296	267
NHPI	*	38	*	1	*	38	*	*	*	36
White	580	615	62	58	692	745	190	180	631	698
Two or More Races	108	126	17	16	105	125	44	45	94	114
Hispanic or Latino	299	290	46	49	293	281	102	105	268	254
EDUCATION LEVEL
< High School	da	da	da	da	198	193	66	62	195	186
High School Graduate	da	da	da	da	409	395	132	131	438	427
Some College/Associate’s Degree	da	da	da	da	431	418	183	167	430	467
College Graduate	da	da	da	da	358	384	85	100	401	424
EMPLOYMENT STATUS
Full-Time	da	da	da	da	592	599	155	163	548	568
Part-Time	da	da	da	da	264	267	112	119	231	229
Unemployed	da	da	da	da	180	190	71	70	158	174
Other¹	da	da	da	da	465	483	103	97	446	472
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.28D – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.28	0.28	0.32	0.32	0.30	0.30	0.58	0.56	0.32	0.33
SEX
Male	0.42	0.42	0.44	0.44	0.46	0.45	0.85	0.78	0.49	0.51
Female	0.31	0.33	0.46	0.47	0.33	0.36	0.77	0.81	0.36	0.38
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.31	0.31	0.35	0.35	0.33	0.33	0.69	0.64	0.35	0.36
AIAN	3.54	2.45	1.27	2.16	4.22	2.87	5.59	5.47	4.84	2.94
Asian	0.65	0.70	0.71	0.89	0.70	0.75	1.87	1.93	0.73	0.82
Black or African American	0.78	0.70	0.72	0.87	0.86	0.76	1.57	1.49	0.96	0.83
NHPI	*	3.01	*	1.16	*	3.23	*	*	*	3.53
White	0.34	0.36	0.45	0.44	0.36	0.38	0.80	0.76	0.38	0.42
Two or More Races	1.63	1.66	1.73	1.50	1.89	1.95	3.10	2.80	2.16	2.29
Hispanic or Latino	0.57	0.53	0.67	0.71	0.65	0.59	1.23	1.20	0.72	0.65
EDUCATION LEVEL
< High School	da	da	da	da	0.81	0.80	1.55	1.52	0.89	0.87
High School Graduate	da	da	da	da	0.59	0.56	0.93	0.88	0.67	0.65
Some College/Associate’s Degree	da	da	da	da	0.56	0.54	1.05	0.99	0.60	0.62
College Graduate	da	da	da	da	0.41	0.43	1.25	1.35	0.43	0.43
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.40	0.42	0.89	0.88	0.43	0.46
Part-Time	da	da	da	da	0.74	0.74	1.05	1.12	0.91	0.87
Unemployed	da	da	da	da	1.44	1.23	1.86	1.64	1.82	1.62
Other¹	da	da	da	da	0.46	0.44	1.01	1.05	0.48	0.48
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.28P – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.9146	0.9247	0.8908	0.2109	0.8621
SEX
Male	0.7518	0.9310	0.7799	0.2670	0.5753
Female	0.5702	0.8209	0.5663	0.4808	0.6857
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6953	0.9222	0.7201	0.3006	0.5201
AIAN	0.1709	0.3893	0.1197	0.6057	0.0833
Asian	0.8188	0.7971	0.8069	0.8727	0.8478
Black or African American	0.2875	0.2917	0.2213	0.2338	0.3427
NHPI	*	*	*	*	*
White	0.1928	0.7617	0.2071	0.4885	0.1356
Two or More Races	0.8566	0.0147	0.7714	0.9410	0.7834
Hispanic or Latino	0.2735	0.7658	0.2685	0.5985	0.3022
EDUCATION LEVEL
< High School	da	da	0.6262	0.6438	0.6933
High School Graduate	da	da	0.3889	0.0971	0.1985
Some College/Associate’s Degree	da	da	0.6440	0.3192	0.3977
College Graduate	da	da	0.1766	0.2421	0.0957
EMPLOYMENT STATUS
Full-Time	da	da	0.6964	0.6304	0.7520
Part-Time	da	da	0.2091	0.0682	0.4950
Unemployed	da	da	0.6126	0.1924	0.9941
Other¹	da	da	0.3046	0.5713	0.3292
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.29C – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	838	865	18	21	828	857	127	110	802	831
SEX
Male	611	643	9	15	601	634	83	77	589	620
Female	520	511	15	16	516	509	81	74	497	498
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	762	765	13	18	753	758	109	98	730	742
AIAN	46	31	<1	1	46	31	3	8	46	30
Asian	147	128	1	*	147	128	18	17	148	126
Black or African American	239	284	1	5	239	283	23	18	239	281
NHPI	*	29	*	<1	*	29	*	*	*	29
White	700	667	12	17	877	835	111	93	851	821
Two or More Races	135	111	4	1	135	111	31	16	131	110
Hispanic or Latino	332	333	12	10	329	330	57	47	315	320
EDUCATION LEVEL
< High School	da	da	da	da	184	229	30	28	189	241
High School Graduate	da	da	da	da	454	396	68	61	519	432
Some College/Associate’s Degree	da	da	da	da	465	437	82	68	546	506
College Graduate	da	da	da	da	406	468	69	58	482	557
EMPLOYMENT STATUS
Full-Time	da	da	da	da	688	633	96	79	661	624
Part-Time	da	da	da	da	275	313	53	49	268	310
Unemployed	da	da	da	da	151	157	37	37	149	152
Other¹	da	da	da	da	549	564	63	49	547	563
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.29D – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.30	0.30	0.07	0.08	0.32	0.33	0.37	0.31	0.36	0.37
SEX
Male	0.44	0.46	0.07	0.11	0.48	0.50	0.48	0.44	0.54	0.56
Female	0.36	0.35	0.12	0.13	0.39	0.38	0.48	0.43	0.43	0.42
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.33	0.33	0.07	0.09	0.36	0.35	0.42	0.37	0.39	0.39
AIAN	2.99	2.02	0.05	0.26	3.56	2.39	2.15	4.33	4.05	2.70
Asian	0.83	0.67	0.09	*	0.90	0.73	0.78	0.74	1.05	0.83
Black or African American	0.64	0.71	0.03	0.13	0.71	0.79	0.50	0.39	0.83	0.90
NHPI	*	2.40	*	0.18	*	2.57	*	*	*	2.95
White	0.41	0.39	0.10	0.13	0.44	0.42	0.55	0.48	0.48	0.46
Two or More Races	1.87	1.55	0.47	0.09	2.16	1.84	2.52	1.45	2.63	2.30
Hispanic or Latino	0.64	0.61	0.18	0.15	0.72	0.69	0.70	0.54	0.85	0.82
EDUCATION LEVEL
< High School	da	da	da	da	0.75	0.95	0.83	0.78	0.87	1.10
High School Graduate	da	da	da	da	0.65	0.56	0.56	0.48	0.77	0.66
Some College/Associate’s Degree	da	da	da	da	0.60	0.56	0.55	0.49	0.72	0.66
College Graduate	da	da	da	da	0.47	0.52	1.10	0.91	0.49	0.54
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.46	0.45	0.63	0.52	0.51	0.50
Part-Time	da	da	da	da	0.78	0.86	0.60	0.52	1.02	1.14
Unemployed	da	da	da	da	1.23	1.13	1.07	0.96	1.73	1.51
Other¹	da	da	da	da	0.51	0.52	0.70	0.56	0.56	0.56
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.29P – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6216	0.3670	0.5651	0.0013	0.9281
SEX
Male	0.7767	0.1324	0.8309	0.0465	0.6051
Female	0.2450	0.9757	0.2292	0.0049	0.4430
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6458	0.4718	0.6005	0.0079	0.8855
AIAN	0.1527	0.3720	0.1144	0.0342	0.0560
Asian	0.8875	*	0.8853	0.5705	0.8303
Black or African American	0.2909	0.2996	0.3076	0.3596	0.2700
NHPI	*	*	*	*	*
White	0.7998	0.4271	0.7511	0.0144	0.9772
Two or More Races	0.1036	0.2693	0.1277	0.0533	0.2487
Hispanic or Latino	0.9509	0.5915	0.8919	0.0522	0.8372
EDUCATION LEVEL
< High School	da	da	0.0411	0.6897	0.0332
High School Graduate	da	da	0.1688	0.0415	0.3127
Some College/Associate’s Degree	da	da	0.5900	0.0245	0.8282
College Graduate	da	da	0.9043	0.1306	0.9216
EMPLOYMENT STATUS
Full-Time	da	da	0.1415	0.0207	0.2564
Part-Time	da	da	0.6277	0.0448	0.3391
Unemployed	da	da	0.9221	1.0000	0.8721
Other¹	da	da	0.5905	0.0834	0.4862
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.30C – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	264	221	17	18	264	220	84	63	245	208
SEX
Male	216	194	9	11	215	193	59	44	210	184
Female	130	108	14	14	129	109	51	49	113	94
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	226	200	12	16	226	199	68	57	211	190
AIAN	7	6	<1	*	7	6	3	3	6	5
Asian	36	45	1	*	36	45	17	12	32	44
Black or African American	75	75	*	4	75	75	12	10	74	74
NHPI	*	2	*	<1	*	2	*	*	*	2
White	201	171	11	15	204	174	66	54	190	163
Two or More Races	25	43	4	1	25	43	12	5	21	42
Hispanic or Latino	130	98	11	7	130	98	42	29	119	90
EDUCATION LEVEL
< High School	da	da	da	da	73	60	17	16	73	57
High School Graduate	da	da	da	da	130	138	37	36	128	133
Some College/Associate’s Degree	da	da	da	da	150	111	54	41	138	105
College Graduate	da	da	da	da	132	112	42	34	127	109
EMPLOYMENT STATUS
Full-Time	da	da	da	da	189	153	65	49	173	140
Part-Time	da	da	da	da	78	83	38	25	68	76
Unemployed	da	da	da	da	86	66	27	22	81	62
Other¹	da	da	da	da	143	118	27	29	140	114
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.30D – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.08	0.06	0.07	0.10	0.08	0.25	0.18	0.11	0.09
SEX
Male	0.16	0.14	0.07	0.08	0.17	0.15	0.35	0.25	0.19	0.17
Female	0.09	0.07	0.11	0.11	0.10	0.08	0.30	0.28	0.10	0.08
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.10	0.09	0.06	0.08	0.11	0.09	0.26	0.22	0.11	0.10
AIAN	0.48	0.45	0.03	*	0.59	0.54	2.09	2.14	0.60	0.52
Asian	0.21	0.24	0.09	*	0.22	0.27	0.77	0.51	0.23	0.30
Black or African American	0.21	0.21	*	0.10	0.24	0.23	0.25	0.22	0.27	0.27
NHPI	*	0.18	*	0.18	*	0.20	*	*	*	0.16
White	0.12	0.10	0.09	0.12	0.13	0.11	0.35	0.29	0.13	0.11
Two or More Races	0.41	0.65	0.45	0.07	0.47	0.77	1.12	0.46	0.51	0.97
Hispanic or Latino	0.25	0.18	0.17	0.11	0.29	0.21	0.51	0.33	0.32	0.23
EDUCATION LEVEL
< High School	da	da	da	da	0.30	0.25	0.47	0.46	0.35	0.28
High School Graduate	da	da	da	da	0.19	0.20	0.32	0.30	0.22	0.23
Some College/Associate’s Degree	da	da	da	da	0.20	0.14	0.39	0.30	0.22	0.16
College Graduate	da	da	da	da	0.15	0.12	0.70	0.56	0.15	0.13
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.15	0.12	0.45	0.34	0.16	0.13
Part-Time	da	da	da	da	0.24	0.25	0.44	0.28	0.29	0.32
Unemployed	da	da	da	da	0.74	0.50	0.79	0.59	0.98	0.66
Other¹	da	da	da	da	0.15	0.12	0.31	0.34	0.16	0.13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.30P – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0126	0.7084	0.0110	0.0138	0.0509
SEX
Male	0.1866	0.6929	0.1727	0.0222	0.4330
Female	0.0056	0.8511	0.0050	0.2110	0.0070
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0652	0.6316	0.0590	0.0350	0.1682
AIAN	0.3080	*	0.2878	0.9718	0.2040
Asian	0.7002	*	0.6878	0.5688	0.5034
Black or African American	0.7731	*	0.7365	0.9326	0.7380
NHPI	*	*	*	*	*
White	0.0418	0.5458	0.0361	0.0633	0.0925
Two or More Races	0.4940	0.2986	0.4163	0.0775	0.1735
Hispanic or Latino	0.0729	0.9692	0.0713	0.1842	0.1320
EDUCATION LEVEL
< High School	da	da	0.2970	0.6374	0.3373
High School Graduate	da	da	0.7074	0.6962	0.6209
Some College/Associate’s Degree	da	da	0.0177	0.0082	0.1095
College Graduate	da	da	0.0253	0.2449	0.0492
EMPLOYMENT STATUS
Full-Time	da	da	0.0659	0.0847	0.1626
Part-Time	da	da	0.0564	0.0034	0.4125
Unemployed	da	da	0.3960	0.7547	0.4048
Other¹	da	da	0.4968	0.5902	0.4242
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.31C – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	170	152	12	5	170	152	30	33	167	147
SEX
Male	146	133	4	4	146	133	22	28	144	129
Female	87	72	11	2	87	72	21	19	84	68
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	155	140	9	3	154	140	27	27	152	137
AIAN	4	1	*	*	4	1	*	*	3	1
Asian	19	41	1	*	19	41	3	3	18	41
Black or African American	63	55	*	*	63	55	4	6	63	54
NHPI	*	2	*	<1	*	2	*	<1	*	2
White	134	116	8	3	134	117	27	26	131	113
Two or More Races	13	40	*	1	12	40	4	4	11	39
Hispanic or Latino	68	54	8	3	68	54	13	19	67	51
EDUCATION LEVEL
< High School	da	da	da	da	59	50	9	14	59	47
High School Graduate	da	da	da	da	84	100	16	16	83	97
Some College/Associate’s Degree	da	da	da	da	104	71	16	17	103	69
College Graduate	da	da	da	da	73	62	19	18	71	60
EMPLOYMENT STATUS
Full-Time	da	da	da	da	110	83	26	24	107	78
Part-Time	da	da	da	da	43	61	11	11	42	60
Unemployed	da	da	da	da	54	43	7	7	54	42
Other¹	da	da	da	da	104	91	9	18	103	89
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.31D – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.05	0.04	0.02	0.07	0.06	0.09	0.09	0.07	0.06
SEX
Male	0.11	0.09	0.03	0.03	0.12	0.10	0.13	0.16	0.13	0.12
Female	0.06	0.05	0.09	0.02	0.07	0.05	0.12	0.11	0.07	0.06
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.07	0.06	0.05	0.02	0.07	0.07	0.11	0.10	0.08	0.07
AIAN	0.27	0.04	*	*	0.33	0.05	*	*	0.34	0.06
Asian	0.11	0.22	0.09	*	0.12	0.24	0.15	0.11	0.13	0.28
Black or African American	0.18	0.16	*	*	0.20	0.17	0.08	0.13	0.23	0.20
NHPI	*	0.13	*	0.18	*	0.14	*	0.01	*	0.16
White	0.08	0.07	0.06	0.02	0.08	0.07	0.15	0.15	0.09	0.08
Two or More Races	0.21	0.61	*	0.07	0.23	0.72	0.40	0.35	0.28	0.91
Hispanic or Latino	0.13	0.10	0.11	0.05	0.15	0.11	0.15	0.21	0.18	0.13
EDUCATION LEVEL
< High School	da	da	da	da	0.24	0.21	0.26	0.40	0.28	0.23
High School Graduate	da	da	da	da	0.12	0.14	0.13	0.13	0.14	0.17
Some College/Associate’s Degree	da	da	da	da	0.14	0.09	0.12	0.13	0.16	0.11
College Graduate	da	da	da	da	0.08	0.07	0.32	0.31	0.09	0.07
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.09	0.07	0.19	0.18	0.10	0.07
Part-Time	da	da	da	da	0.14	0.19	0.12	0.12	0.18	0.25
Unemployed	da	da	da	da	0.47	0.33	0.21	0.20	0.66	0.45
Other¹	da	da	da	da	0.11	0.09	0.11	0.21	0.12	0.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.31P – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4306	0.4242	0.4499	0.9302	0.4512
SEX
Male	0.8450	0.2722	0.8142	0.8236	0.7809
Female	0.2241	0.1618	0.2761	0.6679	0.3066
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4849	0.3457	0.5064	0.3599	0.6251
AIAN	0.0449	*	0.0442	*	0.1022
Asian	0.2335	*	0.2227	0.7581	0.2088
Black or African American	0.8277	*	0.8222	0.5121	0.7746
NHPI	*	*	*	*	*
White	0.2192	0.6090	0.2254	0.2980	0.3162
Two or More Races	0.1168	*	0.0949	0.6122	0.1077
Hispanic or Latino	0.7069	0.8684	0.7075	0.1560	0.4407
EDUCATION LEVEL
< High School	da	da	0.5149	0.5930	0.4309
High School Graduate	da	da	0.1468	0.2979	0.1902
Some College/Associate’s Degree	da	da	0.2020	0.6188	0.2224
College Graduate	da	da	0.1694	0.3641	0.2437
EMPLOYMENT STATUS
Full-Time	da	da	0.2750	0.4472	0.3636
Part-Time	da	da	0.7100	0.2101	0.5168
Unemployed	da	da	0.1956	0.9298	0.1806
Other¹	da	da	0.8113	0.0339	0.9384
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.32C – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	403	460	5	13	403	459	30	25	400	456
SEX
Male	317	391	4	7	316	390	25	19	314	386
Female	243	223	4	11	243	223	17	16	241	224
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	357	432	5	12	357	431	28	21	353	430
AIAN	27	21	<1	*	27	21	<1	2	27	21
Asian	31	25	*	*	31	25	*	6	31	25
Black or African American	169	189	*	*	169	189	8	3	169	189
NHPI	*	16	*	*	*	16	*	*	*	16
White	313	380	3	12	327	398	25	20	325	398
Two or More Races	42	54	*	*	42	54	11	3	40	54
Hispanic or Latino	177	150	1	4	176	150	18	13	175	148
EDUCATION LEVEL
< High School	da	da	da	da	120	165	10	12	122	166
High School Graduate	da	da	da	da	255	261	21	19	264	272
Some College/Associate’s Degree	da	da	da	da	248	261	20	9	258	273
College Graduate	da	da	da	da	134	172	3	1	136	175
EMPLOYMENT STATUS
Full-Time	da	da	da	da	313	278	25	14	311	278
Part-Time	da	da	da	da	117	177	14	5	116	176
Unemployed	da	da	da	da	110	85	12	8	109	84
Other¹	da	da	da	da	245	299	13	18	243	299
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.32D – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.14	0.16	0.02	0.05	0.16	0.17	0.09	0.07	0.18	0.20
SEX
Male	0.23	0.28	0.03	0.05	0.25	0.31	0.14	0.11	0.29	0.35
Female	0.17	0.15	0.03	0.09	0.18	0.17	0.10	0.09	0.21	0.19
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.15	0.18	0.03	0.06	0.17	0.20	0.11	0.08	0.19	0.23
AIAN	1.91	1.50	0.03	*	2.29	1.77	0.35	1.21	2.64	2.04
Asian	0.18	0.14	*	*	0.19	0.15	*	0.24	0.23	0.17
Black or African American	0.47	0.51	*	*	0.52	0.56	0.18	0.06	0.60	0.65
NHPI	*	1.29	*	*	*	1.38	*	*	*	1.60
White	0.18	0.22	0.03	0.10	0.20	0.24	0.14	0.11	0.22	0.27
Two or More Races	0.67	0.79	*	*	0.79	0.94	0.96	0.22	0.97	1.20
Hispanic or Latino	0.34	0.27	0.02	0.06	0.39	0.31	0.22	0.14	0.47	0.38
EDUCATION LEVEL
< High School	da	da	da	da	0.49	0.69	0.27	0.35	0.58	0.80
High School Graduate	da	da	da	da	0.37	0.37	0.18	0.16	0.44	0.45
Some College/Associate’s Degree	da	da	da	da	0.32	0.34	0.15	0.07	0.38	0.40
College Graduate	da	da	da	da	0.15	0.19	0.05	0.01	0.17	0.20
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.24	0.22	0.18	0.10	0.28	0.25
Part-Time	da	da	da	da	0.36	0.53	0.16	0.06	0.49	0.72
Unemployed	da	da	da	da	0.92	0.64	0.37	0.22	1.28	0.89
Other¹	da	da	da	da	0.25	0.30	0.15	0.21	0.28	0.33
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.32P – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3257	0.2664	0.3508	0.0125	0.2605
SEX
Male	0.0431	0.7579	0.0449	0.0896	0.0315
Female	0.1986	0.2517	0.1799	0.0639	0.2319
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1827	0.4730	0.1948	0.0323	0.1485
AIAN	0.4756	*	0.4304	0.2607	0.4041
Asian	0.6348	*	0.6380	*	0.7621
Black or African American	0.5450	*	0.5544	0.1189	0.5221
NHPI	*	*	*	*	*
White	0.1764	0.2805	0.1906	0.1009	0.1545
Two or More Races	0.4092	*	0.3480	0.0977	0.2156
Hispanic or Latino	0.5707	0.1538	0.5379	0.3170	0.6121
EDUCATION LEVEL
< High School	da	da	0.0727	0.6421	0.0639
High School Graduate	da	da	0.5298	0.2924	0.6325
Some College/Associate’s Degree	da	da	0.5455	0.0111	0.4499
College Graduate	da	da	0.1966	0.0407	0.1870
EMPLOYMENT STATUS
Full-Time	da	da	0.7036	0.0563	0.8169
Part-Time	da	da	0.3015	0.0033	0.1949
Unemployed	da	da	0.2212	0.6996	0.2111
Other¹	da	da	0.0789	0.8102	0.0844
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.33C – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	139	117	4	4	139	117	21	15	137	116
SEX
Male	120	105	4	*	120	105	16	13	119	104
Female	67	44	*	4	67	44	13	8	65	43
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	130	113	4	<1	130	113	12	9	130	113
AIAN	5	1	<1	*	5	1	<1	<1	5	1
Asian	*	16	*	*	*	16	*	*	*	16
Black or African American	66	40	*	*	66	40	3	2	66	40
NHPI	*	2	*	*	*	2	*	*	*	2
White	107	98	*	<1	107	98	12	9	106	98
Two or More Races	11	8	*	*	10	8	<1	*	10	8
Hispanic or Latino	48	30	*	4	48	30	17	12	45	28
EDUCATION LEVEL
< High School	da	da	da	da	50	37	6	11	50	35
High School Graduate	da	da	da	da	91	91	20	9	89	92
Some College/Associate’s Degree	da	da	da	da	86	39	4	4	86	39
College Graduate	da	da	da	da	28	22	1	*	28	22
EMPLOYMENT STATUS
Full-Time	da	da	da	da	85	23	20	2	83	23
Part-Time	da	da	da	da	26	48	6	4	25	48
Unemployed	da	da	da	da	70	30	1	4	70	29
Other¹	da	da	da	da	81	91	3	14	81	90
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.33D – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.05	0.04	0.02	0.02	0.05	0.04	0.06	0.04	0.06	0.05
SEX
Male	0.09	0.07	0.03	*	0.10	0.08	0.10	0.07	0.11	0.09
Female	0.05	0.03	*	0.03	0.05	0.03	0.08	0.05	0.06	0.04
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.05	0.02	<0.01	0.06	0.05	0.05	0.03	0.07	0.06
AIAN	0.33	0.04	0.03	*	0.40	0.05	0.03	0.14	0.46	0.05
Asian	*	0.09	*	*	*	0.09	*	*	*	0.11
Black or African American	0.19	0.11	*	*	0.21	0.13	0.07	0.05	0.25	0.15
NHPI	*	0.13	*	*	*	0.14	*	*	*	0.16
White	0.06	0.06	*	<0.01	0.07	0.06	0.07	0.05	0.08	0.07
Two or More Races	0.18	0.12	*	*	0.19	0.15	0.01	*	0.24	0.19
Hispanic or Latino	0.09	0.06	*	0.06	0.11	0.06	0.21	0.14	0.12	0.07
EDUCATION LEVEL
< High School	da	da	da	da	0.20	0.15	0.15	0.32	0.24	0.17
High School Graduate	da	da	da	da	0.13	0.13	0.17	0.08	0.15	0.16
Some College/Associate’s Degree	da	da	da	da	0.11	0.05	0.03	0.03	0.13	0.06
College Graduate	da	da	da	da	0.03	0.02	0.02	*	0.03	0.03
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.07	0.02	0.14	0.01	0.08	0.02
Part-Time	da	da	da	da	0.08	0.15	0.07	0.04	0.11	0.20
Unemployed	da	da	da	da	0.61	0.23	0.04	0.10	0.86	0.31
Other¹	da	da	da	da	0.09	0.09	0.04	0.17	0.10	0.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.33P – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1502	0.5212	0.1428	0.3880	0.1753
SEX
Male	0.4249	*	0.4359	0.4860	0.4900
Female	0.0950	*	0.0775	0.6104	0.0879
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1588	0.3256	0.1639	0.2769	0.1931
AIAN	0.0420	*	0.0426	0.3236	0.0385
Asian	*	*	*	*	*
Black or African American	0.1521	*	0.1507	0.5613	0.1573
NHPI	*	*	*	*	*
White	0.4343	*	0.4310	0.3408	0.4874
Two or More Races	0.2703	*	0.4095	*	0.4187
Hispanic or Latino	0.7955	*	0.6905	0.7634	0.7566
EDUCATION LEVEL
< High School	da	da	0.8567	0.5856	0.7665
High School Graduate	da	da	0.9280	0.2335	0.9004
Some College/Associate’s Degree	da	da	0.0337	0.7573	0.0343
College Graduate	da	da	0.2379	*	0.2516
EMPLOYMENT STATUS
Full-Time	da	da	0.0060	0.0166	0.0238
Part-Time	da	da	0.8634	0.4151	0.7732
Unemployed	da	da	0.0853	0.0765	0.0675
Other¹	da	da	0.4822	0.0841	0.6166
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.34C – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	104	93	4	<1	104	93	3	6	104	93
SEX
Male	91	82	4	*	91	82	<1	6	91	82
Female	50	36	*	<1	50	36	3	1	50	36
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	98	93	4	*	98	93	3	4	98	92
AIAN	2	*	*	*	2	*	*	*	2	*
Asian	*	16	*	*	*	16	*	*	*	16
Black or African American	52	37	*	*	52	37	*	*	52	37
NHPI	*	2	*	*	*	2	*	*	*	2
White	79	83	*	*	79	83	3	4	79	83
Two or More Races	10	7	*	*	9	7	*	*	9	7
Hispanic or Latino	34	11	*	<1	34	11	<1	5	34	10
EDUCATION LEVEL
< High School	da	da	da	da	48	32	1	1	49	31
High School Graduate	da	da	da	da	68	69	2	5	68	69
Some College/Associate’s Degree	da	da	da	da	60	30	<1	3	60	30
College Graduate	da	da	da	da	12	17	1	*	12	17
EMPLOYMENT STATUS
Full-Time	da	da	da	da	75	11	3	*	75	11
Part-Time	da	da	da	da	10	45	*	3	10	45
Unemployed	da	da	da	da	43	27	<1	2	43	26
Other¹	da	da	da	da	57	64	<1	4	57	64
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.34D – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.03	0.02	<0.01	0.04	0.04	0.01	0.02	0.05	0.04
SEX
Male	0.07	0.06	0.03	*	0.07	0.06	<0.01	0.03	0.08	0.07
Female	0.03	0.02	*	<0.01	0.04	0.03	0.02	<0.01	0.04	0.03
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.04	0.04	0.02	*	0.05	0.04	0.01	0.01	0.05	0.05
AIAN	0.16	*	*	*	0.19	*	*	*	0.22	*
Asian	*	0.09	*	*	*	0.09	*	*	*	0.11
Black or African American	0.15	0.10	*	*	0.17	0.12	*	*	0.19	0.14
NHPI	*	0.13	*	*	*	0.14	*	*	*	0.16
White	0.05	0.05	*	*	0.05	0.05	0.02	0.02	0.06	0.06
Two or More Races	0.16	0.11	*	*	0.18	0.13	*	*	0.23	0.17
Hispanic or Latino	0.06	0.02	*	<0.01	0.07	0.02	<0.01	0.05	0.09	0.02
EDUCATION LEVEL
< High School	da	da	da	da	0.20	0.13	0.04	0.04	0.23	0.15
High School Graduate	da	da	da	da	0.10	0.10	0.02	0.04	0.12	0.12
Some College/Associate’s Degree	da	da	da	da	0.08	0.04	<0.01	0.02	0.09	0.05
College Graduate	da	da	da	da	0.01	0.02	0.02	*	0.02	0.02
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.06	0.01	0.02	*	0.07	0.01
Part-Time	da	da	da	da	0.03	0.14	*	0.04	0.04	0.19
Unemployed	da	da	da	da	0.37	0.21	<0.01	0.05	0.53	0.28
Other¹	da	da	da	da	0.06	0.07	<0.01	0.05	0.07	0.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.34P – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3761	0.3432	0.3883	0.1967	0.3576
SEX
Male	0.6348	*	0.6552	0.0340	0.5869
Female	0.2901	*	0.2873	0.1554	0.3167
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5008	*	0.5174	0.8860	0.5147
AIAN	*	*	*	*	*
Asian	*	*	*	*	*
Black or African American	0.5582	*	0.5549	*	0.5529
NHPI	*	*	*	*	*
White	0.7157	*	0.7136	0.8765	0.7094
Two or More Races	0.3894	*	0.5784	*	0.5807
Hispanic or Latino	0.3966	*	0.3917	0.0918	0.2854
EDUCATION LEVEL
< High School	da	da	0.5909	0.7400	0.5810
High School Graduate	da	da	0.5519	0.2518	0.5818
Some College/Associate’s Degree	da	da	0.0397	0.3314	0.0351
College Graduate	da	da	0.8069	*	0.8532
EMPLOYMENT STATUS
Full-Time	da	da	0.0409	*	0.0472
Part-Time	da	da	0.3600	*	0.4013
Unemployed	da	da	0.1852	0.1172	0.1626
Other¹	da	da	0.5230	0.1565	0.5755
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.35C – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	861	900	47	51	849	890	163	178	829	851
SEX
Male	662	668	32	34	650	660	115	129	634	635
Female	489	518	33	36	486	516	106	119	471	498
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	769	801	38	45	763	796	138	144	741	765
AIAN	42	45	1	2	42	45	8	11	43	43
Asian	128	129	8	6	128	129	32	38	124	122
Black or African American	231	227	12	14	231	226	51	58	225	210
NHPI	*	57	*	1	*	57	*	*	*	56
White	694	728	35	44	888	945	142	142	852	917
Two or More Races	149	129	8	6	149	129	36	35	145	122
Hispanic or Latino	361	335	28	25	356	333	86	93	338	313
EDUCATION LEVEL
< High School	da	da	da	da	183	200	44	51	179	200
High School Graduate	da	da	da	da	437	398	94	97	479	439
Some College/Associate’s Degree	da	da	da	da	470	470	129	124	567	545
College Graduate	da	da	da	da	432	493	79	91	511	630
EMPLOYMENT STATUS
Full-Time	da	da	da	da	738	720	129	132	709	696
Part-Time	da	da	da	da	285	321	84	90	271	306
Unemployed	da	da	da	da	155	198	51	64	145	189
Other¹	da	da	da	da	518	545	79	79	512	540
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.35D – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.30	0.31	0.18	0.20	0.33	0.34	0.48	0.51	0.37	0.37
SEX
Male	0.48	0.47	0.24	0.25	0.52	0.52	0.67	0.74	0.59	0.58
Female	0.34	0.35	0.26	0.29	0.37	0.38	0.62	0.69	0.41	0.42
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.33	0.34	0.20	0.24	0.36	0.37	0.53	0.55	0.40	0.41
AIAN	2.93	2.71	0.33	0.83	3.46	3.15	5.08	5.48	3.93	3.62
Asian	0.73	0.67	0.57	0.39	0.79	0.73	1.36	1.53	0.90	0.80
Black or African American	0.60	0.59	0.34	0.39	0.67	0.66	1.01	1.11	0.78	0.73
NHPI	*	4.36	*	0.82	*	4.66	*	*	*	5.27
White	0.41	0.43	0.27	0.33	0.44	0.46	0.67	0.66	0.48	0.50
Two or More Races	2.00	1.78	0.88	0.53	2.31	2.11	2.73	2.76	2.85	2.53
Hispanic or Latino	0.69	0.61	0.42	0.36	0.78	0.70	1.04	1.06	0.91	0.80
EDUCATION LEVEL
< High School	da	da	da	da	0.75	0.83	1.11	1.32	0.84	0.93
High School Graduate	da	da	da	da	0.63	0.57	0.73	0.74	0.73	0.67
Some College/Associate’s Degree	da	da	da	da	0.61	0.60	0.82	0.83	0.72	0.70
College Graduate	da	da	da	da	0.50	0.55	1.16	1.32	0.52	0.57
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.48	0.50	0.80	0.81	0.53	0.53
Part-Time	da	da	da	da	0.80	0.86	0.91	0.92	1.06	1.11
Unemployed	da	da	da	da	1.21	1.29	1.41	1.51	1.59	1.72
Other¹	da	da	da	da	0.48	0.49	0.84	0.87	0.53	0.54
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.35P – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0625	0.3054	0.0756	0.3072	0.1045
SEX
Male	0.1634	0.8295	0.1732	0.0696	0.2941
Female	0.1611	0.2013	0.1985	0.6785	0.1517
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0398	0.2171	0.0486	0.1444	0.0781
AIAN	0.5654	0.1632	0.4476	0.1762	0.3054
Asian	0.8089	0.4614	0.8318	0.5837	0.7042
Black or African American	0.6126	0.7834	0.6206	0.8156	0.6504
NHPI	*	*	*	*	*
White	0.0108	0.0745	0.0146	0.2330	0.0218
Two or More Races	0.4320	0.2005	0.5432	0.2204	0.3421
Hispanic or Latino	0.8185	0.9708	0.8538	0.8366	0.7966
EDUCATION LEVEL
< High School	da	da	0.1636	0.4058	0.2157
High School Graduate	da	da	0.9833	0.8656	0.9917
Some College/Associate’s Degree	da	da	0.8329	0.8050	0.8786
College Graduate	da	da	0.0163	0.1694	0.0259
EMPLOYMENT STATUS
Full-Time	da	da	0.3680	0.6539	0.3941
Part-Time	da	da	0.8323	0.4723	0.9647
Unemployed	da	da	0.0081	0.0665	0.0300
Other¹	da	da	0.1430	0.2013	0.2082
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.36C – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	294	388	41	43	289	385	111	117	263	370
SEX
Male	244	309	30	30	240	307	79	89	225	290
Female	165	209	28	29	161	205	71	74	136	195
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	253	352	34	38	251	350	93	103	231	337
AIAN	26	26	1	1	26	26	1	*	*	*
Asian	57	85	3	*	57	85	28	25	54	80
Black or African American	97	84	10	13	96	83	35	34	92	75
NHPI	4	9	*	1	3	9	*	2	3	9
White	224	305	33	36	228	318	81	90	214	305
Two or More Races	42	79	8	4	42	79	27	27	31	75
Hispanic or Latino	136	140	24	20	133	138	53	52	119	129
EDUCATION LEVEL
< High School	da	da	da	da	66	74	23	30	62	69
High School Graduate	da	da	da	da	133	141	61	59	122	126
Some College/Associate’s Degree	da	da	da	da	165	219	78	80	147	212
College Graduate	da	da	da	da	187	247	46	52	184	262
EMPLOYMENT STATUS
Full-Time	da	da	da	da	241	299	76	82	221	283
Part-Time	da	da	da	da	105	131	58	55	91	124
Unemployed	da	da	da	da	70	100	32	39	61	93
Other¹	da	da	da	da	133	181	47	49	126	175
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.36D – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.10	0.13	0.16	0.16	0.11	0.15	0.33	0.33	0.12	0.16
SEX
Male	0.18	0.22	0.23	0.22	0.19	0.24	0.47	0.51	0.21	0.26
Female	0.11	0.14	0.22	0.23	0.12	0.15	0.42	0.43	0.12	0.17
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.11	0.15	0.18	0.20	0.12	0.16	0.36	0.39	0.12	0.18
AIAN	1.93	1.84	0.28	0.70	2.34	2.16	1.07	*	*	*
Asian	0.33	0.44	0.23	*	0.36	0.48	1.22	1.01	0.39	0.53
Black or African American	0.26	0.23	0.26	0.37	0.29	0.26	0.74	0.71	0.33	0.28
NHPI	0.33	0.78	*	0.82	0.34	0.83	*	1.41	0.38	0.93
White	0.13	0.18	0.26	0.27	0.14	0.19	0.42	0.48	0.15	0.21
Two or More Races	0.68	1.14	0.81	0.39	0.79	1.36	2.26	2.21	0.75	1.62
Hispanic or Latino	0.26	0.26	0.35	0.29	0.29	0.29	0.64	0.59	0.32	0.33
EDUCATION LEVEL
< High School	da	da	da	da	0.27	0.31	0.65	0.82	0.30	0.33
High School Graduate	da	da	da	da	0.19	0.20	0.51	0.48	0.21	0.22
Some College/Associate’s Degree	da	da	da	da	0.21	0.28	0.55	0.58	0.23	0.32
College Graduate	da	da	da	da	0.22	0.27	0.77	0.85	0.22	0.29
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.19	0.24	0.53	0.56	0.20	0.25
Part-Time	da	da	da	da	0.32	0.39	0.65	0.61	0.38	0.51
Unemployed	da	da	da	da	0.62	0.72	0.93	1.01	0.76	0.93
Other¹	da	da	da	da	0.14	0.19	0.52	0.57	0.15	0.20
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.36P – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0020	0.7584	0.0021	0.8694	0.0015
SEX
Male	0.0041	0.7570	0.0035	0.3961	0.0052
Female	0.1879	0.4252	0.2284	0.4420	0.1040
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0008	0.6863	0.0009	0.8928	0.0006
AIAN	0.8825	0.2618	0.8207	*	*
Asian	0.9087	*	0.8793	0.3722	0.6209
Black or African American	0.2874	0.7045	0.2606	0.3793	0.4284
NHPI	0.1122	*	0.1168	*	0.1858
White	0.0004	0.4915	0.0004	0.5529	0.0004
Two or More Races	0.0165	0.0927	0.0087	0.4499	0.0112
Hispanic or Latino	0.7760	0.9336	0.7732	0.8546	0.8212
EDUCATION LEVEL
< High School	da	da	0.8412	0.3579	0.8670
High School Graduate	da	da	0.2787	0.6515	0.1936
Some College/Associate’s Degree	da	da	0.0793	0.7918	0.0400
College Graduate	da	da	0.0183	0.3763	0.0265
EMPLOYMENT STATUS
Full-Time	da	da	0.0360	0.6747	0.0173
Part-Time	da	da	0.4840	0.1977	0.1704
Unemployed	da	da	0.0635	0.3153	0.1033
Other¹	da	da	0.1304	0.0733	0.2779
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.37C – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	152	179	21	27	152	177	55	50	143	168
SEX
Male	124	151	16	19	123	150	37	37	117	146
Female	90	90	13	19	89	88	39	36	80	78
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	132	166	19	25	131	164	50	45	123	157
AIAN	*	5	1	<1	*	5	<1	*	*	2
Asian	34	37	1	*	34	37	18	3	29	37
Black or African American	55	50	8	<1	55	50	19	22	50	45
NHPI	3	7	*	*	*	7	*	1	*	*
White	111	143	17	25	112	143	42	38	106	138
Two or More Races	16	40	5	4	16	40	6	6	14	39
Hispanic or Latino	80	63	9	11	80	62	20	26	78	57
EDUCATION LEVEL
< High School	da	da	da	da	47	47	11	14	46	46
High School Graduate	da	da	da	da	63	78	30	29	57	72
Some College/Associate’s Degree	da	da	da	da	89	81	33	29	81	76
College Graduate	da	da	da	da	101	124	28	26	95	123
EMPLOYMENT STATUS
Full-Time	da	da	da	da	119	145	40	35	111	138
Part-Time	da	da	da	da	47	58	27	22	40	54
Unemployed	da	da	da	da	39	35	19	19	33	29
Other¹	da	da	da	da	80	77	14	24	78	73
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.37D – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.05	0.06	0.08	0.11	0.06	0.07	0.16	0.14	0.06	0.07
SEX
Male	0.09	0.11	0.12	0.15	0.10	0.12	0.22	0.21	0.11	0.13
Female	0.06	0.06	0.11	0.15	0.07	0.07	0.23	0.21	0.07	0.07
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.07	0.10	0.13	0.06	0.08	0.19	0.17	0.07	0.08
AIAN	*	0.37	0.27	0.19	*	0.43	0.11	*	*	0.19
Asian	0.19	0.20	0.09	*	0.21	0.21	0.83	0.11	0.21	0.25
Black or African American	0.16	0.14	0.23	0.01	0.17	0.16	0.43	0.47	0.19	0.17
NHPI	0.31	0.53	*	*	*	0.57	*	0.66	*	*
White	0.07	0.08	0.13	0.20	0.07	0.09	0.24	0.21	0.07	0.10
Two or More Races	0.27	0.61	0.54	0.39	0.30	0.72	0.56	0.56	0.35	0.90
Hispanic or Latino	0.15	0.12	0.13	0.16	0.18	0.13	0.25	0.29	0.21	0.15
EDUCATION LEVEL
< High School	da	da	da	da	0.19	0.20	0.30	0.40	0.22	0.22
High School Graduate	da	da	da	da	0.09	0.11	0.26	0.24	0.10	0.12
Some College/Associate’s Degree	da	da	da	da	0.12	0.10	0.25	0.22	0.13	0.12
College Graduate	da	da	da	da	0.12	0.14	0.49	0.44	0.12	0.14
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.10	0.12	0.29	0.24	0.10	0.13
Part-Time	da	da	da	da	0.15	0.18	0.32	0.25	0.17	0.23
Unemployed	da	da	da	da	0.35	0.27	0.57	0.52	0.41	0.32
Other¹	da	da	da	da	0.08	0.08	0.16	0.28	0.09	0.08
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.37P – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6739	0.7198	0.7158	0.0970	0.3463
SEX
Male	0.4476	0.8150	0.4314	0.5822	0.3313
Female	0.6869	0.4355	0.5735	0.0733	0.8149
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4144	0.8925	0.4239	0.0367	0.1233
AIAN	*	0.4277	*	*	*
Asian	0.7367	*	0.7531	0.0745	0.6728
Black or African American	0.8144	0.1764	0.9218	0.7039	0.9487
NHPI	0.6062	*	*	*	*
White	0.4468	0.4509	0.5205	0.0939	0.2215
Two or More Races	0.0646	0.4481	0.0455	0.7121	0.0343
Hispanic or Latino	0.4924	0.5621	0.4365	0.6181	0.3204
EDUCATION LEVEL
< High School	da	da	0.4784	0.5874	0.3785
High School Graduate	da	da	0.6444	0.3499	0.3744
Some College/Associate’s Degree	da	da	0.4135	0.1291	0.7857
College Graduate	da	da	0.2705	0.4577	0.1794
EMPLOYMENT STATUS
Full-Time	da	da	0.4968	0.0897	0.2205
Part-Time	da	da	0.8707	0.0963	0.2888
Unemployed	da	da	0.3707	0.4915	0.5088
Other¹	da	da	0.9858	0.1274	0.6907
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.38C – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	650	--	115	--	633	--	129	--	624
SEX
Male	--	524	--	81	--	516	--	100	--	500
Female	--	364	--	80	--	354	--	93	--	351
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	587	--	90	--	578	--	109	--	569
AIAN	--	34	--	7	--	34	--	5	--	34
Asian	--	158	--	31	--	149	--	47	--	133
Black or African American	--	150	--	46	--	140	--	43	--	136
NHPI	--	36	--	*	--	35	--	2	--	35
White	--	543	--	79	--	636	--	105	--	621
Two or More Races	--	90	--	22	--	87	--	19	--	84
Hispanic or Latino	--	285	--	69	--	274	--	68	--	262
EDUCATION LEVEL
< High School	da	da	da	da	--	157	--	42	--	156
High School Graduate	da	da	da	da	--	297	--	78	--	301
Some College/Associate’s Degree	da	da	da	da	--	364	--	94	--	400
College Graduate	da	da	da	da	--	400	--	68	--	473
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	490	--	92	--	477
Part-Time	da	da	da	da	--	251	--	76	--	244
Unemployed	da	da	da	da	--	154	--	45	--	151
Other¹	da	da	da	da	--	416	--	65	--	411
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.38D – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.23	--	0.44	--	0.24	--	0.37	--	0.27
SEX
Male	--	0.37	--	0.61	--	0.40	--	0.57	--	0.45
Female	--	0.25	--	0.63	--	0.26	--	0.53	--	0.30
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.25	--	0.47	--	0.27	--	0.42	--	0.30
AIAN	--	2.32	--	2.97	--	2.70	--	2.96	--	3.09
Asian	--	0.80	--	1.90	--	0.83	--	1.79	--	0.87
Black or African American	--	0.41	--	1.08	--	0.43	--	0.89	--	0.50
NHPI	--	2.87	--	*	--	2.99	--	1.39	--	3.41
White	--	0.32	--	0.58	--	0.34	--	0.53	--	0.38
Two or More Races	--	1.31	--	1.88	--	1.50	--	1.62	--	1.84
Hispanic or Latino	--	0.52	--	1.00	--	0.58	--	0.77	--	0.67
EDUCATION LEVEL
< High School	da	da	da	da	--	0.65	--	1.15	--	0.74
High School Graduate	da	da	da	da	--	0.42	--	0.61	--	0.50
Some College/Associate’s Degree	da	da	da	da	--	0.47	--	0.64	--	0.56
College Graduate	da	da	da	da	--	0.44	--	1.03	--	0.47
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.35	--	0.60	--	0.39
Part-Time	da	da	da	da	--	0.72	--	0.82	--	0.95
Unemployed	da	da	da	da	--	1.11	--	1.13	--	1.49
Other¹	da	da	da	da	--	0.40	--	0.72	--	0.43
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.39C – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	163	--	67	--	147	--	60	--	133
SEX
Male	--	138	--	48	--	129	--	44	--	120
Female	--	95	--	48	--	79	--	43	--	63
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	150	--	60	--	136	--	47	--	125
AIAN	--	5	--	4	--	2	--	<1	--	2
Asian	--	46	--	19	--	40	--	18	--	35
Black or African American	--	56	--	32	--	45	--	13	--	43
NHPI	--	9	--	*	--	1	--	*	--	1
White	--	125	--	44	--	120	--	43	--	108
Two or More Races	--	36	--	11	--	35	--	5	--	35
Hispanic or Latino	--	68	--	32	--	58	--	36	--	45
EDUCATION LEVEL
< High School	da	da	da	da	--	36	--	23	--	30
High School Graduate	da	da	da	da	--	58	--	32	--	49
Some College/Associate’s Degree	da	da	da	da	--	75	--	43	--	63
College Graduate	da	da	da	da	--	106	--	22	--	104
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	115	--	33	--	106
Part-Time	da	da	da	da	--	52	--	38	--	36
Unemployed	da	da	da	da	--	48	--	17	--	45
Other¹	da	da	da	da	--	67	--	32	--	58
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.39D – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.06	--	0.26	--	0.06	--	0.17	--	0.06
SEX
Male	--	0.10	--	0.36	--	0.10	--	0.25	--	0.11
Female	--	0.06	--	0.38	--	0.06	--	0.25	--	0.05
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.06	--	0.31	--	0.06	--	0.18	--	0.07
AIAN	--	0.35	--	1.90	--	0.21	--	0.25	--	0.24
Asian	--	0.25	--	1.22	--	0.23	--	0.75	--	0.24
Black or African American	--	0.15	--	0.83	--	0.14	--	0.28	--	0.16
NHPI	--	0.70	--	*	--	0.08	--	*	--	0.09
White	--	0.07	--	0.34	--	0.07	--	0.24	--	0.08
Two or More Races	--	0.56	--	0.99	--	0.64	--	0.48	--	0.80
Hispanic or Latino	--	0.12	--	0.47	--	0.12	--	0.41	--	0.11
EDUCATION LEVEL
< High School	da	da	da	da	--	0.15	--	0.65	--	0.14
High School Graduate	da	da	da	da	--	0.08	--	0.26	--	0.08
Some College/Associate’s Degree	da	da	da	da	--	0.10	--	0.31	--	0.10
College Graduate	da	da	da	da	--	0.12	--	0.36	--	0.12
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.09	--	0.23	--	0.10
Part-Time	da	da	da	da	--	0.16	--	0.42	--	0.15
Unemployed	da	da	da	da	--	0.37	--	0.44	--	0.48
Other¹	da	da	da	da	--	0.07	--	0.38	--	0.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.40C – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	96	--	35	--	88	--	33	--	88
SEX
Male	--	92	--	25	--	89	--	23	--	86
Female	--	38	--	24	--	29	--	24	--	16
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	91	--	33	--	84	--	21	--	81
AIAN	--	4	--	*	--	1	--	<1	--	1
Asian	--	32	--	*	--	30	--	7	--	29
Black or African American	--	45	--	21	--	38	--	5	--	38
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	72	--	19	--	69	--	19	--	67
Two or More Races	--	11	--	8	--	8	--	2	--	8
Hispanic or Latino	--	43	--	13	--	40	--	25	--	31
EDUCATION LEVEL
< High School	da	da	da	da	--	19	--	13	--	13
High School Graduate	da	da	da	da	--	38	--	16	--	35
Some College/Associate’s Degree	da	da	da	da	--	51	--	26	--	44
College Graduate	da	da	da	da	--	70	--	6	--	70
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	67	--	17	--	65
Part-Time	da	da	da	da	--	27	--	26	--	8
Unemployed	da	da	da	da	--	34	--	10	--	32
Other¹	da	da	da	da	--	51	--	7	--	51
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.40D – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.03	--	0.14	--	0.03	--	0.10	--	0.04
SEX
Male	--	0.07	--	0.19	--	0.07	--	0.13	--	0.08
Female	--	0.03	--	0.19	--	0.02	--	0.14	--	0.01
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.04	--	0.17	--	0.04	--	0.08	--	0.04
AIAN	--	0.31	--	*	--	0.11	--	0.08	--	0.13
Asian	--	0.17	--	*	--	0.17	--	0.27	--	0.20
Black or African American	--	0.13	--	0.58	--	0.12	--	0.11	--	0.14
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	0.04	--	0.15	--	0.04	--	0.11	--	0.05
Two or More Races	--	0.18	--	0.73	--	0.16	--	0.18	--	0.19
Hispanic or Latino	--	0.08	--	0.19	--	0.08	--	0.29	--	0.08
EDUCATION LEVEL
< High School	da	da	da	da	--	0.08	--	0.35	--	0.06
High School Graduate	da	da	da	da	--	0.05	--	0.13	--	0.06
Some College/Associate’s Degree	da	da	da	da	--	0.07	--	0.20	--	0.07
College Graduate	da	da	da	da	--	0.08	--	0.10	--	0.08
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.05	--	0.12	--	0.06
Part-Time	da	da	da	da	--	0.08	--	0.30	--	0.03
Unemployed	da	da	da	da	--	0.26	--	0.26	--	0.35
Other¹	da	da	da	da	--	0.05	--	0.08	--	0.06
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.41C – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	547	525	23	27	546	525	47	51	544	517
SEX
Male	430	427	14	11	427	427	37	39	423	421
Female	305	272	18	25	306	273	32	30	306	269
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	497	467	20	26	496	467	43	38	493	461
AIAN	49	24	<1	*	49	24	1	*	49	24
Asian	60	54	*	*	60	53	4	5	60	53
Black or African American	94	74	1	3	94	74	15	5	92	73
NHPI	*	11	*	*	*	11	<1	*	*	11
White	467	448	20	25	512	481	39	37	508	478
Two or More Races	83	77	4	4	83	77	15	4	81	77
Hispanic or Latino	189	218	11	7	188	218	19	34	187	212
EDUCATION LEVEL
< High School	da	da	da	da	138	134	23	17	139	132
High School Graduate	da	da	da	da	319	271	30	38	343	285
Some College/Associate’s Degree	da	da	da	da	310	307	30	25	335	324
College Graduate	da	da	da	da	225	220	10	9	232	231
EMPLOYMENT STATUS
Full-Time	da	da	da	da	401	321	33	22	398	320
Part-Time	da	da	da	da	143	182	22	14	141	181
Unemployed	da	da	da	da	113	109	16	23	111	107
Other¹	da	da	da	da	345	339	23	32	343	337
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.41D – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.19	0.18	0.09	0.11	0.21	0.20	0.14	0.15	0.24	0.23
SEX
Male	0.31	0.30	0.11	0.08	0.34	0.33	0.22	0.22	0.39	0.38
Female	0.21	0.19	0.14	0.20	0.23	0.20	0.19	0.17	0.27	0.23
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.22	0.20	0.11	0.14	0.23	0.22	0.17	0.15	0.26	0.24
AIAN	3.10	1.67	0.13	*	3.68	1.97	1.03	*	4.15	2.27
Asian	0.34	0.28	*	*	0.37	0.31	0.20	0.22	0.43	0.36
Black or African American	0.26	0.21	0.03	0.07	0.29	0.23	0.33	0.12	0.34	0.27
NHPI	*	0.93	*	*	*	1.00	0.04	*	*	1.17
White	0.27	0.26	0.15	0.20	0.30	0.28	0.22	0.20	0.33	0.32
Two or More Races	1.26	1.12	0.43	0.35	1.47	1.32	1.34	0.36	1.83	1.68
Hispanic or Latino	0.36	0.40	0.16	0.10	0.41	0.46	0.23	0.39	0.50	0.55
EDUCATION LEVEL
< High School	da	da	da	da	0.56	0.56	0.63	0.47	0.65	0.65
High School Graduate	da	da	da	da	0.46	0.38	0.26	0.31	0.55	0.46
Some College/Associate’s Degree	da	da	da	da	0.40	0.39	0.23	0.19	0.48	0.47
College Graduate	da	da	da	da	0.26	0.24	0.18	0.15	0.28	0.26
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.31	0.25	0.23	0.16	0.34	0.29
Part-Time	da	da	da	da	0.45	0.55	0.27	0.16	0.61	0.74
Unemployed	da	da	da	da	0.93	0.81	0.46	0.63	1.30	1.11
Other¹	da	da	da	da	0.34	0.34	0.27	0.38	0.38	0.37
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.41P – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1360	0.9213	0.1274	0.0989	0.1751
SEX
Male	0.5844	0.4994	0.5506	0.2396	0.6330
Female	0.0620	0.7784	0.0640	0.2272	0.0847
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0566	0.6960	0.0514	0.0104	0.0826
AIAN	0.0731	*	0.0609	*	0.0504
Asian	0.4381	*	0.5027	0.9869	0.4980
Black or African American	0.3572	0.3331	0.3397	0.1169	0.4526
NHPI	*	*	*	*	*
White	0.1371	0.9740	0.1307	0.0829	0.1685
Two or More Races	0.6891	0.8082	0.7203	0.0259	0.9801
Hispanic or Latino	0.4244	0.4761	0.4230	0.3639	0.4845
EDUCATION LEVEL
< High School	da	da	0.6723	0.0868	0.4883
High School Graduate	da	da	0.1138	0.9417	0.1283
Some College/Associate’s Degree	da	da	0.9325	0.0798	0.9411
College Graduate	da	da	0.1414	0.7900	0.1426
EMPLOYMENT STATUS
Full-Time	da	da	0.0966	0.0097	0.1520
Part-Time	da	da	0.9672	0.0155	0.6927
Unemployed	da	da	0.8869	0.3217	0.9237
Other¹	da	da	0.3433	0.5506	0.2993
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.42C – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	212	184	17	24	212	181	19	29	211	178
SEX
Male	175	159	14	5	174	158	13	25	173	155
Female	116	87	9	24	116	83	13	13	114	83
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	192	170	14	24	191	168	16	22	189	166
AIAN	27	8	<1	*	27	8	1	<1	27	8
Asian	15	25	*	*	15	24	*	*	15	24
Black or African American	41	37	1	3	41	37	2	4	41	36
NHPI	*	5	*	*	*	5	*	*	*	5
White	172	157	14	22	174	157	16	21	172	156
Two or More Races	21	26	4	4	21	25	1	4	21	25
Hispanic or Latino	91	85	9	4	92	85	8	18	91	83
EDUCATION LEVEL
< High School	da	da	da	da	70	74	13	13	69	72
High School Graduate	da	da	da	da	138	112	11	21	140	113
Some College/Associate’s Degree	da	da	da	da	130	101	8	14	131	102
College Graduate	da	da	da	da	61	39	2	1	61	39
EMPLOYMENT STATUS
Full-Time	da	da	da	da	121	77	10	10	120	76
Part-Time	da	da	da	da	54	60	11	3	53	60
Unemployed	da	da	da	da	85	66	7	14	84	64
Other¹	da	da	da	da	143	130	8	21	142	128
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.42D – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.07	0.06	0.07	0.09	0.08	0.07	0.06	0.08	0.09	0.08
SEX
Male	0.13	0.11	0.11	0.04	0.14	0.12	0.08	0.14	0.16	0.14
Female	0.08	0.06	0.07	0.19	0.09	0.06	0.08	0.08	0.10	0.07
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.08	0.07	0.07	0.13	0.09	0.08	0.06	0.09	0.10	0.09
AIAN	1.95	0.62	0.13	*	2.36	0.73	0.78	0.24	2.69	0.84
Asian	0.08	0.14	*	*	0.09	0.14	*	*	0.11	0.16
Black or African American	0.12	0.11	0.03	0.07	0.13	0.12	0.05	0.10	0.16	0.13
NHPI	*	0.43	*	*	*	0.46	*	*	*	0.53
White	0.10	0.09	0.11	0.18	0.11	0.10	0.09	0.12	0.12	0.11
Two or More Races	0.34	0.40	0.43	0.34	0.40	0.47	0.13	0.35	0.50	0.59
Hispanic or Latino	0.17	0.16	0.14	0.06	0.20	0.18	0.10	0.21	0.25	0.21
EDUCATION LEVEL
< High School	da	da	da	da	0.28	0.31	0.36	0.37	0.33	0.35
High School Graduate	da	da	da	da	0.20	0.16	0.09	0.17	0.24	0.19
Some College/Associate’s Degree	da	da	da	da	0.17	0.13	0.06	0.11	0.20	0.16
College Graduate	da	da	da	da	0.07	0.04	0.04	0.01	0.08	0.05
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.10	0.06	0.07	0.07	0.11	0.07
Part-Time	da	da	da	da	0.17	0.19	0.13	0.04	0.23	0.25
Unemployed	da	da	da	da	0.73	0.50	0.20	0.37	1.02	0.68
Other¹	da	da	da	da	0.15	0.14	0.09	0.25	0.17	0.15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.42P – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3028	0.5656	0.2684	0.1454	0.1930
SEX
Male	0.7227	0.7257	0.7313	0.0804	0.5833
Female	0.1756	0.3807	0.1270	0.9734	0.1188
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4537	0.3274	0.3839	0.2767	0.3146
AIAN	0.1625	*	0.1596	0.2438	0.1739
Asian	0.5157	*	0.7001	*	0.6979
Black or African American	0.9093	0.2570	0.8566	0.6937	0.8251
NHPI	*	*	*	*	*
White	0.6599	0.5684	0.6053	0.3466	0.5241
Two or More Races	0.1922	0.8452	0.1952	0.1530	0.2483
Hispanic or Latino	0.4475	0.3211	0.4930	0.3097	0.3943
EDUCATION LEVEL
< High School	da	da	0.9588	0.7637	0.9132
High School Graduate	da	da	0.8939	0.0689	0.9364
Some College/Associate’s Degree	da	da	0.2001	0.3800	0.1662
College Graduate	da	da	0.1998	0.5494	0.2071
EMPLOYMENT STATUS
Full-Time	da	da	0.0386	0.5059	0.0322
Part-Time	da	da	0.4846	0.0332	0.7051
Unemployed	da	da	0.4406	0.2195	0.3210
Other¹	da	da	0.5994	0.0383	0.7934
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.43C – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	168	150	16	22	168	149	14	19	167	147
SEX
Male	138	128	14	4	137	128	12	18	136	126
Female	94	63	8	22	94	59	8	6	93	59
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	147	129	14	22	146	128	12	17	145	125
AIAN	12	3	<1	*	12	3	<1	<1	12	3
Asian	14	19	*	*	14	19	*	*	14	19
Black or African American	30	28	*	3	30	28	*	4	30	27
NHPI	*	2	*	*	*	2	*	*	*	2
White	131	116	13	22	132	115	12	16	130	113
Two or More Races	16	24	*	3	15	24	1	3	15	24
Hispanic or Latino	81	66	8	1	82	66	5	10	82	65
EDUCATION LEVEL
< High School	da	da	da	da	44	48	11	4	43	46
High School Graduate	da	da	da	da	111	94	9	14	111	95
Some College/Associate’s Degree	da	da	da	da	106	78	1	13	107	77
College Graduate	da	da	da	da	51	36	2	*	51	36
EMPLOYMENT STATUS
Full-Time	da	da	da	da	99	54	9	7	99	53
Part-Time	da	da	da	da	48	19	6	<1	47	19
Unemployed	da	da	da	da	38	58	5	5	38	57
Other¹	da	da	da	da	121	112	5	17	121	110
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.43D – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.05	0.06	0.09	0.07	0.06	0.04	0.06	0.07	0.06
SEX
Male	0.10	0.09	0.11	0.03	0.11	0.10	0.07	0.10	0.13	0.11
Female	0.07	0.04	0.06	0.17	0.07	0.04	0.05	0.04	0.08	0.05
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.06	0.07	0.12	0.07	0.06	0.05	0.06	0.08	0.07
AIAN	0.91	0.21	0.03	*	1.11	0.25	0.03	0.14	1.27	0.29
Asian	0.08	0.10	*	*	0.09	0.11	*	*	0.10	0.13
Black or African American	0.09	0.08	*	0.07	0.10	0.09	*	0.10	0.11	0.10
NHPI	*	0.13	*	*	*	0.14	*	*	*	0.16
White	0.08	0.07	0.10	0.17	0.08	0.07	0.07	0.09	0.09	0.08
Two or More Races	0.25	0.38	*	0.26	0.29	0.45	0.11	0.26	0.36	0.56
Hispanic or Latino	0.15	0.12	0.12	0.01	0.18	0.14	0.06	0.11	0.22	0.17
EDUCATION LEVEL
< High School	da	da	da	da	0.18	0.20	0.31	0.11	0.20	0.23
High School Graduate	da	da	da	da	0.16	0.13	0.08	0.11	0.19	0.16
Some College/Associate’s Degree	da	da	da	da	0.14	0.10	0.01	0.10	0.17	0.12
College Graduate	da	da	da	da	0.06	0.04	0.04	*	0.06	0.04
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.08	0.04	0.07	0.05	0.09	0.05
Part-Time	da	da	da	da	0.15	0.06	0.07	<0.01	0.20	0.08
Unemployed	da	da	da	da	0.33	0.44	0.16	0.14	0.47	0.61
Other¹	da	da	da	da	0.13	0.12	0.06	0.20	0.14	0.13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.43P – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3680	0.8273	0.3486	0.2774	0.2891
SEX
Male	0.7742	0.5079	0.8070	0.2705	0.7124
Female	0.1910	0.5045	0.1390	0.8438	0.1246
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7107	0.5281	0.6429	0.2852	0.5606
AIAN	0.2612	*	0.2565	0.4458	0.2525
Asian	0.9879	*	0.9858	*	0.9879
Black or African American	0.8609	*	0.7763	*	0.6741
NHPI	*	*	*	*	*
White	0.8214	0.6068	0.7570	0.4908	0.6950
Two or More Races	0.0937	*	0.0793	0.1975	0.0960
Hispanic or Latino	0.2025	0.1926	0.2415	0.7105	0.2247
EDUCATION LEVEL
< High School	da	da	0.7585	0.2960	0.6134
High School Graduate	da	da	0.9356	0.3137	0.9959
Some College/Associate’s Degree	da	da	0.1500	0.0621	0.0983
College Graduate	da	da	0.4836	*	0.5086
EMPLOYMENT STATUS
Full-Time	da	da	0.0240	0.9863	0.0233
Part-Time	da	da	0.0555	0.1666	0.0803
Unemployed	da	da	0.7617	0.7988	0.7585
Other¹	da	da	0.5457	0.0393	0.7043
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.44C – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	843	913	102	110	829	901	150	155	817	877
SEX
Male	596	609	75	79	590	600	103	114	582	583
Female	613	626	72	82	604	619	107	107	590	613
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	773	844	84	88	766	833	126	134	765	811
AIAN	47	43	4	5	47	43	7	10	47	40
Asian	184	250	20	25	182	248	39	47	178	242
Black or African American	368	376	37	43	365	371	63	59	351	357
NHPI	*	52	*	*	*	50	*	*	*	49
White	687	725	83	82	960	977	121	135	938	942
Two or More Races	146	110	16	19	145	108	26	26	143	104
Hispanic or Latino	350	363	63	65	340	360	81	82	325	353
EDUCATION LEVEL
< High School	da	da	da	da	256	280	43	51	300	322
High School Graduate	da	da	da	da	474	481	87	100	581	568
Some College/Associate’s Degree	da	da	da	da	496	479	114	112	644	595
College Graduate	da	da	da	da	419	468	68	58	491	568
EMPLOYMENT STATUS
Full-Time	da	da	da	da	669	657	109	105	647	641
Part-Time	da	da	da	da	299	319	79	87	291	304
Unemployed	da	da	da	da	158	167	42	46	151	159
Other¹	da	da	da	da	745	804	84	89	739	788
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.44D – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.30	0.32	0.39	0.42	0.32	0.34	0.44	0.44	0.37	0.39
SEX
Male	0.43	0.43	0.57	0.60	0.47	0.47	0.61	0.65	0.54	0.53
Female	0.42	0.43	0.57	0.64	0.46	0.46	0.63	0.62	0.51	0.52
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.33	0.36	0.44	0.46	0.36	0.39	0.49	0.51	0.41	0.43
AIAN	3.22	2.79	1.90	2.54	3.77	3.34	4.77	5.33	4.15	3.67
Asian	0.97	1.19	1.34	1.62	1.05	1.29	1.66	1.80	1.20	1.46
Black or African American	0.84	0.80	0.93	1.09	0.94	0.89	1.22	1.15	1.06	1.03
NHPI	*	3.91	*	*	*	4.03	*	*	*	4.57
White	0.40	0.42	0.58	0.58	0.43	0.45	0.60	0.66	0.48	0.50
Two or More Races	1.93	1.58	1.65	1.77	2.25	1.85	2.20	2.13	2.82	2.30
Hispanic or Latino	0.67	0.66	0.93	0.94	0.75	0.75	0.98	0.93	0.87	0.91
EDUCATION LEVEL
< High School	da	da	da	da	1.05	1.17	1.14	1.34	1.20	1.34
High School Graduate	da	da	da	da	0.68	0.68	0.68	0.73	0.82	0.82
Some College/Associate’s Degree	da	da	da	da	0.64	0.61	0.76	0.73	0.75	0.71
College Graduate	da	da	da	da	0.48	0.52	1.09	0.89	0.51	0.55
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.43	0.45	0.70	0.68	0.47	0.50
Part-Time	da	da	da	da	0.82	0.84	0.86	0.88	1.10	1.10
Unemployed	da	da	da	da	1.21	1.15	1.20	1.18	1.65	1.54
Other¹	da	da	da	da	0.59	0.64	0.88	0.95	0.64	0.69
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.44P – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.2751	0.0364	0.4234	0.1945	0.2749
SEX
Male	0.0422	0.0390	0.0767	0.4629	0.0490
Female	0.5991	0.4412	0.5151	0.2700	0.6592
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5041	0.2263	0.6131	0.3333	0.4861
AIAN	0.7255	0.7416	0.6245	0.7361	0.5722
Asian	0.1064	0.2712	0.1327	0.8615	0.1296
Black or African American	0.4900	0.4182	0.4117	0.7252	0.3601
NHPI	*	*	*	*	*
White	0.2727	0.6495	0.3050	0.2057	0.2026
Two or More Races	0.1450	0.5650	0.1316	0.7596	0.1464
Hispanic or Latino	0.2083	0.0725	0.3553	0.3842	0.2396
EDUCATION LEVEL
< High School	da	da	0.9951	0.3132	0.8583
High School Graduate	da	da	0.4151	0.6024	0.4217
Some College/Associate’s Degree	da	da	0.5180	0.1638	0.7081
College Graduate	da	da	0.1313	0.0126	0.0593
EMPLOYMENT STATUS
Full-Time	da	da	0.5650	0.1742	0.7395
Part-Time	da	da	0.6530	0.5741	0.7186
Unemployed	da	da	0.7975	0.4603	0.6002
Other¹	da	da	0.1242	0.0782	0.0768
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.45C – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	324	312	50	39	324	309	59	82	314	295
SEX
Male	244	251	35	25	242	250	45	48	236	244
Female	213	185	36	30	211	183	39	59	203	174
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	293	287	38	31	293	285	54	71	288	274
AIAN	24	11	2	4	24	10	*	*	23	9
Asian	79	51	9	8	78	50	9	15	78	48
Black or African American	141	109	16	8	140	108	29	25	134	106
NHPI	23	16	*	*	*	16	2	*	*	16
White	253	250	33	29	262	256	41	66	257	246
Two or More Races	54	54	4	6	54	54	12	6	52	54
Hispanic or Latino	137	126	32	24	135	123	28	37	131	118
EDUCATION LEVEL
< High School	da	da	da	da	108	106	23	20	106	105
High School Graduate	da	da	da	da	190	172	33	47	192	172
Some College/Associate’s Degree	da	da	da	da	195	193	39	51	195	190
College Graduate	da	da	da	da	150	125	23	24	152	128
EMPLOYMENT STATUS
Full-Time	da	da	da	da	219	184	39	47	215	178
Part-Time	da	da	da	da	72	90	24	45	69	77
Unemployed	da	da	da	da	65	73	15	22	64	69
Other¹	da	da	da	da	227	228	35	35	223	226
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.45D – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.11	0.11	0.19	0.15	0.13	0.12	0.17	0.23	0.14	0.13
SEX
Male	0.18	0.18	0.27	0.19	0.19	0.20	0.26	0.27	0.22	0.22
Female	0.15	0.13	0.28	0.23	0.16	0.14	0.23	0.34	0.18	0.15
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.13	0.12	0.20	0.16	0.14	0.13	0.21	0.27	0.15	0.15
AIAN	1.73	0.81	1.02	1.97	2.07	0.88	*	*	2.32	0.89
Asian	0.45	0.27	0.65	0.54	0.48	0.29	0.41	0.62	0.56	0.32
Black or African American	0.39	0.30	0.44	0.23	0.43	0.33	0.63	0.53	0.49	0.38
NHPI	2.05	1.27	*	*	*	1.36	1.42	*	*	1.57
White	0.15	0.15	0.25	0.23	0.16	0.16	0.23	0.36	0.18	0.17
Two or More Races	0.84	0.79	0.47	0.56	0.98	0.95	1.10	0.51	1.20	1.18
Hispanic or Latino	0.26	0.23	0.48	0.35	0.30	0.26	0.34	0.43	0.35	0.30
EDUCATION LEVEL
< High School	da	da	da	da	0.44	0.44	0.62	0.56	0.50	0.51
High School Graduate	da	da	da	da	0.27	0.25	0.29	0.38	0.32	0.29
Some College/Associate’s Degree	da	da	da	da	0.25	0.25	0.30	0.38	0.30	0.29
College Graduate	da	da	da	da	0.17	0.14	0.40	0.40	0.18	0.15
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.18	0.15	0.28	0.33	0.20	0.16
Part-Time	da	da	da	da	0.22	0.27	0.29	0.50	0.29	0.33
Unemployed	da	da	da	da	0.56	0.55	0.43	0.57	0.77	0.73
Other¹	da	da	da	da	0.24	0.23	0.41	0.41	0.26	0.25
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.45P – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0779	0.0659	0.1320	0.4572	0.0867
SEX
Male	0.2521	0.1880	0.3216	0.5578	0.3730
Female	0.1932	0.1856	0.2696	0.1028	0.1206
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0806	0.0562	0.1275	0.5388	0.0940
AIAN	0.2176	0.5155	0.1608	*	0.1687
Asian	0.7904	0.7076	0.8262	0.7685	0.7823
Black or African American	0.2346	0.0020	0.3734	0.9428	0.3572
NHPI	0.7370	*	*	*	*
White	0.2322	0.3639	0.2749	0.3292	0.1866
Two or More Races	0.9293	0.5983	0.9487	0.0836	0.6949
Hispanic or Latino	0.7048	0.5196	0.8075	0.6818	0.7099
EDUCATION LEVEL
< High School	da	da	0.7362	0.6217	0.6575
High School Graduate	da	da	0.8189	0.3284	0.6571
Some College/Associate’s Degree	da	da	0.3317	0.5987	0.2537
College Graduate	da	da	0.0775	0.9777	0.0780
EMPLOYMENT STATUS
Full-Time	da	da	0.0349	0.9910	0.0332
Part-Time	da	da	0.1032	0.2504	0.1980
Unemployed	da	da	0.6064	0.1046	0.9620
Other¹	da	da	0.3344	0.6108	0.3684
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.46C – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	169	181	29	19	168	181	28	38	165	178
SEX
Male	136	150	23	9	135	150	21	19	132	148
Female	108	100	18	17	107	99	17	31	106	94
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	141	164	14	14	142	164	23	25	139	163
AIAN	5	6	1	1	5	5	<1	*	5	1
Asian	51	12	1	7	51	10	3	2	51	10
Black or African American	62	50	9	4	62	50	9	9	61	49
NHPI	2	2	*	*	2	2	*	*	2	*
White	131	152	10	11	134	153	21	23	132	152
Two or More Races	10	39	2	2	10	39	5	2	9	39
Hispanic or Latino	89	71	25	12	85	70	15	26	84	66
EDUCATION LEVEL
< High School	da	da	da	da	71	61	8	13	70	59
High School Graduate	da	da	da	da	118	87	10	23	119	84
Some College/Associate’s Degree	da	da	da	da	87	135	24	20	84	136
College Graduate	da	da	da	da	62	59	4	14	62	58
EMPLOYMENT STATUS
Full-Time	da	da	da	da	111	73	16	11	109	73
Part-Time	da	da	da	da	37	47	6	25	36	40
Unemployed	da	da	da	da	31	35	9	14	30	32
Other¹	da	da	da	da	118	157	20	19	116	156
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.46D – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.06	0.11	0.07	0.07	0.07	0.08	0.11	0.07	0.08
SEX
Male	0.10	0.11	0.17	0.07	0.11	0.12	0.13	0.11	0.12	0.13
Female	0.07	0.07	0.14	0.13	0.08	0.07	0.10	0.18	0.09	0.08
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.07	0.07	0.07	0.07	0.08	0.09	0.10	0.07	0.09
AIAN	0.39	0.40	0.24	0.51	0.47	0.46	0.16	*	0.55	0.11
Asian	0.29	0.07	0.09	0.49	0.32	0.06	0.12	0.08	0.37	0.07
Black or African American	0.18	0.14	0.26	0.11	0.20	0.16	0.19	0.20	0.23	0.18
NHPI	0.15	0.13	*	*	0.16	0.14	*	*	0.18	*
White	0.08	0.09	0.08	0.09	0.08	0.10	0.12	0.13	0.09	0.11
Two or More Races	0.16	0.59	0.27	0.19	0.19	0.71	0.43	0.14	0.21	0.89
Hispanic or Latino	0.17	0.13	0.37	0.18	0.19	0.15	0.18	0.30	0.23	0.17
EDUCATION LEVEL
< High School	da	da	da	da	0.29	0.25	0.22	0.37	0.33	0.29
High School Graduate	da	da	da	da	0.17	0.12	0.09	0.19	0.20	0.14
Some College/Associate’s Degree	da	da	da	da	0.11	0.17	0.18	0.15	0.13	0.21
College Graduate	da	da	da	da	0.07	0.07	0.07	0.24	0.08	0.07
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.09	0.06	0.11	0.08	0.10	0.07
Part-Time	da	da	da	da	0.12	0.14	0.08	0.27	0.15	0.17
Unemployed	da	da	da	da	0.27	0.27	0.28	0.38	0.37	0.35
Other¹	da	da	da	da	0.13	0.16	0.23	0.23	0.14	0.18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.46P – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6524	0.5385	0.7149	0.3989	0.5926
SEX
Male	0.5331	0.1382	0.6525	0.4649	0.7271
Female	0.9207	0.5834	1.0000	0.0977	0.6683
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6051	0.9174	0.6112	0.8727	0.5907
AIAN	0.2997	0.7011	0.2580	*	0.0197
Asian	0.3583	0.2600	0.2795	0.6971	0.2891
Black or African American	0.3719	0.1940	0.4591	0.7484	0.4241
NHPI	0.9523	*	0.9469	*	*
White	0.8646	0.8621	0.8498	0.8888	0.8313
Two or More Races	0.1498	0.7188	0.1389	0.1701	0.0936
Hispanic or Latino	0.9863	0.4715	0.8711	0.2555	0.8867
EDUCATION LEVEL
< High School	da	da	0.6767	0.5690	0.7380
High School Graduate	da	da	0.2893	0.0282	0.1476
Some College/Associate’s Degree	da	da	0.5288	0.1703	0.3580
College Graduate	da	da	0.4403	0.1393	0.2963
EMPLOYMENT STATUS
Full-Time	da	da	0.0210	0.1024	0.0377
Part-Time	da	da	0.1068	0.0420	0.3962
Unemployed	da	da	0.2213	0.2269	0.4001
Other¹	da	da	0.7701	0.9484	0.7765
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.47C – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	467	466	89	89	453	455	150	150	416	438
SEX
Male	306	329	61	64	300	319	97	113	277	297
Female	348	336	63	68	340	330	105	89	317	319
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	423	430	79	84	414	421	132	122	387	407
AIAN	24	12	7	2	22	11	6	1	22	11
Asian	135	104	13	19	134	102	18	43	133	94
Black or African American	152	126	13	20	151	122	35	31	149	115
NHPI	12	*	*	*	11	*	*	*	8	*
White	380	388	82	85	411	420	135	127	370	396
Two or More Races	56	85	10	13	54	84	26	20	48	82
Hispanic or Latino	160	178	40	36	151	172	66	80	133	145
EDUCATION LEVEL
< High School	da	da	da	da	115	87	33	48	110	71
High School Graduate	da	da	da	da	195	218	68	76	183	210
Some College/Associate’s Degree	da	da	da	da	279	259	112	109	264	257
College Graduate	da	da	da	da	258	275	68	57	273	312
EMPLOYMENT STATUS
Full-Time	da	da	da	da	342	362	82	99	325	351
Part-Time	da	da	da	da	154	157	83	73	125	137
Unemployed	da	da	da	da	118	111	41	47	110	98
Other¹	da	da	da	da	256	261	83	82	245	251
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.47D – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.16	0.16	0.34	0.34	0.18	0.17	0.44	0.43	0.19	0.19
SEX
Male	0.22	0.23	0.46	0.48	0.24	0.25	0.57	0.64	0.26	0.27
Female	0.24	0.23	0.50	0.54	0.26	0.25	0.62	0.51	0.27	0.27
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.18	0.18	0.41	0.44	0.20	0.20	0.51	0.47	0.21	0.22
AIAN	1.71	0.87	2.96	1.13	1.98	0.99	3.80	0.92	2.21	1.16
Asian	0.75	0.52	0.87	1.21	0.82	0.56	0.80	1.68	0.94	0.60
Black or African American	0.43	0.35	0.37	0.56	0.47	0.38	0.77	0.66	0.54	0.42
NHPI	1.10	*	*	*	1.10	*	*	*	0.93	*
White	0.22	0.23	0.58	0.60	0.23	0.24	0.65	0.62	0.24	0.26
Two or More Races	0.89	1.26	1.07	1.22	1.03	1.48	2.16	1.72	1.15	1.83
Hispanic or Latino	0.31	0.33	0.58	0.52	0.33	0.36	0.80	0.92	0.36	0.37
EDUCATION LEVEL
< High School	da	da	da	da	0.47	0.36	0.91	1.31	0.53	0.35
High School Graduate	da	da	da	da	0.28	0.31	0.56	0.58	0.31	0.35
Some College/Associate’s Degree	da	da	da	da	0.36	0.33	0.74	0.75	0.40	0.38
College Graduate	da	da	da	da	0.30	0.31	1.06	0.88	0.31	0.32
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.27	0.27	0.56	0.63	0.29	0.30
Part-Time	da	da	da	da	0.47	0.46	0.89	0.77	0.53	0.55
Unemployed	da	da	da	da	0.98	0.84	1.18	1.19	1.29	1.05
Other¹	da	da	da	da	0.26	0.26	0.90	0.92	0.28	0.27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.47P – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5938	0.8733	0.6068	0.5848	0.4718
SEX
Male	0.2207	0.9111	0.1988	0.2948	0.3254
Female	0.6736	0.7484	0.6181	0.0490	0.9455
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7601	0.6848	0.8167	0.3181	0.5692
AIAN	0.1448	0.1408	0.2832	0.0346	0.5599
Asian	0.6385	0.9094	0.6257	0.0709	0.3116
Black or African American	0.1588	0.0345	0.0878	0.2968	0.1413
NHPI	*	*	*	*	*
White	0.4115	0.8482	0.4189	0.2440	0.2085
Two or More Races	0.1413	0.7494	0.1209	0.6659	0.1387
Hispanic or Latino	0.3818	0.6633	0.3068	0.4335	0.4465
EDUCATION LEVEL
< High School	da	da	0.0390	0.2375	0.0047
High School Graduate	da	da	0.1145	0.5415	0.1594
Some College/Associate’s Degree	da	da	0.9425	0.2530	0.6001
College Graduate	da	da	0.8137	0.3613	0.6610
EMPLOYMENT STATUS
Full-Time	da	da	0.2653	0.9688	0.2570
Part-Time	da	da	0.7380	0.3186	0.9132
Unemployed	da	da	0.1979	0.5068	0.2616
Other¹	da	da	0.8299	0.8862	0.8189
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.48C – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	193	209	32	31	190	206	79	73	170	193
SEX
Male	133	161	20	22	132	159	55	53	121	151
Female	133	125	27	23	130	124	57	51	113	111
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	180	198	29	27	178	195	71	61	161	186
AIAN	9	3	2	1	8	3	1	*	8	3
Asian	36	49	8	10	35	48	12	18	32	44
Black or African American	57	44	5	4	57	44	19	11	54	42
NHPI	4	5	*	*	4	5	*	*	*	5
White	158	185	27	24	162	186	70	58	144	175
Two or More Races	19	32	4	4	19	31	4	6	18	31
Hispanic or Latino	67	66	16	14	65	64	38	40	52	48
EDUCATION LEVEL
< High School	da	da	da	da	38	30	15	21	34	21
High School Graduate	da	da	da	da	84	109	29	32	77	101
Some College/Associate’s Degree	da	da	da	da	108	114	59	52	91	103
College Graduate	da	da	da	da	127	129	49	34	118	129
EMPLOYMENT STATUS
Full-Time	da	da	da	da	152	158	46	46	143	148
Part-Time	da	da	da	da	67	72	47	38	47	61
Unemployed	da	da	da	da	41	47	21	26	34	38
Other¹	da	da	da	da	87	104	40	35	75	99
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.48D – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.07	0.07	0.12	0.12	0.07	0.08	0.23	0.21	0.08	0.08
SEX
Male	0.10	0.11	0.15	0.17	0.10	0.12	0.32	0.30	0.11	0.14
Female	0.09	0.08	0.21	0.18	0.10	0.09	0.33	0.29	0.10	0.09
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.08	0.08	0.15	0.14	0.08	0.09	0.28	0.23	0.09	0.10
AIAN	0.64	0.23	0.84	0.57	0.76	0.25	0.66	*	0.86	0.27
Asian	0.21	0.26	0.55	0.69	0.22	0.27	0.55	0.76	0.23	0.30
Black or African American	0.16	0.12	0.13	0.10	0.18	0.14	0.41	0.24	0.20	0.16
NHPI	0.33	0.45	*	*	0.35	0.48	*	*	*	0.52
White	0.09	0.11	0.21	0.19	0.10	0.12	0.37	0.32	0.10	0.12
Two or More Races	0.31	0.48	0.46	0.43	0.36	0.57	0.40	0.55	0.44	0.71
Hispanic or Latino	0.13	0.12	0.24	0.21	0.14	0.13	0.46	0.45	0.14	0.12
EDUCATION LEVEL
< High School	da	da	da	da	0.15	0.13	0.42	0.59	0.17	0.10
High School Graduate	da	da	da	da	0.12	0.15	0.25	0.27	0.13	0.17
Some College/Associate’s Degree	da	da	da	da	0.14	0.15	0.44	0.38	0.14	0.16
College Graduate	da	da	da	da	0.15	0.14	0.81	0.56	0.14	0.15
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.12	0.13	0.32	0.32	0.13	0.13
Part-Time	da	da	da	da	0.21	0.22	0.54	0.43	0.20	0.26
Unemployed	da	da	da	da	0.36	0.37	0.63	0.68	0.42	0.42
Other¹	da	da	da	da	0.09	0.11	0.46	0.41	0.09	0.11
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.48P – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7588	0.5309	0.8241	0.2681	0.8425
SEX
Male	0.6819	0.9568	0.6775	0.7200	0.5653
Female	0.3435	0.4617	0.4074	0.2271	0.7110
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7380	0.6913	0.7738	0.1036	0.7611
AIAN	0.3476	0.6062	0.4115	*	0.4382
Asian	0.7120	0.7755	0.7538	0.8317	0.8019
Black or African American	0.4939	0.1942	0.4257	0.0996	0.7804
NHPI	0.5955	*	0.6027	*	*
White	0.7765	0.5126	0.8438	0.1403	0.7146
Two or More Races	0.5588	0.7398	0.5099	0.1244	0.7332
Hispanic or Latino	0.9115	0.5869	0.8114	0.5071	0.8306
EDUCATION LEVEL
< High School	da	da	0.4727	0.2863	0.1188
High School Graduate	da	da	0.6434	0.6967	0.7423
Some College/Associate’s Degree	da	da	0.9155	0.2637	0.4515
College Graduate	da	da	0.4966	0.1898	0.7881
EMPLOYMENT STATUS
Full-Time	da	da	0.9199	0.6913	0.8291
Part-Time	da	da	0.4228	0.1125	0.8688
Unemployed	da	da	0.9336	0.8235	0.9880
Other¹	da	da	0.9490	0.8589	0.9617
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.49C – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	111	118	10	11	111	117	48	31	95	111
SEX
Male	84	86	7	10	83	85	37	20	74	83
Female	73	75	7	5	72	75	30	25	60	67
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	99	114	9	10	99	113	41	27	85	108
AIAN	<1	1	<1	*	*	1	*	<1	*	1
Asian	15	43	*	*	15	43	10	*	12	42
Black or African American	32	20	2	*	32	20	14	5	29	20
NHPI	*	*	*	*	*	*	*	*	*	*
White	90	101	9	10	90	101	37	24	77	95
Two or More Races	16	29	<1	1	16	29	1	2	15	28
Hispanic or Latino	51	32	1	5	51	32	26	16	43	25
EDUCATION LEVEL
< High School	da	da	da	da	30	14	9	11	29	7
High School Graduate	da	da	da	da	53	43	13	19	51	37
Some College/Associate’s Degree	da	da	da	da	67	80	43	20	51	77
College Graduate	da	da	da	da	56	69	15	9	56	70
EMPLOYMENT STATUS
Full-Time	da	da	da	da	79	106	22	23	76	101
Part-Time	da	da	da	da	44	29	37	16	23	25
Unemployed	da	da	da	da	18	10	9	8	15	6
Other¹	da	da	da	da	56	41	21	13	52	39
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.49D – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.04	0.04	0.04	0.04	0.04	0.14	0.09	0.04	0.05
SEX
Male	0.06	0.06	0.05	0.07	0.07	0.07	0.22	0.11	0.07	0.08
Female	0.05	0.05	0.05	0.04	0.05	0.06	0.18	0.14	0.05	0.06
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.04	0.05	0.05	0.05	0.05	0.05	0.16	0.10	0.05	0.06
AIAN	<0.01	0.11	0.03	*	*	0.09	*	0.03	*	0.10
Asian	0.09	0.23	*	*	0.10	0.25	0.44	*	0.09	0.28
Black or African American	0.09	0.06	0.06	*	0.10	0.06	0.31	0.11	0.11	0.07
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.05	0.06	0.07	0.08	0.06	0.06	0.21	0.14	0.06	0.07
Two or More Races	0.25	0.44	0.03	0.11	0.30	0.52	0.14	0.18	0.37	0.66
Hispanic or Latino	0.10	0.06	0.02	0.07	0.11	0.07	0.32	0.19	0.12	0.06
EDUCATION LEVEL
< High School	da	da	da	da	0.12	0.06	0.25	0.32	0.14	0.04
High School Graduate	da	da	da	da	0.08	0.06	0.12	0.16	0.09	0.06
Some College/Associate’s Degree	da	da	da	da	0.09	0.10	0.33	0.15	0.08	0.12
College Graduate	da	da	da	da	0.07	0.08	0.26	0.14	0.07	0.08
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.06	0.09	0.16	0.16	0.07	0.09
Part-Time	da	da	da	da	0.14	0.09	0.43	0.18	0.10	0.11
Unemployed	da	da	da	da	0.16	0.08	0.28	0.21	0.19	0.07
Other¹	da	da	da	da	0.06	0.04	0.24	0.16	0.06	0.05
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.49P – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7269	0.9028	0.7411	0.0733	0.2855
SEX
Male	0.9741	0.5845	0.9777	0.1123	0.5628
Female	0.6136	0.5547	0.5846	0.3578	0.3067
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5047	0.7912	0.4937	0.0261	0.1239
AIAN	0.1401	*	*	*	*
Asian	0.1605	*	0.1617	*	0.1063
Black or African American	0.6600	*	0.7430	0.1193	0.7265
NHPI	*	*	*	*	*
White	0.7920	0.8901	0.7855	0.0737	0.3430
Two or More Races	0.5647	0.2101	0.5849	0.6493	0.6059
Hispanic or Latino	0.5226	0.2493	0.4623	0.8634	0.3105
EDUCATION LEVEL
< High School	da	da	0.2026	0.7431	0.1122
High School Graduate	da	da	0.7543	0.1187	0.8083
Some College/Associate’s Degree	da	da	0.6950	0.0098	0.0722
College Graduate	da	da	0.7108	0.2427	0.5440
EMPLOYMENT STATUS
Full-Time	da	da	0.1219	0.9925	0.1066
Part-Time	da	da	0.2899	0.0804	0.6996
Unemployed	da	da	0.2566	0.8286	0.2206
Other¹	da	da	0.3551	0.1930	0.6165
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.50C – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	750	752	79	66	738	747	105	106	731	734
SEX
Male	473	478	47	51	471	475	71	66	467	469
Female	532	555	61	46	522	550	80	85	510	543
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	707	655	69	56	696	653	93	94	688	642
AIAN	49	30	3	2	49	30	6	7	49	29
Asian	199	124	13	16	195	123	14	24	194	120
Black or African American	236	225	21	17	234	223	33	29	231	219
NHPI	24	47	1	*	24	47	3	*	24	47
White	622	584	65	51	738	762	94	91	719	749
Two or More Races	98	122	9	10	97	122	20	25	96	118
Hispanic or Latino	277	322	38	37	274	319	52	51	272	315
EDUCATION LEVEL
< High School	da	da	da	da	198	176	38	26	212	176
High School Graduate	da	da	da	da	400	364	64	63	430	392
Some College/Associate’s Degree	da	da	da	da	413	413	77	82	464	484
College Graduate	da	da	da	da	390	403	52	41	456	499
EMPLOYMENT STATUS
Full-Time	da	da	da	da	512	487	73	74	503	478
Part-Time	da	da	da	da	264	296	60	60	256	286
Unemployed	da	da	da	da	117	138	41	28	109	134
Other¹	da	da	da	da	558	601	54	58	551	595
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.50D – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.26	0.26	0.31	0.25	0.29	0.28	0.31	0.30	0.33	0.32
SEX
Male	0.34	0.34	0.35	0.38	0.38	0.37	0.41	0.37	0.43	0.43
Female	0.37	0.38	0.49	0.36	0.39	0.41	0.47	0.49	0.44	0.46
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.31	0.28	0.36	0.29	0.33	0.30	0.36	0.36	0.37	0.34
AIAN	3.28	2.07	1.29	1.17	3.86	2.45	3.73	3.99	4.31	2.76
Asian	1.09	0.64	0.87	1.05	1.16	0.69	0.66	0.96	1.34	0.78
Black or African American	0.61	0.56	0.56	0.45	0.68	0.62	0.69	0.63	0.79	0.72
NHPI	2.20	3.63	0.60	*	2.40	3.90	2.63	*	2.71	4.44
White	0.37	0.34	0.48	0.39	0.39	0.37	0.47	0.48	0.44	0.41
Two or More Races	1.50	1.70	0.99	0.97	1.75	1.99	1.76	2.06	2.17	2.41
Hispanic or Latino	0.53	0.59	0.55	0.53	0.60	0.67	0.63	0.59	0.73	0.81
EDUCATION LEVEL
< High School	da	da	da	da	0.81	0.73	1.00	0.73	0.94	0.85
High School Graduate	da	da	da	da	0.58	0.52	0.52	0.51	0.68	0.61
Some College/Associate’s Degree	da	da	da	da	0.54	0.53	0.54	0.58	0.64	0.63
College Graduate	da	da	da	da	0.45	0.45	0.85	0.65	0.48	0.47
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.37	0.35	0.49	0.49	0.41	0.38
Part-Time	da	da	da	da	0.73	0.82	0.68	0.63	0.97	1.07
Unemployed	da	da	da	da	0.98	1.00	1.15	0.74	1.30	1.35
Other¹	da	da	da	da	0.51	0.53	0.62	0.66	0.55	0.57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.50P – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5370	0.0278	0.6676	0.0287	0.9237
SEX
Male	0.6950	0.8006	0.7325	0.1779	0.5738
Female	0.2383	0.0010	0.3780	0.1003	0.5315
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8000	0.0472	0.9252	0.0333	0.8303
AIAN	0.1400	0.9747	0.1127	0.7514	0.0955
Asian	0.0949	0.4309	0.0733	0.2146	0.0500
Black or African American	0.3101	0.5147	0.3283	0.1068	0.4513
NHPI	0.3532	*	0.3616	*	0.3670
White	0.5266	0.0500	0.4260	0.0292	0.2625
Two or More Races	0.6603	0.1809	0.5287	0.5005	0.6072
Hispanic or Latino	0.4281	0.3101	0.4870	0.6013	0.5510
EDUCATION LEVEL
< High School	da	da	0.0322	0.0063	0.0874
High School Graduate	da	da	0.8720	0.7184	0.7706
Some College/Associate’s Degree	da	da	0.1573	0.9835	0.1525
College Graduate	da	da	0.1423	0.0075	0.2416
EMPLOYMENT STATUS
Full-Time	da	da	0.0250	0.0322	0.0556
Part-Time	da	da	0.2480	0.4771	0.1536
Unemployed	da	da	0.3691	0.0073	0.8621
Other¹	da	da	0.3427	0.3831	0.4106
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.51C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	259	248	25	26	258	245	48	55	252	238
SEX
Male	183	193	18	13	181	191	34	31	177	189
Female	178	161	20	23	176	160	33	46	172	155
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	237	215	24	23	236	213	42	46	230	208
AIAN	4	19	<1	*	4	19	1	*	3	18
Asian	55	33	4	*	55	33	7	12	54	31
Black or African American	82	49	6	4	81	49	16	10	80	47
NHPI	*	7	*	*	*	7	*	*	*	7
White	207	196	22	22	209	199	37	42	202	194
Two or More Races	29	53	5	4	28	53	13	10	25	52
Hispanic or Latino	115	110	13	13	114	110	23	30	112	105
EDUCATION LEVEL
< High School	da	da	da	da	50	62	17	15	47	61
High School Graduate	da	da	da	da	138	116	23	36	138	109
Some College/Associate’s Degree	da	da	da	da	126	146	31	37	122	143
College Graduate	da	da	da	da	157	146	22	17	157	149
EMPLOYMENT STATUS
Full-Time	da	da	da	da	169	136	34	33	166	130
Part-Time	da	da	da	da	76	109	22	33	73	102
Unemployed	da	da	da	da	46	67	18	13	41	66
Other¹	da	da	da	da	169	169	20	31	167	166
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.51D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.09	0.10	0.10	0.10	0.09	0.14	0.16	0.11	0.10
SEX
Male	0.13	0.14	0.14	0.10	0.14	0.15	0.20	0.18	0.16	0.17
Female	0.12	0.11	0.16	0.18	0.13	0.12	0.19	0.26	0.15	0.13
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.10	0.09	0.12	0.12	0.11	0.10	0.16	0.18	0.12	0.11
AIAN	0.27	1.38	0.09	*	0.33	1.63	0.76	*	0.36	1.81
Asian	0.31	0.18	0.27	*	0.34	0.20	0.33	0.49	0.39	0.21
Black or African American	0.23	0.14	0.16	0.10	0.26	0.15	0.35	0.22	0.30	0.17
NHPI	*	0.54	*	*	*	0.58	*	*	*	0.67
White	0.12	0.11	0.17	0.18	0.13	0.12	0.21	0.24	0.14	0.14
Two or More Races	0.47	0.79	0.53	0.40	0.54	0.94	1.17	0.84	0.61	1.17
Hispanic or Latino	0.22	0.20	0.18	0.19	0.25	0.23	0.28	0.35	0.30	0.27
EDUCATION LEVEL
< High School	da	da	da	da	0.21	0.26	0.48	0.41	0.23	0.30
High School Graduate	da	da	da	da	0.20	0.16	0.20	0.30	0.23	0.19
Some College/Associate’s Degree	da	da	da	da	0.16	0.19	0.23	0.28	0.19	0.22
College Graduate	da	da	da	da	0.18	0.16	0.38	0.28	0.19	0.17
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.14	0.11	0.24	0.23	0.15	0.12
Part-Time	da	da	da	da	0.24	0.33	0.26	0.36	0.31	0.43
Unemployed	da	da	da	da	0.40	0.52	0.54	0.36	0.50	0.71
Other¹	da	da	da	da	0.18	0.18	0.23	0.37	0.19	0.19
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.51P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5200	0.9519	0.5145	0.7767	0.5454
SEX
Male	0.9074	0.7949	0.9167	0.1870	0.8915
Female	0.4125	0.9042	0.3981	0.4358	0.2958
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6598	0.8012	0.6703	0.5546	0.7520
AIAN	0.0560	*	0.0630	*	0.0972
Asian	0.6219	*	0.6634	0.5862	0.5716
Black or African American	0.2580	0.4091	0.2830	0.2860	0.3902
NHPI	*	*	*	*	*
White	0.7848	0.8261	0.7590	0.7798	0.7939
Two or More Races	0.3045	0.3548	0.2498	0.5001	0.1593
Hispanic or Latino	0.5819	0.7325	0.5451	0.6308	0.4648
EDUCATION LEVEL
< High School	da	da	0.4937	0.1723	0.2659
High School Graduate	da	da	0.9672	0.2060	0.7807
Some College/Associate’s Degree	da	da	0.9360	0.9090	0.9087
College Graduate	da	da	0.2017	0.0866	0.2866
EMPLOYMENT STATUS
Full-Time	da	da	0.0058	0.0633	0.0154
Part-Time	da	da	0.2836	0.7575	0.3023
Unemployed	da	da	0.6569	0.2894	0.4303
Other¹	da	da	0.4791	0.0525	0.6745
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.52C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	124	146	14	13	123	145	24	32	119	142
SEX
Male	83	122	7	6	83	122	20	13	81	121
Female	89	83	12	11	88	83	14	29	87	78
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	96	141	11	13	95	140	22	27	91	138
AIAN	1	7	<1	*	1	6	<1	*	1	6
Asian	2	20	*	*	2	20	*	2	2	19
Black or African American	23	19	1	2	23	19	6	5	23	18
NHPI	*	*	*	*	*	*	*	*	*	*
White	91	132	10	12	90	132	19	27	86	129
Two or More Races	14	36	*	4	13	36	11	4	7	36
Hispanic or Latino	78	38	9	1	77	38	10	16	77	34
EDUCATION LEVEL
< High School	da	da	da	da	36	19	14	4	33	18
High School Graduate	da	da	da	da	71	79	11	21	70	76
Some College/Associate’s Degree	da	da	da	da	61	80	13	21	60	78
College Graduate	da	da	da	da	66	91	11	10	65	91
EMPLOYMENT STATUS
Full-Time	da	da	da	da	66	83	16	16	64	81
Part-Time	da	da	da	da	53	84	14	16	51	82
Unemployed	da	da	da	da	31	43	11	5	29	42
Other¹	da	da	da	da	81	75	6	21	80	72
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.52D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.05	0.05	0.05	0.05	0.06	0.07	0.09	0.05	0.06
SEX
Male	0.06	0.09	0.05	0.04	0.07	0.10	0.11	0.07	0.07	0.11
Female	0.06	0.06	0.09	0.09	0.07	0.06	0.09	0.17	0.08	0.07
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.04	0.06	0.06	0.07	0.04	0.07	0.09	0.10	0.05	0.07
AIAN	0.04	0.48	0.03	*	0.05	0.56	0.16	*	0.05	0.64
Asian	0.01	0.11	*	*	0.01	0.11	*	0.08	0.01	0.13
Black or African American	0.07	0.05	0.02	0.07	0.07	0.06	0.13	0.10	0.08	0.07
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.05	0.08	0.08	0.09	0.06	0.08	0.11	0.15	0.06	0.09
Two or More Races	0.22	0.54	*	0.39	0.25	0.65	0.99	0.35	0.17	0.82
Hispanic or Latino	0.15	0.07	0.13	0.01	0.17	0.08	0.12	0.18	0.21	0.09
EDUCATION LEVEL
< High School	da	da	da	da	0.15	0.08	0.39	0.10	0.16	0.09
High School Graduate	da	da	da	da	0.10	0.11	0.09	0.17	0.12	0.13
Some College/Associate’s Degree	da	da	da	da	0.08	0.10	0.10	0.16	0.09	0.12
College Graduate	da	da	da	da	0.08	0.10	0.19	0.17	0.08	0.11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.05	0.07	0.11	0.11	0.06	0.08
Part-Time	da	da	da	da	0.17	0.26	0.17	0.18	0.22	0.34
Unemployed	da	da	da	da	0.27	0.33	0.32	0.14	0.36	0.45
Other¹	da	da	da	da	0.09	0.08	0.07	0.25	0.09	0.08
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.52P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.2527	0.7264	0.2409	0.9516	0.2176
SEX
Male	0.0766	0.9490	0.0779	0.0958	0.0400
Female	0.7584	0.7158	0.7896	0.2580	0.5514
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0413	0.6582	0.0457	0.8580	0.0338
AIAN	0.0425	*	0.0582	*	0.0692
Asian	0.0910	*	0.0912	*	0.1082
Black or African American	0.7591	0.4551	0.8095	0.8059	0.7555
NHPI	*	*	*	*	*
White	0.1041	0.7813	0.1107	0.8887	0.1016
Two or More Races	0.1482	*	0.1466	0.3429	0.0657
Hispanic or Latino	0.1379	0.1226	0.1800	0.8118	0.1543
EDUCATION LEVEL
< High School	da	da	0.0832	0.0256	0.3143
High School Graduate	da	da	0.4194	0.2300	0.5779
Some College/Associate’s Degree	da	da	0.2950	0.5520	0.3355
College Graduate	da	da	0.3520	0.3797	0.2906
EMPLOYMENT STATUS
Full-Time	da	da	0.6665	0.1759	0.4453
Part-Time	da	da	0.1063	0.9832	0.0971
Unemployed	da	da	0.7747	0.2745	0.5785
Other¹	da	da	0.9861	0.0496	0.6743
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.53C – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	652	630	62	46	645	628	98	95	638	622
SEX
Male	392	419	31	32	389	418	68	58	387	416
Female	483	494	53	33	478	492	73	76	469	491
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	601	561	54	40	595	559	86	82	589	556
AIAN	49	25	2	2	49	25	*	*	48	25
Asian	172	114	13	11	167	113	13	14	166	112
Black or African American	195	192	17	10	193	191	28	24	190	189
NHPI	24	47	*	<1	24	47	3	*	23	*
White	517	510	50	35	607	623	84	77	593	618
Two or More Races	78	112	6	10	78	112	20	24	76	110
Hispanic or Latino	253	274	30	21	251	272	50	49	246	269
EDUCATION LEVEL
< High School	da	da	da	da	181	144	36	22	187	144
High School Graduate	da	da	da	da	351	323	59	57	370	342
Some College/Associate’s Degree	da	da	da	da	366	371	69	68	403	427
College Graduate	da	da	da	da	358	345	47	38	403	408
EMPLOYMENT STATUS
Full-Time	da	da	da	da	441	413	69	64	432	407
Part-Time	da	da	da	da	233	267	54	54	224	259
Unemployed	da	da	da	da	96	121	37	23	88	119
Other¹	da	da	da	da	486	514	50	50	478	509
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.53D – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.23	0.22	0.24	0.18	0.25	0.24	0.29	0.27	0.29	0.27
SEX
Male	0.28	0.30	0.24	0.24	0.31	0.33	0.40	0.33	0.36	0.38
Female	0.33	0.34	0.42	0.26	0.36	0.37	0.43	0.44	0.41	0.42
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.26	0.24	0.28	0.21	0.28	0.26	0.33	0.31	0.32	0.30
AIAN	3.27	1.78	0.82	1.03	3.85	2.10	*	*	4.30	2.36
Asian	0.95	0.59	0.90	0.72	1.00	0.64	0.60	0.58	1.15	0.73
Black or African American	0.53	0.50	0.47	0.26	0.59	0.55	0.60	0.52	0.68	0.64
NHPI	2.16	3.61	*	<0.01	2.35	3.86	2.63	*	2.64	*
White	0.30	0.30	0.38	0.27	0.33	0.32	0.44	0.42	0.37	0.36
Two or More Races	1.22	1.57	0.68	0.95	1.44	1.84	1.74	2.03	1.77	2.27
Hispanic or Latino	0.48	0.50	0.44	0.30	0.55	0.57	0.61	0.55	0.66	0.69
EDUCATION LEVEL
< High School	da	da	da	da	0.74	0.60	0.94	0.63	0.86	0.70
High School Graduate	da	da	da	da	0.51	0.46	0.49	0.46	0.59	0.54
Some College/Associate’s Degree	da	da	da	da	0.47	0.48	0.49	0.50	0.57	0.57
College Graduate	da	da	da	da	0.41	0.38	0.78	0.60	0.44	0.41
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.33	0.30	0.47	0.43	0.37	0.34
Part-Time	da	da	da	da	0.66	0.75	0.62	0.58	0.87	0.98
Unemployed	da	da	da	da	0.83	0.90	1.06	0.61	1.09	1.23
Other¹	da	da	da	da	0.45	0.46	0.58	0.58	0.49	0.50
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.53P – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6118	0.0033	0.7682	0.0110	0.9160
SEX
Male	0.7033	0.6779	0.6946	0.0728	0.4894
Female	0.3244	0.0009	0.4749	0.0859	0.6547
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9367	0.0170	0.8060	0.0101	0.5320
AIAN	0.0516	0.3739	0.0350	*	0.0294
Asian	0.3141	0.7090	0.3134	0.9086	0.3171
Black or African American	0.5855	0.1068	0.6557	0.0248	0.8994
NHPI	0.3653	*	0.3684	*	*
White	0.5429	0.0388	0.4512	0.0341	0.2847
Two or More Races	0.3895	0.9896	0.3558	0.4900	0.4293
Hispanic or Latino	0.1960	0.0468	0.2525	0.5505	0.3007
EDUCATION LEVEL
< High School	da	da	0.0690	0.0036	0.1856
High School Graduate	da	da	0.7081	0.5150	0.5764
Some College/Associate’s Degree	da	da	0.2414	0.7707	0.2178
College Graduate	da	da	0.1904	0.0165	0.3016
EMPLOYMENT STATUS
Full-Time	da	da	0.1086	0.0096	0.2413
Part-Time	da	da	0.1772	0.6569	0.1177
Unemployed	da	da	0.5208	0.0068	0.8916
Other¹	da	da	0.7255	0.5863	0.7951
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.54C – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	225	221	18	23	225	219	45	53	217	210
SEX
Male	152	172	11	11	151	170	33	28	146	168
Female	164	142	17	20	162	141	31	45	158	135
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	196	184	17	20	196	182	40	43	188	177
AIAN	4	18	<1	*	4	18	1	*	3	*
Asian	55	31	*	*	55	31	7	4	54	31
Black or African American	64	46	5	3	64	46	15	9	62	44
NHPI	*	7	*	*	*	7	*	*	*	7
White	169	166	16	20	171	167	34	41	164	161
Two or More Races	22	39	5	<1	21	39	13	10	17	38
Hispanic or Latino	115	109	12	11	113	108	23	30	111	104
EDUCATION LEVEL
< High School	da	da	da	da	44	62	17	13	40	61
High School Graduate	da	da	da	da	134	105	20	36	133	98
Some College/Associate’s Degree	da	da	da	da	117	132	30	34	112	129
College Graduate	da	da	da	da	116	117	22	17	116	117
EMPLOYMENT STATUS
Full-Time	da	da	da	da	155	125	32	33	152	119
Part-Time	da	da	da	da	72	106	22	31	69	101
Unemployed	da	da	da	da	45	66	18	13	40	64
Other¹	da	da	da	da	140	133	19	29	137	130
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.54D – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.08	0.08	0.07	0.09	0.09	0.08	0.13	0.15	0.10	0.09
SEX
Male	0.11	0.12	0.09	0.08	0.12	0.13	0.19	0.16	0.13	0.15
Female	0.11	0.10	0.14	0.16	0.12	0.10	0.18	0.26	0.14	0.11
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.08	0.08	0.09	0.11	0.09	0.09	0.16	0.17	0.10	0.09
AIAN	0.27	1.31	0.03	*	0.33	1.54	0.76	*	0.36	*
Asian	0.31	0.17	*	*	0.34	0.18	0.33	0.15	0.39	0.21
Black or African American	0.18	0.13	0.12	0.08	0.20	0.14	0.32	0.20	0.23	0.16
NHPI	*	0.54	*	*	*	0.58	*	*	*	0.67
White	0.10	0.10	0.12	0.16	0.11	0.10	0.20	0.23	0.12	0.11
Two or More Races	0.35	0.59	0.49	0.02	0.41	0.70	1.17	0.84	0.40	0.86
Hispanic or Latino	0.22	0.20	0.18	0.16	0.25	0.23	0.28	0.34	0.30	0.27
EDUCATION LEVEL
< High School	da	da	da	da	0.18	0.26	0.47	0.37	0.19	0.29
High School Graduate	da	da	da	da	0.19	0.15	0.18	0.30	0.23	0.17
Some College/Associate’s Degree	da	da	da	da	0.15	0.17	0.22	0.26	0.17	0.20
College Graduate	da	da	da	da	0.13	0.13	0.38	0.28	0.14	0.14
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.13	0.10	0.23	0.23	0.14	0.11
Part-Time	da	da	da	da	0.22	0.32	0.26	0.34	0.29	0.43
Unemployed	da	da	da	da	0.40	0.51	0.54	0.35	0.49	0.69
Other¹	da	da	da	da	0.15	0.14	0.22	0.34	0.16	0.15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.54P – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4557	0.8285	0.4346	0.8296	0.4481
SEX
Male	0.9733	0.9302	0.9867	0.1052	0.7317
Female	0.2674	0.8531	0.2517	0.2730	0.1451
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6744	0.7532	0.6439	0.7046	0.6935
AIAN	0.1789	*	0.2021	*	*
Asian	0.5227	*	0.5204	0.5491	0.5716
Black or African American	0.5146	0.6084	0.5332	0.3062	0.6964
NHPI	*	*	*	*	*
White	0.8105	0.4353	0.7411	0.8838	0.7041
Two or More Races	0.4930	0.0611	0.3567	0.5574	0.2122
Hispanic or Latino	0.4424	0.9082	0.4375	0.8212	0.3992
EDUCATION LEVEL
< High School	da	da	0.3640	0.0706	0.1387
High School Graduate	da	da	0.7999	0.0745	0.4644
Some College/Associate’s Degree	da	da	0.7463	0.8481	0.7763
College Graduate	da	da	0.2033	0.1449	0.2948
EMPLOYMENT STATUS
Full-Time	da	da	0.0159	0.2008	0.0293
Part-Time	da	da	0.2257	0.9122	0.2164
Unemployed	da	da	0.7737	0.2321	0.5011
Other¹	da	da	0.8343	0.0731	0.9092
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.55C – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	112	132	13	11	110	131	23	30	107	128
SEX
Male	73	110	7	6	73	110	18	12	71	110
Female	82	75	11	10	81	74	14	27	80	70
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	89	126	10	11	88	126	21	25	84	124
AIAN	1	2	<1	*	1	2	<1	*	1	2
Asian	2	19	*	*	2	19	*	*	2	19
Black or African American	23	13	1	2	23	13	2	4	22	12
NHPI	*	*	*	*	*	*	*	*	*	*
White	84	119	9	11	83	118	18	24	79	116
Two or More Races	13	36	*	*	12	36	11	4	6	36
Hispanic or Latino	68	38	9	1	67	37	10	15	67	34
EDUCATION LEVEL
< High School	da	da	da	da	27	19	14	2	23	18
High School Graduate	da	da	da	da	60	75	9	20	59	72
Some College/Associate’s Degree	da	da	da	da	61	77	12	18	59	75
College Graduate	da	da	da	da	62	74	10	10	61	74
EMPLOYMENT STATUS
Full-Time	da	da	da	da	62	65	14	15	60	63
Part-Time	da	da	da	da	52	83	14	16	50	81
Unemployed	da	da	da	da	31	39	11	5	29	39
Other¹	da	da	da	da	66	72	6	19	65	70
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.55D – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.05	0.05	0.04	0.04	0.05	0.07	0.09	0.05	0.06
SEX
Male	0.05	0.08	0.05	0.04	0.06	0.09	0.11	0.07	0.07	0.10
Female	0.06	0.05	0.09	0.08	0.06	0.06	0.08	0.15	0.07	0.06
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.04	0.05	0.05	0.06	0.04	0.06	0.08	0.10	0.04	0.07
AIAN	0.04	0.17	0.03	*	0.05	0.20	0.16	*	0.05	0.22
Asian	0.01	0.10	*	*	0.01	0.11	*	*	0.01	0.13
Black or African American	0.06	0.04	0.02	0.07	0.07	0.04	0.04	0.09	0.08	0.04
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.05	0.07	0.07	0.09	0.05	0.07	0.10	0.14	0.06	0.08
Two or More Races	0.21	0.55	*	*	0.24	0.65	0.99	0.35	0.14	0.82
Hispanic or Latino	0.13	0.07	0.13	0.01	0.15	0.08	0.12	0.18	0.18	0.09
EDUCATION LEVEL
< High School	da	da	da	da	0.11	0.08	0.39	0.05	0.11	0.09
High School Graduate	da	da	da	da	0.09	0.11	0.07	0.17	0.10	0.12
Some College/Associate’s Degree	da	da	da	da	0.08	0.10	0.09	0.14	0.09	0.12
College Graduate	da	da	da	da	0.07	0.08	0.18	0.17	0.08	0.09
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.05	0.05	0.10	0.11	0.06	0.06
Part-Time	da	da	da	da	0.16	0.25	0.16	0.18	0.22	0.34
Unemployed	da	da	da	da	0.27	0.30	0.32	0.13	0.36	0.42
Other¹	da	da	da	da	0.07	0.07	0.07	0.22	0.08	0.08
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.55P – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.2823	0.5782	0.2601	0.8005	0.2157
SEX
Male	0.0629	0.8603	0.0639	0.1211	0.0326
Female	0.6309	0.5875	0.6746	0.4292	0.4988
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0751	0.7897	0.0800	0.7027	0.0545
AIAN	0.1114	*	0.1082	*	0.1466
Asian	0.1083	*	0.1085	*	0.1082
Black or African American	0.8132	0.4816	0.7578	0.6749	0.7012
NHPI	*	*	*	*	*
White	0.1425	0.6377	0.1567	0.9074	0.1286
Two or More Races	0.1593	*	0.1222	0.3429	0.0522
Hispanic or Latino	0.2538	0.1264	0.3268	0.8506	0.2931
EDUCATION LEVEL
< High School	da	da	0.1249	0.0123	0.6220
High School Graduate	da	da	0.3761	0.1446	0.5684
Some College/Associate’s Degree	da	da	0.4208	0.7900	0.4282
College Graduate	da	da	0.4042	0.3972	0.3309
EMPLOYMENT STATUS
Full-Time	da	da	0.9109	0.2934	0.6908
Part-Time	da	da	0.1018	0.8451	0.0840
Unemployed	da	da	0.8460	0.2100	0.9110
Other¹	da	da	0.7703	0.0906	0.9649
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.56C – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	497	500	50	51	493	496	62	65	488	495
SEX
Male	330	317	33	42	329	315	30	40	325	313
Female	353	354	37	33	350	350	53	51	344	349
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	474	449	41	40	471	449	55	59	466	447
AIAN	26	19	2	2	25	19	*	2	25	19
Asian	104	66	9	12	104	64	6	21	104	59
Black or African American	170	132	12	14	169	132	16	16	168	130
NHPI	*	8	<1	*	*	8	*	*	*	5
White	411	417	37	36	436	462	54	54	429	459
Two or More Races	70	53	8	4	70	53	8	5	69	53
Hispanic or Latino	169	181	27	33	167	177	28	27	166	173
EDUCATION LEVEL
< High School	da	da	da	da	131	88	19	16	134	85
High School Graduate	da	da	da	da	259	221	29	35	267	226
Some College/Associate’s Degree	da	da	da	da	262	279	47	50	268	289
College Graduate	da	da	da	da	273	280	27	20	283	300
EMPLOYMENT STATUS
Full-Time	da	da	da	da	313	290	33	42	312	289
Part-Time	da	da	da	da	161	158	35	29	157	156
Unemployed	da	da	da	da	77	82	24	17	74	79
Other¹	da	da	da	da	336	358	33	39	335	355
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.56D – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.18	0.17	0.19	0.20	0.19	0.19	0.18	0.18	0.22	0.22
SEX
Male	0.24	0.22	0.25	0.31	0.26	0.25	0.18	0.23	0.30	0.28
Female	0.24	0.24	0.29	0.26	0.26	0.26	0.31	0.29	0.30	0.30
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.21	0.19	0.22	0.21	0.22	0.21	0.21	0.23	0.25	0.24
AIAN	1.93	1.40	1.03	0.74	2.29	1.65	*	1.50	2.54	1.88
Asian	0.59	0.35	0.63	0.82	0.64	0.37	0.27	0.86	0.74	0.40
Black or African American	0.46	0.36	0.33	0.38	0.51	0.40	0.35	0.35	0.59	0.46
NHPI	*	0.64	0.15	*	*	0.69	*	*	*	0.49
White	0.24	0.24	0.28	0.28	0.26	0.26	0.29	0.29	0.29	0.30
Two or More Races	1.10	0.81	0.87	0.42	1.28	0.96	0.73	0.45	1.61	1.20
Hispanic or Latino	0.32	0.33	0.40	0.47	0.37	0.37	0.35	0.30	0.45	0.44
EDUCATION LEVEL
< High School	da	da	da	da	0.54	0.37	0.53	0.44	0.63	0.42
High School Graduate	da	da	da	da	0.37	0.31	0.25	0.29	0.44	0.38
Some College/Associate’s Degree	da	da	da	da	0.34	0.36	0.34	0.37	0.40	0.42
College Graduate	da	da	da	da	0.32	0.31	0.46	0.33	0.34	0.33
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.24	0.23	0.24	0.29	0.27	0.26
Part-Time	da	da	da	da	0.48	0.48	0.41	0.31	0.64	0.64
Unemployed	da	da	da	da	0.65	0.62	0.70	0.45	0.87	0.83
Other¹	da	da	da	da	0.34	0.36	0.38	0.45	0.37	0.39
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.56P – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0931	0.6045	0.1000	0.4459	0.1236
SEX
Male	0.3625	0.5762	0.3223	0.4357	0.2847
Female	0.1325	0.1627	0.1663	0.1553	0.2418
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1102	0.5204	0.1207	0.5961	0.1359
AIAN	0.9520	0.4751	0.9287	*	0.8122
Asian	0.2287	0.5516	0.1956	0.0193	0.0862
Black or African American	0.1105	0.6689	0.1006	0.6970	0.0881
NHPI	*	*	*	*	*
White	0.5620	0.5616	0.5893	0.2404	0.6961
Two or More Races	0.0849	0.0203	0.1462	0.1868	0.1916
Hispanic or Latino	0.6894	0.9808	0.6795	0.5545	0.7503
EDUCATION LEVEL
< High School	da	da	0.0084	0.6462	0.0092
High School Graduate	da	da	0.1750	0.5189	0.1615
Some College/Associate’s Degree	da	da	0.1945	0.6627	0.1625
College Graduate	da	da	0.0512	0.0852	0.0710
EMPLOYMENT STATUS
Full-Time	da	da	0.0029	0.6571	0.0035
Part-Time	da	da	0.4948	0.2927	0.6636
Unemployed	da	da	0.3643	0.2159	0.5209
Other¹	da	da	0.4525	0.4579	0.5143
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.57C – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	148	127	18	17	147	125	19	19	146	124
SEX
Male	124	98	15	7	123	97	11	15	122	96
Female	82	80	10	15	82	79	16	11	81	78
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	134	123	17	15	132	122	19	17	131	121
AIAN	2	7	<1	*	2	7	<1	*	2	7
Asian	4	11	4	*	*	11	*	11	*	*
Black or African American	51	16	4	2	51	16	7	3	50	15
NHPI	<1	*	*	*	<1	*	*	*	<1	*
White	122	116	16	15	122	116	18	12	120	115
Two or More Races	19	37	2	4	19	36	2	3	19	36
Hispanic or Latino	67	26	7	7	66	25	3	7	66	24
EDUCATION LEVEL
< High School	da	da	da	da	25	10	4	7	25	7
High School Graduate	da	da	da	da	65	52	13	7	64	51
Some College/Associate’s Degree	da	da	da	da	59	65	13	16	57	63
College Graduate	da	da	da	da	116	93	4	2	116	94
EMPLOYMENT STATUS
Full-Time	da	da	da	da	86	61	12	6	84	61
Part-Time	da	da	da	da	50	21	5	12	49	17
Unemployed	da	da	da	da	10	20	5	3	9	20
Other¹	da	da	da	da	110	106	13	13	110	105
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.57D – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.05	0.04	0.07	0.07	0.06	0.05	0.06	0.05	0.07	0.05
SEX
Male	0.09	0.07	0.12	0.05	0.10	0.08	0.07	0.09	0.11	0.09
Female	0.06	0.05	0.08	0.12	0.06	0.06	0.09	0.07	0.07	0.07
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.05	0.09	0.08	0.06	0.06	0.07	0.07	0.07	0.06
AIAN	0.16	0.54	0.08	*	0.19	0.63	0.16	*	0.22	0.73
Asian	0.02	0.06	0.27	*	*	0.07	*	0.47	*	*
Black or African American	0.15	0.04	0.10	0.06	0.16	0.05	0.14	0.07	0.19	0.06
NHPI	0.03	*	*	*	0.04	*	*	*	0.04	*
White	0.07	0.07	0.12	0.12	0.08	0.07	0.10	0.07	0.09	0.08
Two or More Races	0.31	0.56	0.20	0.40	0.36	0.66	0.16	0.29	0.46	0.84
Hispanic or Latino	0.13	0.05	0.10	0.10	0.15	0.05	0.04	0.08	0.18	0.06
EDUCATION LEVEL
< High School	da	da	da	da	0.10	0.04	0.10	0.20	0.12	0.04
High School Graduate	da	da	da	da	0.09	0.07	0.11	0.05	0.11	0.09
Some College/Associate’s Degree	da	da	da	da	0.08	0.08	0.10	0.12	0.09	0.10
College Graduate	da	da	da	da	0.13	0.10	0.08	0.03	0.14	0.11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.07	0.05	0.09	0.05	0.08	0.06
Part-Time	da	da	da	da	0.16	0.06	0.06	0.14	0.21	0.07
Unemployed	da	da	da	da	0.09	0.15	0.15	0.07	0.11	0.21
Other¹	da	da	da	da	0.12	0.11	0.15	0.15	0.13	0.12
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.57P – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3990	0.8652	0.4114	0.5379	0.4661
SEX
Male	0.2846	0.3998	0.3277	0.7535	0.3134
Female	0.9697	0.5860	0.9614	0.2425	0.8803
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6583	0.8403	0.6752	0.3435	0.7814
AIAN	0.1838	*	0.2222	*	0.2102
Asian	0.4699	*	*	*	*
Black or African American	0.3405	0.4936	0.3676	0.5332	0.4103
NHPI	*	*	*	*	*
White	0.6430	0.9342	0.6475	0.1266	0.7947
Two or More Races	0.3863	0.4877	0.4227	0.7647	0.4354
Hispanic or Latino	0.2628	0.9613	0.2724	0.2875	0.2232
EDUCATION LEVEL
< High School	da	da	0.6920	0.2945	0.4594
High School Graduate	da	da	0.6612	0.0712	0.9045
Some College/Associate’s Degree	da	da	0.8927	0.7559	0.9522
College Graduate	da	da	0.4016	0.2902	0.4213
EMPLOYMENT STATUS
Full-Time	da	da	0.0595	0.0427	0.1016
Part-Time	da	da	0.3655	0.4683	0.2681
Unemployed	da	da	0.2891	0.7921	0.2403
Other¹	da	da	0.6571	0.8330	0.6747
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.58C – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	72	61	6	6	72	61	8	12	71	60
SEX
Male	60	52	3	1	60	52	7	6	59	52
Female	40	32	5	6	39	31	4	11	39	29
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	44	61	5	6	44	60	8	11	43	59
AIAN	<1	6	*	*	<1	6	<1	*	*	6
Asian	*	2	*	*	*	2	*	2	*	*
Black or African American	7	14	*	<1	7	14	6	3	3	14
NHPI	*	*	*	*	*	*	*	*	*	*
White	43	58	5	4	43	58	6	11	43	57
Two or More Races	4	8	*	4	4	7	*	*	4	7
Hispanic or Latino	57	4	3	1	57	4	3	4	57	<1
EDUCATION LEVEL
< High School	da	da	da	da	25	5	*	4	25	4
High School Graduate	da	da	da	da	45	24	7	6	44	23
Some College/Associate’s Degree	da	da	da	da	12	22	4	10	11	20
College Graduate	da	da	da	da	49	51	3	2	49	51
EMPLOYMENT STATUS
Full-Time	da	da	da	da	30	52	7	4	29	52
Part-Time	da	da	da	da	43	11	4	5	43	10
Unemployed	da	da	da	da	*	17	*	2	*	17
Other¹	da	da	da	da	49	23	3	10	48	21
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.58D – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.03	0.02	0.02	0.02	0.03	0.02	0.02	0.03	0.03	0.03
SEX
Male	0.04	0.04	0.02	0.01	0.05	0.04	0.04	0.03	0.05	0.05
Female	0.03	0.02	0.04	0.04	0.03	0.02	0.03	0.06	0.03	0.02
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.02	0.03	0.03	0.03	0.02	0.03	0.03	0.04	0.02	0.03
AIAN	0.02	0.45	*	*	0.02	0.52	0.16	*	*	0.60
Asian	*	0.01	*	*	*	0.01	*	0.08	*	*
Black or African American	0.02	0.04	*	<0.01	0.02	0.04	0.13	0.06	0.01	0.05
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.03	0.03	0.04	0.03	0.03	0.04	0.03	0.06	0.03	0.04
Two or More Races	0.07	0.13	*	0.39	0.08	0.13	*	*	0.10	0.17
Hispanic or Latino	0.11	0.01	0.04	0.01	0.12	0.01	0.03	0.05	0.15	<0.01
EDUCATION LEVEL
< High School	da	da	da	da	0.10	0.02	*	0.10	0.12	0.02
High School Graduate	da	da	da	da	0.06	0.03	0.06	0.05	0.08	0.04
Some College/Associate’s Degree	da	da	da	da	0.02	0.03	0.03	0.07	0.02	0.03
College Graduate	da	da	da	da	0.06	0.06	0.06	0.03	0.06	0.06
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.02	0.04	0.05	0.03	0.03	0.05
Part-Time	da	da	da	da	0.14	0.04	0.04	0.05	0.19	0.04
Unemployed	da	da	da	da	*	0.13	*	0.05	*	0.18
Other¹	da	da	da	da	0.05	0.02	0.03	0.12	0.06	0.02
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.58P – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7101	0.7117	0.7323	0.4511	0.6412
SEX
Male	0.7472	0.5483	0.7646	0.8812	0.7767
Female	0.8528	0.8879	0.8678	0.2796	0.6712
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5300	0.9321	0.5230	0.6252	0.5770
AIAN	0.1290	*	0.1730	*	*
Asian	*	*	*	*	*
Black or African American	0.2903	*	0.2941	0.6599	0.1753
NHPI	*	*	*	*	*
White	0.8518	0.3285	0.7837	0.5001	0.8705
Two or More Races	0.4170	*	0.7146	*	0.7124
Hispanic or Latino	0.1585	0.4337	0.1704	0.3795	0.1460
EDUCATION LEVEL
< High School	da	da	0.5784	*	0.4273
High School Graduate	da	da	0.6285	0.8756	0.6428
Some College/Associate’s Degree	da	da	0.3015	0.4641	0.4223
College Graduate	da	da	0.7663	0.8156	0.7757
EMPLOYMENT STATUS
Full-Time	da	da	0.7106	0.2272	0.5885
Part-Time	da	da	0.3689	0.4351	0.3136
Unemployed	da	da	*	*	*
Other¹	da	da	0.4659	0.1968	0.3161
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.59C – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	577	577	42	43	574	575	85	91	560	568
SEX
Male	339	371	28	29	337	370	61	56	334	367
Female	438	444	32	30	435	444	65	71	425	438
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	531	511	37	36	529	509	75	78	518	504
AIAN	45	24	1	2	45	24	*	*	45	23
Asian	132	89	12	10	132	88	12	10	131	87
Black or African American	150	171	15	9	147	170	22	24	145	167
NHPI	14	46	*	*	14	46	3	*	14	*
White	472	467	32	31	527	545	74	72	513	537
Two or More Races	73	108	8	7	73	108	18	25	71	106
Hispanic or Latino	233	245	22	21	233	244	42	45	229	239
EDUCATION LEVEL
< High School	da	da	da	da	158	157	30	21	159	156
High School Graduate	da	da	da	da	312	289	49	54	327	299
Some College/Associate’s Degree	da	da	da	da	319	326	60	65	346	355
College Graduate	da	da	da	da	307	318	43	33	340	360
EMPLOYMENT STATUS
Full-Time	da	da	da	da	384	340	61	58	375	334
Part-Time	da	da	da	da	199	233	45	50	193	223
Unemployed	da	da	da	da	88	107	33	23	80	104
Other¹	da	da	da	da	430	455	43	48	421	448
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.59D – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.20	0.20	0.16	0.17	0.22	0.22	0.25	0.26	0.25	0.25
SEX
Male	0.24	0.26	0.21	0.22	0.27	0.29	0.35	0.32	0.31	0.33
Female	0.30	0.30	0.26	0.24	0.33	0.33	0.38	0.41	0.37	0.37
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.23	0.22	0.20	0.19	0.25	0.24	0.29	0.30	0.28	0.27
AIAN	3.09	1.69	0.49	0.97	3.64	1.99	*	*	4.08	2.22
Asian	0.74	0.48	0.85	0.67	0.80	0.51	0.52	0.43	0.92	0.59
Black or African American	0.42	0.45	0.42	0.26	0.46	0.50	0.47	0.52	0.53	0.58
NHPI	1.33	3.56	*	*	1.44	3.80	2.63	*	1.57	*
White	0.28	0.27	0.25	0.25	0.30	0.30	0.39	0.39	0.33	0.33
Two or More Races	1.14	1.55	0.81	0.65	1.34	1.82	1.63	2.08	1.64	2.26
Hispanic or Latino	0.45	0.45	0.32	0.30	0.51	0.51	0.51	0.51	0.61	0.61
EDUCATION LEVEL
< High School	da	da	da	da	0.64	0.65	0.81	0.59	0.74	0.75
High School Graduate	da	da	da	da	0.45	0.41	0.41	0.44	0.53	0.49
Some College/Associate’s Degree	da	da	da	da	0.41	0.42	0.44	0.48	0.49	0.50
College Graduate	da	da	da	da	0.36	0.35	0.71	0.54	0.38	0.38
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.29	0.26	0.42	0.39	0.32	0.28
Part-Time	da	da	da	da	0.59	0.67	0.53	0.55	0.78	0.88
Unemployed	da	da	da	da	0.77	0.79	0.95	0.60	0.99	1.07
Other¹	da	da	da	da	0.42	0.43	0.50	0.56	0.45	0.46
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.59P – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.9110	0.1585	0.9663	0.1977	0.8634
SEX
Male	0.5193	0.9231	0.5373	0.2700	0.4165
Female	0.5132	0.0444	0.5879	0.5070	0.6622
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5028	0.1620	0.4576	0.0812	0.3100
AIAN	0.1246	0.1129	0.0883	*	0.0781
Asian	0.3054	0.7491	0.3155	0.7362	0.3306
Black or African American	0.4900	0.2654	0.4369	0.3911	0.3589
NHPI	0.1377	*	0.1366	*	*
White	0.4808	0.3372	0.4567	0.0895	0.3163
Two or More Races	0.3410	0.3972	0.2809	0.4389	0.3552
Hispanic or Latino	0.0972	0.6479	0.0983	0.6025	0.0780
EDUCATION LEVEL
< High School	da	da	0.4634	0.0185	0.7183
High School Graduate	da	da	0.7737	0.6014	0.7984
Some College/Associate’s Degree	da	da	0.5081	0.9080	0.5172
College Graduate	da	da	0.4698	0.0253	0.6485
EMPLOYMENT STATUS
Full-Time	da	da	0.1136	0.0615	0.2084
Part-Time	da	da	0.1778	0.8958	0.1400
Unemployed	da	da	0.8469	0.0376	0.6713
Other¹	da	da	0.5957	0.1888	0.7161
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.60C – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	230	207	18	20	230	205	43	51	223	197
SEX
Male	168	165	11	10	167	164	32	29	163	161
Female	146	127	17	17	144	127	27	42	141	120
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	204	178	16	18	204	178	37	40	198	172
AIAN	4	19	<1	*	4	19	1	*	3	*
Asian	55	30	*	*	55	30	7	4	54	30
Black or African American	57	42	4	4	57	42	8	8	56	40
NHPI	3	7	*	*	3	7	*	*	3	7
White	184	161	15	17	186	163	33	38	179	158
Two or More Races	21	39	5	4	21	39	13	10	16	38
Hispanic or Latino	109	93	12	10	108	93	22	30	106	87
EDUCATION LEVEL
< High School	da	da	da	da	42	43	17	14	39	40
High School Graduate	da	da	da	da	128	102	20	33	126	95
Some College/Associate’s Degree	da	da	da	da	110	124	28	34	105	120
College Graduate	da	da	da	da	133	116	18	17	133	116
EMPLOYMENT STATUS
Full-Time	da	da	da	da	151	117	30	29	148	112
Part-Time	da	da	da	da	71	93	21	31	68	88
Unemployed	da	da	da	da	44	64	16	13	39	63
Other¹	da	da	da	da	146	127	18	29	144	123
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.60D – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.08	0.07	0.07	0.08	0.09	0.08	0.13	0.14	0.10	0.09
SEX
Male	0.12	0.12	0.08	0.08	0.13	0.13	0.19	0.16	0.15	0.15
Female	0.10	0.09	0.13	0.14	0.11	0.09	0.16	0.24	0.12	0.10
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.09	0.08	0.08	0.09	0.10	0.08	0.15	0.15	0.11	0.09
AIAN	0.26	1.33	0.03	*	0.32	1.57	0.73	*	0.35	*
Asian	0.31	0.16	*	*	0.34	0.17	0.33	0.15	0.39	0.20
Black or African American	0.16	0.12	0.12	0.10	0.18	0.13	0.18	0.18	0.21	0.14
NHPI	0.30	0.54	*	*	0.33	0.58	*	*	0.37	0.67
White	0.11	0.09	0.12	0.13	0.12	0.10	0.19	0.21	0.13	0.11
Two or More Races	0.34	0.58	0.49	0.39	0.40	0.70	1.16	0.84	0.39	0.86
Hispanic or Latino	0.21	0.17	0.18	0.15	0.24	0.19	0.27	0.34	0.28	0.22
EDUCATION LEVEL
< High School	da	da	da	da	0.17	0.18	0.47	0.40	0.19	0.20
High School Graduate	da	da	da	da	0.18	0.14	0.18	0.27	0.22	0.16
Some College/Associate’s Degree	da	da	da	da	0.14	0.16	0.21	0.25	0.16	0.18
College Graduate	da	da	da	da	0.15	0.13	0.31	0.28	0.16	0.14
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.12	0.10	0.21	0.20	0.14	0.10
Part-Time	da	da	da	da	0.22	0.28	0.25	0.34	0.29	0.37
Unemployed	da	da	da	da	0.38	0.50	0.48	0.34	0.49	0.68
Other¹	da	da	da	da	0.16	0.13	0.21	0.35	0.17	0.14
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.60P – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1913	0.8607	0.1927	0.9374	0.1861
SEX
Male	0.3390	0.9385	0.3366	0.1636	0.4756
Female	0.3679	0.8822	0.3696	0.2688	0.2148
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4159	0.9809	0.4080	0.5814	0.4621
AIAN	0.1482	*	0.1674	*	*
Asian	0.3976	*	0.3957	0.5491	0.4392
Black or African American	0.6972	0.9840	0.6938	0.5535	0.7622
NHPI	0.4978	*	0.5027	*	0.4981
White	0.4043	0.8863	0.3913	0.7871	0.4042
Two or More Races	0.3107	0.5583	0.2643	0.6008	0.1496
Hispanic or Latino	0.2188	0.7302	0.2257	0.4513	0.1528
EDUCATION LEVEL
< High School	da	da	0.8231	0.1250	0.3981
High School Graduate	da	da	0.5334	0.2173	0.3380
Some College/Associate’s Degree	da	da	0.7465	0.7949	0.6809
College Graduate	da	da	0.1441	0.2399	0.1892
EMPLOYMENT STATUS
Full-Time	da	da	0.0088	0.1359	0.0193
Part-Time	da	da	0.3883	0.8208	0.4051
Unemployed	da	da	0.8002	0.2911	0.5722
Other¹	da	da	0.8580	0.0428	0.5799
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.61C – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	840	914	102	110	827	902	150	155	815	878
SEX
Male	598	609	76	79	592	600	103	114	584	583
Female	614	627	72	82	604	620	107	107	590	614
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	772	845	85	88	764	833	126	134	764	811
AIAN	48	43	4	5	48	43	7	10	47	40
Asian	184	250	20	25	182	248	39	47	178	242
Black or African American	370	376	37	43	367	371	63	59	353	357
NHPI	*	52	*	*	*	50	*	*	*	49
White	686	725	83	82	959	977	121	135	937	942
Two or More Races	146	110	17	19	145	108	26	26	143	104
Hispanic or Latino	349	363	63	65	339	360	81	82	324	353
EDUCATION LEVEL
< High School	da	da	da	da	256	280	43	52	301	322
High School Graduate	da	da	da	da	474	481	87	100	580	568
Some College/Associate’s Degree	da	da	da	da	497	479	114	112	645	596
College Graduate	da	da	da	da	419	468	68	58	491	568
EMPLOYMENT STATUS
Full-Time	da	da	da	da	669	658	109	105	647	642
Part-Time	da	da	da	da	299	319	79	87	291	304
Unemployed	da	da	da	da	158	167	42	46	151	159
Other¹	da	da	da	da	743	805	84	89	736	789
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.61D – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.30	0.32	0.40	0.42	0.32	0.34	0.44	0.44	0.36	0.39
SEX
Male	0.43	0.43	0.57	0.60	0.47	0.47	0.61	0.65	0.54	0.53
Female	0.42	0.43	0.57	0.64	0.46	0.46	0.63	0.62	0.51	0.52
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.33	0.36	0.44	0.46	0.36	0.39	0.49	0.51	0.41	0.43
AIAN	3.24	2.79	1.90	2.54	3.81	3.34	4.77	5.33	4.19	3.67
Asian	0.97	1.19	1.34	1.62	1.05	1.29	1.66	1.80	1.20	1.46
Black or African American	0.84	0.80	0.93	1.09	0.94	0.89	1.22	1.15	1.06	1.03
NHPI	*	3.91	*	*	*	4.03	*	*	*	4.57
White	0.40	0.42	0.58	0.58	0.43	0.45	0.60	0.66	0.48	0.50
Two or More Races	1.93	1.58	1.71	1.77	2.25	1.85	2.20	2.14	2.82	2.30
Hispanic or Latino	0.67	0.66	0.93	0.94	0.74	0.75	0.98	0.93	0.87	0.91
EDUCATION LEVEL
< High School	da	da	da	da	1.05	1.17	1.14	1.35	1.20	1.34
High School Graduate	da	da	da	da	0.68	0.68	0.68	0.73	0.82	0.82
Some College/Associate’s Degree	da	da	da	da	0.65	0.61	0.76	0.73	0.75	0.71
College Graduate	da	da	da	da	0.48	0.52	1.09	0.89	0.51	0.55
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.43	0.45	0.70	0.68	0.47	0.50
Part-Time	da	da	da	da	0.82	0.84	0.86	0.88	1.10	1.10
Unemployed	da	da	da	da	1.21	1.15	1.20	1.18	1.65	1.54
Other¹	da	da	da	da	0.58	0.64	0.88	0.95	0.64	0.69
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.61P – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3166	0.0383	0.4765	0.2084	0.3204
SEX
Male	0.0579	0.0421	0.1014	0.4805	0.0676
Female	0.6049	0.4367	0.5199	0.2820	0.6610
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5675	0.2389	0.6803	0.3475	0.5509
AIAN	0.6902	0.7416	0.5912	0.7361	0.5397
Asian	0.1064	0.2712	0.1327	0.8615	0.1296
Black or African American	0.4220	0.4182	0.3505	0.7070	0.3011
NHPI	*	*	*	*	*
White	0.2966	0.6495	0.3310	0.2110	0.2237
Two or More Races	0.1329	0.6939	0.1263	0.7824	0.1390
Hispanic or Latino	0.2098	0.0711	0.3588	0.4003	0.2453
EDUCATION LEVEL
< High School	da	da	0.9654	0.2864	0.8195
High School Graduate	da	da	0.4514	0.5763	0.4629
Some College/Associate’s Degree	da	da	0.4787	0.1638	0.6609
College Graduate	da	da	0.1345	0.0126	0.0610
EMPLOYMENT STATUS
Full-Time	da	da	0.5259	0.1836	0.6905
Part-Time	da	da	0.6831	0.5741	0.7512
Unemployed	da	da	0.8225	0.4321	0.6129
Other¹	da	da	0.1397	0.0803	0.0879
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.62C – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	329	318	50	39	328	315	59	82	318	300
SEX
Male	253	258	36	25	251	257	45	48	244	251
Female	213	186	36	30	211	183	39	60	204	175
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	295	293	38	32	294	292	54	71	289	281
AIAN	24	12	2	4	24	11	*	*	24	10
Asian	79	51	9	8	78	50	9	15	78	48
Black or African American	143	110	16	8	142	109	29	25	136	107
NHPI	27	16	*	*	27	16	2	*	*	16
White	255	257	33	29	264	263	41	66	259	253
Two or More Races	54	54	6	6	54	54	12	6	52	54
Hispanic or Latino	147	126	32	24	142	123	28	38	138	118
EDUCATION LEVEL
< High School	da	da	da	da	110	106	23	20	108	106
High School Graduate	da	da	da	da	195	176	33	48	196	176
Some College/Associate’s Degree	da	da	da	da	201	194	39	51	201	191
College Graduate	da	da	da	da	150	128	23	24	152	132
EMPLOYMENT STATUS
Full-Time	da	da	da	da	224	186	39	48	220	179
Part-Time	da	da	da	da	74	90	24	45	70	77
Unemployed	da	da	da	da	65	77	15	23	64	71
Other¹	da	da	da	da	229	236	35	35	225	233
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.62D – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.12	0.11	0.19	0.15	0.13	0.12	0.17	0.23	0.14	0.13
SEX
Male	0.18	0.18	0.27	0.19	0.20	0.20	0.26	0.28	0.23	0.23
Female	0.15	0.13	0.28	0.24	0.16	0.14	0.23	0.34	0.18	0.15
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.13	0.13	0.20	0.17	0.14	0.14	0.21	0.27	0.15	0.15
AIAN	1.75	0.88	1.02	1.97	2.09	0.97	*	*	2.35	1.01
Asian	0.45	0.27	0.65	0.54	0.48	0.29	0.41	0.62	0.56	0.32
Black or African American	0.40	0.30	0.44	0.23	0.44	0.33	0.63	0.53	0.49	0.38
NHPI	2.41	1.27	*	*	2.61	1.36	1.42	*	*	1.57
White	0.15	0.15	0.25	0.23	0.16	0.16	0.23	0.37	0.18	0.18
Two or More Races	0.84	0.80	0.64	0.56	0.98	0.95	1.10	0.52	1.20	1.18
Hispanic or Latino	0.28	0.23	0.48	0.35	0.31	0.26	0.34	0.43	0.37	0.30
EDUCATION LEVEL
< High School	da	da	da	da	0.45	0.44	0.63	0.56	0.51	0.51
High School Graduate	da	da	da	da	0.28	0.25	0.29	0.39	0.33	0.30
Some College/Associate’s Degree	da	da	da	da	0.26	0.25	0.30	0.38	0.31	0.29
College Graduate	da	da	da	da	0.17	0.14	0.40	0.40	0.18	0.15
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.18	0.15	0.28	0.33	0.20	0.17
Part-Time	da	da	da	da	0.23	0.28	0.29	0.50	0.30	0.33
Unemployed	da	da	da	da	0.56	0.58	0.43	0.61	0.78	0.75
Other¹	da	da	da	da	0.24	0.24	0.41	0.41	0.26	0.26
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.62P – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0490	0.0697	0.0844	0.3265	0.0471
SEX
Male	0.1887	0.1612	0.2465	0.6404	0.2778
Female	0.1581	0.2272	0.2169	0.0651	0.0820
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0664	0.0593	0.1063	0.3986	0.0703
AIAN	0.2672	0.5155	0.2015	*	0.2136
Asian	0.7904	0.7076	0.8262	0.7685	0.7823
Black or African American	0.1638	0.0020	0.2727	0.9044	0.2549
NHPI	0.4378	*	0.4736	*	*
White	0.2534	0.4247	0.2921	0.2342	0.1868
Two or More Races	0.9673	0.9558	0.9417	0.0990	0.6989
Hispanic or Latino	0.4907	0.5320	0.5651	0.6330	0.4610
EDUCATION LEVEL
< High School	da	da	0.8457	0.6826	0.7783
High School Graduate	da	da	0.7197	0.2186	0.5305
Some College/Associate’s Degree	da	da	0.2261	0.5473	0.1604
College Graduate	da	da	0.1044	0.9777	0.1050
EMPLOYMENT STATUS
Full-Time	da	da	0.0132	0.9550	0.0122
Part-Time	da	da	0.1405	0.2504	0.2629
Unemployed	da	da	0.4250	0.0322	0.8593
Other¹	da	da	0.3422	0.6601	0.3707
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.63C – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	177	190	29	19	176	190	28	38	173	186
SEX
Male	145	156	23	9	143	156	21	19	140	155
Female	110	103	18	17	109	102	17	31	108	97
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	145	172	14	14	146	172	24	25	144	170
AIAN	6	6	1	1	6	5	<1	*	6	1
Asian	51	12	1	7	51	10	3	2	51	10
Black or African American	63	50	9	4	62	50	9	10	62	49
NHPI	2	2	*	*	2	2	*	*	2	*
White	135	160	10	11	138	161	21	23	135	160
Two or More Races	11	40	5	2	10	40	5	2	9	40
Hispanic or Latino	98	71	25	12	94	71	15	26	93	67
EDUCATION LEVEL
< High School	da	da	da	da	72	64	8	13	72	63
High School Graduate	da	da	da	da	125	88	10	23	125	85
Some College/Associate’s Degree	da	da	da	da	96	137	24	20	93	138
College Graduate	da	da	da	da	62	59	4	14	62	58
EMPLOYMENT STATUS
Full-Time	da	da	da	da	118	77	16	11	116	76
Part-Time	da	da	da	da	37	48	6	25	36	41
Unemployed	da	da	da	da	38	36	9	14	37	33
Other¹	da	da	da	da	120	165	20	19	118	164
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.63D – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.07	0.11	0.07	0.07	0.07	0.08	0.11	0.08	0.08
SEX
Male	0.10	0.11	0.17	0.07	0.11	0.12	0.13	0.11	0.13	0.14
Female	0.08	0.07	0.14	0.13	0.08	0.08	0.10	0.18	0.09	0.08
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.07	0.08	0.07	0.07	0.08	0.09	0.10	0.08	0.09
AIAN	0.43	0.40	0.24	0.51	0.52	0.46	0.16	*	0.60	0.12
Asian	0.29	0.07	0.09	0.49	0.32	0.06	0.12	0.08	0.37	0.07
Black or African American	0.18	0.14	0.26	0.11	0.20	0.16	0.19	0.21	0.23	0.18
NHPI	0.15	0.13	*	*	0.16	0.14	*	*	0.18	*
White	0.08	0.09	0.08	0.09	0.09	0.10	0.12	0.13	0.10	0.11
Two or More Races	0.18	0.61	0.51	0.19	0.19	0.72	0.44	0.19	0.22	0.91
Hispanic or Latino	0.19	0.13	0.37	0.18	0.21	0.15	0.18	0.30	0.25	0.17
EDUCATION LEVEL
< High School	da	da	da	da	0.29	0.27	0.22	0.37	0.34	0.31
High School Graduate	da	da	da	da	0.18	0.13	0.09	0.19	0.21	0.15
Some College/Associate’s Degree	da	da	da	da	0.12	0.18	0.18	0.15	0.14	0.21
College Graduate	da	da	da	da	0.07	0.07	0.07	0.24	0.08	0.07
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.10	0.06	0.11	0.08	0.11	0.07
Part-Time	da	da	da	da	0.12	0.15	0.08	0.27	0.16	0.17
Unemployed	da	da	da	da	0.33	0.28	0.28	0.38	0.45	0.36
Other¹	da	da	da	da	0.13	0.17	0.23	0.23	0.14	0.18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.63P – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4007	0.4847	0.4545	0.3751	0.3537
SEX
Male	0.2739	0.1065	0.3599	0.5403	0.4003
Female	0.9229	0.5684	1.0000	0.1034	0.6786
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5092	0.7842	0.5256	0.8409	0.5026
AIAN	0.1690	0.7011	0.1414	*	0.0082
Asian	0.3583	0.2600	0.2795	0.6971	0.2891
Black or African American	0.3147	0.1940	0.3928	0.6484	0.3499
NHPI	0.9523	*	0.9469	*	*
White	0.7634	0.8510	0.7484	0.9315	0.7368
Two or More Races	0.1288	0.3105	0.0952	0.2872	0.0675
Hispanic or Latino	0.5655	0.4839	0.6675	0.2422	0.4552
EDUCATION LEVEL
< High School	da	da	0.6668	0.5539	0.7289
High School Graduate	da	da	0.1383	0.0203	0.0607
Some College/Associate’s Degree	da	da	0.7101	0.1593	0.5147
College Graduate	da	da	0.4800	0.1393	0.3289
EMPLOYMENT STATUS
Full-Time	da	da	0.0069	0.0807	0.0137
Part-Time	da	da	0.0740	0.0393	0.3000
Unemployed	da	da	0.4140	0.1659	0.7091
Other¹	da	da	0.9038	0.9558	0.9118
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.64C – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	536	521	90	89	525	511	165	157	490	498
SEX
Male	378	397	61	65	374	389	104	116	355	370
Female	376	362	63	69	368	354	111	99	341	343
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	482	476	79	84	475	468	144	129	452	456
AIAN	36	15	7	2	36	15	7	4	35	15
Asian	140	117	13	20	139	114	24	45	136	106
Black or African American	173	148	13	21	172	145	36	32	170	139
NHPI	*	*	*	*	*	*	*	*	*	*
White	428	430	83	85	481	475	149	136	440	450
Two or More Races	56	91	11	13	55	90	28	21	48	88
Hispanic or Latino	209	221	40	37	202	217	69	83	181	192
EDUCATION LEVEL
< High School	da	da	da	da	146	122	38	50	141	108
High School Graduate	da	da	da	da	267	262	76	84	268	262
Some College/Associate’s Degree	da	da	da	da	322	277	121	115	312	285
College Graduate	da	da	da	da	272	293	78	66	296	330
EMPLOYMENT STATUS
Full-Time	da	da	da	da	386	396	102	108	366	384
Part-Time	da	da	da	da	173	185	86	77	145	166
Unemployed	da	da	da	da	151	135	45	50	143	123
Other¹	da	da	da	da	327	310	86	86	318	300
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.64D – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.19	0.18	0.35	0.34	0.20	0.19	0.48	0.45	0.22	0.22
SEX
Male	0.27	0.28	0.46	0.49	0.30	0.30	0.61	0.66	0.33	0.34
Female	0.26	0.25	0.50	0.54	0.28	0.26	0.66	0.57	0.30	0.29
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.21	0.20	0.42	0.44	0.22	0.22	0.56	0.49	0.24	0.24
AIAN	2.46	1.14	2.96	1.13	2.93	1.34	4.29	2.27	3.33	1.52
Asian	0.78	0.59	0.88	1.29	0.84	0.63	1.05	1.77	0.96	0.67
Black or African American	0.48	0.40	0.37	0.58	0.53	0.44	0.79	0.68	0.61	0.49
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.25	0.25	0.58	0.60	0.27	0.27	0.70	0.64	0.28	0.29
Two or More Races	0.90	1.35	1.08	1.26	1.05	1.58	2.32	1.76	1.16	1.96
Hispanic or Latino	0.40	0.41	0.59	0.53	0.44	0.46	0.83	0.95	0.49	0.49
EDUCATION LEVEL
< High School	da	da	da	da	0.60	0.51	1.01	1.34	0.67	0.53
High School Graduate	da	da	da	da	0.38	0.37	0.62	0.64	0.45	0.43
Some College/Associate’s Degree	da	da	da	da	0.42	0.36	0.78	0.77	0.47	0.41
College Graduate	da	da	da	da	0.31	0.33	1.19	1.00	0.33	0.34
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.29	0.29	0.67	0.68	0.32	0.32
Part-Time	da	da	da	da	0.52	0.54	0.92	0.80	0.60	0.67
Unemployed	da	da	da	da	1.22	0.99	1.28	1.23	1.63	1.28
Other¹	da	da	da	da	0.33	0.31	0.92	0.94	0.36	0.33
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.64P – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7955	0.6866	0.7305	0.3411	0.9500
SEX
Male	0.5891	0.9441	0.5948	0.8319	0.6307
Female	0.3531	0.6299	0.2954	0.0898	0.5497
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7330	0.5369	0.6457	0.2440	0.9022
AIAN	0.0501	0.1306	0.0872	0.0462	0.1790
Asian	0.8701	0.6939	0.8225	0.1508	0.5009
Black or African American	0.1952	0.0164	0.1100	0.3769	0.1562
NHPI	*	*	*	*	*
White	0.8983	0.8079	0.9317	0.2334	0.6434
Two or More Races	0.0481	0.9690	0.0430	0.8058	0.0265
Hispanic or Latino	0.8045	0.7544	0.7656	0.8240	0.8162
EDUCATION LEVEL
< High School	da	da	0.0830	0.4741	0.0365
High School Graduate	da	da	0.1637	0.8201	0.1781
Some College/Associate’s Degree	da	da	0.4094	0.1223	0.7297
College Graduate	da	da	0.8247	0.5367	0.9355
EMPLOYMENT STATUS
Full-Time	da	da	0.8036	0.5215	0.6711
Part-Time	da	da	0.5781	0.1770	0.9964
Unemployed	da	da	0.1658	0.7093	0.1703
Other¹	da	da	0.9807	0.7806	0.9495
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.65C – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	355	327	36	41	351	325	113	89	329	314
SEX
Male	288	275	25	24	285	274	74	65	275	264
Female	199	178	28	34	196	179	74	67	176	164
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	310	302	33	37	305	301	95	78	289	292
AIAN	29	11	2	1	29	11	3	3	29	10
Asian	50	67	8	13	49	66	20	24	44	62
Black or African American	94	92	5	6	94	92	20	14	93	89
NHPI	*	7	*	<1	*	7	*	*	*	7
White	281	266	31	34	295	277	96	76	277	266
Two or More Races	31	57	6	6	31	57	13	8	28	56
Hispanic or Latino	161	142	18	16	161	142	50	47	147	129
EDUCATION LEVEL
< High School	da	da	da	da	95	94	25	24	93	90
High School Graduate	da	da	da	da	195	192	48	49	196	188
Some College/Associate’s Degree	da	da	da	da	199	172	76	63	186	170
College Graduate	da	da	da	da	183	170	62	49	176	170
EMPLOYMENT STATUS
Full-Time	da	da	da	da	258	225	81	65	240	211
Part-Time	da	da	da	da	107	123	53	46	92	112
Unemployed	da	da	da	da	106	93	33	34	100	86
Other¹	da	da	da	da	200	192	47	45	193	187
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.65D – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.13	0.11	0.14	0.16	0.14	0.12	0.33	0.26	0.15	0.14
SEX
Male	0.21	0.20	0.19	0.18	0.23	0.21	0.43	0.37	0.25	0.24
Female	0.14	0.12	0.22	0.27	0.15	0.13	0.44	0.38	0.15	0.14
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.13	0.13	0.17	0.20	0.14	0.14	0.37	0.30	0.16	0.16
AIAN	2.04	0.80	0.85	0.57	2.46	0.94	2.33	2.15	2.79	1.03
Asian	0.28	0.35	0.56	0.85	0.31	0.37	0.89	0.97	0.32	0.41
Black or African American	0.27	0.25	0.13	0.16	0.30	0.28	0.45	0.31	0.34	0.32
NHPI	*	0.60	*	0.18	*	0.65	*	*	*	0.72
White	0.17	0.16	0.24	0.27	0.18	0.17	0.49	0.40	0.19	0.18
Two or More Races	0.52	0.86	0.64	0.55	0.61	1.03	1.17	0.74	0.69	1.29
Hispanic or Latino	0.31	0.26	0.26	0.23	0.35	0.30	0.60	0.53	0.39	0.33
EDUCATION LEVEL
< High School	da	da	da	da	0.39	0.39	0.69	0.67	0.44	0.44
High School Graduate	da	da	da	da	0.28	0.27	0.40	0.40	0.33	0.32
Some College/Associate’s Degree	da	da	da	da	0.26	0.22	0.54	0.45	0.29	0.26
College Graduate	da	da	da	da	0.21	0.19	1.01	0.79	0.21	0.19
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.20	0.18	0.55	0.43	0.22	0.19
Part-Time	da	da	da	da	0.33	0.37	0.60	0.50	0.39	0.47
Unemployed	da	da	da	da	0.90	0.70	0.96	0.88	1.19	0.91
Other¹	da	da	da	da	0.21	0.20	0.52	0.51	0.22	0.21
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.65P – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0928	0.8924	0.0842	0.0476	0.2441
SEX
Male	0.5053	0.9291	0.4948	0.1362	0.7589
Female	0.0491	0.8128	0.0421	0.1429	0.1003
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2113	0.7829	0.1916	0.0360	0.4711
AIAN	0.1069	0.5261	0.1107	0.5464	0.1251
Asian	0.3196	0.4908	0.3792	0.9660	0.3273
Black or African American	0.7658	0.0528	0.6699	0.2580	0.8400
NHPI	*	*	*	*	*
White	0.1759	0.8531	0.1755	0.0567	0.4076
Two or More Races	0.0837	0.8209	0.0735	0.5687	0.0462
Hispanic or Latino	0.2322	0.7975	0.2320	0.6952	0.2432
EDUCATION LEVEL
< High School	da	da	0.5476	0.6114	0.6271
High School Graduate	da	da	0.5576	0.9585	0.5596
Some College/Associate’s Degree	da	da	0.0829	0.0339	0.2968
College Graduate	da	da	0.0935	0.2924	0.1544
EMPLOYMENT STATUS
Full-Time	da	da	0.1100	0.1412	0.2130
Part-Time	da	da	0.2341	0.0224	0.8029
Unemployed	da	da	0.5954	0.9968	0.5549
Other¹	da	da	0.8382	0.9573	0.8389
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.66C – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	255	220	20	26	254	222	60	46	244	215
SEX
Male	211	188	16	11	210	188	44	36	204	182
Female	140	113	13	23	139	117	42	32	128	110
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	224	206	19	25	223	208	49	39	215	202
AIAN	13	3	<1	*	13	3	*	<1	13	3
Asian	25	59	1	*	25	59	10	10	23	58
Black or African American	71	62	2	3	71	62	15	9	70	61
NHPI	*	2	*	<1	*	2	*	<1	*	2
White	198	179	18	24	201	183	46	36	193	177
Two or More Races	25	55	4	3	25	55	5	4	24	54
Hispanic or Latino	116	91	8	6	117	91	29	26	112	86
EDUCATION LEVEL
< High School	da	da	da	da	74	67	17	18	73	63
High School Graduate	da	da	da	da	146	136	22	25	147	135
Some College/Associate’s Degree	da	da	da	da	156	116	46	29	151	114
College Graduate	da	da	da	da	106	96	23	20	103	96
EMPLOYMENT STATUS
Full-Time	da	da	da	da	164	139	33	33	158	132
Part-Time	da	da	da	da	77	70	39	19	67	67
Unemployed	da	da	da	da	63	69	13	11	61	67
Other¹	da	da	da	da	163	131	23	28	161	127
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.66D – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.08	0.08	0.10	0.10	0.08	0.18	0.13	0.11	0.09
SEX
Male	0.15	0.13	0.12	0.08	0.17	0.15	0.26	0.20	0.19	0.17
Female	0.10	0.08	0.10	0.18	0.11	0.09	0.25	0.18	0.11	0.09
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.10	0.09	0.10	0.13	0.11	0.10	0.19	0.15	0.12	0.11
AIAN	0.94	0.24	0.03	*	1.14	0.27	*	0.15	1.30	0.31
Asian	0.14	0.31	0.09	*	0.15	0.34	0.46	0.41	0.16	0.39
Black or African American	0.20	0.17	0.06	0.07	0.22	0.19	0.33	0.20	0.26	0.22
NHPI	*	0.13	*	0.18	*	0.14	*	0.01	*	0.16
White	0.12	0.11	0.14	0.19	0.13	0.11	0.25	0.21	0.14	0.12
Two or More Races	0.41	0.83	0.43	0.28	0.47	0.99	0.44	0.40	0.59	1.25
Hispanic or Latino	0.22	0.17	0.12	0.08	0.26	0.19	0.36	0.30	0.30	0.22
EDUCATION LEVEL
< High School	da	da	da	da	0.30	0.28	0.47	0.50	0.35	0.31
High School Graduate	da	da	da	da	0.21	0.19	0.19	0.20	0.25	0.23
Some College/Associate’s Degree	da	da	da	da	0.20	0.15	0.34	0.22	0.24	0.17
College Graduate	da	da	da	da	0.12	0.11	0.38	0.33	0.13	0.11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.13	0.11	0.23	0.23	0.15	0.12
Part-Time	da	da	da	da	0.24	0.22	0.45	0.22	0.29	0.28
Unemployed	da	da	da	da	0.54	0.53	0.38	0.30	0.75	0.72
Other¹	da	da	da	da	0.17	0.14	0.26	0.33	0.19	0.15
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.66P – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3449	0.8006	0.3273	0.2296	0.4721
SEX
Male	0.5210	0.7419	0.4979	0.4940	0.5864
Female	0.4668	0.9404	0.4593	0.2960	0.6374
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6872	0.7940	0.6606	0.0470	0.9923
AIAN	0.1621	*	0.1316	*	0.1668
Asian	0.0813	*	0.0787	0.6016	0.0536
Black or African American	0.8791	0.9521	0.8708	0.4323	0.9880
NHPI	*	*	*	*	*
White	0.3741	0.8134	0.3565	0.0758	0.5878
Two or More Races	0.0435	0.8804	0.0413	0.6744	0.0446
Hispanic or Latino	0.2003	0.9819	0.1954	0.4037	0.1087
EDUCATION LEVEL
< High School	da	da	0.5265	0.9202	0.5305
High School Graduate	da	da	0.3337	0.1184	0.4593
Some College/Associate’s Degree	da	da	0.1086	0.0586	0.2694
College Graduate	da	da	0.3559	0.2221	0.5004
EMPLOYMENT STATUS
Full-Time	da	da	0.4725	0.5763	0.5425
Part-Time	da	da	0.1381	0.0261	0.5429
Unemployed	da	da	0.7033	0.6634	0.7353
Other¹	da	da	0.9674	0.3084	0.8272
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.67C – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	573	--	101	--	568	--	155	--	545
SEX
Male	--	455	--	64	--	453	--	110	--	432
Female	--	351	--	70	--	343	--	105	--	324
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	523	--	88	--	521	--	131	--	503
AIAN	--	34	--	5	--	34	--	6	--	34
Asian	--	120	--	23	--	115	--	42	--	104
Black or African American	--	172	--	38	--	167	--	46	--	160
NHPI	--	20	--	*	--	18	--	2	--	18
White	--	449	--	78	--	496	--	125	--	471
Two or More Races	--	103	--	12	--	103	--	29	--	97
Hispanic or Latino	--	227	--	44	--	220	--	76	--	205
EDUCATION LEVEL
< High School	da	da	da	da	--	151	--	43	--	150
High School Graduate	da	da	da	da	--	281	--	87	--	280
Some College/Associate’s Degree	da	da	da	da	--	297	--	112	--	303
College Graduate	da	da	da	da	--	336	--	76	--	368
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	422	--	111	--	404
Part-Time	da	da	da	da	--	207	--	85	--	188
Unemployed	da	da	da	da	--	158	--	55	--	149
Other¹	da	da	da	da	--	319	--	72	--	316
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.67D – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.20	--	0.39	--	0.22	--	0.44	--	0.24
SEX
Male	--	0.32	--	0.48	--	0.35	--	0.63	--	0.39
Female	--	0.24	--	0.55	--	0.25	--	0.61	--	0.28
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.22	--	0.46	--	0.24	--	0.50	--	0.27
AIAN	--	2.30	--	2.16	--	2.72	--	3.85	--	3.13
Asian	--	0.62	--	1.50	--	0.64	--	1.66	--	0.68
Black or African American	--	0.44	--	0.97	--	0.49	--	0.91	--	0.56
NHPI	--	1.63	--	*	--	1.57	--	1.51	--	1.81
White	--	0.26	--	0.58	--	0.28	--	0.61	--	0.31
Two or More Races	--	1.43	--	1.12	--	1.70	--	2.39	--	2.03
Hispanic or Latino	--	0.42	--	0.64	--	0.46	--	0.86	--	0.53
EDUCATION LEVEL
< High School	da	da	da	da	--	0.63	--	1.15	--	0.70
High School Graduate	da	da	da	da	--	0.40	--	0.67	--	0.46
Some College/Associate’s Degree	da	da	da	da	--	0.38	--	0.77	--	0.44
College Graduate	da	da	da	da	--	0.37	--	1.17	--	0.39
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.32	--	0.70	--	0.35
Part-Time	da	da	da	da	--	0.59	--	0.86	--	0.75
Unemployed	da	da	da	da	--	1.09	--	1.36	--	1.44
Other¹	da	da	da	da	--	0.32	--	0.80	--	0.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.68C – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	368	--	56	--	368	--	76	--	357
SEX
Male	--	315	--	35	--	314	--	52	--	306
Female	--	188	--	43	--	185	--	57	--	172
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	334	--	51	--	336	--	64	--	328
AIAN	--	10	--	4	--	9	--	*	--	7
Asian	--	73	--	14	--	71	--	12	--	70
Black or African American	--	103	--	22	--	99	--	26	--	96
NHPI	--	7	--	<1	--	7	--	2	--	7
White	--	297	--	43	--	308	--	58	--	302
Two or More Races	--	69	--	9	--	69	--	9	--	68
Hispanic or Latino	--	146	--	22	--	143	--	47	--	132
EDUCATION LEVEL
< High School	da	da	da	da	--	102	--	24	--	98
High School Graduate	da	da	da	da	--	176	--	46	--	172
Some College/Associate’s Degree	da	da	da	da	--	205	--	55	--	206
College Graduate	da	da	da	da	--	193	--	34	--	200
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	245	--	49	--	236
Part-Time	da	da	da	da	--	128	--	47	--	119
Unemployed	da	da	da	da	--	88	--	25	--	84
Other¹	da	da	da	da	--	224	--	41	--	222
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.68D – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.13	--	0.22	--	0.14	--	0.22	--	0.16
SEX
Male	--	0.22	--	0.26	--	0.25	--	0.29	--	0.28
Female	--	0.13	--	0.34	--	0.14	--	0.33	--	0.15
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.14	--	0.27	--	0.16	--	0.24	--	0.17
AIAN	--	0.71	--	1.96	--	0.77	--	*	--	0.73
Asian	--	0.38	--	0.90	--	0.40	--	0.51	--	0.46
Black or African American	--	0.28	--	0.60	--	0.30	--	0.54	--	0.35
NHPI	--	0.57	--	0.18	--	0.61	--	1.27	--	0.67
White	--	0.17	--	0.33	--	0.19	--	0.32	--	0.21
Two or More Races	--	1.02	--	0.85	--	1.21	--	0.76	--	1.53
Hispanic or Latino	--	0.27	--	0.32	--	0.30	--	0.54	--	0.34
EDUCATION LEVEL
< High School	da	da	da	da	--	0.42	--	0.66	--	0.47
High School Graduate	da	da	da	da	--	0.25	--	0.38	--	0.29
Some College/Associate’s Degree	da	da	da	da	--	0.26	--	0.40	--	0.31
College Graduate	da	da	da	da	--	0.21	--	0.55	--	0.23
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.20	--	0.34	--	0.21
Part-Time	da	da	da	da	--	0.39	--	0.52	--	0.50
Unemployed	da	da	da	da	--	0.67	--	0.67	--	0.89
Other¹	da	da	da	da	--	0.23	--	0.48	--	0.25
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.69C – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	188	231	83	96	69	88
AGE GROUP
12-17	25	27	15	15	13	15
18 or Older	186	228	82	95	68	87
18-25	39	39	22	26	17	25
26 or Older	181	224	81	91	68	84
SEX
Male	145	161	58	79	54	73
Female	121	165	59	52	42	50
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	173	211	80	88	66	84
AIAN	7	6	4	5	3	2
Asian	15	20	10	8	10	8
Black or African American	52	73	37	25	23	24
NHPI	5	8	*	7	*	5
White	164	191	72	76	63	72
Two or More Races	43	46	16	35	10	35
Hispanic or Latino	75	101	24	35	23	29
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.69D – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2023 and 2024
Demographic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	0.07	0.08	0.03	0.03	0.02	0.03
AGE GROUP
12-17	0.10	0.10	0.06	0.06	0.05	0.06
18 or Older	0.07	0.09	0.03	0.04	0.03	0.03
18-25	0.12	0.11	0.06	0.07	0.05	0.07
26 or Older	0.08	0.10	0.04	0.04	0.03	0.04
SEX
Male	0.10	0.11	0.04	0.06	0.04	0.05
Female	0.08	0.11	0.04	0.04	0.03	0.03
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.07	0.09	0.03	0.04	0.03	0.04
AIAN	0.54	0.47	0.31	0.40	0.26	0.16
Asian	0.08	0.11	0.06	0.04	0.06	0.04
Black or African American	0.15	0.21	0.11	0.07	0.07	0.07
NHPI	0.42	0.66	*	0.55	*	0.38
White	0.10	0.11	0.04	0.04	0.04	0.04
Two or More Races	0.68	0.71	0.25	0.54	0.16	0.54
Hispanic or Latino	0.14	0.18	0.05	0.06	0.04	0.05
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.69P – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Demographic Characteristic	Any Fentanyl Use¹ (2023)	Fentanyl Misuse² (2023)	IMF Use (2023)
TOTAL	0.0767	0.8357	0.7846
AGE GROUP
12-17	0.7151	0.6878	0.9000
18 or Older	0.0685	0.8835	0.8006
18-25	0.5315	0.8744	0.5273
26 or Older	0.0493	0.8450	0.9348
SEX
Male	0.2846	0.2738	0.4260
Female	0.1507	0.0912	0.5205
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1140	0.5822	0.8700
AIAN	0.6743	0.8457	0.4873
Asian	0.8082	0.7182	0.6831
Black or African American	0.4371	0.5603	0.7775
NHPI	0.3294	*	*
White	0.2073	0.4174	0.6938
Two or More Races	0.4007	0.2199	0.1279
Hispanic or Latino	0.4341	0.3513	0.7112
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.70C – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	918	1,015	119	131	908	1,003	235	227	834	954
GEOGRAPHIC REGION
Northeast	374	424	41	57	370	422	94	94	341	397
Midwest	382	438	46	50	373	432	89	99	341	407
South	556	558	80	81	551	555	151	140	507	529
West	481	531	64	67	467	517	119	125	444	496
COUNTY TYPE
Large Metro	990	1,083	117	119	959	1,058	261	261	856	975
Small Metro	722	767	75	75	696	745	228	240	594	664
Nonmetro	462	431	47	40	446	417	150	117	389	364
Urbanized	291	292	28	24	286	284	119	98	239	236
Less Urbanized	360	345	35	32	344	332	91	69	304	299
Completely Rural	115	72	*	9	101	69	20	15	93	66
POVERTY LEVEL¹
Less Than 100%	435	516	57	55	428	505	185	172	388	455
100-199%	476	445	69	67	467	433	155	139	412	395
200% or More	991	1,041	110	109	955	1,023	230	228	874	958
HEALTH INSURANCE²
Private	912	926	108	108	880	911	268	265	792	845
Medicaid/CHIP	573	575	92	83	550	559	168	138	483	519
Other³	502	515	34	25	498	514	72	81	497	505
No Coverage	310	305	21	26	309	302	86	104	292	279
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.70D – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.32	0.35	0.46	0.51	0.35	0.38	0.69	0.65	0.37	0.42
GEOGRAPHIC REGION
Northeast	0.76	0.85	1.01	1.41	0.82	0.92	1.63	1.59	0.87	1.00
Midwest	0.66	0.74	0.85	0.93	0.71	0.81	1.25	1.35	0.75	0.88
South	0.51	0.50	0.78	0.79	0.56	0.55	1.15	1.03	0.59	0.60
West	0.72	0.78	1.05	1.09	0.77	0.84	1.49	1.51	0.84	0.92
COUNTY TYPE
Large Metro	0.46	0.51	0.67	0.72	0.50	0.55	0.98	0.95	0.54	0.60
Small Metro	0.58	0.54	0.75	0.76	0.62	0.59	1.20	1.10	0.65	0.66
Nonmetro	0.76	0.88	1.12	1.19	0.82	0.93	1.95	1.87	0.87	0.98
Urbanized	1.26	1.42	2.15	2.17	1.34	1.48	2.82	2.91	1.36	1.56
Less Urbanized	1.06	1.16	1.40	1.52	1.18	1.24	2.87	2.50	1.26	1.34
Completely Rural	2.21	2.14	*	3.76	2.63	2.31	4.52	4.50	2.81	2.45
POVERTY LEVEL¹
Less Than 100%	0.79	0.86	0.94	0.93	0.89	0.94	1.33	1.37	1.06	1.12
100-199%	0.68	0.68	1.14	1.06	0.74	0.75	1.47	1.34	0.81	0.83
200% or More	0.40	0.43	0.60	0.66	0.42	0.47	0.92	0.86	0.45	0.51
HEALTH INSURANCE²
Private	0.40	0.42	0.63	0.68	0.43	0.46	0.88	0.85	0.45	0.50
Medicaid/CHIP	0.69	0.76	0.74	0.72	0.82	0.88	1.20	1.19	0.95	1.02
Other³	0.56	0.59	2.23	1.65	0.57	0.60	1.97	2.15	0.59	0.61
No Coverage	1.11	1.00	1.58	2.05	1.17	1.04	1.63	1.61	1.35	1.26
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.70P – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1562	0.5930	0.1820	0.3422	0.0999
GEOGRAPHIC REGION
Northeast	0.9810	0.7076	0.9348	0.1175	0.7784
Midwest	0.0428	0.8952	0.0392	0.7239	0.0224
South	0.7881	0.8617	0.7507	0.8293	0.7705
West	0.1808	0.5460	0.2056	0.9600	0.1875
COUNTY TYPE
Large Metro	0.4646	0.8092	0.4787	0.5647	0.5241
Small Metro	0.6165	0.5324	0.6963	0.0344	0.3191
Nonmetro	0.0807	0.9808	0.0862	0.4857	0.0459
Urbanized	0.3794	0.8996	0.3808	0.4196	0.3195
Less Urbanized	0.0516	0.9000	0.0601	0.8567	0.0391
Completely Rural	0.3840	*	0.4441	0.2649	0.5723
POVERTY LEVEL¹
Less Than 100%	0.4311	0.2628	0.5963	0.5519	0.4162
100-199%	0.8239	0.9465	0.8494	0.0263	0.3979
200% or More	0.2072	0.9671	0.2037	0.4330	0.2497
HEALTH INSURANCE²
Private	0.1691	0.7228	0.1722	0.7039	0.1339
Medicaid/CHIP	0.3596	0.8097	0.3877	0.0201	0.1014
Other³	0.3195	0.4751	0.2980	0.8209	0.2744
No Coverage	0.2906	0.0194	0.1745	0.2402	0.0608
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.71C – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	829	845	91	95	813	832	200	198	750	791
GEOGRAPHIC REGION
Northeast	339	364	27	47	334	363	75	78	313	348
Midwest	344	361	36	33	337	357	83	85	319	336
South	488	477	61	57	482	466	123	120	452	439
West	454	454	50	47	442	447	108	111	405	429
COUNTY TYPE
Large Metro	777	841	74	82	753	827	200	198	681	772
Small Metro	571	563	54	50	556	547	155	183	481	492
Nonmetro	371	311	33	29	363	302	108	84	326	269
Urbanized	237	213	18	16	233	208	81	69	205	175
Less Urbanized	285	247	28	23	278	240	71	54	250	218
Completely Rural	81	52	4	5	79	51	15	11	72	49
POVERTY LEVEL¹
Less Than 100%	351	420	41	40	345	412	132	133	316	376
100-199%	406	357	41	48	402	350	133	113	354	319
200% or More	756	777	78	73	730	767	166	176	684	714
HEALTH INSURANCE²
Private	701	695	73	72	679	683	196	205	624	630
Medicaid/CHIP	482	475	64	59	469	464	135	111	416	443
Other³	422	395	18	21	422	394	56	65	418	389
No Coverage	270	262	16	22	270	259	70	89	257	239
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.71D – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.29	0.29	0.35	0.37	0.32	0.32	0.59	0.57	0.34	0.35
GEOGRAPHIC REGION
Northeast	0.69	0.73	0.67	1.16	0.74	0.79	1.30	1.31	0.80	0.87
Midwest	0.59	0.61	0.65	0.62	0.64	0.67	1.17	1.17	0.70	0.73
South	0.45	0.43	0.59	0.56	0.49	0.46	0.94	0.89	0.53	0.50
West	0.68	0.67	0.81	0.77	0.73	0.72	1.34	1.35	0.77	0.80
COUNTY TYPE
Large Metro	0.41	0.43	0.48	0.53	0.44	0.46	0.87	0.83	0.47	0.51
Small Metro	0.49	0.46	0.60	0.55	0.53	0.49	0.93	0.99	0.56	0.54
Nonmetro	0.73	0.70	0.94	0.89	0.79	0.74	1.58	1.56	0.85	0.77
Urbanized	1.18	1.16	1.38	1.44	1.25	1.22	2.23	2.49	1.32	1.26
Less Urbanized	1.03	0.93	1.29	1.28	1.16	0.99	2.44	2.13	1.25	1.07
Completely Rural	2.42	1.69	1.31	2.25	2.56	1.85	3.84	3.12	2.68	2.02
POVERTY LEVEL¹
Less Than 100%	0.68	0.75	0.71	0.69	0.76	0.83	1.07	1.18	0.91	0.99
100-199%	0.63	0.57	0.72	0.83	0.69	0.62	1.36	1.16	0.75	0.69
200% or More	0.33	0.35	0.48	0.46	0.35	0.38	0.77	0.77	0.38	0.41
HEALTH INSURANCE²
Private	0.34	0.34	0.48	0.47	0.37	0.37	0.77	0.78	0.39	0.40
Medicaid/CHIP	0.64	0.68	0.55	0.55	0.75	0.79	1.07	1.04	0.87	0.94
Other³	0.49	0.47	1.21	1.43	0.50	0.47	1.71	1.89	0.51	0.49
No Coverage	1.01	0.91	1.20	1.75	1.07	0.94	1.44	1.52	1.25	1.12
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.71P – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.8364	0.5241	0.7476	0.3685	0.8987
GEOGRAPHIC REGION
Northeast	0.9260	0.2947	0.8221	0.4806	0.9299
Midwest	0.6097	0.7808	0.5997	0.8173	0.6281
South	0.6192	0.2271	0.4901	0.5222	0.5753
West	0.8776	0.3462	0.9395	0.5525	0.9490
COUNTY TYPE
Large Metro	0.9806	0.9746	0.9766	0.6733	0.9605
Small Metro	0.3877	0.4101	0.3096	0.0775	0.5841
Nonmetro	0.5852	0.4288	0.6871	0.4512	0.5808
Urbanized	0.9585	0.5452	0.8976	0.5122	0.8859
Less Urbanized	0.3229	0.6714	0.3785	0.7259	0.3052
Completely Rural	0.6046	0.6983	0.5524	0.2708	0.6625
POVERTY LEVEL¹
Less Than 100%	0.6698	0.6557	0.7892	0.9503	0.7650
100-199%	0.2895	0.3297	0.2150	0.0015	0.7525
200% or More	0.9702	0.9821	0.9636	0.2465	0.8272
HEALTH INSURANCE²
Private	0.8816	0.9462	0.8969	0.5110	0.9813
Medicaid/CHIP	0.7726	0.8174	0.8381	0.0345	0.4120
Other³	0.9375	0.5915	0.9135	0.7777	0.9561
No Coverage	0.1636	0.0446	0.1053	0.2769	0.0367
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.72C – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	876	974	107	107	866	957	238	224	792	909
GEOGRAPHIC REGION
Northeast	368	410	36	48	364	407	92	94	340	381
Midwest	372	415	45	43	367	408	90	98	333	385
South	515	529	66	69	510	521	155	141	468	490
West	461	503	62	52	450	493	121	120	422	474
COUNTY TYPE
Large Metro	895	995	98	87	871	982	253	246	778	906
Small Metro	676	707	63	65	655	687	224	225	550	616
Nonmetro	426	388	36	34	418	377	142	111	366	329
Urbanized	280	265	23	18	277	260	116	96	232	212
Less Urbanized	323	311	29	29	314	301	82	62	279	273
Completely Rural	101	62	16	8	95	61	18	14	89	56
POVERTY LEVEL¹
Less Than 100%	410	464	46	46	404	455	181	165	358	403
100-199%	428	410	59	57	418	403	150	134	364	361
200% or More	909	967	96	82	882	953	221	215	807	892
HEALTH INSURANCE²
Private	843	857	93	83	817	843	260	253	734	784
Medicaid/CHIP	542	532	80	72	524	519	159	129	458	482
Other³	455	473	22	22	454	471	68	78	450	463
No Coverage	295	284	16	23	294	281	85	99	276	258
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.72D – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.31	0.34	0.41	0.41	0.34	0.36	0.70	0.64	0.35	0.40
GEOGRAPHIC REGION
Northeast	0.75	0.82	0.89	1.18	0.81	0.89	1.60	1.60	0.87	0.96
Midwest	0.64	0.71	0.83	0.79	0.69	0.76	1.26	1.34	0.73	0.83
South	0.47	0.47	0.64	0.67	0.52	0.51	1.18	1.04	0.54	0.56
West	0.69	0.74	1.02	0.84	0.74	0.80	1.51	1.45	0.80	0.88
COUNTY TYPE
Large Metro	0.43	0.48	0.60	0.56	0.47	0.52	0.99	0.93	0.50	0.57
Small Metro	0.55	0.53	0.68	0.69	0.60	0.57	1.22	1.11	0.61	0.63
Nonmetro	0.75	0.84	0.97	1.00	0.83	0.89	1.90	1.77	0.88	0.93
Urbanized	1.25	1.36	1.81	1.55	1.33	1.42	2.82	2.87	1.36	1.49
Less Urbanized	1.02	1.13	1.32	1.43	1.16	1.21	2.63	2.27	1.26	1.30
Completely Rural	2.70	1.99	2.68	3.48	3.04	2.20	4.20	4.62	3.25	2.26
POVERTY LEVEL¹
Less Than 100%	0.76	0.80	0.77	0.81	0.86	0.88	1.36	1.35	1.00	1.03
100-199%	0.63	0.65	1.01	0.95	0.69	0.71	1.47	1.29	0.74	0.78
200% or More	0.37	0.42	0.56	0.52	0.40	0.45	0.90	0.83	0.42	0.48
HEALTH INSURANCE²
Private	0.38	0.40	0.58	0.54	0.41	0.43	0.89	0.85	0.43	0.47
Medicaid/CHIP	0.68	0.72	0.66	0.65	0.80	0.84	1.18	1.17	0.91	0.97
Other³	0.52	0.54	1.51	1.48	0.53	0.55	1.92	2.12	0.54	0.56
No Coverage	1.08	0.97	1.25	1.81	1.14	1.00	1.66	1.58	1.31	1.21
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.72P – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3021	0.1858	0.2393	0.0961	0.0927
GEOGRAPHIC REGION
Northeast	0.9876	0.9832	0.9795	0.1301	0.7427
Midwest	0.0640	0.2953	0.0482	0.4827	0.0220
South	0.8100	0.9033	0.8040	0.3298	0.9631
West	0.4771	0.1228	0.3681	0.8216	0.3231
COUNTY TYPE
Large Metro	0.5695	0.0767	0.4298	0.8980	0.4025
Small Metro	0.8550	0.8757	0.8966	0.0072	0.3507
Nonmetro	0.1560	0.9539	0.1691	0.4713	0.1109
Urbanized	0.7316	0.6420	0.6912	0.3066	0.6201
Less Urbanized	0.0478	0.6669	0.0632	0.9491	0.0459
Completely Rural	0.4589	0.8703	0.4719	0.4160	0.5385
POVERTY LEVEL¹
Less Than 100%	0.9168	0.6703	0.7826	0.4827	0.9861
100-199%	0.8777	0.5773	0.9185	0.0115	0.5097
200% or More	0.1586	0.0959	0.1040	0.9930	0.0910
HEALTH INSURANCE²
Private	0.2958	0.1165	0.1989	0.2991	0.1100
Medicaid/CHIP	0.8667	0.5284	0.8132	0.0104	0.2939
Other³	0.1925	0.8211	0.1901	0.6455	0.1577
No Coverage	0.2470	0.0350	0.1611	0.3169	0.0590
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.73C – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	787	795	83	83	774	781	198	196	714	742
GEOGRAPHIC REGION
Northeast	319	338	25	40	315	337	74	79	297	323
Midwest	338	338	32	30	331	334	83	85	311	314
South	447	454	51	51	441	444	121	119	412	417
West	429	429	49	43	419	424	108	112	381	406
COUNTY TYPE
Large Metro	737	777	70	68	716	768	197	192	647	714
Small Metro	547	533	45	49	533	519	151	176	460	470
Nonmetro	349	299	30	26	343	292	105	79	309	261
Urbanized	229	206	17	12	227	202	78	67	200	170
Less Urbanized	264	237	24	22	258	231	71	48	232	212
Completely Rural	81	51	3	*	79	50	15	10	72	48
POVERTY LEVEL¹
Less Than 100%	331	394	32	35	327	387	127	130	298	352
100-199%	373	344	37	43	369	338	130	108	323	308
200% or More	722	724	72	63	699	714	163	173	655	664
HEALTH INSURANCE²
Private	664	662	68	62	645	651	190	199	594	602
Medicaid/CHIP	468	445	55	52	457	436	131	107	403	416
Other³	387	375	17	19	387	373	56	64	382	369
No Coverage	262	254	12	20	262	252	70	88	249	231
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.73D – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.28	0.28	0.32	0.32	0.30	0.30	0.58	0.56	0.32	0.33
GEOGRAPHIC REGION
Northeast	0.65	0.68	0.62	0.98	0.70	0.74	1.29	1.33	0.76	0.81
Midwest	0.58	0.57	0.59	0.56	0.63	0.62	1.17	1.17	0.68	0.68
South	0.41	0.41	0.50	0.49	0.45	0.44	0.93	0.88	0.48	0.48
West	0.64	0.63	0.80	0.70	0.69	0.68	1.34	1.36	0.72	0.76
COUNTY TYPE
Large Metro	0.39	0.39	0.45	0.44	0.42	0.43	0.87	0.82	0.45	0.47
Small Metro	0.47	0.44	0.51	0.54	0.51	0.47	0.91	0.98	0.53	0.53
Nonmetro	0.70	0.68	0.86	0.80	0.76	0.72	1.58	1.51	0.82	0.76
Urbanized	1.15	1.13	1.36	1.06	1.22	1.19	2.19	2.46	1.30	1.24
Less Urbanized	0.98	0.93	1.14	1.25	1.10	0.99	2.48	1.97	1.18	1.07
Completely Rural	2.41	1.66	1.25	*	2.56	1.82	3.84	3.26	2.68	1.97
POVERTY LEVEL¹
Less Than 100%	0.66	0.71	0.55	0.62	0.74	0.79	1.04	1.16	0.88	0.93
100-199%	0.59	0.55	0.66	0.76	0.65	0.60	1.35	1.12	0.70	0.67
200% or More	0.32	0.33	0.45	0.41	0.34	0.35	0.76	0.77	0.37	0.38
HEALTH INSURANCE²
Private	0.33	0.33	0.45	0.41	0.35	0.35	0.75	0.77	0.37	0.38
Medicaid/CHIP	0.63	0.64	0.48	0.48	0.74	0.75	1.05	1.03	0.85	0.89
Other³	0.46	0.44	1.18	1.29	0.47	0.45	1.69	1.89	0.48	0.46
No Coverage	1.00	0.90	0.94	1.61	1.06	0.93	1.45	1.51	1.24	1.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.73P – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.9146	0.9247	0.8908	0.2109	0.8621
GEOGRAPHIC REGION
Northeast	0.9956	0.8012	0.9726	0.5476	0.9257
Midwest	0.8119	0.5832	0.7868	0.8311	0.8306
South	0.7881	0.2146	0.6524	0.2405	0.8987
West	0.9323	0.1675	0.9648	0.4861	0.8251
COUNTY TYPE
Large Metro	0.9048	0.2246	0.8014	0.9166	0.7892
Small Metro	0.4121	0.1136	0.2890	0.0776	0.5629
Nonmetro	0.5867	0.8658	0.6373	0.2836	0.4724
Urbanized	0.9352	0.8374	0.9455	0.4146	0.9675
Less Urbanized	0.2714	0.7776	0.3131	0.5124	0.2100
Completely Rural	0.4671	*	0.4189	0.2502	0.5141
POVERTY LEVEL¹
Less Than 100%	0.4952	0.7093	0.5897	0.7504	0.6058
100-199%	0.3603	0.6364	0.3047	0.0002	0.9046
200% or More	0.9663	0.5482	0.9736	0.4336	0.8738
HEALTH INSURANCE²
Private	0.9044	0.5887	0.9772	0.2984	0.8088
Medicaid/CHIP	0.7859	0.9305	0.8111	0.0135	0.3344
Other³	0.7550	0.9641	0.7591	0.7341	0.7056
No Coverage	0.1776	0.0344	0.1175	0.2052	0.0338
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.74C – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	264	221	17	18	264	220	84	63	245	208
GEOGRAPHIC REGION
Northeast	91	113	2	2	91	113	31	25	91	109
Midwest	93	82	8	7	93	82	26	26	87	79
South	148	126	11	14	148	124	52	41	138	116
West	168	115	8	7	168	115	52	34	154	106
COUNTY TYPE
Large Metro	209	185	12	10	208	184	68	55	192	174
Small Metro	136	117	11	13	136	117	49	30	127	107
Nonmetro	92	71	3	6	92	71	25	20	88	67
Urbanized	60	59	<1	<1	60	59	18	17	57	57
Less Urbanized	69	38	3	6	69	38	18	12	67	35
Completely Rural	4	1	*	*	4	1	2	<1	3	1
POVERTY LEVEL¹
Less Than 100%	113	118	3	8	112	117	34	24	107	115
100-199%	97	103	9	9	96	102	38	36	82	95
200% or More	219	159	14	13	218	158	64	48	208	146
HEALTH INSURANCE²
Private	197	139	14	8	196	139	68	49	185	128
Medicaid/CHIP	133	141	9	13	132	141	30	30	131	139
Other³	117	70	*	4	117	70	31	23	113	66
No Coverage	94	82	3	8	94	80	26	19	92	78
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.74D – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.08	0.06	0.07	0.10	0.08	0.25	0.18	0.11	0.09
GEOGRAPHIC REGION
Northeast	0.19	0.23	0.06	0.05	0.20	0.25	0.54	0.43	0.23	0.28
Midwest	0.16	0.14	0.15	0.13	0.18	0.15	0.37	0.36	0.19	0.17
South	0.14	0.11	0.11	0.14	0.15	0.12	0.39	0.31	0.16	0.13
West	0.25	0.17	0.14	0.12	0.28	0.19	0.64	0.41	0.29	0.20
COUNTY TYPE
Large Metro	0.13	0.11	0.09	0.07	0.14	0.12	0.36	0.29	0.15	0.13
Small Metro	0.15	0.12	0.13	0.15	0.17	0.13	0.40	0.25	0.18	0.14
Nonmetro	0.24	0.20	0.08	0.20	0.26	0.22	0.51	0.42	0.29	0.25
Urbanized	0.38	0.40	0.02	0.03	0.41	0.43	0.74	0.66	0.46	0.51
Less Urbanized	0.35	0.21	0.15	0.39	0.38	0.23	0.80	0.60	0.43	0.25
Completely Rural	0.13	0.06	*	*	0.15	0.07	0.59	0.16	0.14	0.07
POVERTY LEVEL¹
Less Than 100%	0.25	0.25	0.06	0.14	0.28	0.28	0.37	0.27	0.34	0.34
100-199%	0.17	0.18	0.16	0.18	0.19	0.20	0.47	0.43	0.20	0.22
200% or More	0.12	0.08	0.09	0.08	0.13	0.09	0.35	0.26	0.14	0.09
HEALTH INSURANCE²
Private	0.11	0.08	0.10	0.05	0.12	0.08	0.33	0.25	0.13	0.09
Medicaid/CHIP	0.22	0.24	0.08	0.13	0.27	0.28	0.31	0.33	0.32	0.34
Other³	0.15	0.09	*	0.26	0.15	0.09	1.05	0.81	0.15	0.09
No Coverage	0.38	0.32	0.22	0.64	0.40	0.33	0.56	0.37	0.50	0.41
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.74P – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0126	0.7084	0.0110	0.0138	0.0509
GEOGRAPHIC REGION
Northeast	0.8262	0.6450	0.8284	0.1416	0.8321
Midwest	0.2546	0.6228	0.2705	0.1310	0.4892
South	0.1016	0.5991	0.0870	0.5426	0.1072
West	0.0773	0.5907	0.0704	0.1020	0.1511
COUNTY TYPE
Large Metro	0.1736	0.6006	0.1826	0.4367	0.2417
Small Metro	0.0151	0.5178	0.0119	0.0019	0.0874
Nonmetro	0.5926	0.3416	0.5350	0.3209	0.6668
Urbanized	0.9732	0.7936	0.9762	0.9498	0.9866
Less Urbanized	0.4040	0.3364	0.3407	0.1888	0.5405
Completely Rural	0.4589	*	0.4427	0.3267	0.6594
POVERTY LEVEL¹
Less Than 100%	0.5255	0.0909	0.4369	0.0736	0.7097
100-199%	0.9653	0.6607	0.9219	0.0542	0.5129
200% or More	0.0055	0.5693	0.0062	0.2625	0.0100
HEALTH INSURANCE²
Private	0.0262	0.3608	0.0312	0.0465	0.1091
Medicaid/CHIP	0.3892	0.4203	0.3409	0.6413	0.3788
Other³	0.0163	*	0.0146	0.2059	0.0297
No Coverage	0.6168	0.3544	0.5550	0.1693	0.8231
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.75C – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	170	152	12	5	170	152	30	33	167	147
GEOGRAPHIC REGION
Northeast	68	79	*	2	68	79	13	14	67	77
Midwest	65	56	4	<1	65	56	9	12	64	54
South	76	96	11	2	75	96	18	22	74	91
West	115	65	*	3	115	64	18	15	114	64
COUNTY TYPE
Large Metro	138	116	9	1	138	116	25	30	136	111
Small Metro	74	83	8	4	74	83	16	14	71	81
Nonmetro	67	51	*	<1	67	51	7	4	66	50
Urbanized	54	45	*	<1	54	45	6	3	53	44
Less Urbanized	40	19	*	<1	40	19	4	1	40	19
Completely Rural	2	3	*	*	2	3	*	*	2	3
POVERTY LEVEL¹
Less Than 100%	77	96	1	2	77	96	10	13	77	94
100-199%	49	78	8	1	48	77	18	16	44	76
200% or More	138	85	8	4	138	85	23	25	136	82
HEALTH INSURANCE²
Private	131	69	11	3	131	68	25	23	128	65
Medicaid/CHIP	98	118	5	3	98	118	11	21	98	116
Other³	103	51	*	*	103	51	12	7	102	50
No Coverage	37	50	*	*	37	50	12	7	35	49
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.75D – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.05	0.04	0.02	0.07	0.06	0.09	0.09	0.07	0.06
GEOGRAPHIC REGION
Northeast	0.14	0.16	*	0.05	0.15	0.17	0.23	0.24	0.17	0.19
Midwest	0.11	0.09	0.08	0.01	0.12	0.10	0.13	0.16	0.14	0.12
South	0.07	0.09	0.11	0.02	0.08	0.10	0.14	0.17	0.09	0.10
West	0.17	0.09	*	0.06	0.19	0.10	0.23	0.19	0.22	0.12
COUNTY TYPE
Large Metro	0.09	0.07	0.06	0.01	0.10	0.08	0.14	0.16	0.11	0.09
Small Metro	0.08	0.09	0.09	0.05	0.09	0.10	0.14	0.12	0.10	0.11
Nonmetro	0.18	0.15	*	0.01	0.19	0.16	0.15	0.08	0.22	0.18
Urbanized	0.35	0.31	*	0.03	0.38	0.34	0.26	0.16	0.43	0.40
Less Urbanized	0.21	0.11	*	0.01	0.23	0.12	0.19	0.05	0.26	0.13
Completely Rural	0.06	0.11	*	*	0.07	0.12	*	*	0.08	0.13
POVERTY LEVEL¹
Less Than 100%	0.17	0.20	0.02	0.04	0.19	0.23	0.11	0.16	0.25	0.29
100-199%	0.09	0.14	0.15	0.02	0.10	0.15	0.22	0.19	0.11	0.18
200% or More	0.07	0.05	0.06	0.02	0.08	0.05	0.13	0.14	0.09	0.05
HEALTH INSURANCE²
Private	0.08	0.04	0.08	0.02	0.08	0.04	0.13	0.12	0.09	0.05
Medicaid/CHIP	0.16	0.20	0.04	0.03	0.20	0.24	0.11	0.24	0.24	0.29
Other³	0.13	0.06	*	*	0.13	0.07	0.42	0.26	0.14	0.07
No Coverage	0.15	0.20	*	*	0.16	0.21	0.26	0.15	0.19	0.26
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.75P – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4306	0.4242	0.4499	0.9302	0.4512
GEOGRAPHIC REGION
Northeast	0.7169	*	0.7388	0.3828	0.5917
Midwest	0.5467	0.2446	0.5814	0.7120	0.5250
South	0.8450	0.1976	0.7571	0.5346	0.8678
West	0.1505	*	0.1333	0.7068	0.1473
COUNTY TYPE
Large Metro	0.8459	0.2329	0.8948	0.6749	0.8128
Small Metro	0.4444	0.9920	0.4378	0.5439	0.4924
Nonmetro	0.4760	*	0.4628	0.2719	0.5305
Urbanized	0.7867	*	0.7811	0.6690	0.8276
Less Urbanized	0.2954	*	0.2877	0.1229	0.3586
Completely Rural	0.7365	*	0.7433	*	0.7409
POVERTY LEVEL¹
Less Than 100%	0.8046	0.4609	0.8436	0.8064	0.8899
100-199%	0.1813	0.3514	0.1564	0.4105	0.0864
200% or More	0.0367	0.6363	0.0396	0.7311	0.0314
HEALTH INSURANCE²
Private	0.0134	0.3899	0.0161	0.2316	0.0328
Medicaid/CHIP	0.3073	0.9737	0.3141	0.0554	0.4922
Other³	0.0330	*	0.0329	0.6144	0.0370
No Coverage	0.5235	*	0.5349	0.7203	0.4596
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.76C – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	403	460	139	117	104	93
GEOGRAPHIC REGION
Northeast	168	246	62	75	53	50
Midwest	153	181	62	34	45	28
South	240	265	82	79	44	70
West	237	245	70	25	61	22
COUNTY TYPE
Large Metro	330	389	108	80	91	49
Small Metro	248	270	73	75	31	73
Nonmetro	138	161	45	40	40	32
Urbanized	106	112	25	32	21	27
Less Urbanized	85	110	37	23	35	16
Completely Rural	31	42	2	3	*	3
POVERTY LEVEL¹
Less Than 100%	214	253	84	90	62	74
100-199%	175	208	50	57	25	53
200% or More	328	338	95	37	76	20
HEALTH INSURANCE²
Private	297	295	76	27	74	22
Medicaid/CHIP	235	312	81	106	49	85
Other³	242	227	77	40	61	35
No Coverage	144	128	55	28	15	6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.76D – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.14	0.16	0.05	0.04	0.04	0.03
GEOGRAPHIC REGION
Northeast	0.34	0.50	0.13	0.15	0.11	0.10
Midwest	0.26	0.31	0.11	0.06	0.08	0.05
South	0.22	0.24	0.07	0.07	0.04	0.06
West	0.35	0.36	0.10	0.04	0.09	0.03
COUNTY TYPE
Large Metro	0.20	0.23	0.07	0.05	0.06	0.03
Small Metro	0.25	0.27	0.08	0.08	0.04	0.08
Nonmetro	0.34	0.44	0.12	0.11	0.11	0.09
Urbanized	0.64	0.73	0.16	0.22	0.14	0.19
Less Urbanized	0.40	0.57	0.19	0.13	0.18	0.09
Completely Rural	1.02	1.36	0.08	0.11	*	0.11
POVERTY LEVEL¹
Less Than 100%	0.44	0.52	0.19	0.19	0.14	0.16
100-199%	0.31	0.35	0.09	0.10	0.05	0.09
200% or More	0.17	0.18	0.05	0.02	0.04	0.01
HEALTH INSURANCE²
Private	0.17	0.17	0.04	0.02	0.04	0.01
Medicaid/CHIP	0.35	0.49	0.13	0.18	0.08	0.14
Other³	0.30	0.28	0.10	0.05	0.08	0.04
No Coverage	0.58	0.50	0.23	0.11	0.06	0.02
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.76P – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.3257	0.1502	0.3761
GEOGRAPHIC REGION
Northeast	0.4249	0.9150	0.5332
Midwest	0.2672	0.1329	0.3742
South	0.6021	0.6094	0.7969
West	0.8072	0.1959	0.4177
COUNTY TYPE
Large Metro	0.2781	0.1589	0.0961
Small Metro	0.9804	0.4448	0.4369
Nonmetro	0.6283	0.9430	0.8399
Urbanized	0.4825	0.7566	0.7420
Less Urbanized	0.2619	0.8197	0.4691
Completely Rural	0.3528	0.9582	*
POVERTY LEVEL¹
Less Than 100%	0.7239	0.5564	0.8282
100-199%	0.2656	0.7597	0.2547
200% or More	0.6915	0.0329	0.0321
HEALTH INSURANCE²
Private	0.2004	0.0520	0.0970
Medicaid/CHIP	0.1926	0.6572	0.3263
Other³	0.8881	0.0289	0.1075
No Coverage	0.1301	0.6216	0.1376
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.77C – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	861	900	294	388	152	179
GEOGRAPHIC REGION
Northeast	321	406	106	205	56	82
Midwest	305	375	100	124	45	64
South	516	514	171	212	95	100
West	517	488	204	216	97	103
COUNTY TYPE
Large Metro	808	890	261	356	137	164
Small Metro	626	618	166	185	73	75
Nonmetro	396	349	83	103	35	29
Urbanized	237	251	59	65	17	18
Less Urbanized	318	282	59	80	30	22
Completely Rural	104	62	15	11	10	4
POVERTY LEVEL¹
Less Than 100%	316	355	119	163	55	68
100-199%	362	365	115	151	68	80
200% or More	892	905	251	327	130	151
HEALTH INSURANCE²
Private	815	817	237	310	115	140
Medicaid/CHIP	420	455	161	175	85	80
Other³	513	446	107	104	48	34
No Coverage	225	266	88	132	60	73
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.77D – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	0.30	0.31	0.10	0.13	0.05	0.06
GEOGRAPHIC REGION
Northeast	0.66	0.82	0.22	0.41	0.11	0.17
Midwest	0.52	0.64	0.17	0.21	0.08	0.11
South	0.47	0.46	0.16	0.19	0.09	0.09
West	0.77	0.72	0.30	0.32	0.15	0.15
COUNTY TYPE
Large Metro	0.42	0.45	0.16	0.21	0.09	0.10
Small Metro	0.54	0.50	0.18	0.18	0.08	0.08
Nonmetro	0.78	0.74	0.22	0.29	0.09	0.08
Urbanized	1.21	1.23	0.37	0.45	0.11	0.13
Less Urbanized	1.12	1.07	0.30	0.42	0.15	0.12
Completely Rural	2.64	2.10	0.48	0.39	0.32	0.13
POVERTY LEVEL¹
Less Than 100%	0.64	0.66	0.26	0.34	0.12	0.15
100-199%	0.58	0.60	0.21	0.27	0.13	0.14
200% or More	0.38	0.39	0.13	0.17	0.07	0.08
HEALTH INSURANCE²
Private	0.39	0.37	0.13	0.17	0.07	0.08
Medicaid/CHIP	0.59	0.66	0.25	0.29	0.14	0.14
Other³	0.56	0.52	0.13	0.13	0.06	0.04
No Coverage	0.87	0.98	0.37	0.51	0.25	0.29
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.77P – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Past Year (2023)	Past Month (2023)
TOTAL	0.0625	0.0020	0.6739
GEOGRAPHIC REGION
Northeast	0.4348	0.3767	0.5712
Midwest	0.0226	0.0604	0.4508
South	0.8464	0.0305	0.9099
West	0.3193	0.1598	0.9961
COUNTY TYPE
Large Metro	0.0198	0.0026	0.2890
Small Metro	0.9415	0.8875	0.2173
Nonmetro	0.7833	0.1903	0.6427
Urbanized	0.7875	0.9162	0.8422
Less Urbanized	0.7029	0.0516	0.8323
Completely Rural	0.5364	0.3901	0.4275
POVERTY LEVEL¹
Less Than 100%	0.7486	0.9127	0.7558
100-199%	0.2801	0.1516	0.9809
200% or More	0.0522	0.0014	0.5108
HEALTH INSURANCE²
Private	0.2906	0.0008	0.4343
Medicaid/CHIP	0.7802	0.3477	0.3442
Other³	0.8621	0.4837	0.0646
No Coverage	0.0668	0.0263	0.5675
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.78C – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	163	--	67	--	147	--	60	--	133
GEOGRAPHIC REGION
Northeast	--	75	--	21	--	73	--	25	--	66
Midwest	--	58	--	30	--	49	--	21	--	43
South	--	84	--	38	--	77	--	34	--	70
West	--	104	--	40	--	94	--	39	--	84
COUNTY TYPE
Large Metro	--	141	--	56	--	129	--	51	--	121
Small Metro	--	77	--	36	--	66	--	33	--	53
Nonmetro	--	42	--	16	--	37	--	17	--	30
Urbanized	--	30	--	10	--	27	--	15	--	18
Less Urbanized	--	28	--	13	--	25	--	6	--	24
Completely Rural	--	4	--	4	--	2	--	2	--	<1
POVERTY LEVEL¹
Less Than 100%	--	66	--	26	--	61	--	36	--	46
100-199%	--	58	--	30	--	48	--	25	--	41
200% or More	--	141	--	56	--	127	--	44	--	118
HEALTH INSURANCE²
Private	--	134	--	51	--	122	--	51	--	113
Medicaid/CHIP	--	82	--	42	--	70	--	29	--	62
Other³	--	52	--	12	--	51	--	14	--	49
No Coverage	--	50	--	13	--	49	--	15	--	46
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.78D – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.06	--	0.26	--	0.06	--	0.17	--	0.06
GEOGRAPHIC REGION
Northeast	--	0.15	--	0.51	--	0.16	--	0.43	--	0.17
Midwest	--	0.10	--	0.56	--	0.09	--	0.29	--	0.09
South	--	0.08	--	0.37	--	0.08	--	0.25	--	0.08
West	--	0.15	--	0.66	--	0.15	--	0.48	--	0.16
COUNTY TYPE
Large Metro	--	0.08	--	0.36	--	0.09	--	0.27	--	0.09
Small Metro	--	0.08	--	0.42	--	0.08	--	0.26	--	0.07
Nonmetro	--	0.12	--	0.57	--	0.11	--	0.37	--	0.11
Urbanized	--	0.21	--	0.86	--	0.20	--	0.68	--	0.16
Less Urbanized	--	0.15	--	0.84	--	0.15	--	0.34	--	0.17
Completely Rural	--	0.14	--	1.53	--	0.06	--	0.49	--	<0.01
POVERTY LEVEL¹
Less Than 100%	--	0.14	--	0.46	--	0.15	--	0.40	--	0.14
100-199%	--	0.10	--	0.55	--	0.09	--	0.29	--	0.10
200% or More	--	0.07	--	0.36	--	0.07	--	0.25	--	0.08
HEALTH INSURANCE²
Private	--	0.07	--	0.34	--	0.08	--	0.25	--	0.08
Medicaid/CHIP	--	0.14	--	0.38	--	0.14	--	0.32	--	0.16
Other³	--	0.07	--	0.85	--	0.06	--	0.47	--	0.06
No Coverage	--	0.20	--	1.05	--	0.20	--	0.31	--	0.24
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.79C – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	96	--	35	--	88	--	33	--	88
GEOGRAPHIC REGION
Northeast	--	39	--	14	--	37	--	13	--	35
Midwest	--	41	--	17	--	38	--	13	--	35
South	--	58	--	21	--	53	--	13	--	52
West	--	57	--	17	--	54	--	25	--	58
COUNTY TYPE
Large Metro	--	82	--	30	--	76	--	28	--	78
Small Metro	--	44	--	17	--	41	--	17	--	37
Nonmetro	--	25	--	9	--	21	--	6	--	20
Urbanized	--	21	--	7	--	17	--	2	--	17
Less Urbanized	--	13	--	5	--	12	--	5	--	11
Completely Rural	--	1	--	*	--	*	--	*	--	*
POVERTY LEVEL¹
Less Than 100%	--	33	--	14	--	30	--	13	--	26
100-199%	--	31	--	20	--	21	--	13	--	16
200% or More	--	84	--	25	--	81	--	27	--	82
HEALTH INSURANCE²
Private	--	82	--	25	--	78	--	28	--	79
Medicaid/CHIP	--	48	--	25	--	40	--	17	--	36
Other³	--	42	--	6	--	41	--	8	--	41
No Coverage	--	31	--	5	--	31	--	5	--	30
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.79D – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.03	--	0.14	--	0.03	--	0.10	--	0.04
GEOGRAPHIC REGION
Northeast	--	0.08	--	0.35	--	0.08	--	0.22	--	0.09
Midwest	--	0.07	--	0.32	--	0.07	--	0.18	--	0.08
South	--	0.05	--	0.21	--	0.05	--	0.09	--	0.06
West	--	0.08	--	0.27	--	0.09	--	0.30	--	0.11
COUNTY TYPE
Large Metro	--	0.05	--	0.20	--	0.05	--	0.15	--	0.06
Small Metro	--	0.05	--	0.20	--	0.05	--	0.14	--	0.05
Nonmetro	--	0.07	--	0.30	--	0.07	--	0.13	--	0.07
Urbanized	--	0.14	--	0.65	--	0.13	--	0.09	--	0.15
Less Urbanized	--	0.07	--	0.31	--	0.08	--	0.29	--	0.08
Completely Rural	--	0.03	--	*	--	*	--	*	--	*
POVERTY LEVEL¹
Less Than 100%	--	0.07	--	0.26	--	0.07	--	0.16	--	0.08
100-199%	--	0.06	--	0.36	--	0.04	--	0.16	--	0.04
200% or More	--	0.05	--	0.16	--	0.05	--	0.15	--	0.05
HEALTH INSURANCE²
Private	--	0.05	--	0.16	--	0.05	--	0.14	--	0.06
Medicaid/CHIP	--	0.08	--	0.23	--	0.08	--	0.19	--	0.09
Other³	--	0.05	--	0.45	--	0.05	--	0.28	--	0.05
No Coverage	--	0.12	--	0.37	--	0.13	--	0.11	--	0.16
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.80C – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	212	184	17	24	212	181	19	29	211	178
GEOGRAPHIC REGION
Northeast	63	71	<1	22	63	67	7	6	62	66
Midwest	61	70	5	3	61	70	8	13	60	70
South	146	136	16	5	146	136	12	21	146	133
West	121	95	5	9	120	94	10	12	119	93
COUNTY TYPE
Large Metro	168	152	17	24	168	150	15	17	166	148
Small Metro	107	75	2	4	107	75	5	19	107	73
Nonmetro	76	98	*	4	76	97	10	13	74	96
Urbanized	44	48	*	3	44	48	4	4	43	46
Less Urbanized	55	74	*	3	55	74	9	12	53	73
Completely Rural	26	39	*	*	26	39	*	<1	26	39
POVERTY LEVEL¹
Less Than 100%	125	130	2	9	125	130	13	16	124	128
100-199%	123	88	8	4	124	88	5	18	123	86
200% or More	119	112	15	22	118	110	13	16	117	109
HEALTH INSURANCE²
Private	84	97	17	23	83	94	12	16	82	93
Medicaid/CHIP	137	126	4	9	137	126	12	21	136	124
Other³	102	68	*	<1	102	68	4	1	102	68
No Coverage	112	62	<1	*	112	62	6	11	112	60
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.80D – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.07	0.06	0.07	0.09	0.08	0.07	0.06	0.08	0.09	0.08
GEOGRAPHIC REGION
Northeast	0.13	0.14	0.01	0.54	0.14	0.15	0.13	0.10	0.16	0.17
Midwest	0.11	0.12	0.09	0.05	0.12	0.13	0.11	0.18	0.13	0.15
South	0.13	0.12	0.15	0.05	0.15	0.13	0.09	0.16	0.17	0.15
West	0.18	0.14	0.09	0.14	0.20	0.15	0.13	0.15	0.23	0.17
COUNTY TYPE
Large Metro	0.11	0.09	0.12	0.16	0.12	0.10	0.08	0.09	0.13	0.11
Small Metro	0.12	0.08	0.02	0.05	0.13	0.09	0.04	0.16	0.15	0.10
Nonmetro	0.19	0.27	*	0.14	0.21	0.30	0.24	0.29	0.23	0.34
Urbanized	0.28	0.33	*	0.24	0.31	0.36	0.23	0.19	0.35	0.41
Less Urbanized	0.26	0.40	*	0.21	0.29	0.43	0.43	0.62	0.32	0.49
Completely Rural	0.68	1.26	*	*	0.77	1.39	*	0.16	0.85	1.56
POVERTY LEVEL¹
Less Than 100%	0.27	0.27	0.04	0.16	0.31	0.31	0.15	0.19	0.39	0.38
100-199%	0.22	0.16	0.14	0.08	0.25	0.17	0.07	0.21	0.29	0.20
200% or More	0.06	0.06	0.10	0.15	0.07	0.06	0.07	0.09	0.08	0.07
HEALTH INSURANCE²
Private	0.05	0.06	0.12	0.15	0.05	0.06	0.06	0.08	0.06	0.07
Medicaid/CHIP	0.22	0.21	0.04	0.09	0.27	0.25	0.12	0.24	0.33	0.30
Other³	0.13	0.09	*	0.01	0.13	0.09	0.15	0.02	0.14	0.09
No Coverage	0.46	0.24	0.01	*	0.49	0.26	0.14	0.22	0.60	0.32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.80P – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3028	0.5656	0.2684	0.1454	0.1930
GEOGRAPHIC REGION
Northeast	0.8883	0.2270	0.8833	0.4915	0.9398
Midwest	0.9375	0.7252	0.9269	0.1126	0.8732
South	0.3683	0.4934	0.3962	0.2301	0.3124
West	0.3795	0.7306	0.3642	0.8494	0.3508
COUNTY TYPE
Large Metro	0.5043	0.9448	0.4973	0.9663	0.4853
Small Metro	0.1524	0.1373	0.1334	0.0224	0.0616
Nonmetro	0.5693	*	0.6296	0.7752	0.6292
Urbanized	0.7196	*	0.6740	0.7822	0.7331
Less Urbanized	0.6067	*	0.6553	0.5235	0.7298
Completely Rural	0.2734	*	0.2878	*	0.2741
POVERTY LEVEL¹
Less Than 100%	0.4436	0.1763	0.5182	0.4181	0.6068
100-199%	0.0623	1.0000	0.0613	0.0525	0.0356
200% or More	0.3668	0.8677	0.3472	0.9320	0.3493
HEALTH INSURANCE²
Private	0.7436	0.9481	0.7471	0.9033	0.7564
Medicaid/CHIP	0.7378	0.1669	0.8172	0.0570	0.9458
Other³	0.2211	*	0.2204	0.0847	0.2420
No Coverage	0.0356	*	0.0343	0.4655	0.0301
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.81C – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	168	150	16	22	168	149	14	19	167	147
GEOGRAPHIC REGION
Northeast	47	56	<1	22	47	51	3	3	46	50
Midwest	50	63	4	3	50	63	5	11	50	62
South	107	97	15	3	108	96	10	15	107	95
West	106	69	2	1	106	69	8	4	105	69
COUNTY TYPE
Large Metro	148	117	16	22	148	115	11	6	147	114
Small Metro	59	53	2	3	59	52	3	15	58	51
Nonmetro	51	73	*	3	51	73	9	10	49	71
Urbanized	34	45	*	3	34	45	3	3	33	43
Less Urbanized	37	42	*	*	37	42	8	10	36	41
Completely Rural	5	38	*	*	5	38	*	<1	5	38
POVERTY LEVEL¹
Less Than 100%	98	101	<1	4	98	101	12	8	96	99
100-199%	105	48	8	1	106	48	3	14	106	46
200% or More	84	92	14	22	83	90	8	11	83	89
HEALTH INSURANCE²
Private	67	53	16	22	65	49	8	12	64	47
Medicaid/CHIP	112	116	4	4	112	116	9	12	111	115
Other³	88	45	*	<1	88	45	3	1	88	45
No Coverage	77	52	<1	*	77	52	5	9	77	51
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.81D – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.05	0.06	0.09	0.07	0.06	0.04	0.06	0.07	0.06
GEOGRAPHIC REGION
Northeast	0.10	0.11	0.01	0.53	0.10	0.11	0.05	0.05	0.12	0.13
Midwest	0.09	0.11	0.07	0.05	0.09	0.12	0.08	0.15	0.11	0.13
South	0.10	0.09	0.15	0.03	0.11	0.10	0.08	0.11	0.13	0.11
West	0.16	0.10	0.03	0.02	0.17	0.11	0.10	0.05	0.20	0.13
COUNTY TYPE
Large Metro	0.09	0.07	0.11	0.15	0.10	0.08	0.06	0.03	0.12	0.09
Small Metro	0.07	0.06	0.02	0.04	0.07	0.06	0.02	0.13	0.08	0.07
Nonmetro	0.13	0.21	*	0.09	0.14	0.23	0.21	0.23	0.16	0.26
Urbanized	0.22	0.31	*	0.23	0.24	0.34	0.15	0.15	0.27	0.39
Less Urbanized	0.18	0.23	*	*	0.20	0.25	0.39	0.50	0.23	0.28
Completely Rural	0.18	1.27	*	*	0.20	1.40	*	0.14	0.22	1.57
POVERTY LEVEL¹
Less Than 100%	0.22	0.21	<0.01	0.06	0.25	0.24	0.14	0.09	0.31	0.30
100-199%	0.19	0.09	0.14	0.02	0.21	0.10	0.03	0.16	0.25	0.11
200% or More	0.05	0.05	0.10	0.15	0.05	0.05	0.05	0.06	0.05	0.06
HEALTH INSURANCE²
Private	0.04	0.03	0.11	0.15	0.04	0.03	0.04	0.06	0.05	0.03
Medicaid/CHIP	0.18	0.19	0.04	0.04	0.22	0.24	0.10	0.14	0.27	0.29
Other³	0.11	0.06	*	0.01	0.11	0.06	0.11	0.02	0.12	0.06
No Coverage	0.32	0.21	0.01	*	0.34	0.22	0.12	0.18	0.42	0.27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.81P – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3680	0.8273	0.3486	0.2774	0.2891
GEOGRAPHIC REGION
Northeast	0.6382	0.2723	0.8856	0.6037	0.9060
Midwest	0.7077	1.0000	0.7121	0.1046	0.8880
South	0.4567	0.2678	0.5300	0.5658	0.4819
West	0.2038	0.7912	0.2031	0.5123	0.2182
COUNTY TYPE
Large Metro	0.2294	0.9082	0.2336	0.5334	0.2466
Small Metro	0.4627	0.1703	0.4166	0.0422	0.2250
Nonmetro	0.3006	*	0.3285	0.7899	0.3282
Urbanized	0.9790	*	0.9337	0.7300	0.9563
Less Urbanized	0.5382	*	0.5580	0.8109	0.5905
Completely Rural	0.1133	*	0.1177	*	0.1203
POVERTY LEVEL¹
Less Than 100%	0.6108	0.0972	0.6679	0.8985	0.6816
100-199%	0.0371	0.3974	0.0429	0.0799	0.0260
200% or More	0.7561	0.8086	0.7127	0.7459	0.6837
HEALTH INSURANCE²
Private	0.7414	0.9796	0.7199	0.5448	0.6315
Medicaid/CHIP	0.5799	0.4563	0.6098	0.2499	0.7069
Other³	0.4226	*	0.4214	0.1997	0.4454
No Coverage	0.1334	*	0.1305	0.6032	0.1202
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.82C – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	843	913	102	110	829	901	150	155	817	877
GEOGRAPHIC REGION
Northeast	332	369	32	44	331	367	55	59	324	352
Midwest	389	346	44	44	382	341	52	63	380	332
South	567	616	80	71	562	606	107	98	548	594
West	433	432	41	56	423	429	72	74	410	417
COUNTY TYPE
Large Metro	879	930	92	92	855	916	133	126	819	888
Small Metro	674	717	67	68	664	701	87	114	636	657
Nonmetro	583	477	36	56	565	462	71	64	542	432
Urbanized	433	297	28	49	416	281	49	44	400	260
Less Urbanized	389	387	23	26	380	379	53	45	359	358
Completely Rural	134	121	9	10	130	119	11	18	125	111
POVERTY LEVEL¹
Less Than 100%	432	456	53	53	421	449	79	81	409	431
100-199%	483	496	56	50	475	489	83	85	464	476
200% or More	900	920	87	94	882	905	123	116	859	881
HEALTH INSURANCE²
Private	839	862	81	90	821	849	140	132	794	824
Medicaid/CHIP	547	520	79	82	533	506	87	93	513	489
Other³	745	708	31	24	743	707	49	47	739	704
No Coverage	217	234	21	22	215	232	49	54	206	225
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.82D – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.30	0.32	0.39	0.42	0.32	0.34	0.44	0.44	0.37	0.39
GEOGRAPHIC REGION
Northeast	0.68	0.74	0.80	1.08	0.74	0.80	0.96	1.00	0.83	0.89
Midwest	0.67	0.59	0.81	0.81	0.72	0.64	0.73	0.86	0.83	0.72
South	0.52	0.55	0.77	0.69	0.57	0.60	0.82	0.73	0.64	0.68
West	0.65	0.63	0.67	0.91	0.70	0.69	0.90	0.90	0.78	0.78
COUNTY TYPE
Large Metro	0.39	0.44	0.56	0.57	0.43	0.47	0.63	0.61	0.48	0.53
Small Metro	0.51	0.53	0.70	0.70	0.56	0.57	0.71	0.75	0.64	0.64
Nonmetro	1.01	0.88	0.95	1.48	1.07	0.95	1.33	1.17	1.21	1.05
Urbanized	1.79	1.30	1.95	2.77	1.86	1.45	1.95	1.60	2.12	1.62
Less Urbanized	1.13	1.33	1.00	1.53	1.26	1.43	2.09	1.74	1.40	1.58
Completely Rural	4.10	2.28	3.06	4.31	4.25	2.51	3.21	4.56	4.75	2.84
POVERTY LEVEL¹
Less Than 100%	0.76	0.77	0.84	0.89	0.86	0.85	0.82	0.84	1.06	1.04
100-199%	0.71	0.70	0.97	0.89	0.77	0.77	0.93	0.91	0.89	0.90
200% or More	0.37	0.39	0.51	0.57	0.39	0.41	0.63	0.58	0.43	0.45
HEALTH INSURANCE²
Private	0.37	0.38	0.52	0.56	0.39	0.41	0.64	0.57	0.44	0.46
Medicaid/CHIP	0.67	0.68	0.65	0.71	0.80	0.81	0.82	0.92	0.96	0.98
Other³	0.70	0.70	2.03	1.66	0.71	0.71	1.60	1.54	0.74	0.74
No Coverage	0.82	0.82	1.59	1.70	0.86	0.85	1.01	1.01	1.03	1.04
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.82P – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.2751	0.0364	0.4234	0.1945	0.2749
GEOGRAPHIC REGION
Northeast	0.5945	0.8903	0.6125	0.5516	0.5183
Midwest	0.9317	0.2480	0.9373	0.9240	0.9340
South	0.8871	0.9876	0.9039	0.7025	0.8359
West	0.1292	0.0007	0.2697	0.0506	0.1376
COUNTY TYPE
Large Metro	0.0743	0.6966	0.0801	0.2340	0.0467
Small Metro	0.3223	0.0598	0.2018	0.4769	0.2497
Nonmetro	0.3647	0.0353	0.5470	0.8781	0.4354
Urbanized	0.6196	0.1664	0.4997	0.4809	0.6870
Less Urbanized	0.0759	0.1056	0.1315	0.7299	0.1369
Completely Rural	0.6469	0.5596	0.7093	0.4596	0.7731
POVERTY LEVEL¹
Less Than 100%	0.6705	0.7226	0.7871	0.6337	0.7880
100-199%	0.2639	0.0615	0.3878	0.2738	0.2297
200% or More	0.6545	0.1929	0.7589	0.4413	0.6606
HEALTH INSURANCE²
Private	0.9221	0.4258	0.8666	0.0432	0.8217
Medicaid/CHIP	0.2357	0.0359	0.4550	0.7120	0.5454
Other³	0.1872	0.7924	0.1924	0.9199	0.1920
No Coverage	0.7417	0.6616	0.7943	0.3565	0.5815
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.83C – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	324	312	50	39	324	309	59	82	314	295
GEOGRAPHIC REGION
Northeast	117	156	14	11	116	156	21	26	114	153
Midwest	115	120	20	17	115	118	21	25	115	114
South	214	195	39	29	214	192	40	63	210	183
West	175	144	17	18	173	143	28	35	167	137
COUNTY TYPE
Large Metro	250	236	39	31	248	233	46	63	240	224
Small Metro	187	174	29	21	184	171	36	44	178	162
Nonmetro	125	123	16	13	125	121	15	32	121	118
Urbanized	67	83	9	9	65	82	10	20	64	81
Less Urbanized	98	87	13	10	98	85	13	23	94	81
Completely Rural	31	22	1	*	31	22	2	1	31	22
POVERTY LEVEL¹
Less Than 100%	140	207	28	21	137	206	30	34	134	202
100-199%	157	145	20	21	154	142	32	41	154	136
200% or More	268	204	36	27	266	202	39	55	261	191
HEALTH INSURANCE²
Private	247	211	35	26	246	210	43	61	241	199
Medicaid/CHIP	167	212	35	28	162	210	36	43	155	202
Other³	189	147	14	7	189	146	19	25	189	145
No Coverage	86	92	4	11	86	90	24	17	83	88
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.83D – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.11	0.11	0.19	0.15	0.13	0.12	0.17	0.23	0.14	0.13
GEOGRAPHIC REGION
Northeast	0.24	0.31	0.34	0.27	0.26	0.34	0.36	0.43	0.29	0.39
Midwest	0.20	0.20	0.37	0.32	0.22	0.22	0.29	0.35	0.25	0.25
South	0.20	0.18	0.38	0.28	0.22	0.19	0.31	0.47	0.24	0.21
West	0.26	0.21	0.27	0.30	0.28	0.23	0.35	0.42	0.32	0.26
COUNTY TYPE
Large Metro	0.15	0.14	0.27	0.21	0.17	0.15	0.24	0.33	0.19	0.17
Small Metro	0.20	0.18	0.34	0.25	0.22	0.20	0.32	0.35	0.25	0.22
Nonmetro	0.30	0.34	0.45	0.44	0.33	0.37	0.35	0.69	0.37	0.43
Urbanized	0.43	0.54	0.70	0.78	0.46	0.58	0.56	0.90	0.52	0.72
Less Urbanized	0.45	0.47	0.65	0.62	0.51	0.51	0.57	1.11	0.56	0.56
Completely Rural	0.93	0.75	0.35	*	1.01	0.82	0.56	0.22	1.14	0.92
POVERTY LEVEL¹
Less Than 100%	0.30	0.42	0.48	0.37	0.33	0.48	0.35	0.40	0.41	0.59
100-199%	0.28	0.25	0.38	0.39	0.30	0.28	0.40	0.47	0.36	0.32
200% or More	0.14	0.11	0.23	0.18	0.15	0.12	0.22	0.31	0.17	0.12
HEALTH INSURANCE²
Private	0.14	0.12	0.24	0.17	0.15	0.13	0.23	0.30	0.17	0.14
Medicaid/CHIP	0.26	0.35	0.31	0.27	0.31	0.42	0.36	0.47	0.37	0.49
Other³	0.24	0.19	0.98	0.49	0.24	0.19	0.67	0.89	0.25	0.19
No Coverage	0.36	0.36	0.32	0.86	0.38	0.37	0.53	0.34	0.45	0.45
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.83P – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0779	0.0659	0.1320	0.4572	0.0867
GEOGRAPHIC REGION
Northeast	0.9001	0.2233	0.8154	0.8166	0.8432
Midwest	0.4500	0.0919	0.6396	0.8042	0.6754
South	0.1194	0.5112	0.1430	0.2481	0.0776
West	0.3226	0.4699	0.3559	0.8173	0.3577
COUNTY TYPE
Large Metro	0.0630	0.1347	0.1063	0.6383	0.0771
Small Metro	0.2915	0.1908	0.3826	0.9825	0.3749
Nonmetro	0.5753	0.7415	0.6127	0.2736	0.7589
Urbanized	0.7624	0.7430	0.7907	0.5578	0.8755
Less Urbanized	0.4774	0.8927	0.5050	0.3249	0.6396
Completely Rural	0.5647	*	0.5594	0.4771	0.5891
POVERTY LEVEL¹
Less Than 100%	0.0309	0.7946	0.0293	0.9455	0.0265
100-199%	0.5758	0.9138	0.5637	0.8582	0.5801
200% or More	0.0000	0.0201	0.0001	0.3049	0.0000
HEALTH INSURANCE²
Private	0.0124	0.1252	0.0214	0.2594	0.0096
Medicaid/CHIP	0.1064	0.2608	0.0698	0.7089	0.0764
Other³	0.1382	0.1079	0.1688	0.7881	0.1577
No Coverage	0.8639	0.1617	0.7483	0.0945	0.9173
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.84C – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	169	181	29	19	168	181	28	38	165	178
GEOGRAPHIC REGION
Northeast	45	129	5	6	44	128	4	13	44	128
Midwest	65	62	11	2	64	62	10	16	63	60
South	111	81	25	16	110	81	20	30	107	76
West	117	77	8	6	117	76	16	10	114	76
COUNTY TYPE
Large Metro	137	160	19	17	137	160	20	27	133	158
Small Metro	82	70	21	5	79	70	19	21	77	67
Nonmetro	64	57	5	5	63	57	7	19	63	54
Urbanized	31	42	4	3	31	42	1	9	31	41
Less Urbanized	55	40	1	4	55	40	7	*	54	37
Completely Rural	4	9	1	*	4	9	*	<1	4	9
POVERTY LEVEL¹
Less Than 100%	72	147	24	10	68	146	17	18	66	145
100-199%	93	66	8	11	92	65	14	22	91	62
200% or More	123	86	15	11	123	85	17	24	120	82
HEALTH INSURANCE²
Private	129	84	12	12	129	84	20	25	128	80
Medicaid/CHIP	103	150	26	11	99	149	16	26	98	147
Other³	67	77	5	6	66	77	9	7	67	77
No Coverage	38	43	2	7	37	43	9	6	36	43
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.84D – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.06	0.11	0.07	0.07	0.07	0.08	0.11	0.07	0.08
GEOGRAPHIC REGION
Northeast	0.09	0.26	0.12	0.15	0.10	0.28	0.08	0.21	0.11	0.32
Midwest	0.11	0.10	0.19	0.04	0.12	0.12	0.14	0.22	0.14	0.13
South	0.10	0.07	0.25	0.16	0.11	0.08	0.16	0.22	0.12	0.09
West	0.17	0.11	0.14	0.10	0.19	0.12	0.19	0.13	0.22	0.14
COUNTY TYPE
Large Metro	0.09	0.10	0.14	0.12	0.10	0.11	0.11	0.14	0.11	0.12
Small Metro	0.09	0.07	0.25	0.07	0.10	0.08	0.16	0.17	0.11	0.09
Nonmetro	0.16	0.16	0.14	0.18	0.18	0.18	0.16	0.42	0.20	0.20
Urbanized	0.21	0.29	0.36	0.24	0.22	0.32	0.06	0.41	0.25	0.38
Less Urbanized	0.28	0.23	0.03	0.29	0.31	0.25	0.32	*	0.34	0.27
Completely Rural	0.14	0.32	0.25	*	0.15	0.35	*	0.14	0.16	0.39
POVERTY LEVEL¹
Less Than 100%	0.16	0.31	0.41	0.18	0.17	0.35	0.20	0.22	0.21	0.44
100-199%	0.17	0.12	0.15	0.21	0.19	0.13	0.17	0.25	0.22	0.15
200% or More	0.07	0.05	0.10	0.07	0.07	0.05	0.10	0.13	0.08	0.05
HEALTH INSURANCE²
Private	0.08	0.05	0.09	0.08	0.08	0.05	0.11	0.13	0.09	0.06
Medicaid/CHIP	0.17	0.25	0.24	0.11	0.20	0.30	0.17	0.29	0.24	0.37
Other³	0.08	0.10	0.37	0.47	0.09	0.10	0.32	0.25	0.09	0.10
No Coverage	0.16	0.17	0.19	0.61	0.17	0.18	0.19	0.12	0.20	0.22
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.84P – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6524	0.5385	0.7149	0.3989	0.5926
GEOGRAPHIC REGION
Northeast	0.2539	0.9053	0.2564	0.1069	0.3252
Midwest	0.8407	0.0144	0.6251	0.5085	0.7175
South	0.3038	0.7042	0.2624	0.5887	0.1906
West	0.3045	0.4259	0.3309	0.5009	0.3693
COUNTY TYPE
Large Metro	0.6754	0.8107	0.6532	0.5141	0.5726
Small Metro	0.4740	0.1331	0.6791	0.8700	0.7077
Nonmetro	0.4701	0.6011	0.5056	0.2219	0.6820
Urbanized	0.6553	0.3011	0.5809	0.0153	0.8631
Less Urbanized	0.7399	0.0842	0.8546	*	0.8869
Completely Rural	0.1259	*	0.1260	*	0.1345
POVERTY LEVEL¹
Less Than 100%	0.1397	0.3956	0.1049	0.6601	0.1198
100-199%	0.6874	0.3462	0.6002	0.4596	0.4858
200% or More	0.0434	0.5361	0.0539	0.7099	0.0404
HEALTH INSURANCE²
Private	0.0586	0.9159	0.0581	0.6931	0.0436
Medicaid/CHIP	0.5727	0.1280	0.4238	0.2000	0.5742
Other³	0.6798	0.5283	0.7182	0.8683	0.7326
No Coverage	0.8129	0.2491	0.9427	0.1352	0.7060
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.85C – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	467	466	89	89	453	455	150	150	416	438
GEOGRAPHIC REGION
Northeast	175	193	27	39	171	185	56	58	162	181
Midwest	178	205	34	33	176	201	64	59	161	184
South	286	296	65	64	278	288	83	106	266	280
West	241	252	39	40	231	248	77	71	206	232
COUNTY TYPE
Large Metro	405	404	74	73	391	392	122	123	360	374
Small Metro	265	313	54	57	250	298	98	106	213	276
Nonmetro	187	154	26	26	180	148	51	46	165	133
Urbanized	120	94	14	15	118	89	46	36	103	76
Less Urbanized	141	120	21	20	135	115	24	28	127	106
Completely Rural	39	38	6	6	37	37	8	8	35	35
POVERTY LEVEL¹
Less Than 100%	167	188	26	28	162	185	81	78	140	164
100-199%	193	166	37	33	193	159	74	64	178	144
200% or More	429	453	79	81	412	442	112	124	381	427
HEALTH INSURANCE²
Private	413	424	79	78	396	416	136	140	358	397
Medicaid/CHIP	222	220	48	49	213	211	69	66	196	198
Other³	198	217	21	24	197	216	43	38	195	212
No Coverage	122	115	13	14	122	114	33	36	117	105
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.85D – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.16	0.16	0.34	0.34	0.18	0.17	0.44	0.43	0.19	0.19
GEOGRAPHIC REGION
Northeast	0.36	0.39	0.65	0.95	0.38	0.40	0.98	0.99	0.41	0.46
Midwest	0.31	0.35	0.63	0.61	0.33	0.38	0.89	0.81	0.35	0.40
South	0.26	0.27	0.63	0.62	0.28	0.28	0.64	0.78	0.31	0.32
West	0.36	0.37	0.64	0.65	0.38	0.40	0.96	0.86	0.39	0.43
COUNTY TYPE
Large Metro	0.23	0.22	0.47	0.47	0.25	0.24	0.62	0.60	0.27	0.27
Small Metro	0.27	0.28	0.60	0.59	0.28	0.30	0.75	0.75	0.29	0.34
Nonmetro	0.39	0.38	0.69	0.85	0.42	0.40	0.93	0.89	0.45	0.44
Urbanized	0.62	0.52	0.97	1.44	0.68	0.54	1.67	1.41	0.72	0.59
Less Urbanized	0.55	0.59	1.07	1.19	0.58	0.63	1.02	1.10	0.63	0.69
Completely Rural	1.22	1.06	2.19	2.38	1.28	1.11	2.46	2.84	1.35	1.16
POVERTY LEVEL¹
Less Than 100%	0.36	0.39	0.44	0.53	0.40	0.43	0.85	0.84	0.44	0.49
100-199%	0.35	0.29	0.67	0.59	0.39	0.31	0.89	0.71	0.43	0.34
200% or More	0.21	0.21	0.48	0.50	0.23	0.23	0.58	0.63	0.24	0.25
HEALTH INSURANCE²
Private	0.22	0.21	0.51	0.50	0.23	0.23	0.62	0.62	0.24	0.25
Medicaid/CHIP	0.35	0.36	0.43	0.47	0.42	0.42	0.69	0.69	0.47	0.49
Other³	0.24	0.27	1.45	1.67	0.25	0.27	1.40	1.26	0.25	0.28
No Coverage	0.49	0.46	0.99	1.11	0.52	0.47	0.73	0.73	0.62	0.55
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.85P – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5938	0.8733	0.6068	0.5848	0.4718
GEOGRAPHIC REGION
Northeast	0.8179	0.5405	0.8997	0.7508	0.9657
Midwest	0.1589	0.8078	0.1413	0.8785	0.1015
South	0.7183	0.5843	0.6151	0.8678	0.5612
West	0.5887	0.8996	0.5953	0.3662	0.3624
COUNTY TYPE
Large Metro	0.6694	0.7004	0.7198	0.9520	0.7038
Small Metro	0.0690	0.6461	0.0739	0.2483	0.0197
Nonmetro	0.6503	0.5483	0.5538	0.9561	0.4807
Urbanized	0.7610	0.5331	0.6716	0.2606	0.8661
Less Urbanized	0.6303	0.7656	0.5618	0.0948	0.3371
Completely Rural	0.6916	0.8433	0.6509	0.7313	0.5726
POVERTY LEVEL¹
Less Than 100%	0.5753	0.4130	0.6897	0.6837	0.4803
100-199%	0.0249	0.7663	0.0245	0.0514	0.0923
200% or More	0.1479	0.9531	0.1407	0.4035	0.1940
HEALTH INSURANCE²
Private	0.2297	0.9766	0.2223	0.9731	0.1962
Medicaid/CHIP	0.4643	0.3404	0.3131	0.9871	0.2759
Other³	0.4845	0.1277	0.3843	0.3050	0.2754
No Coverage	0.6914	0.7222	0.6533	0.7022	0.7181
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.86C – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	193	209	32	31	190	206	79	73	170	193
GEOGRAPHIC REGION
Northeast	76	93	8	8	76	94	30	30	69	89
Midwest	82	72	12	9	80	71	30	32	76	68
South	114	123	25	23	112	118	45	44	101	107
West	101	125	15	17	101	125	46	38	85	116
COUNTY TYPE
Large Metro	171	179	28	26	168	177	69	56	146	167
Small Metro	86	105	16	15	84	104	41	42	71	94
Nonmetro	58	53	5	8	58	53	17	25	55	44
Urbanized	30	33	3	7	30	32	10	23	29	18
Less Urbanized	48	43	2	4	48	42	12	12	46	41
Completely Rural	9	3	*	*	9	3	6	*	6	3
POVERTY LEVEL¹
Less Than 100%	64	97	6	6	64	97	41	34	46	91
100-199%	73	72	13	10	73	71	45	33	58	61
200% or More	168	171	30	29	164	169	54	56	152	159
HEALTH INSURANCE²
Private	155	168	29	27	151	167	68	63	134	157
Medicaid/CHIP	93	104	11	15	92	103	34	28	85	98
Other³	60	99	9	8	59	99	32	20	50	97
No Coverage	53	73	2	*	53	70	20	21	49	67
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.86D – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.07	0.07	0.12	0.12	0.07	0.08	0.23	0.21	0.08	0.08
GEOGRAPHIC REGION
Northeast	0.16	0.19	0.20	0.21	0.17	0.20	0.52	0.50	0.17	0.22
Midwest	0.14	0.12	0.23	0.17	0.15	0.13	0.42	0.43	0.17	0.15
South	0.10	0.11	0.25	0.22	0.11	0.12	0.35	0.33	0.12	0.12
West	0.15	0.18	0.24	0.28	0.17	0.20	0.58	0.46	0.16	0.22
COUNTY TYPE
Large Metro	0.11	0.11	0.19	0.17	0.11	0.12	0.37	0.29	0.11	0.13
Small Metro	0.10	0.11	0.19	0.17	0.10	0.12	0.34	0.34	0.10	0.13
Nonmetro	0.15	0.15	0.14	0.29	0.16	0.16	0.36	0.57	0.18	0.16
Urbanized	0.18	0.22	0.28	0.64	0.19	0.23	0.43	1.03	0.22	0.16
Less Urbanized	0.23	0.23	0.12	0.29	0.26	0.26	0.55	0.61	0.29	0.28
Completely Rural	0.31	0.12	*	*	0.33	0.13	1.96	*	0.26	0.14
POVERTY LEVEL¹
Less Than 100%	0.14	0.21	0.11	0.11	0.16	0.23	0.46	0.39	0.15	0.28
100-199%	0.13	0.13	0.23	0.18	0.15	0.14	0.56	0.39	0.14	0.15
200% or More	0.09	0.09	0.20	0.19	0.09	0.10	0.29	0.31	0.10	0.10
HEALTH INSURANCE²
Private	0.09	0.09	0.20	0.18	0.09	0.10	0.34	0.31	0.10	0.11
Medicaid/CHIP	0.16	0.18	0.10	0.15	0.19	0.21	0.36	0.31	0.21	0.25
Other³	0.08	0.13	0.61	0.54	0.08	0.13	1.09	0.70	0.07	0.13
No Coverage	0.22	0.29	0.19	*	0.23	0.29	0.44	0.42	0.26	0.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.86P – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7588	0.5309	0.8241	0.2681	0.8425
GEOGRAPHIC REGION
Northeast	0.5433	0.5248	0.5014	0.8735	0.5217
Midwest	0.2313	0.2296	0.2987	0.3917	0.4818
South	0.5302	0.5402	0.5962	0.5436	0.7390
West	0.6515	0.3886	0.7396	0.4088	0.4872
COUNTY TYPE
Large Metro	0.8497	0.3409	0.9629	0.2382	0.6655
Small Metro	0.4523	0.9636	0.4478	0.3802	0.6542
Nonmetro	0.5324	0.4905	0.6095	0.2486	0.9657
Urbanized	0.4438	0.4797	0.5261	0.1590	0.6258
Less Urbanized	0.6151	0.5453	0.6692	0.6793	0.7520
Completely Rural	0.1052	*	0.1548	*	0.4593
POVERTY LEVEL¹
Less Than 100%	0.8679	0.2662	0.9087	0.3205	0.6625
100-199%	0.2001	0.4962	0.2416	0.0971	0.6583
200% or More	0.7736	0.8274	0.7386	0.7330	0.8154
HEALTH INSURANCE²
Private	0.8153	0.7567	0.7676	0.3276	0.4627
Medicaid/CHIP	0.2435	0.6805	0.2553	0.4543	0.3557
Other³	0.7271	0.2737	0.8066	0.4719	0.9934
No Coverage	0.3073	*	0.3357	0.6474	0.2354
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.87C – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	111	118	10	11	111	117	48	31	95	111
GEOGRAPHIC REGION
Northeast	44	50	2	2	44	50	20	15	41	48
Midwest	54	29	6	3	54	29	20	14	50	24
South	69	73	4	10	69	72	33	17	59	68
West	48	74	6	2	48	74	21	16	34	69
COUNTY TYPE
Large Metro	91	105	6	8	91	105	39	22	77	103
Small Metro	52	48	8	7	51	48	29	17	40	39
Nonmetro	38	28	<1	<1	38	28	6	13	37	22
Urbanized	12	20	<1	*	12	20	6	11	10	11
Less Urbanized	36	20	<1	<1	36	20	2	7	36	19
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	42	29	1	4	42	29	30	14	29	24
100-199%	35	34	6	2	35	34	19	15	32	30
200% or More	91	109	7	10	91	109	33	22	84	105
HEALTH INSURANCE²
Private	81	103	7	10	81	103	37	28	71	99
Medicaid/CHIP	66	38	6	5	65	37	20	12	62	35
Other³	36	31	1	*	36	31	25	3	25	31
No Coverage	24	44	2	<1	24	44	11	5	21	44
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.87D – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.04	0.04	0.04	0.04	0.04	0.14	0.09	0.04	0.05
GEOGRAPHIC REGION
Northeast	0.09	0.10	0.06	0.05	0.10	0.11	0.36	0.25	0.10	0.12
Midwest	0.09	0.05	0.11	0.06	0.10	0.05	0.28	0.20	0.11	0.05
South	0.06	0.07	0.04	0.10	0.07	0.07	0.25	0.12	0.07	0.08
West	0.07	0.11	0.10	0.03	0.08	0.12	0.26	0.20	0.06	0.13
COUNTY TYPE
Large Metro	0.06	0.06	0.04	0.05	0.06	0.07	0.21	0.12	0.06	0.08
Small Metro	0.06	0.05	0.09	0.09	0.06	0.06	0.25	0.14	0.06	0.05
Nonmetro	0.10	0.08	0.01	0.01	0.11	0.09	0.13	0.30	0.12	0.08
Urbanized	0.08	0.13	0.02	*	0.08	0.15	0.25	0.48	0.09	0.10
Less Urbanized	0.18	0.12	0.01	0.01	0.20	0.13	0.09	0.39	0.23	0.14
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.09	0.06	0.01	0.08	0.11	0.07	0.35	0.17	0.09	0.07
100-199%	0.07	0.06	0.11	0.03	0.07	0.07	0.23	0.18	0.08	0.07
200% or More	0.05	0.06	0.05	0.07	0.05	0.06	0.19	0.12	0.05	0.07
HEALTH INSURANCE²
Private	0.05	0.06	0.05	0.07	0.05	0.06	0.19	0.14	0.05	0.07
Medicaid/CHIP	0.11	0.06	0.06	0.05	0.13	0.08	0.21	0.13	0.16	0.09
Other³	0.05	0.04	0.05	*	0.05	0.04	0.89	0.10	0.03	0.04
No Coverage	0.10	0.17	0.19	0.01	0.10	0.18	0.25	0.09	0.12	0.23
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.87P – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7269	0.9028	0.7411	0.0733	0.2855
GEOGRAPHIC REGION
Northeast	0.6383	0.9629	0.6424	0.8400	0.5709
Midwest	0.0776	0.4317	0.0900	0.2195	0.1827
South	0.4388	0.2854	0.5096	0.1448	0.1827
West	0.4979	0.4616	0.4676	0.5791	0.3043
COUNTY TYPE
Large Metro	0.2505	0.6385	0.2632	0.2310	0.1017
Small Metro	0.1124	0.7555	0.1184	0.0535	0.3808
Nonmetro	0.8355	0.7542	0.8464	0.3375	0.8968
Urbanized	0.5908	*	0.5864	0.8006	0.6267
Less Urbanized	0.9414	0.6490	0.9276	0.2490	0.7443
Completely Rural	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.1781	0.3484	0.1462	0.1625	0.5160
100-199%	0.2404	0.2111	0.3041	0.3080	0.5392
200% or More	0.1897	0.6652	0.2024	0.4340	0.1124
HEALTH INSURANCE²
Private	0.3045	0.4787	0.3308	0.2773	0.1525
Medicaid/CHIP	0.0613	0.7322	0.0639	0.4979	0.0896
Other³	0.5571	*	0.5674	0.2111	0.9087
No Coverage	0.1811	0.2755	0.1668	0.0678	0.0537
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.88C – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	750	752	79	66	738	747	105	106	731	734
GEOGRAPHIC REGION
Northeast	312	298	27	23	308	292	43	45	308	286
Midwest	314	274	28	34	309	274	44	47	304	269
South	505	490	62	44	498	490	69	67	497	483
West	347	398	29	33	343	391	55	46	336	379
COUNTY TYPE
Large Metro	694	724	62	56	681	713	95	87	663	699
Small Metro	525	530	39	39	517	524	67	70	506	508
Nonmetro	340	305	37	18	331	300	42	35	318	290
Urbanized	184	195	15	12	181	192	24	18	177	186
Less Urbanized	274	227	18	14	270	223	34	30	255	213
Completely Rural	111	91	*	2	93	91	8	5	92	91
POVERTY LEVEL¹
Less Than 100%	295	317	27	28	292	312	56	52	280	305
100-199%	357	355	30	24	356	352	58	59	350	342
200% or More	720	766	70	55	709	759	87	84	694	742
HEALTH INSURANCE²
Private	661	710	70	53	650	702	97	89	634	687
Medicaid/CHIP	371	378	40	42	364	370	53	61	356	361
Other³	558	563	16	11	557	563	31	40	555	561
No Coverage	165	173	15	7	164	173	37	26	158	169
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.88D – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.26	0.26	0.31	0.25	0.29	0.28	0.31	0.30	0.33	0.32
GEOGRAPHIC REGION
Northeast	0.64	0.60	0.65	0.56	0.69	0.64	0.75	0.76	0.79	0.72
Midwest	0.54	0.46	0.52	0.62	0.59	0.51	0.62	0.65	0.67	0.58
South	0.46	0.44	0.61	0.42	0.50	0.48	0.53	0.50	0.58	0.55
West	0.52	0.58	0.47	0.54	0.56	0.63	0.68	0.56	0.64	0.71
COUNTY TYPE
Large Metro	0.37	0.36	0.43	0.37	0.40	0.39	0.47	0.44	0.45	0.44
Small Metro	0.48	0.44	0.45	0.44	0.52	0.48	0.51	0.52	0.61	0.55
Nonmetro	0.66	0.67	1.00	0.60	0.72	0.71	0.85	0.75	0.81	0.80
Urbanized	1.00	1.05	1.13	1.05	1.07	1.09	1.05	0.80	1.24	1.24
Less Urbanized	0.91	0.91	0.91	0.85	1.00	0.99	1.36	1.33	1.12	1.09
Completely Rural	2.01	2.97	*	0.94	2.30	3.33	2.33	1.67	2.61	3.70
POVERTY LEVEL¹
Less Than 100%	0.59	0.62	0.47	0.49	0.67	0.69	0.60	0.61	0.83	0.86
100-199%	0.59	0.58	0.55	0.45	0.65	0.64	0.69	0.66	0.77	0.75
200% or More	0.33	0.33	0.45	0.36	0.35	0.35	0.46	0.42	0.39	0.39
HEALTH INSURANCE²
Private	0.32	0.32	0.48	0.35	0.35	0.34	0.45	0.42	0.39	0.38
Medicaid/CHIP	0.53	0.57	0.36	0.40	0.64	0.67	0.51	0.65	0.77	0.80
Other³	0.61	0.60	1.15	0.78	0.62	0.61	1.09	1.31	0.65	0.63
No Coverage	0.66	0.64	1.18	0.57	0.69	0.67	0.77	0.52	0.83	0.82
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.88P – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5370	0.0278	0.6676	0.0287	0.9237
GEOGRAPHIC REGION
Northeast	0.2557	0.1017	0.3020	0.8628	0.3217
Midwest	0.8954	0.8276	0.8968	0.5241	0.9838
South	0.6823	0.0689	0.8237	0.2808	0.9556
West	0.7133	0.5937	0.6884	0.0183	0.4406
COUNTY TYPE
Large Metro	0.8175	0.1282	0.6885	0.5769	0.6387
Small Metro	0.2889	0.4397	0.3047	0.0166	0.4896
Nonmetro	0.6051	0.0758	0.6838	0.2380	0.9170
Urbanized	0.5985	0.6626	0.6113	0.1304	0.9279
Less Urbanized	0.9299	0.4417	0.9113	0.9148	0.9233
Completely Rural	0.7014	*	0.9918	0.5346	0.9597
POVERTY LEVEL¹
Less Than 100%	0.5475	0.9609	0.4793	0.3377	0.5278
100-199%	0.2446	0.1415	0.2804	0.2959	0.4098
200% or More	0.8788	0.0352	0.6965	0.1314	0.5480
HEALTH INSURANCE²
Private	0.6010	0.0971	0.7582	0.0346	0.9802
Medicaid/CHIP	0.5006	0.4892	0.5187	0.3364	0.3625
Other³	0.3172	0.0238	0.2873	0.7219	0.2784
No Coverage	0.5273	0.2380	0.5629	0.0554	0.8757
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.89C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	259	248	25	26	258	245	48	55	252	238
GEOGRAPHIC REGION
Northeast	107	95	5	7	107	95	18	13	105	93
Midwest	84	103	9	11	84	103	17	25	82	96
South	200	170	20	21	199	167	33	42	194	163
West	104	105	14	9	104	104	26	22	96	101
COUNTY TYPE
Large Metro	234	202	21	19	234	200	38	40	226	193
Small Metro	121	126	13	15	120	123	27	33	117	118
Nonmetro	67	105	4	12	66	103	15	22	64	99
Urbanized	46	85	3	9	45	82	6	8	45	82
Less Urbanized	48	51	3	7	47	50	13	19	45	45
Completely Rural	8	35	*	*	8	35	2	3	7	*
POVERTY LEVEL¹
Less Than 100%	87	111	8	9	87	110	21	26	85	107
100-199%	126	110	11	12	124	109	24	29	123	105
200% or More	215	199	23	22	214	197	36	40	209	194
HEALTH INSURANCE²
Private	200	175	23	20	200	172	36	40	194	167
Medicaid/CHIP	117	145	10	18	117	142	24	34	116	136
Other³	158	143	8	4	158	143	13	15	158	142
No Coverage	74	69	2	2	74	69	19	13	72	67
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.89D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.09	0.10	0.10	0.10	0.09	0.14	0.16	0.11	0.10
GEOGRAPHIC REGION
Northeast	0.22	0.19	0.13	0.17	0.24	0.21	0.31	0.22	0.27	0.23
Midwest	0.14	0.17	0.17	0.20	0.16	0.19	0.24	0.35	0.18	0.21
South	0.18	0.15	0.19	0.20	0.20	0.16	0.25	0.31	0.23	0.19
West	0.16	0.15	0.23	0.15	0.17	0.17	0.33	0.27	0.18	0.19
COUNTY TYPE
Large Metro	0.14	0.12	0.15	0.13	0.16	0.14	0.20	0.21	0.18	0.15
Small Metro	0.13	0.13	0.16	0.18	0.14	0.14	0.24	0.27	0.16	0.16
Nonmetro	0.17	0.29	0.12	0.39	0.19	0.31	0.34	0.51	0.21	0.35
Urbanized	0.30	0.57	0.23	0.81	0.32	0.60	0.33	0.37	0.37	0.71
Less Urbanized	0.24	0.27	0.15	0.44	0.26	0.29	0.61	0.97	0.29	0.30
Completely Rural	0.25	1.19	*	*	0.27	1.31	0.56	1.05	0.28	*
POVERTY LEVEL¹
Less Than 100%	0.19	0.23	0.13	0.17	0.22	0.26	0.25	0.31	0.27	0.32
100-199%	0.23	0.20	0.21	0.22	0.25	0.22	0.30	0.34	0.29	0.25
200% or More	0.11	0.11	0.15	0.14	0.12	0.11	0.20	0.21	0.14	0.13
HEALTH INSURANCE²
Private	0.12	0.10	0.16	0.14	0.13	0.11	0.19	0.20	0.14	0.12
Medicaid/CHIP	0.19	0.24	0.09	0.17	0.23	0.29	0.25	0.37	0.28	0.34
Other³	0.20	0.18	0.58	0.30	0.20	0.18	0.46	0.51	0.21	0.19
No Coverage	0.31	0.27	0.14	0.14	0.32	0.29	0.41	0.25	0.39	0.36
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.89P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.5200	0.9519	0.5145	0.7767	0.5454
GEOGRAPHIC REGION
Northeast	0.3523	0.4491	0.3237	0.0910	0.4557
Midwest	0.2958	0.8797	0.2847	0.8676	0.2818
South	0.3928	0.5339	0.3479	0.3203	0.2463
West	0.9276	0.1617	0.9468	0.2414	0.7088
COUNTY TYPE
Large Metro	0.3143	0.5354	0.3398	0.9884	0.3309
Small Metro	0.3906	0.5755	0.4223	0.5550	0.5064
Nonmetro	0.0913	0.0330	0.1382	0.8254	0.1330
Urbanized	0.3157	0.1870	0.3728	0.8862	0.3410
Less Urbanized	0.2693	0.0739	0.3802	0.7507	0.4145
Completely Rural	0.2320	*	0.2386	0.4550	*
POVERTY LEVEL¹
Less Than 100%	0.2794	0.8790	0.3009	0.7873	0.3175
100-199%	0.6302	0.8732	0.6099	0.8484	0.5710
200% or More	0.3156	0.8199	0.3280	0.5030	0.3843
HEALTH INSURANCE²
Private	0.1668	0.5855	0.1863	0.2815	0.2526
Medicaid/CHIP	0.0774	0.1458	0.1084	0.1087	0.1926
Other³	1.0000	0.1059	0.9471	0.9112	0.9551
No Coverage	0.2424	0.7353	0.2297	0.1139	0.4071
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.90C – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	124	146	14	13	123	145	24	32	119	142
GEOGRAPHIC REGION
Northeast	60	73	1	3	60	73	6	9	60	72
Midwest	60	61	2	8	60	60	9	18	59	57
South	79	89	11	8	77	88	14	22	76	86
West	46	65	8	4	45	65	17	13	38	65
COUNTY TYPE
Large Metro	92	116	10	7	91	115	17	25	88	113
Small Metro	69	62	9	7	69	62	17	11	66	61
Nonmetro	46	67	1	8	46	67	5	17	46	65
Urbanized	33	45	*	*	33	44	2	5	33	44
Less Urbanized	32	36	1	5	32	36	4	15	31	33
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	42	62	4	4	42	63	14	23	39	59
100-199%	55	60	8	5	55	59	12	13	54	58
200% or More	102	120	10	11	101	119	17	17	99	118
HEALTH INSURANCE²
Private	76	103	13	10	75	103	15	21	72	101
Medicaid/CHIP	75	82	5	7	75	82	16	23	73	79
Other³	75	79	*	*	75	79	10	2	74	79
No Coverage	36	51	*	*	36	51	8	3	35	51
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.90D – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.05	0.05	0.05	0.05	0.06	0.07	0.09	0.05	0.06
GEOGRAPHIC REGION
Northeast	0.12	0.15	0.03	0.08	0.13	0.16	0.11	0.15	0.15	0.18
Midwest	0.10	0.10	0.03	0.16	0.11	0.11	0.12	0.25	0.13	0.12
South	0.07	0.08	0.10	0.08	0.08	0.09	0.11	0.16	0.09	0.10
West	0.07	0.10	0.14	0.06	0.07	0.11	0.21	0.15	0.07	0.12
COUNTY TYPE
Large Metro	0.06	0.07	0.07	0.05	0.06	0.08	0.09	0.14	0.07	0.09
Small Metro	0.08	0.07	0.11	0.08	0.08	0.07	0.15	0.09	0.10	0.09
Nonmetro	0.12	0.19	0.04	0.28	0.13	0.21	0.11	0.38	0.15	0.23
Urbanized	0.22	0.31	*	*	0.24	0.34	0.11	0.21	0.27	0.40
Less Urbanized	0.16	0.20	0.07	0.31	0.18	0.22	0.21	0.77	0.20	0.23
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.09	0.13	0.06	0.07	0.11	0.15	0.16	0.27	0.13	0.18
100-199%	0.10	0.11	0.15	0.09	0.11	0.12	0.15	0.15	0.13	0.14
200% or More	0.06	0.06	0.07	0.07	0.06	0.07	0.09	0.10	0.06	0.08
HEALTH INSURANCE²
Private	0.04	0.06	0.09	0.07	0.05	0.06	0.08	0.11	0.05	0.07
Medicaid/CHIP	0.12	0.14	0.05	0.07	0.15	0.17	0.16	0.26	0.18	0.20
Other³	0.09	0.10	*	*	0.10	0.10	0.36	0.06	0.10	0.11
No Coverage	0.15	0.20	*	*	0.16	0.21	0.18	0.06	0.19	0.27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.90P – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.2527	0.7264	0.2409	0.9516	0.2176
GEOGRAPHIC REGION
Northeast	0.3663	0.3469	0.3858	0.6522	0.3535
Midwest	0.3206	0.2323	0.3809	0.4033	0.4828
South	0.9189	0.5899	0.9616	0.7990	0.9153
West	0.4200	0.1595	0.3436	0.3850	0.1859
COUNTY TYPE
Large Metro	0.2802	0.4950	0.2520	0.5599	0.2895
Small Metro	0.5097	0.4103	0.5773	0.0136	0.9746
Nonmetro	0.1466	0.1883	0.1899	0.1023	0.2924
Urbanized	0.7633	*	0.8681	0.2812	0.9223
Less Urbanized	0.1648	0.4503	0.1951	0.1287	0.4022
Completely Rural	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.0593	0.9269	0.0644	0.2811	0.0945
100-199%	0.9766	0.6063	0.9793	0.7198	0.9102
200% or More	0.6297	0.8797	0.6185	0.3197	0.5087
HEALTH INSURANCE²
Private	0.4050	0.4492	0.3513	0.6828	0.3764
Medicaid/CHIP	0.1849	0.5268	0.2047	0.5012	0.2455
Other³	0.8381	*	0.8387	0.1284	0.7279
No Coverage	0.8029	*	0.8123	0.0563	0.5848
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.91C – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	652	630	62	46	645	628	98	95	638	622
GEOGRAPHIC REGION
Northeast	257	272	20	18	254	269	39	40	253	266
Midwest	268	246	24	23	266	246	41	41	263	244
South	450	409	49	32	444	407	62	61	444	404
West	297	312	23	15	297	312	51	43	287	305
COUNTY TYPE
Large Metro	587	588	52	32	579	583	84	74	563	577
Small Metro	431	450	31	29	425	445	60	60	417	431
Nonmetro	291	233	21	17	286	229	40	33	274	223
Urbanized	156	145	11	11	156	141	22	17	153	137
Less Urbanized	237	180	11	14	235	176	32	28	220	171
Completely Rural	89	74	14	*	80	74	8	5	79	73
POVERTY LEVEL¹
Less Than 100%	269	286	20	22	267	282	51	46	258	277
100-199%	325	314	22	18	324	313	53	51	318	305
200% or More	607	616	55	37	599	613	79	73	590	603
HEALTH INSURANCE²
Private	560	578	55	34	553	574	87	77	541	566
Medicaid/CHIP	335	332	29	30	333	326	48	56	327	319
Other³	488	484	14	9	488	483	29	24	487	482
No Coverage	152	143	14	4	151	142	34	24	145	138
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.91D – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.23	0.22	0.24	0.18	0.25	0.24	0.29	0.27	0.29	0.27
GEOGRAPHIC REGION
Northeast	0.52	0.55	0.50	0.45	0.57	0.59	0.68	0.68	0.65	0.67
Midwest	0.46	0.42	0.44	0.43	0.50	0.46	0.58	0.56	0.58	0.53
South	0.41	0.37	0.47	0.31	0.45	0.40	0.47	0.45	0.52	0.46
West	0.44	0.46	0.38	0.25	0.49	0.50	0.64	0.52	0.54	0.57
COUNTY TYPE
Large Metro	0.33	0.30	0.36	0.22	0.35	0.33	0.42	0.39	0.39	0.38
Small Metro	0.41	0.39	0.35	0.33	0.45	0.42	0.47	0.47	0.52	0.48
Nonmetro	0.58	0.53	0.58	0.56	0.64	0.56	0.83	0.71	0.73	0.64
Urbanized	0.86	0.84	0.88	0.96	0.93	0.88	1.05	0.75	1.08	1.02
Less Urbanized	0.85	0.73	0.58	0.83	0.94	0.79	1.33	1.31	1.04	0.90
Completely Rural	1.79	2.45	3.18	*	1.98	2.73	2.33	1.72	2.20	3.00
POVERTY LEVEL¹
Less Than 100%	0.55	0.57	0.35	0.39	0.63	0.63	0.57	0.54	0.78	0.79
100-199%	0.54	0.52	0.40	0.34	0.60	0.58	0.63	0.58	0.70	0.68
200% or More	0.29	0.28	0.36	0.25	0.31	0.30	0.42	0.38	0.34	0.33
HEALTH INSURANCE²
Private	0.29	0.27	0.38	0.23	0.31	0.29	0.42	0.38	0.35	0.33
Medicaid/CHIP	0.50	0.51	0.26	0.28	0.60	0.61	0.48	0.61	0.74	0.73
Other³	0.56	0.53	1.02	0.63	0.57	0.54	1.03	0.82	0.59	0.56
No Coverage	0.62	0.54	1.07	0.37	0.65	0.56	0.73	0.48	0.78	0.69
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.91P – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.6118	0.0033	0.7682	0.0110	0.9160
GEOGRAPHIC REGION
Northeast	0.5958	0.3346	0.6325	0.9768	0.6392
Midwest	0.7557	0.2874	0.8115	0.2354	0.9637
South	0.6975	0.0718	0.8136	0.3100	0.9445
West	0.8551	0.0238	0.7553	0.0051	0.4382
COUNTY TYPE
Large Metro	0.8046	0.0075	0.6209	0.4150	0.5445
Small Metro	0.4573	0.1716	0.4998	0.0168	0.7598
Nonmetro	0.3984	0.7166	0.3676	0.1506	0.5875
Urbanized	0.2897	0.9578	0.2762	0.1618	0.4774
Less Urbanized	0.8360	0.6141	0.7299	0.5993	0.8041
Completely Rural	0.9692	*	0.8891	0.4534	0.8261
POVERTY LEVEL¹
Less Than 100%	0.3872	0.8841	0.3402	0.1737	0.4193
100-199%	0.4453	0.4013	0.4561	0.2452	0.6278
200% or More	0.8109	0.0016	0.5952	0.0905	0.4408
HEALTH INSURANCE²
Private	0.6806	0.0116	0.8869	0.0263	0.8374
Medicaid/CHIP	0.3001	0.4867	0.3035	0.2697	0.1887
Other³	0.5563	0.0599	0.5243	0.0812	0.4611
No Coverage	0.3311	0.2415	0.3551	0.0237	0.6770
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.92C – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	225	221	18	23	225	219	45	53	217	210
GEOGRAPHIC REGION
Northeast	98	81	3	5	98	81	17	12	96	79
Midwest	74	93	9	11	73	94	17	21	72	88
South	164	152	13	19	164	149	31	41	159	145
West	99	89	12	6	99	89	25	21	91	84
COUNTY TYPE
Large Metro	197	186	15	16	197	185	36	38	188	177
Small Metro	110	112	11	13	109	111	25	32	107	105
Nonmetro	60	77	3	11	60	74	15	22	57	69
Urbanized	43	49	3	9	43	44	6	8	42	43
Less Urbanized	41	47	1	6	40	47	13	19	38	42
Completely Rural	8	35	*	*	8	35	2	3	7	*
POVERTY LEVEL¹
Less Than 100%	83	98	6	7	83	97	19	26	82	94
100-199%	120	104	10	11	119	103	22	29	118	99
200% or More	173	170	16	19	174	168	35	36	167	165
HEALTH INSURANCE²
Private	163	155	17	18	163	153	35	37	157	148
Medicaid/CHIP	108	130	8	16	108	128	22	33	107	121
Other³	123	114	7	4	123	114	13	15	123	113
No Coverage	67	68	2	1	67	68	15	12	65	66
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.92D – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.08	0.08	0.07	0.09	0.09	0.08	0.13	0.15	0.10	0.09
GEOGRAPHIC REGION
Northeast	0.20	0.16	0.08	0.12	0.22	0.18	0.30	0.21	0.25	0.20
Midwest	0.13	0.16	0.16	0.20	0.14	0.17	0.23	0.28	0.16	0.19
South	0.15	0.14	0.13	0.18	0.17	0.15	0.24	0.31	0.18	0.17
West	0.15	0.13	0.20	0.10	0.16	0.14	0.32	0.26	0.17	0.16
COUNTY TYPE
Large Metro	0.12	0.11	0.11	0.11	0.13	0.12	0.19	0.20	0.15	0.14
Small Metro	0.12	0.12	0.14	0.15	0.13	0.13	0.22	0.26	0.15	0.15
Nonmetro	0.16	0.21	0.09	0.37	0.17	0.22	0.34	0.50	0.19	0.24
Urbanized	0.28	0.34	0.22	0.79	0.31	0.33	0.33	0.36	0.35	0.38
Less Urbanized	0.20	0.25	0.07	0.39	0.22	0.27	0.61	0.97	0.24	0.28
Completely Rural	0.25	1.19	*	*	0.27	1.31	0.56	1.05	0.28	*
POVERTY LEVEL¹
Less Than 100%	0.18	0.21	0.11	0.12	0.21	0.23	0.22	0.30	0.26	0.29
100-199%	0.22	0.19	0.19	0.20	0.24	0.20	0.27	0.34	0.28	0.23
200% or More	0.09	0.09	0.11	0.13	0.10	0.10	0.20	0.20	0.11	0.11
HEALTH INSURANCE²
Private	0.09	0.09	0.12	0.12	0.10	0.09	0.18	0.18	0.11	0.10
Medicaid/CHIP	0.18	0.22	0.07	0.15	0.21	0.26	0.23	0.37	0.26	0.30
Other³	0.15	0.14	0.47	0.30	0.16	0.15	0.45	0.51	0.16	0.15
No Coverage	0.28	0.27	0.14	0.11	0.29	0.28	0.33	0.25	0.36	0.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.92P – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4557	0.8285	0.4346	0.8296	0.4481
GEOGRAPHIC REGION
Northeast	0.3282	0.5436	0.3119	0.1055	0.4376
Midwest	0.2925	0.9787	0.2880	0.6876	0.2291
South	0.5453	0.3224	0.4702	0.1602	0.2797
West	0.4837	0.1684	0.5727	0.2103	0.7808
COUNTY TYPE
Large Metro	0.3444	0.8419	0.3491	0.9326	0.3396
Small Metro	0.6061	0.4632	0.6585	0.8032	0.6993
Nonmetro	0.3352	0.0459	0.4719	0.9973	0.4375
Urbanized	0.9924	0.2680	0.8673	0.7224	0.9373
Less Urbanized	0.3634	0.0581	0.5053	0.8794	0.5096
Completely Rural	0.2579	*	0.2645	0.4550	*
POVERTY LEVEL¹
Less Than 100%	0.5419	0.7400	0.5522	0.5227	0.6517
100-199%	0.7522	0.8986	0.7520	0.6027	0.6553
200% or More	0.2835	0.6662	0.2635	0.2979	0.3523
HEALTH INSURANCE²
Private	0.1547	0.8462	0.1614	0.1512	0.2598
Medicaid/CHIP	0.2036	0.2577	0.2510	0.0937	0.4259
Other³	0.7779	0.4907	0.7537	0.8772	0.7680
No Coverage	0.4911	0.9340	0.4786	0.4143	0.6012
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.93C – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	112	132	13	11	110	131	23	30	107	128
GEOGRAPHIC REGION
Northeast	60	54	1	3	60	54	6	9	60	53
Midwest	35	59	1	8	35	58	8	15	34	56
South	76	85	11	7	74	85	12	21	73	82
West	45	63	8	<1	44	63	17	11	37	63
COUNTY TYPE
Large Metro	82	100	10	5	81	100	17	25	77	97
Small Metro	65	60	8	6	65	60	15	4	63	59
Nonmetro	39	65	1	8	39	64	4	17	39	62
Urbanized	33	44	*	*	33	44	2	4	33	44
Less Urbanized	20	32	1	5	20	32	3	15	20	28
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	41	60	4	1	41	60	12	22	39	56
100-199%	55	57	8	5	54	57	12	13	53	55
200% or More	87	106	10	10	86	106	16	14	83	105
HEALTH INSURANCE²
Private	72	88	12	10	71	88	14	18	68	86
Medicaid/CHIP	64	80	5	6	64	79	15	23	62	76
Other³	69	77	*	*	69	77	10	<1	68	77
No Coverage	35	49	*	*	35	49	6	2	35	49
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.93D – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.04	0.05	0.05	0.04	0.04	0.05	0.07	0.09	0.05	0.06
GEOGRAPHIC REGION
Northeast	0.12	0.11	0.02	0.08	0.13	0.12	0.10	0.15	0.15	0.13
Midwest	0.06	0.10	0.02	0.16	0.07	0.11	0.11	0.21	0.07	0.12
South	0.07	0.08	0.10	0.07	0.08	0.08	0.09	0.16	0.09	0.09
West	0.07	0.09	0.12	0.01	0.07	0.10	0.21	0.14	0.07	0.12
COUNTY TYPE
Large Metro	0.05	0.06	0.07	0.04	0.06	0.07	0.09	0.13	0.06	0.08
Small Metro	0.07	0.07	0.10	0.07	0.08	0.07	0.13	0.04	0.09	0.08
Nonmetro	0.10	0.19	0.02	0.28	0.11	0.20	0.09	0.38	0.13	0.23
Urbanized	0.22	0.31	*	*	0.24	0.33	0.11	0.19	0.27	0.40
Less Urbanized	0.10	0.18	0.04	0.31	0.11	0.20	0.16	0.76	0.13	0.20
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.09	0.13	0.06	0.01	0.10	0.15	0.14	0.27	0.13	0.17
100-199%	0.10	0.10	0.15	0.09	0.11	0.11	0.15	0.15	0.13	0.13
200% or More	0.05	0.06	0.07	0.07	0.05	0.06	0.09	0.08	0.06	0.07
HEALTH INSURANCE²
Private	0.04	0.05	0.09	0.07	0.05	0.05	0.07	0.09	0.05	0.06
Medicaid/CHIP	0.11	0.13	0.05	0.06	0.13	0.16	0.16	0.26	0.15	0.19
Other³	0.09	0.10	*	*	0.09	0.10	0.35	<0.01	0.09	0.10
No Coverage	0.15	0.20	*	*	0.16	0.21	0.13	0.04	0.19	0.26
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.93P – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.2823	0.5782	0.2601	0.8005	0.2157
GEOGRAPHIC REGION
Northeast	0.7263	0.1752	0.7697	0.7615	0.7349
Midwest	0.0386	0.2143	0.0532	0.5098	0.0669
South	0.7045	0.3238	0.7803	0.6201	0.6888
West	0.4400	0.1086	0.3656	0.2006	0.1573
COUNTY TYPE
Large Metro	0.4545	0.3005	0.3967	0.7950	0.4088
Small Metro	0.7860	0.3897	0.8583	0.0049	0.7406
Nonmetro	0.1469	0.1915	0.1917	0.1090	0.2945
Urbanized	0.8752	*	0.9742	0.4302	0.9955
Less Urbanized	0.0722	0.3902	0.0927	0.1159	0.2537
Completely Rural	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.1411	0.2961	0.1351	0.2865	0.2001
100-199%	0.7450	0.5397	0.7955	0.6011	0.8869
200% or More	0.4591	0.9788	0.4577	0.1981	0.3370
HEALTH INSURANCE²
Private	0.5220	0.5172	0.4642	0.9905	0.4412
Medicaid/CHIP	0.1674	0.9851	0.1696	0.4727	0.2067
Other³	0.6620	*	0.6625	0.1357	0.5626
No Coverage	0.9901	*	0.9811	0.0411	0.8220
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.94C – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	497	500	50	51	493	496	62	65	488	495
GEOGRAPHIC REGION
Northeast	199	182	17	15	197	181	25	21	197	180
Midwest	192	177	18	25	190	174	23	33	187	172
South	313	332	38	34	312	334	38	43	309	333
West	262	256	20	28	259	248	35	25	259	245
COUNTY TYPE
Large Metro	386	421	35	45	383	415	48	53	376	414
Small Metro	321	251	28	27	317	249	40	36	316	244
Nonmetro	175	187	23	9	173	186	19	16	169	183
Urbanized	112	121	12	8	111	120	14	9	110	118
Less Urbanized	130	139	12	5	129	138	13	14	126	135
Completely Rural	37	43	16	*	30	43	2	1	30	42
POVERTY LEVEL¹
Less Than 100%	174	187	18	18	171	185	28	33	166	183
100-199%	203	200	23	17	202	199	33	35	201	196
200% or More	436	440	40	46	434	434	47	45	430	431
HEALTH INSURANCE²
Private	403	416	40	44	402	409	53	48	398	405
Medicaid/CHIP	222	211	30	31	217	208	30	33	215	206
Other³	342	331	15	8	341	331	21	35	340	330
No Coverage	83	99	10	5	82	99	15	11	81	98
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.94D – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.18	0.17	0.19	0.20	0.19	0.19	0.18	0.18	0.22	0.22
GEOGRAPHIC REGION
Northeast	0.41	0.37	0.43	0.37	0.44	0.40	0.43	0.36	0.50	0.45
Midwest	0.33	0.30	0.33	0.47	0.36	0.32	0.32	0.46	0.41	0.37
South	0.29	0.30	0.37	0.33	0.32	0.33	0.29	0.32	0.36	0.38
West	0.39	0.38	0.33	0.46	0.43	0.40	0.44	0.31	0.49	0.46
COUNTY TYPE
Large Metro	0.23	0.24	0.24	0.30	0.25	0.26	0.25	0.28	0.28	0.30
Small Metro	0.33	0.25	0.33	0.32	0.37	0.27	0.32	0.28	0.43	0.31
Nonmetro	0.41	0.49	0.63	0.31	0.44	0.53	0.42	0.38	0.50	0.61
Urbanized	0.65	0.76	0.91	0.66	0.70	0.81	0.66	0.43	0.81	0.95
Less Urbanized	0.56	0.71	0.59	0.30	0.61	0.77	0.60	0.69	0.68	0.86
Completely Rural	0.92	1.41	3.20	*	1.03	1.57	0.75	0.31	1.15	1.76
POVERTY LEVEL¹
Less Than 100%	0.37	0.39	0.32	0.33	0.41	0.44	0.31	0.39	0.51	0.55
100-199%	0.37	0.35	0.42	0.32	0.41	0.39	0.41	0.40	0.48	0.46
200% or More	0.22	0.22	0.27	0.30	0.24	0.23	0.26	0.24	0.27	0.26
HEALTH INSURANCE²
Private	0.22	0.22	0.28	0.29	0.24	0.24	0.27	0.24	0.27	0.27
Medicaid/CHIP	0.35	0.34	0.27	0.30	0.41	0.41	0.31	0.36	0.50	0.49
Other³	0.41	0.40	1.04	0.55	0.42	0.41	0.73	1.17	0.44	0.42
No Coverage	0.34	0.39	0.78	0.44	0.36	0.41	0.33	0.22	0.44	0.51
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.94P – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0931	0.6045	0.1000	0.4459	0.1236
GEOGRAPHIC REGION
Northeast	0.0388	0.3836	0.0438	0.6258	0.0520
Midwest	0.8397	0.6980	0.7934	0.1847	0.6309
South	0.6586	0.4054	0.7249	0.2620	0.8409
West	0.3195	0.7438	0.2911	0.3484	0.3477
COUNTY TYPE
Large Metro	0.6057	0.9339	0.5971	0.8705	0.5697
Small Metro	0.0179	0.8042	0.0159	0.1487	0.0254
Nonmetro	0.8806	0.0168	0.7215	0.7372	0.6298
Urbanized	0.7768	0.5215	0.8210	0.3295	0.9806
Less Urbanized	0.7339	0.0464	0.6628	0.5543	0.7053
Completely Rural	0.7156	*	0.4017	0.3740	0.3668
POVERTY LEVEL¹
Less Than 100%	0.8282	0.7343	0.8869	0.4044	0.9590
100-199%	0.2253	0.0957	0.2893	0.5353	0.3626
200% or More	0.1261	0.9730	0.1262	0.2611	0.1596
HEALTH INSURANCE²
Private	0.1129	0.7386	0.1048	0.1301	0.1526
Medicaid/CHIP	0.5231	0.8068	0.5270	0.4388	0.4197
Other³	0.5772	0.0248	0.5209	0.4385	0.5700
No Coverage	0.6261	0.3772	0.6763	0.2360	0.8340
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.95C – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	148	127	18	17	147	125	19	19	146	124
GEOGRAPHIC REGION
Northeast	62	56	4	5	61	56	4	5	61	55
Midwest	56	43	3	2	55	43	6	15	55	40
South	112	86	14	14	111	84	16	5	109	84
West	53	61	10	8	52	61	7	8	52	60
COUNTY TYPE
Large Metro	121	84	17	11	120	83	11	15	119	82
Small Metro	84	62	6	12	83	60	15	11	81	59
Nonmetro	32	73	3	4	32	73	6	4	31	72
Urbanized	18	70	1	3	18	70	1	3	18	70
Less Urbanized	26	21	2	3	26	20	6	3	26	20
Completely Rural	1	2	*	*	1	2	*	*	*	2
POVERTY LEVEL¹
Less Than 100%	32	53	6	7	31	53	10	7	30	52
100-199%	45	38	7	5	44	38	15	4	42	37
200% or More	139	109	16	15	138	108	8	17	138	106
HEALTH INSURANCE²
Private	115	85	16	11	114	84	12	16	114	82
Medicaid/CHIP	71	65	7	13	71	64	9	8	70	64
Other³	109	87	8	*	109	87	5	3	109	87
No Coverage	35	19	<1	1	35	19	11	4	34	18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.95D – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.05	0.04	0.07	0.07	0.06	0.05	0.06	0.05	0.07	0.05
GEOGRAPHIC REGION
Northeast	0.13	0.11	0.10	0.13	0.14	0.12	0.07	0.08	0.16	0.14
Midwest	0.10	0.07	0.06	0.03	0.10	0.08	0.08	0.21	0.12	0.09
South	0.10	0.08	0.14	0.13	0.11	0.08	0.13	0.04	0.13	0.10
West	0.08	0.09	0.16	0.13	0.09	0.10	0.09	0.10	0.10	0.11
COUNTY TYPE
Large Metro	0.08	0.05	0.12	0.07	0.08	0.06	0.06	0.08	0.10	0.06
Small Metro	0.09	0.07	0.08	0.15	0.10	0.07	0.13	0.09	0.12	0.08
Nonmetro	0.08	0.21	0.07	0.14	0.09	0.23	0.14	0.09	0.10	0.26
Urbanized	0.12	0.48	0.05	0.24	0.13	0.52	0.06	0.14	0.15	0.62
Less Urbanized	0.14	0.12	0.13	0.21	0.15	0.13	0.27	0.14	0.17	0.14
Completely Rural	0.05	0.08	*	*	0.05	0.09	*	*	*	0.10
POVERTY LEVEL¹
Less Than 100%	0.07	0.11	0.10	0.12	0.08	0.13	0.11	0.09	0.10	0.16
100-199%	0.08	0.07	0.13	0.10	0.09	0.08	0.19	0.04	0.10	0.09
200% or More	0.08	0.06	0.11	0.10	0.08	0.06	0.05	0.09	0.09	0.07
HEALTH INSURANCE²
Private	0.07	0.05	0.11	0.07	0.07	0.05	0.06	0.08	0.08	0.06
Medicaid/CHIP	0.12	0.11	0.06	0.13	0.14	0.13	0.10	0.09	0.17	0.16
Other³	0.14	0.11	0.53	*	0.14	0.11	0.18	0.09	0.15	0.12
No Coverage	0.15	0.07	0.02	0.09	0.16	0.08	0.24	0.09	0.19	0.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.95P – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3990	0.8652	0.4114	0.5379	0.4661
GEOGRAPHIC REGION
Northeast	0.9005	0.6364	0.8679	0.9159	0.8758
Midwest	0.6200	0.4288	0.6489	0.3439	0.4886
South	0.3187	0.6629	0.2868	0.0275	0.4249
West	0.7558	0.3051	0.6390	0.5082	0.7037
COUNTY TYPE
Large Metro	0.5489	0.3118	0.6457	0.6139	0.6038
Small Metro	0.0956	0.4170	0.0757	0.1839	0.1156
Nonmetro	0.2271	0.3610	0.2509	0.8686	0.2420
Urbanized	0.1917	0.1862	0.2093	0.2096	0.2263
Less Urbanized	0.9666	0.8441	0.9902	0.5647	0.9056
Completely Rural	0.7281	*	0.7343	*	*
POVERTY LEVEL¹
Less Than 100%	0.1234	0.8189	0.1296	0.9715	0.1205
100-199%	0.4940	0.9230	0.4804	0.0852	0.8019
200% or More	0.2256	0.7439	0.2411	0.5353	0.2196
HEALTH INSURANCE²
Private	0.2211	0.4418	0.2582	0.6677	0.2291
Medicaid/CHIP	0.4045	0.2493	0.5127	0.8335	0.5016
Other³	0.4458	*	0.5092	0.2973	0.5355
No Coverage	0.2352	0.4738	0.2247	0.1496	0.4105
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.96C – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	72	61	6	6	72	61	8	12	71	60
GEOGRAPHIC REGION
Northeast	43	49	1	1	43	49	2	<1	43	49
Midwest	47	15	1	1	47	15	4	10	47	12
South	32	27	<1	4	32	27	7	5	31	27
West	11	17	6	4	9	17	1	6	9	16
COUNTY TYPE
Large Metro	43	56	5	4	43	56	2	7	43	55
Small Metro	52	18	4	4	51	18	8	10	51	15
Nonmetro	25	17	1	1	25	17	3	3	25	17
Urbanized	<1	4	*	1	<1	4	*	2	<1	4
Less Urbanized	25	16	1	<1	25	16	3	2	25	16
Completely Rural	*	2	*	*	*	2	*	*	*	2
POVERTY LEVEL¹
Less Than 100%	15	21	3	4	15	20	6	6	14	19
100-199%	8	17	1	1	8	17	1	3	8	17
200% or More	70	55	5	4	70	55	5	10	69	54
HEALTH INSURANCE²
Private	33	54	5	4	33	54	5	11	32	53
Medicaid/CHIP	57	24	4	4	57	23	3	4	57	23
Other³	50	18	*	*	50	18	3	2	50	18
No Coverage	15	14	*	*	15	14	6	3	14	14
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.96D – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.03	0.02	0.02	0.02	0.03	0.02	0.02	0.03	0.03	0.03
GEOGRAPHIC REGION
Northeast	0.09	0.10	0.03	0.01	0.10	0.11	0.03	0.01	0.11	0.12
Midwest	0.08	0.03	0.02	0.01	0.09	0.03	0.06	0.13	0.10	0.03
South	0.03	0.02	<0.01	0.04	0.03	0.03	0.05	0.03	0.04	0.03
West	0.02	0.03	0.10	0.06	0.02	0.03	0.01	0.07	0.02	0.03
COUNTY TYPE
Large Metro	0.03	0.03	0.03	0.03	0.03	0.04	0.01	0.04	0.03	0.04
Small Metro	0.06	0.02	0.05	0.05	0.06	0.02	0.07	0.08	0.07	0.02
Nonmetro	0.07	0.05	0.03	0.03	0.07	0.05	0.06	0.06	0.08	0.06
Urbanized	<0.01	0.03	*	0.06	<0.01	0.03	*	0.08	<0.01	0.04
Less Urbanized	0.13	0.09	0.06	0.03	0.15	0.10	0.13	0.12	0.16	0.11
Completely Rural	*	0.08	*	*	*	0.09	*	*	*	0.10
POVERTY LEVEL¹
Less Than 100%	0.03	0.04	0.06	0.07	0.04	0.05	0.08	0.07	0.04	0.06
100-199%	0.02	0.03	0.02	0.02	0.02	0.03	0.01	0.04	0.02	0.04
200% or More	0.04	0.03	0.03	0.02	0.04	0.03	0.03	0.06	0.05	0.04
HEALTH INSURANCE²
Private	0.02	0.03	0.04	0.03	0.02	0.03	0.03	0.06	0.02	0.04
Medicaid/CHIP	0.09	0.04	0.03	0.04	0.11	0.05	0.03	0.04	0.14	0.06
Other³	0.06	0.02	*	*	0.07	0.02	0.09	0.06	0.07	0.02
No Coverage	0.06	0.06	*	*	0.07	0.06	0.13	0.05	0.08	0.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.96P – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7101	0.7117	0.7323	0.4511	0.6412
GEOGRAPHIC REGION
Northeast	0.7458	0.4382	0.7342	0.5275	0.7201
Midwest	0.2662	0.7909	0.2680	0.6195	0.2137
South	0.8892	0.1828	0.7837	0.8152	0.8165
West	0.8155	0.3001	0.5300	0.1065	0.8668
COUNTY TYPE
Large Metro	0.3456	0.6441	0.3235	0.0573	0.4282
Small Metro	0.0727	0.9684	0.0719	0.6899	0.0787
Nonmetro	0.9508	0.9664	0.9484	0.5959	0.8971
Urbanized	0.0567	*	0.0763	*	0.1672
Less Urbanized	0.6773	0.4982	0.6904	0.9540	0.6833
Completely Rural	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.3010	0.8062	0.3169	0.5526	0.3932
100-199%	0.2803	0.4959	0.3039	0.2263	0.3974
200% or More	0.3517	0.3891	0.3833	0.8290	0.3641
HEALTH INSURANCE²
Private	0.9018	0.3845	0.8322	0.3634	0.9746
Medicaid/CHIP	0.6671	0.6750	0.6359	0.6944	0.6094
Other³	0.3110	*	0.3109	0.6936	0.3210
No Coverage	0.9563	*	0.9510	0.6220	0.9180
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.97C – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	577	577	42	43	574	575	85	91	560	568
GEOGRAPHIC REGION
Northeast	233	258	16	17	230	255	33	34	229	255
Midwest	221	216	21	21	220	217	36	39	215	213
South	393	382	30	31	391	382	56	60	387	380
West	268	253	16	13	270	253	44	40	258	248
COUNTY TYPE
Large Metro	500	499	28	29	498	497	68	73	481	488
Small Metro	374	395	27	28	372	393	51	52	364	382
Nonmetro	237	196	18	15	234	192	35	32	228	185
Urbanized	127	126	7	7	127	124	21	16	125	120
Less Urbanized	190	138	9	14	189	135	27	26	181	129
Completely Rural	77	61	*	*	69	61	8	2	67	60
POVERTY LEVEL¹
Less Than 100%	238	244	19	21	237	241	41	39	229	238
100-199%	291	275	14	16	292	275	48	48	285	267
200% or More	516	531	37	32	512	531	69	69	500	523
HEALTH INSURANCE²
Private	468	480	34	30	466	480	71	74	454	468
Medicaid/CHIP	305	292	26	29	305	286	44	50	300	280
Other³	422	441	8	8	421	441	24	20	420	440
No Coverage	138	117	11	4	138	117	29	23	134	113
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.97D – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.20	0.20	0.16	0.17	0.22	0.22	0.25	0.26	0.25	0.25
GEOGRAPHIC REGION
Northeast	0.48	0.52	0.39	0.42	0.51	0.56	0.58	0.57	0.58	0.64
Midwest	0.38	0.37	0.39	0.38	0.42	0.41	0.50	0.53	0.47	0.46
South	0.36	0.34	0.29	0.30	0.40	0.38	0.43	0.44	0.45	0.43
West	0.40	0.37	0.27	0.21	0.44	0.41	0.55	0.48	0.49	0.46
COUNTY TYPE
Large Metro	0.29	0.28	0.19	0.20	0.31	0.31	0.35	0.37	0.35	0.35
Small Metro	0.38	0.35	0.32	0.32	0.41	0.39	0.41	0.41	0.47	0.44
Nonmetro	0.51	0.46	0.51	0.50	0.56	0.50	0.75	0.69	0.64	0.56
Urbanized	0.72	0.75	0.61	0.59	0.78	0.79	0.98	0.71	0.90	0.92
Less Urbanized	0.73	0.58	0.48	0.82	0.81	0.63	1.18	1.24	0.93	0.71
Completely Rural	1.63	2.01	*	*	1.73	2.23	2.34	0.82	1.90	2.47
POVERTY LEVEL¹
Less Than 100%	0.50	0.50	0.33	0.38	0.57	0.56	0.48	0.46	0.70	0.70
100-199%	0.50	0.47	0.26	0.30	0.56	0.53	0.57	0.56	0.65	0.62
200% or More	0.25	0.25	0.24	0.22	0.27	0.27	0.37	0.37	0.29	0.30
HEALTH INSURANCE²
Private	0.25	0.24	0.24	0.20	0.27	0.26	0.35	0.36	0.30	0.29
Medicaid/CHIP	0.46	0.46	0.24	0.28	0.56	0.55	0.44	0.54	0.69	0.66
Other³	0.49	0.51	0.58	0.55	0.50	0.52	0.85	0.70	0.52	0.53
No Coverage	0.57	0.46	0.87	0.34	0.59	0.48	0.62	0.47	0.72	0.59
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.97P – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.9110	0.1585	0.9663	0.1977	0.8634
GEOGRAPHIC REGION
Northeast	0.7608	0.7834	0.7629	0.8973	0.7852
Midwest	0.1859	0.3466	0.1634	0.4344	0.1178
South	0.4265	0.7374	0.4281	0.9203	0.4393
West	0.9810	0.0959	0.9526	0.0842	0.7210
COUNTY TYPE
Large Metro	0.7428	0.2358	0.6806	0.4045	0.7858
Small Metro	0.6688	0.4187	0.6936	0.0049	0.9667
Nonmetro	0.6771	0.8615	0.6350	0.3779	0.8316
Urbanized	0.6300	0.8346	0.6265	0.2987	0.8838
Less Urbanized	0.7767	0.4314	0.6611	0.9481	0.6500
Completely Rural	0.7768	*	0.6625	0.1048	0.5503
POVERTY LEVEL¹
Less Than 100%	0.5980	0.5032	0.5026	0.6430	0.4965
100-199%	0.4016	0.7753	0.3928	0.3073	0.5234
200% or More	0.5374	0.0394	0.4328	0.4984	0.3726
HEALTH INSURANCE²
Private	0.9706	0.0753	0.8393	0.3973	0.7253
Medicaid/CHIP	0.6906	0.9460	0.6514	0.4353	0.5137
Other³	0.4721	0.4289	0.4636	0.1699	0.4191
No Coverage	0.2563	0.4861	0.2616	0.2062	0.4017
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.98C – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	230	207	18	20	230	205	43	51	223	197
GEOGRAPHIC REGION
Northeast	90	82	3	5	90	82	17	12	88	81
Midwest	71	89	9	8	70	90	16	20	69	84
South	182	136	12	17	181	134	29	40	177	129
West	97	88	12	5	97	88	23	18	90	86
COUNTY TYPE
Large Metro	207	159	15	13	207	159	33	39	199	152
Small Metro	106	104	10	14	106	103	25	27	102	99
Nonmetro	58	84	3	9	58	81	14	22	55	77
Urbanized	43	59	2	6	42	56	6	8	42	55
Less Urbanized	38	47	2	6	38	47	13	19	35	42
Completely Rural	8	*	*	*	8	*	2	1	7	*
POVERTY LEVEL¹
Less Than 100%	79	76	6	8	79	75	17	25	78	71
100-199%	113	80	10	10	112	79	22	27	111	75
200% or More	189	167	16	16	189	167	32	35	185	165
HEALTH INSURANCE²
Private	178	143	16	14	178	142	33	35	172	138
Medicaid/CHIP	103	121	8	16	103	118	22	33	102	111
Other³	130	95	7	2	130	95	9	11	129	94
No Coverage	67	65	2	1	67	65	16	12	64	64
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.98D – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.08	0.07	0.07	0.08	0.09	0.08	0.13	0.14	0.10	0.09
GEOGRAPHIC REGION
Northeast	0.18	0.16	0.08	0.11	0.20	0.18	0.30	0.21	0.22	0.20
Midwest	0.12	0.15	0.16	0.15	0.13	0.17	0.23	0.28	0.15	0.18
South	0.17	0.12	0.12	0.17	0.18	0.13	0.22	0.30	0.21	0.15
West	0.15	0.13	0.20	0.09	0.16	0.14	0.29	0.22	0.17	0.16
COUNTY TYPE
Large Metro	0.13	0.10	0.11	0.09	0.14	0.11	0.18	0.20	0.16	0.12
Small Metro	0.12	0.11	0.12	0.16	0.13	0.12	0.22	0.22	0.14	0.14
Nonmetro	0.15	0.23	0.08	0.29	0.17	0.25	0.33	0.50	0.18	0.27
Urbanized	0.28	0.40	0.18	0.52	0.30	0.41	0.33	0.36	0.34	0.48
Less Urbanized	0.19	0.25	0.08	0.39	0.21	0.27	0.59	0.97	0.22	0.28
Completely Rural	0.25	*	*	*	0.27	*	0.56	0.42	0.28	*
POVERTY LEVEL¹
Less Than 100%	0.18	0.16	0.11	0.14	0.20	0.18	0.21	0.30	0.25	0.21
100-199%	0.20	0.14	0.18	0.19	0.22	0.16	0.28	0.31	0.26	0.18
200% or More	0.10	0.09	0.10	0.11	0.11	0.10	0.18	0.19	0.12	0.11
HEALTH INSURANCE²
Private	0.10	0.08	0.11	0.09	0.11	0.09	0.17	0.17	0.12	0.10
Medicaid/CHIP	0.17	0.20	0.07	0.16	0.21	0.24	0.23	0.37	0.25	0.28
Other³	0.16	0.12	0.47	0.13	0.17	0.12	0.32	0.38	0.17	0.13
No Coverage	0.28	0.26	0.14	0.06	0.29	0.27	0.35	0.25	0.35	0.34
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.98P – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.1913	0.8607	0.1927	0.9374	0.1861
GEOGRAPHIC REGION
Northeast	0.2074	0.6985	0.1993	0.1068	0.2967
Midwest	0.2042	0.5133	0.1787	0.6045	0.1268
South	0.1884	0.3243	0.1529	0.1158	0.0701
West	0.5048	0.1469	0.6029	0.2526	0.7861
COUNTY TYPE
Large Metro	0.0574	0.3065	0.0679	0.5664	0.0464
Small Metro	0.6614	0.8753	0.6695	0.3458	0.8511
Nonmetro	0.1482	0.0496	0.2029	0.9156	0.1829
Urbanized	0.6319	0.3489	0.6818	0.6988	0.6101
Less Urbanized	0.1910	0.0655	0.2803	0.6875	0.3168
Completely Rural	*	*	*	0.9301	*
POVERTY LEVEL¹
Less Than 100%	0.9302	0.8746	0.9739	0.2917	0.7950
100-199%	0.3895	0.8762	0.3906	0.9429	0.3830
200% or More	0.2510	0.8473	0.2591	0.5104	0.3068
HEALTH INSURANCE²
Private	0.0643	0.3138	0.0794	0.1966	0.1261
Medicaid/CHIP	0.2167	0.1569	0.2842	0.0787	0.4963
Other³	0.6482	0.2009	0.6880	0.7573	0.6679
No Coverage	0.4325	0.4788	0.4280	0.3458	0.5635
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.99C – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	840	914	102	110	827	902	150	155	815	878
GEOGRAPHIC REGION
Northeast	333	369	32	44	331	368	55	59	324	352
Midwest	389	346	44	44	382	341	52	63	380	332
South	567	618	80	71	562	608	107	98	549	596
West	433	432	41	56	424	429	72	74	410	417
COUNTY TYPE
Large Metro	878	931	92	92	854	917	133	126	819	889
Small Metro	675	720	67	68	664	704	87	114	636	660
Nonmetro	583	477	36	56	565	462	71	64	542	432
Urbanized	434	298	28	49	416	281	49	44	401	260
Less Urbanized	389	388	23	26	380	379	53	45	359	358
Completely Rural	134	121	9	10	130	119	11	18	125	111
POVERTY LEVEL¹
Less Than 100%	432	456	53	53	421	449	79	82	410	431
100-199%	482	497	56	50	474	490	83	85	463	476
200% or More	900	922	87	94	881	906	123	116	859	882
HEALTH INSURANCE²
Private	838	862	81	90	820	849	140	132	793	824
Medicaid/CHIP	548	519	79	82	533	506	87	93	513	488
Other³	745	708	31	24	743	707	49	47	739	704
No Coverage	218	235	21	22	216	232	49	54	206	225
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.99D – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.30	0.32	0.40	0.42	0.32	0.34	0.44	0.44	0.36	0.39
GEOGRAPHIC REGION
Northeast	0.68	0.74	0.80	1.08	0.74	0.81	0.96	1.00	0.83	0.89
Midwest	0.67	0.59	0.82	0.81	0.72	0.64	0.73	0.86	0.83	0.72
South	0.52	0.55	0.77	0.69	0.57	0.60	0.82	0.73	0.64	0.68
West	0.65	0.63	0.67	0.91	0.70	0.69	0.90	0.90	0.78	0.78
COUNTY TYPE
Large Metro	0.39	0.44	0.56	0.57	0.43	0.47	0.63	0.61	0.48	0.53
Small Metro	0.51	0.53	0.70	0.70	0.56	0.58	0.71	0.75	0.64	0.64
Nonmetro	1.01	0.88	0.95	1.48	1.07	0.96	1.33	1.18	1.21	1.05
Urbanized	1.79	1.31	1.95	2.77	1.86	1.45	1.95	1.60	2.12	1.62
Less Urbanized	1.13	1.33	1.00	1.53	1.26	1.43	2.09	1.74	1.40	1.58
Completely Rural	4.10	2.28	3.06	4.31	4.25	2.51	3.21	4.56	4.75	2.84
POVERTY LEVEL¹
Less Than 100%	0.76	0.77	0.84	0.89	0.86	0.85	0.82	0.85	1.06	1.04
100-199%	0.71	0.70	0.97	0.89	0.77	0.77	0.93	0.91	0.89	0.90
200% or More	0.37	0.39	0.51	0.57	0.39	0.42	0.63	0.58	0.43	0.46
HEALTH INSURANCE²
Private	0.37	0.38	0.52	0.56	0.39	0.41	0.64	0.57	0.44	0.46
Medicaid/CHIP	0.67	0.68	0.66	0.71	0.80	0.81	0.82	0.92	0.97	0.98
Other³	0.70	0.70	2.03	1.66	0.71	0.71	1.60	1.54	0.74	0.74
No Coverage	0.82	0.82	1.59	1.70	0.86	0.85	1.01	1.01	1.03	1.04
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.99P – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3166	0.0383	0.4765	0.2084	0.3204
GEOGRAPHIC REGION
Northeast	0.5958	0.8903	0.6138	0.5741	0.5237
Midwest	0.9597	0.2778	0.9155	0.9288	0.9127
South	0.9449	0.9934	0.9633	0.7345	0.9018
West	0.1443	0.0007	0.2956	0.0506	0.1541
COUNTY TYPE
Large Metro	0.0906	0.7230	0.0966	0.2415	0.0583
Small Metro	0.3207	0.0586	0.2005	0.4869	0.2467
Nonmetro	0.3846	0.0353	0.5725	0.9139	0.4634
Urbanized	0.5674	0.1664	0.4517	0.4958	0.6259
Less Urbanized	0.0718	0.1056	0.1253	0.6959	0.1323
Completely Rural	0.6469	0.5596	0.7093	0.4596	0.7731
POVERTY LEVEL¹
Less Than 100%	0.6972	0.7142	0.8178	0.6730	0.8290
100-199%	0.2860	0.0615	0.4167	0.2777	0.2516
200% or More	0.7006	0.2042	0.8045	0.4504	0.7067
HEALTH INSURANCE²
Private	0.8952	0.4258	0.8396	0.0447	0.8516
Medicaid/CHIP	0.2942	0.0390	0.5391	0.6952	0.6448
Other³	0.2054	0.7924	0.2110	0.9199	0.2107
No Coverage	0.7449	0.6616	0.7977	0.3850	0.5940
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.100C – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	329	318	50	39	328	315	59	82	318	300
GEOGRAPHIC REGION
Northeast	118	162	14	12	118	162	21	26	116	158
Midwest	115	121	21	17	116	119	21	26	116	115
South	222	200	39	29	221	196	40	62	216	187
West	177	146	17	18	175	145	28	35	168	139
COUNTY TYPE
Large Metro	257	244	39	31	254	241	46	63	245	231
Small Metro	188	177	29	21	184	174	36	44	178	165
Nonmetro	127	124	16	13	126	122	15	32	123	118
Urbanized	69	85	9	9	68	83	10	20	67	82
Less Urbanized	99	88	13	10	98	86	13	23	95	81
Completely Rural	31	22	1	*	31	22	2	1	31	22
POVERTY LEVEL¹
Less Than 100%	141	214	28	21	139	213	30	35	136	208
100-199%	159	150	20	21	158	148	32	41	157	142
200% or More	273	206	36	27	270	203	39	54	266	192
HEALTH INSURANCE²
Private	252	212	35	26	249	211	43	60	244	200
Medicaid/CHIP	170	219	35	28	165	216	36	43	157	208
Other³	190	153	14	7	190	152	19	25	189	151
No Coverage	90	94	4	11	90	91	24	18	87	89
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.100D – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.12	0.11	0.19	0.15	0.13	0.12	0.17	0.23	0.14	0.13
GEOGRAPHIC REGION
Northeast	0.24	0.33	0.34	0.28	0.26	0.35	0.36	0.44	0.30	0.40
Midwest	0.20	0.20	0.38	0.32	0.22	0.22	0.29	0.35	0.25	0.25
South	0.20	0.18	0.38	0.28	0.22	0.19	0.31	0.46	0.25	0.21
West	0.26	0.21	0.27	0.30	0.29	0.23	0.35	0.42	0.32	0.26
COUNTY TYPE
Large Metro	0.15	0.14	0.27	0.21	0.17	0.16	0.24	0.33	0.19	0.17
Small Metro	0.20	0.18	0.34	0.25	0.22	0.20	0.32	0.35	0.25	0.22
Nonmetro	0.31	0.35	0.45	0.44	0.34	0.38	0.35	0.69	0.38	0.43
Urbanized	0.45	0.55	0.70	0.78	0.48	0.59	0.56	0.90	0.54	0.73
Less Urbanized	0.45	0.47	0.65	0.62	0.51	0.51	0.57	1.11	0.56	0.57
Completely Rural	0.93	0.75	0.35	*	1.01	0.82	0.56	0.22	1.14	0.92
POVERTY LEVEL¹
Less Than 100%	0.30	0.44	0.48	0.37	0.34	0.49	0.35	0.41	0.42	0.61
100-199%	0.28	0.26	0.38	0.39	0.31	0.29	0.40	0.47	0.37	0.33
200% or More	0.14	0.11	0.23	0.18	0.15	0.12	0.22	0.30	0.17	0.13
HEALTH INSURANCE²
Private	0.14	0.12	0.24	0.18	0.15	0.13	0.23	0.30	0.17	0.14
Medicaid/CHIP	0.26	0.36	0.32	0.27	0.31	0.43	0.36	0.47	0.38	0.51
Other³	0.24	0.19	0.98	0.49	0.24	0.20	0.67	0.89	0.25	0.20
No Coverage	0.37	0.36	0.32	0.86	0.39	0.37	0.53	0.35	0.47	0.46
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.100P – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0490	0.0697	0.0844	0.3265	0.0471
GEOGRAPHIC REGION
Northeast	0.8547	0.3407	0.7908	0.6832	0.8404
Midwest	0.3283	0.0706	0.5046	0.8933	0.5187
South	0.0825	0.5248	0.0978	0.1676	0.0452
West	0.3027	0.4699	0.3345	0.7896	0.3390
COUNTY TYPE
Large Metro	0.0291	0.1178	0.0524	0.4967	0.0322
Small Metro	0.3528	0.2476	0.4412	0.9210	0.4234
Nonmetro	0.6506	0.7415	0.6908	0.2305	0.8567
Urbanized	0.9459	0.7430	0.9764	0.5200	0.9366
Less Urbanized	0.4411	0.8927	0.4682	0.2813	0.6117
Completely Rural	0.5647	*	0.5594	0.4771	0.5891
POVERTY LEVEL¹
Less Than 100%	0.0280	0.8126	0.0272	0.9042	0.0279
100-199%	0.6279	0.9138	0.6180	0.7780	0.6521
200% or More	0.0000	0.0214	0.0000	0.2379	0.0000
HEALTH INSURANCE²
Private	0.0071	0.1544	0.0117	0.1761	0.0043
Medicaid/CHIP	0.1739	0.2322	0.1199	0.6406	0.1393
Other³	0.1313	0.1079	0.1600	0.7881	0.1513
No Coverage	0.8597	0.1617	0.7451	0.1234	0.9493
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.101C – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	177	190	29	19	176	190	28	38	173	186
GEOGRAPHIC REGION
Northeast	52	135	5	6	52	135	5	13	52	134
Midwest	67	65	11	2	66	65	10	16	65	63
South	120	84	25	16	119	84	20	30	117	79
West	117	79	8	6	117	78	16	11	115	78
COUNTY TYPE
Large Metro	144	166	20	17	144	166	20	27	142	164
Small Metro	84	76	21	5	82	76	19	21	80	74
Nonmetro	64	58	5	5	64	58	7	19	63	54
Urbanized	32	44	4	3	31	44	1	9	31	41
Less Urbanized	56	40	1	4	56	40	7	*	55	37
Completely Rural	4	9	1	*	4	9	*	<1	4	9
POVERTY LEVEL¹
Less Than 100%	77	154	24	10	73	154	17	18	71	153
100-199%	97	69	8	11	97	68	14	22	96	65
200% or More	128	87	15	11	129	86	17	24	126	83
HEALTH INSURANCE²
Private	134	85	12	12	134	84	20	25	133	80
Medicaid/CHIP	110	159	27	11	107	158	16	26	105	156
Other³	69	78	5	6	69	77	9	7	70	77
No Coverage	43	45	2	7	43	44	9	7	42	44
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.101D – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.06	0.07	0.11	0.07	0.07	0.07	0.08	0.11	0.08	0.08
GEOGRAPHIC REGION
Northeast	0.11	0.27	0.12	0.15	0.12	0.30	0.08	0.22	0.13	0.34
Midwest	0.11	0.11	0.21	0.04	0.13	0.12	0.14	0.22	0.14	0.14
South	0.11	0.08	0.25	0.16	0.12	0.08	0.16	0.22	0.14	0.09
West	0.18	0.12	0.14	0.10	0.19	0.13	0.19	0.13	0.22	0.15
COUNTY TYPE
Large Metro	0.09	0.10	0.14	0.12	0.10	0.11	0.11	0.14	0.11	0.13
Small Metro	0.09	0.08	0.25	0.07	0.10	0.09	0.16	0.17	0.11	0.10
Nonmetro	0.17	0.17	0.14	0.18	0.18	0.18	0.16	0.42	0.21	0.20
Urbanized	0.21	0.30	0.36	0.24	0.22	0.33	0.08	0.41	0.26	0.38
Less Urbanized	0.28	0.23	0.03	0.29	0.31	0.25	0.32	*	0.35	0.27
Completely Rural	0.14	0.32	0.25	*	0.15	0.35	*	0.14	0.16	0.39
POVERTY LEVEL¹
Less Than 100%	0.17	0.33	0.41	0.18	0.18	0.37	0.20	0.22	0.22	0.46
100-199%	0.18	0.13	0.15	0.21	0.20	0.14	0.17	0.25	0.23	0.16
200% or More	0.07	0.05	0.10	0.07	0.08	0.05	0.10	0.13	0.08	0.05
HEALTH INSURANCE²
Private	0.08	0.05	0.09	0.08	0.08	0.05	0.11	0.13	0.10	0.06
Medicaid/CHIP	0.18	0.27	0.24	0.11	0.21	0.32	0.17	0.29	0.26	0.39
Other³	0.09	0.10	0.37	0.47	0.09	0.10	0.32	0.25	0.09	0.10
No Coverage	0.18	0.18	0.19	0.61	0.19	0.18	0.19	0.13	0.23	0.23
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.101P – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.4007	0.4847	0.4545	0.3751	0.3537
GEOGRAPHIC REGION
Northeast	0.3413	0.8497	0.3466	0.1099	0.4244
Midwest	0.8811	0.0085	0.6427	0.5191	0.7263
South	0.1287	0.6985	0.1079	0.5522	0.0686
West	0.3001	0.4259	0.3256	0.5231	0.3599
COUNTY TYPE
Large Metro	0.3486	0.9198	0.3442	0.5005	0.2837
Small Metro	0.5916	0.1401	0.8003	0.9091	0.8224
Nonmetro	0.5359	0.6011	0.5744	0.2158	0.7620
Urbanized	0.7587	0.3011	0.6825	0.0149	0.9768
Less Urbanized	0.7564	0.0842	0.8720	*	0.9023
Completely Rural	0.1259	*	0.1260	*	0.1345
POVERTY LEVEL¹
Less Than 100%	0.1563	0.4084	0.1225	0.6146	0.1430
100-199%	0.5156	0.3462	0.4424	0.4052	0.3408
200% or More	0.0131	0.4302	0.0181	0.7514	0.0134
HEALTH INSURANCE²
Private	0.0291	0.9051	0.0288	0.7386	0.0204
Medicaid/CHIP	0.7435	0.1050	0.5762	0.1896	0.7458
Other³	0.8642	0.5283	0.9041	0.8683	0.9186
No Coverage	1.0000	0.2491	0.8740	0.2135	0.9291
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.102C – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	536	521	90	89	525	511	165	157	490	498
GEOGRAPHIC REGION
Northeast	183	215	27	39	182	208	67	61	173	207
Midwest	200	212	35	33	197	207	65	61	180	192
South	325	338	65	64	318	333	91	110	309	322
West	296	289	39	40	288	283	90	76	263	272
COUNTY TYPE
Large Metro	481	469	75	73	469	458	140	133	437	442
Small Metro	305	343	54	58	291	329	107	111	254	304
Nonmetro	231	204	26	26	225	198	59	55	208	181
Urbanized	154	125	14	16	152	121	50	42	138	106
Less Urbanized	172	155	21	20	167	150	34	34	154	138
Completely Rural	47	60	6	6	46	59	8	8	44	59
POVERTY LEVEL¹
Less Than 100%	222	254	26	30	218	250	89	83	200	232
100-199%	235	209	37	33	235	203	79	73	216	187
200% or More	474	482	80	81	458	473	126	129	426	459
HEALTH INSURANCE²
Private	451	453	80	78	433	445	153	146	395	425
Medicaid/CHIP	277	278	49	50	267	270	74	71	254	260
Other³	259	238	21	24	258	237	46	44	255	232
No Coverage	173	141	13	14	173	141	39	42	168	131
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.102D – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.19	0.18	0.35	0.34	0.20	0.19	0.48	0.45	0.22	0.22
GEOGRAPHIC REGION
Northeast	0.37	0.43	0.65	0.96	0.40	0.46	1.16	1.04	0.44	0.52
Midwest	0.34	0.36	0.65	0.61	0.37	0.39	0.91	0.84	0.39	0.42
South	0.30	0.30	0.64	0.62	0.32	0.33	0.69	0.81	0.36	0.37
West	0.44	0.42	0.64	0.65	0.47	0.46	1.12	0.92	0.50	0.51
COUNTY TYPE
Large Metro	0.27	0.26	0.48	0.47	0.29	0.28	0.69	0.63	0.32	0.31
Small Metro	0.30	0.30	0.60	0.60	0.32	0.33	0.79	0.77	0.34	0.36
Nonmetro	0.46	0.49	0.69	0.85	0.50	0.53	1.01	0.99	0.55	0.60
Urbanized	0.81	0.68	0.97	1.46	0.88	0.71	1.66	1.54	0.98	0.82
Less Urbanized	0.63	0.74	1.07	1.22	0.67	0.79	1.35	1.30	0.73	0.88
Completely Rural	1.01	1.62	2.19	2.38	1.12	1.78	2.49	2.85	1.20	1.94
POVERTY LEVEL¹
Less Than 100%	0.47	0.51	0.45	0.54	0.53	0.57	0.90	0.89	0.61	0.67
100-199%	0.41	0.36	0.67	0.59	0.45	0.39	0.95	0.81	0.50	0.43
200% or More	0.23	0.22	0.49	0.50	0.24	0.24	0.64	0.64	0.26	0.26
HEALTH INSURANCE²
Private	0.23	0.22	0.52	0.50	0.25	0.24	0.67	0.63	0.26	0.27
Medicaid/CHIP	0.43	0.44	0.44	0.48	0.50	0.51	0.74	0.73	0.59	0.61
Other³	0.31	0.30	1.45	1.68	0.32	0.30	1.48	1.43	0.33	0.31
No Coverage	0.67	0.55	0.99	1.14	0.70	0.58	0.86	0.84	0.86	0.68
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.102P – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.7955	0.6866	0.7305	0.3411	0.9500
GEOGRAPHIC REGION
Northeast	0.7835	0.5866	0.8460	0.6889	0.9344
Midwest	0.2956	0.7886	0.2713	0.6649	0.1839
South	0.4436	0.5214	0.3557	0.8217	0.2996
West	0.8868	0.6287	0.8230	0.1537	0.8202
COUNTY TYPE
Large Metro	0.5833	0.7615	0.6148	0.8400	0.6586
Small Metro	0.5427	0.5074	0.6180	0.1333	0.3011
Nonmetro	0.6155	0.3877	0.5095	0.9420	0.4749
Urbanized	0.6501	0.4329	0.5740	0.3444	0.6744
Less Urbanized	0.5392	0.6231	0.4558	0.3036	0.3180
Completely Rural	0.3266	0.8433	0.3239	0.6098	0.2700
POVERTY LEVEL¹
Less Than 100%	0.5886	0.1381	0.7710	0.3399	0.4981
100-199%	0.0299	0.8087	0.0283	0.0660	0.0820
200% or More	0.5919	0.9744	0.5844	0.6073	0.6740
HEALTH INSURANCE²
Private	0.4939	0.9110	0.4987	0.6497	0.3893
Medicaid/CHIP	0.6428	0.2479	0.4590	0.8749	0.4550
Other³	0.5620	0.1539	0.6567	0.1874	0.8349
No Coverage	0.1535	0.5845	0.1340	0.7416	0.1448
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.103C – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	355	327	36	41	351	325	113	89	329	314
GEOGRAPHIC REGION
Northeast	123	139	8	23	123	138	43	37	119	134
Midwest	120	115	15	12	119	114	35	39	114	111
South	221	219	29	24	217	216	62	57	208	204
West	220	180	15	19	219	179	73	47	199	172
COUNTY TYPE
Large Metro	305	293	32	35	300	290	98	75	278	281
Small Metro	176	162	17	17	174	161	60	53	162	145
Nonmetro	130	123	6	10	130	122	33	34	123	114
Urbanized	77	77	3	8	77	77	19	28	73	67
Less Urbanized	101	87	4	7	101	86	26	20	96	83
Completely Rural	28	39	*	*	28	39	7	1	27	39
POVERTY LEVEL¹
Less Than 100%	164	191	7	13	164	190	52	40	155	186
100-199%	160	143	13	11	160	142	57	49	145	132
200% or More	282	246	34	37	276	247	81	71	261	234
HEALTH INSURANCE²
Private	250	229	32	36	242	228	96	76	225	218
Medicaid/CHIP	189	202	15	19	188	201	45	41	179	198
Other³	157	137	9	8	157	137	37	30	153	133
No Coverage	137	115	4	8	137	114	31	30	135	109
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.103D – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.13	0.11	0.14	0.16	0.14	0.12	0.33	0.26	0.15	0.14
GEOGRAPHIC REGION
Northeast	0.25	0.28	0.21	0.58	0.27	0.30	0.74	0.63	0.30	0.34
Midwest	0.21	0.20	0.28	0.22	0.23	0.21	0.49	0.54	0.25	0.24
South	0.20	0.20	0.28	0.24	0.22	0.21	0.47	0.42	0.24	0.23
West	0.33	0.26	0.25	0.32	0.36	0.29	0.91	0.57	0.38	0.32
COUNTY TYPE
Large Metro	0.18	0.17	0.22	0.24	0.20	0.19	0.51	0.38	0.21	0.21
Small Metro	0.19	0.16	0.20	0.20	0.21	0.18	0.48	0.41	0.23	0.19
Nonmetro	0.31	0.33	0.16	0.35	0.34	0.36	0.63	0.71	0.38	0.40
Urbanized	0.45	0.49	0.28	0.69	0.49	0.53	0.73	1.16	0.55	0.58
Less Urbanized	0.47	0.45	0.19	0.43	0.52	0.49	1.07	0.94	0.57	0.56
Completely Rural	0.64	1.26	*	*	0.74	1.39	2.02	0.49	0.82	1.56
POVERTY LEVEL¹
Less Than 100%	0.35	0.39	0.13	0.23	0.40	0.44	0.55	0.46	0.49	0.54
100-199%	0.28	0.25	0.25	0.21	0.31	0.28	0.70	0.57	0.34	0.31
200% or More	0.15	0.13	0.22	0.25	0.16	0.14	0.43	0.38	0.17	0.15
HEALTH INSURANCE²
Private	0.14	0.12	0.22	0.24	0.15	0.14	0.46	0.36	0.16	0.15
Medicaid/CHIP	0.30	0.33	0.13	0.19	0.37	0.39	0.46	0.45	0.43	0.47
Other³	0.20	0.18	0.61	0.58	0.20	0.18	1.24	1.06	0.20	0.18
No Coverage	0.54	0.45	0.29	0.65	0.57	0.47	0.67	0.59	0.70	0.57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.103P – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.0928	0.8924	0.0842	0.0476	0.2441
GEOGRAPHIC REGION
Northeast	0.9315	0.4896	0.9853	0.2780	0.7381
Midwest	0.3757	0.2069	0.4497	0.3150	0.6483
South	0.2006	0.5327	0.2168	0.6791	0.2338
West	0.3411	0.1246	0.2712	0.0995	0.5407
COUNTY TYPE
Large Metro	0.4944	0.6549	0.5259	0.1601	0.8613
Small Metro	0.0235	0.5970	0.0183	0.0636	0.0533
Nonmetro	0.9717	0.2659	0.9349	0.7049	0.8320
Urbanized	0.9945	0.2848	0.9161	0.1776	0.5942
Less Urbanized	0.8837	0.4433	0.8110	0.7839	0.8612
Completely Rural	0.5604	*	0.5418	0.0654	0.3882
POVERTY LEVEL¹
Less Than 100%	0.9279	0.2950	0.9660	0.0232	0.6019
100-199%	0.3229	0.7451	0.3273	0.0864	0.6371
200% or More	0.0893	0.9356	0.0897	0.7667	0.0913
HEALTH INSURANCE²
Private	0.2866	0.8999	0.2790	0.0465	0.6927
Medicaid/CHIP	0.7478	0.7313	0.6975	0.6315	0.7575
Other³	0.0414	0.4193	0.0459	0.3209	0.0685
No Coverage	0.2645	0.4844	0.2348	0.3838	0.3289
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.104C – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	255	220	20	26	254	222	60	46	244	215
GEOGRAPHIC REGION
Northeast	89	101	2	22	89	98	25	21	87	94
Midwest	92	82	7	4	92	82	20	22	89	79
South	139	152	18	12	139	151	38	28	134	146
West	160	115	6	4	160	115	34	22	152	112
COUNTY TYPE
Large Metro	221	194	17	23	221	192	51	37	210	189
Small Metro	103	108	11	9	102	108	32	26	97	101
Nonmetro	84	83	<1	3	84	83	14	17	82	80
Urbanized	62	57	<1	3	62	57	10	12	60	52
Less Urbanized	56	47	<1	<1	56	47	10	12	54	45
Completely Rural	6	38	*	*	6	38	*	<1	6	38
POVERTY LEVEL¹
Less Than 100%	128	133	1	6	128	133	34	20	122	131
100-199%	121	95	10	2	121	95	26	26	117	91
200% or More	176	158	18	25	175	160	41	33	170	156
HEALTH INSURANCE²
Private	163	130	19	25	162	129	44	37	154	125
Medicaid/CHIP	152	151	8	7	152	151	24	27	149	148
Other³	137	73	1	<1	137	73	29	8	134	72
No Coverage	88	80	2	<1	88	80	17	12	86	78
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.104D – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.09	0.08	0.08	0.10	0.10	0.08	0.18	0.13	0.11	0.09
GEOGRAPHIC REGION
Northeast	0.18	0.20	0.06	0.54	0.20	0.22	0.43	0.36	0.22	0.24
Midwest	0.16	0.14	0.13	0.07	0.17	0.15	0.27	0.30	0.20	0.17
South	0.13	0.14	0.17	0.11	0.14	0.15	0.29	0.21	0.16	0.17
West	0.24	0.17	0.10	0.07	0.26	0.19	0.42	0.27	0.29	0.21
COUNTY TYPE
Large Metro	0.14	0.12	0.12	0.16	0.15	0.13	0.27	0.20	0.16	0.15
Small Metro	0.12	0.11	0.13	0.11	0.13	0.12	0.27	0.21	0.14	0.14
Nonmetro	0.22	0.23	0.01	0.09	0.24	0.26	0.28	0.38	0.27	0.29
Urbanized	0.39	0.39	0.02	0.23	0.43	0.42	0.42	0.53	0.48	0.47
Less Urbanized	0.28	0.26	0.01	0.01	0.31	0.28	0.43	0.63	0.35	0.31
Completely Rural	0.19	1.27	*	*	0.21	1.40	*	0.14	0.24	1.57
POVERTY LEVEL¹
Less Than 100%	0.28	0.28	0.02	0.11	0.32	0.32	0.39	0.24	0.39	0.39
100-199%	0.22	0.17	0.19	0.05	0.24	0.18	0.32	0.30	0.28	0.21
200% or More	0.09	0.08	0.12	0.16	0.10	0.09	0.23	0.19	0.11	0.10
HEALTH INSURANCE²
Private	0.09	0.07	0.13	0.17	0.10	0.08	0.22	0.19	0.11	0.09
Medicaid/CHIP	0.25	0.25	0.07	0.07	0.30	0.30	0.25	0.29	0.36	0.36
Other³	0.17	0.09	0.05	0.01	0.17	0.09	0.99	0.28	0.18	0.10
No Coverage	0.36	0.32	0.19	0.01	0.38	0.33	0.38	0.25	0.47	0.41
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.104P – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
TOTAL	0.3449	0.8006	0.3273	0.2296	0.4721
GEOGRAPHIC REGION
Northeast	0.5278	0.2386	0.6694	0.5866	0.5580
Midwest	0.2010	0.4331	0.2175	0.5988	0.2652
South	0.9893	0.5413	0.9675	0.5016	0.8368
West	0.2153	0.8275	0.2099	0.4972	0.2545
COUNTY TYPE
Large Metro	0.6593	0.9236	0.6525	0.3837	0.8004
Small Metro	0.2001	0.9363	0.1911	0.2601	0.2763
Nonmetro	0.8807	0.2794	0.9245	0.6756	0.9712
Urbanized	0.6991	0.2963	0.6698	0.9229	0.6563
Less Urbanized	0.8886	0.6490	0.8582	0.6776	0.7868
Completely Rural	0.1256	*	0.1304	*	0.1332
POVERTY LEVEL¹
Less Than 100%	0.8444	0.0693	0.7549	0.1498	0.9768
100-199%	0.3854	0.1468	0.4368	0.4939	0.5235
200% or More	0.5115	0.7091	0.4846	0.8492	0.5026
HEALTH INSURANCE²
Private	0.3351	0.8190	0.3216	0.1572	0.5405
Medicaid/CHIP	0.5889	0.7036	0.6194	0.3173	0.7725
Other³	0.0308	0.3946	0.0311	0.1526	0.0538
No Coverage	0.3671	0.2755	0.3661	0.2187	0.5086
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.105C – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	573	--	101	--	568	--	155	--	545
GEOGRAPHIC REGION
Northeast	--	262	--	37	--	260	--	61	--	258
Midwest	--	218	--	41	--	215	--	57	--	204
South	--	345	--	58	--	348	--	94	--	330
West	--	316	--	54	--	307	--	98	--	282
COUNTY TYPE
Large Metro	--	524	--	90	--	511	--	142	--	489
Small Metro	--	336	--	49	--	326	--	107	--	292
Nonmetro	--	206	--	26	--	198	--	58	--	177
Urbanized	--	137	--	17	--	132	--	44	--	112
Less Urbanized	--	147	--	20	--	141	--	38	--	131
Completely Rural	--	51	--	4	--	51	--	4	--	51
POVERTY LEVEL¹
Less Than 100%	--	311	--	40	--	307	--	75	--	297
100-199%	--	243	--	40	--	234	--	78	--	219
200% or More	--	499	--	86	--	490	--	129	--	463
HEALTH INSURANCE²
Private	--	469	--	80	--	463	--	133	--	440
Medicaid/CHIP	--	317	--	55	--	310	--	77	--	296
Other³	--	239	--	16	--	239	--	43	--	235
No Coverage	--	177	--	19	--	175	--	53	--	166
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.105D – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.20	--	0.39	--	0.22	--	0.44	--	0.24
GEOGRAPHIC REGION
Northeast	--	0.53	--	0.91	--	0.57	--	1.03	--	0.65
Midwest	--	0.37	--	0.75	--	0.40	--	0.78	--	0.44
South	--	0.31	--	0.57	--	0.34	--	0.70	--	0.38
West	--	0.46	--	0.89	--	0.50	--	1.19	--	0.53
COUNTY TYPE
Large Metro	--	0.29	--	0.57	--	0.32	--	0.69	--	0.35
Small Metro	--	0.31	--	0.56	--	0.34	--	0.73	--	0.37
Nonmetro	--	0.50	--	0.88	--	0.53	--	1.10	--	0.57
Urbanized	--	0.78	--	1.56	--	0.81	--	1.62	--	0.87
Less Urbanized	--	0.65	--	1.18	--	0.70	--	1.63	--	0.78
Completely Rural	--	1.59	--	1.62	--	1.76	--	1.41	--	1.96
POVERTY LEVEL¹
Less Than 100%	--	0.60	--	0.68	--	0.67	--	0.78	--	0.82
100-199%	--	0.42	--	0.72	--	0.45	--	0.88	--	0.50
200% or More	--	0.25	--	0.55	--	0.27	--	0.67	--	0.28
HEALTH INSURANCE²
Private	--	0.24	--	0.53	--	0.26	--	0.59	--	0.29
Medicaid/CHIP	--	0.49	--	0.50	--	0.58	--	0.81	--	0.68
Other³	--	0.30	--	1.16	--	0.31	--	1.42	--	0.32
No Coverage	--	0.66	--	1.52	--	0.69	--	1.01	--	0.83
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.106C – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	368	--	56	--	368	--	76	--	357
GEOGRAPHIC REGION
Northeast	--	193	--	30	--	194	--	32	--	188
Midwest	--	137	--	20	--	138	--	32	--	133
South	--	215	--	37	--	211	--	50	--	207
West	--	181	--	20	--	180	--	38	--	173
COUNTY TYPE
Large Metro	--	329	--	48	--	323	--	57	--	320
Small Metro	--	172	--	27	--	172	--	49	--	156
Nonmetro	--	111	--	14	--	109	--	30	--	104
Urbanized	--	79	--	10	--	78	--	17	--	76
Less Urbanized	--	70	--	9	--	67	--	24	--	62
Completely Rural	--	38	--	1	--	38	--	1	--	39
POVERTY LEVEL¹
Less Than 100%	--	208	--	24	--	206	--	37	--	203
100-199%	--	143	--	25	--	140	--	40	--	136
200% or More	--	275	--	44	--	275	--	60	--	266
HEALTH INSURANCE²
Private	--	254	--	42	--	251	--	60	--	243
Medicaid/CHIP	--	228	--	36	--	225	--	43	--	221
Other³	--	141	--	9	--	140	--	16	--	139
No Coverage	--	117	--	10	--	118	--	26	--	114
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.106D – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.13	--	0.22	--	0.14	--	0.22	--	0.16
GEOGRAPHIC REGION
Northeast	--	0.39	--	0.74	--	0.42	--	0.53	--	0.47
Midwest	--	0.23	--	0.38	--	0.26	--	0.44	--	0.29
South	--	0.19	--	0.36	--	0.21	--	0.37	--	0.24
West	--	0.27	--	0.33	--	0.29	--	0.46	--	0.32
COUNTY TYPE
Large Metro	--	0.20	--	0.31	--	0.21	--	0.30	--	0.24
Small Metro	--	0.17	--	0.32	--	0.19	--	0.37	--	0.21
Nonmetro	--	0.31	--	0.46	--	0.33	--	0.65	--	0.37
Urbanized	--	0.53	--	0.93	--	0.57	--	0.75	--	0.67
Less Urbanized	--	0.37	--	0.56	--	0.39	--	1.17	--	0.42
Completely Rural	--	1.28	--	0.64	--	1.42	--	0.31	--	1.60
POVERTY LEVEL¹
Less Than 100%	--	0.43	--	0.42	--	0.48	--	0.43	--	0.60
100-199%	--	0.25	--	0.46	--	0.28	--	0.46	--	0.32
200% or More	--	0.14	--	0.29	--	0.16	--	0.33	--	0.17
HEALTH INSURANCE²
Private	--	0.14	--	0.28	--	0.15	--	0.29	--	0.17
Medicaid/CHIP	--	0.37	--	0.34	--	0.45	--	0.47	--	0.54
Other³	--	0.18	--	0.65	--	0.18	--	0.56	--	0.19
No Coverage	--	0.45	--	0.84	--	0.48	--	0.50	--	0.59
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.107C – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	188	231	83	96	69	88
GEOGRAPHIC REGION
Northeast	58	103	33	60	30	56
Midwest	84	119	44	38	28	35
South	122	123	49	43	40	39
West	101	119	41	48	40	46
COUNTY TYPE
Large Metro	149	163	67	68	57	63
Small Metro	98	138	43	54	33	48
Nonmetro	61	96	27	39	21	39
Urbanized	50	54	17	36	10	35
Less Urbanized	35	81	21	16	19	16
Completely Rural	9	3	1	3	*	3
POVERTY LEVEL³
Less Than 100%	89	141	52	69	39	66
100-199%	111	101	45	51	45	48
200% or More	129	150	51	39	41	35
HEALTH INSURANCE⁴
Private	120	135	43	35	32	27
Medicaid/CHIP	110	156	66	81	55	76
Other⁵	124	165	32	39	14	39
No Coverage	46	54	28	27	24	26
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.107D – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	0.07	0.08	0.03	0.03	0.02	0.03
GEOGRAPHIC REGION
Northeast	0.12	0.21	0.07	0.12	0.06	0.11
Midwest	0.14	0.20	0.08	0.06	0.05	0.06
South	0.11	0.11	0.04	0.04	0.04	0.04
West	0.15	0.17	0.06	0.07	0.06	0.07
COUNTY TYPE
Large Metro	0.09	0.10	0.04	0.04	0.04	0.04
Small Metro	0.11	0.14	0.05	0.06	0.04	0.05
Nonmetro	0.16	0.27	0.07	0.11	0.06	0.11
Urbanized	0.32	0.36	0.11	0.25	0.06	0.25
Less Urbanized	0.17	0.44	0.11	0.09	0.10	0.09
Completely Rural	0.29	0.13	0.05	0.09	*	0.09
POVERTY LEVEL³
Less Than 100%	0.19	0.30	0.11	0.15	0.08	0.14
100-199%	0.20	0.18	0.08	0.09	0.08	0.09
200% or More	0.07	0.08	0.03	0.02	0.02	0.02
HEALTH INSURANCE⁴
Private	0.07	0.08	0.03	0.02	0.02	0.02
Medicaid/CHIP	0.18	0.26	0.11	0.14	0.09	0.13
Other⁵	0.15	0.21	0.04	0.05	0.02	0.05
No Coverage	0.19	0.21	0.12	0.11	0.10	0.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.107P – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2023)	Fentanyl Misuse² (2023)	IMF Use (2023)
TOTAL	0.0767	0.8357	0.7846
GEOGRAPHIC REGION
Northeast	0.1490	0.4373	0.5218
Midwest	0.3537	0.3226	0.6338
South	0.6217	0.8103	0.8903
West	0.3670	0.9123	0.9475
COUNTY TYPE
Large Metro	0.7398	0.3804	0.4449
Small Metro	0.0522	0.4692	0.3288
Nonmetro	0.2000	0.8506	0.3843
Urbanized	0.9623	0.8137	0.4291
Less Urbanized	0.0564	0.9257	0.7789
Completely Rural	0.5760	0.5820	*
POVERTY LEVEL³
Less Than 100%	0.0176	0.6677	0.2861
100-199%	0.6805	0.7569	0.9086
200% or More	0.6900	0.1743	0.3889
HEALTH INSURANCE⁴
Private	0.7621	0.1736	0.2835
Medicaid/CHIP	0.0347	0.7675	0.7052
Other⁵	0.0361	0.2925	0.0375
No Coverage	0.9808	0.5613	0.4194
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.108C – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	861	900	47	51	849	890	163	178	829	851
PCP	343	331	14	12	343	330	22	28	343	329
LSD	707	732	33	33	700	725	127	135	681	692
Peyote¹	271	308	6	10	270	307	17	18	269	306
Mescaline¹	340	365	5	9	338	364	21	18	336	362
Psilocybin	--	747	--	46	--	744	--	158	--	711
Ecstasy	579	558	22	24	576	556	106	106	567	537
Ketamine	271	289	13	19	270	288	55	56	260	287
DMT, AMT, or 5-MeO-DIPT/Foxy	228	236	14	13	226	237	62	46	219	230
Salvia divinorum	254	269	11	8	253	268	38	40	251	266
INHALANTS²	--	650	--	115	--	633	--	129	--	624
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	--	443	--	21	--	440	--	67	--	437
Correction Fluid, Degreaser, or Cleaning Fluid¹	--	160	--	30	--	157	--	32	--	153
Gasoline or Lighter Fluid¹	--	207	--	67	--	196	--	52	--	188
Glue, Shoe Polish, or Toluene^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Halothane, Ether, or Other Anesthetics¹	--	133	--	10	--	133	--	12	--	133
Lacquer Thinner or Other Paint Solvents¹	--	115	--	29	--	113	--	29	--	110
Lighter Gases¹	--	75	--	22	--	72	--	33	--	65
Nitrous Oxide or Whippits¹	--	498	--	25	--	493	--	78	--	479
Felt-Tip Pens or Felt-Tip/Magic Markers^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Spray Paints¹	--	142	--	47	--	133	--	44	--	126
Computer Cleaner/Air Duster¹	--	174	--	29	--	172	--	39	--	165
Other Aerosol Sprays¹	--	204	--	31	--	200	--	38	--	196
NEEDLE USE^1,4	308	311	11	14	307	310	24	38	307	310
Heroin Needle Use¹	241	215	9	1	240	215	14	20	240	214
Cocaine Needle Use¹	252	203	4	1	253	203	8	17	253	202
Methamphetamine Needle Use¹	220	225	4	3	221	225	14	20	222	224
Illegally Made Fentanyl Needle Use^1,4	56	99	4	12	55	99	13	20	54	97
HEROIN	329	324	10	10	328	324	31	27	327	320
Smoke Heroin¹	211	199	9	9	210	199	19	25	210	196
Sniff or Snort Heroin¹	249	298	9	10	250	297	30	20	248	296
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ The 2024 estimates are not reported because of changes made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.108D – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	0.30	0.31	0.18	0.20	0.33	0.34	0.48	0.51	0.37	0.37
PCP	0.12	0.11	0.05	0.05	0.13	0.13	0.06	0.08	0.15	0.14
LSD	0.25	0.25	0.13	0.13	0.27	0.28	0.37	0.39	0.30	0.30
Peyote¹	0.10	0.11	0.02	0.04	0.10	0.12	0.05	0.05	0.12	0.13
Mescaline¹	0.12	0.13	0.02	0.03	0.13	0.14	0.06	0.05	0.15	0.16
Psilocybin	--	0.26	--	0.18	--	0.28	--	0.45	--	0.31
Ecstasy	0.20	0.19	0.08	0.09	0.22	0.21	0.31	0.30	0.25	0.24
Ketamine	0.10	0.10	0.05	0.07	0.10	0.11	0.16	0.16	0.12	0.13
DMT, AMT, or 5-MeO-DIPT/Foxy	0.08	0.08	0.05	0.05	0.09	0.09	0.18	0.13	0.10	0.10
Salvia divinorum	0.09	0.09	0.04	0.03	0.10	0.10	0.11	0.11	0.11	0.12
INHALANTS²	--	0.23	--	0.44	--	0.24	--	0.37	--	0.27
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	--	0.15	--	0.08	--	0.17	--	0.19	--	0.19
Correction Fluid, Degreaser, or Cleaning Fluid¹	--	0.06	--	0.12	--	0.06	--	0.09	--	0.07
Gasoline or Lighter Fluid¹	--	0.07	--	0.26	--	0.07	--	0.15	--	0.08
Glue, Shoe Polish, or Toluene^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Halothane, Ether, or Other Anesthetics¹	--	0.05	--	0.04	--	0.05	--	0.03	--	0.06
Lacquer Thinner or Other Paint Solvents¹	--	0.04	--	0.11	--	0.04	--	0.08	--	0.05
Lighter Gases¹	--	0.03	--	0.08	--	0.03	--	0.09	--	0.03
Nitrous Oxide or Whippits¹	--	0.17	--	0.10	--	0.19	--	0.22	--	0.21
Felt-Tip Pens or Felt-Tip/Magic Markers^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Spray Paints¹	--	0.05	--	0.18	--	0.05	--	0.13	--	0.06
Computer Cleaner/Air Duster¹	--	0.06	--	0.11	--	0.07	--	0.11	--	0.07
Other Aerosol Sprays¹	--	0.07	--	0.12	--	0.08	--	0.11	--	0.09
NEEDLE USE^1,4	0.11	0.11	0.04	0.05	0.12	0.12	0.07	0.11	0.14	0.14
Heroin Needle Use¹	0.09	0.07	0.03	<0.01	0.09	0.08	0.04	0.06	0.11	0.09
Cocaine Needle Use¹	0.09	0.07	0.02	<0.01	0.10	0.08	0.02	0.05	0.11	0.09
Methamphetamine Needle Use¹	0.08	0.08	0.02	0.01	0.09	0.09	0.04	0.06	0.10	0.10
Illegally Made Fentanyl Needle Use^1,4	0.02	0.03	0.01	0.05	0.02	0.04	0.04	0.06	0.02	0.04
HEROIN	0.12	0.11	0.04	0.04	0.13	0.12	0.09	0.08	0.15	0.14
Smoke Heroin¹	0.07	0.07	0.03	0.04	0.08	0.08	0.06	0.07	0.09	0.09
Sniff or Snort Heroin¹	0.09	0.10	0.03	0.04	0.10	0.11	0.09	0.06	0.11	0.13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ The 2024 estimates are not reported because of changes made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.108P – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug or Method of Administration	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
HALLUCINOGENS	0.0625	0.3054	0.0756	0.3072	0.1045
PCP	0.7454	0.7776	0.7395	0.6843	0.7255
LSD	0.8627	0.5384	0.8717	0.1530	0.6566
Peyote¹	0.3310	0.3910	0.3494	0.4298	0.3199
Mescaline¹	0.5104	0.4364	0.5323	0.0833	0.4584
Psilocybin	--	--	--	--	--
Ecstasy	0.4420	0.9091	0.4181	0.0615	0.6648
Ketamine	0.1295	0.2180	0.1529	0.2719	0.0963
DMT, AMT, or 5-MeO-DIPT/Foxy	0.9087	0.6357	0.9158	0.0294	0.6621
Salvia divinorum	0.3204	0.7493	0.3233	0.2707	0.2412
INHALANTS²	--	--	--	--	--
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	--	--	--	--	--
Correction Fluid, Degreaser, or Cleaning Fluid¹	--	--	--	--	--
Gasoline or Lighter Fluid¹	--	--	--	--	--
Glue, Shoe Polish, or Toluene^1,3	--	--	--	--	--
Halothane, Ether, or Other Anesthetics¹	--	--	--	--	--
Lacquer Thinner or Other Paint Solvents¹	--	--	--	--	--
Lighter Gases¹	--	--	--	--	--
Nitrous Oxide or Whippits¹	--	--	--	--	--
Felt-Tip Pens or Felt-Tip/Magic Markers^1,3	--	--	--	--	--
Spray Paints¹	--	--	--	--	--
Computer Cleaner/Air Duster¹	--	--	--	--	--
Other Aerosol Sprays¹	--	--	--	--	--
NEEDLE USE^1,4	0.1669	0.8027	0.1692	0.1960	0.2128
Heroin Needle Use¹	0.8031	0.1656	0.7840	0.6284	0.8039
Cocaine Needle Use¹	0.4730	0.4398	0.4747	0.3588	0.5027
Methamphetamine Needle Use¹	0.2506	0.9869	0.2575	0.7007	0.2686
Illegally Made Fentanyl Needle Use^1,4	0.0002	0.5416	0.0002	0.3998	0.0003
HEROIN	0.6597	0.7876	0.6808	0.2222	0.5890
Smoke Heroin¹	0.4825	0.8942	0.4940	0.8404	0.5006
Sniff or Snort Heroin¹	0.1365	0.9083	0.1421	0.0333	0.0895
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ The 2024 estimates are not reported because of changes made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ The estimates that are used in these comparisons exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.109C – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	294	388	41	43	289	385	111	117	263	370
PCP	45	27	12	1	44	27	1	10	44	25
LSD	126	138	26	24	124	139	47	46	110	129
Psilocybin	--	328	--	37	--	325	--	106	--	308
Ecstasy	170	136	17	16	169	134	60	49	152	124
Ketamine	101	134	11	9	102	134	30	35	95	131
DMT, AMT, or 5-MeO-DIPT/Foxy	83	79	13	8	82	77	25	14	79	76
Salvia divinorum	24	24	5	8	23	22	10	4	21	22
INHALANTS¹	--	163	--	67	--	147	--	60	--	133
NEEDLE USE^2,3	110	125	9	12	109	124	9	28	109	121
Heroin Needle Use²	84	63	8	<1	83	63	2	7	83	62
Cocaine Needle Use²	33	44	4	<1	33	44	2	6	32	44
Methamphetamine Needle Use²	80	89	4	3	80	89	6	12	79	88
Illegally Made Fentanyl Needle Use^2,3	39	61	3	12	39	59	6	18	39	57
HEROIN	84	86	4	6	84	86	8	14	84	85
Smoke Heroin²	42	88	4	4	42	88	6	13	41	87
Sniff or Snort Heroin²	71	57	8	6	71	56	9	9	70	57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents with unknown specific drug information were excluded from the respective analyses. ³ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.109D – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Standard Errors of Percentages, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	0.10	0.13	0.16	0.16	0.11	0.15	0.33	0.33	0.12	0.16
PCP	0.02	0.01	0.05	<0.01	0.02	0.01	<0.01	0.03	0.02	0.01
LSD	0.04	0.05	0.10	0.09	0.05	0.05	0.14	0.13	0.05	0.06
Psilocybin	--	0.11	--	0.14	--	0.12	--	0.30	--	0.14
Ecstasy	0.06	0.05	0.06	0.06	0.07	0.05	0.18	0.14	0.07	0.05
Ketamine	0.04	0.05	0.04	0.04	0.04	0.05	0.09	0.10	0.04	0.06
DMT, AMT, or 5-MeO-DIPT/Foxy	0.03	0.03	0.05	0.03	0.03	0.03	0.07	0.04	0.04	0.03
Salvia divinorum	0.01	0.01	0.02	0.03	0.01	0.01	0.03	0.01	0.01	0.01
INHALANTS¹	--	0.06	--	0.26	--	0.06	--	0.17	--	0.06
NEEDLE USE^2,3	0.04	0.04	0.03	0.05	0.04	0.05	0.03	0.08	0.05	0.05
Heroin Needle Use²	0.03	0.02	0.03	<0.01	0.03	0.02	0.01	0.02	0.04	0.03
Cocaine Needle Use²	0.01	0.02	0.02	<0.01	0.01	0.02	0.01	0.02	0.01	0.02
Methamphetamine Needle Use²	0.03	0.03	0.02	0.01	0.03	0.03	0.02	0.03	0.04	0.04
Illegally Made Fentanyl Needle Use^2,3	0.01	0.02	0.01	0.05	0.02	0.02	0.02	0.05	0.02	0.02
HEROIN	0.03	0.03	0.02	0.02	0.03	0.03	0.02	0.04	0.04	0.04
Smoke Heroin²	0.01	0.03	0.02	0.02	0.02	0.03	0.02	0.04	0.02	0.04
Sniff or Snort Heroin²	0.03	0.02	0.03	0.02	0.03	0.02	0.03	0.03	0.03	0.02
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents with unknown specific drug information were excluded from the respective analyses. ³ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.109P – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2024 Versus 2023
Drug or Method of Administration	Aged 12+ (2023)	Aged 12-17 (2023)	Aged 18+ (2023)	Aged 18-25 (2023)	Aged 26+ (2023)
HALLUCINOGENS	0.0020	0.7584	0.0021	0.8694	0.0015
PCP	0.4922	0.0752	0.7899	0.0105	0.4507
LSD	0.5376	0.3770	0.6573	0.0235	0.6643
Psilocybin	--	--	--	--	--
Ecstasy	0.4286	0.4279	0.4653	0.0946	0.8732
Ketamine	0.0605	0.8398	0.0583	0.7012	0.0368
DMT, AMT, or 5-MeO-DIPT/Foxy	0.3027	0.2382	0.3706	0.2280	0.5394
Salvia divinorum	0.3867	0.4368	0.2588	0.1372	0.5130
INHALANTS¹	--	--	--	--	--
NEEDLE USE^2,3	0.3621	0.9790	0.3652	0.0095	0.6502
Heroin Needle Use²	0.2062	0.1832	0.2437	0.0894	0.1978
Cocaine Needle Use²	0.7538	0.3432	0.7025	0.1813	0.8173
Methamphetamine Needle Use²	0.7660	0.8788	0.7659	0.1896	0.8753
Illegally Made Fentanyl Needle Use^2,3	0.2628	0.4703	0.3129	0.1191	0.5364
HEROIN	0.3138	0.3907	0.2844	0.1509	0.1994
Smoke Heroin²	0.2032	0.9476	0.2047	0.0711	0.3088
Sniff or Snort Heroin²	0.3572	0.7880	0.3684	0.8703	0.3536
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents with unknown specific drug information were excluded from the respective analyses. ³ The estimates that are used in these comparisons exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.110C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	843	913	324	312	0.50	0.47
Hydrocodone Products¹	661	724	227	206	0.65	0.58
Oxycodone Products¹	558	597	183	181	0.81	0.80
OxyContin^®	346	394	126	147	1.51	1.57
Tramadol Products¹	482	491	151	121	0.95	0.78
Codeine Products¹	542	549	146	143	0.74	0.71
Morphine Products¹	303	284	49	52	0.98	0.90
Prescription Fentanyl Products²	183	221	68	67	2.40	2.14
Buprenorphine Products¹	202	229	94	98	2.81	2.48
Oxymorphone Products¹	90	132	34	20	4.14	2.17
Demerol^®1	85	152	40	11	*	1.27
Hydromorphone Products¹	170	150	76	22	4.42	1.33
Methadone¹	147	135	46	67	3.10	4.57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.110D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	0.30	0.32	0.11	0.11	0.50	0.47
Hydrocodone Products¹	0.23	0.25	0.08	0.07	0.65	0.58
Oxycodone Products¹	0.20	0.21	0.06	0.06	0.81	0.80
OxyContin^®	0.12	0.14	0.04	0.05	1.51	1.57
Tramadol Products¹	0.17	0.17	0.05	0.04	0.95	0.78
Codeine Products¹	0.19	0.19	0.05	0.05	0.74	0.71
Morphine Products¹	0.11	0.10	0.02	0.02	0.98	0.90
Prescription Fentanyl Products²	0.06	0.08	0.02	0.02	2.40	2.14
Buprenorphine Products¹	0.07	0.08	0.03	0.03	2.81	2.48
Oxymorphone Products¹	0.03	0.05	0.01	0.01	4.14	2.17
Demerol^®1	0.03	0.05	0.01	<0.01	*	1.27
Hydromorphone Products¹	0.06	0.05	0.03	0.01	4.42	1.33
Methadone¹	0.05	0.05	0.02	0.02	3.10	4.57
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.110P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Prescription Opioid Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)
ANY PRESCRIPTION OPIOID	0.2751	0.0779	0.0238
Hydrocodone Products¹	0.7785	0.3656	0.3023
Oxycodone Products¹	0.4259	0.0373	0.0140
OxyContin^®	0.1466	0.4823	0.2098
Tramadol Products¹	0.8755	0.4140	0.4228
Codeine Products¹	0.7798	0.7543	0.8361
Morphine Products¹	0.0535	0.9268	0.5914
Prescription Fentanyl Products²	0.1159	0.3065	0.0682
Buprenorphine Products¹	0.1379	0.3215	0.7179
Oxymorphone Products¹	0.2950	0.0955	0.0293
Demerol^®1	0.0124	0.1993	*
Hydromorphone Products¹	0.5809	0.1091	0.0632
Methadone¹	0.4743	0.9559	0.7231
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.111C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	102	110	50	39	1.68	1.25
Hydrocodone Products¹	53	55	18	21	2.56	2.89
Oxycodone Products¹	44	56	20	24	3.43	3.24
OxyContin^®	28	32	13	17	*	*
Tramadol Products¹	39	39	5	16	2.00	4.36
Codeine Products¹	78	76	37	28	2.34	1.79
Morphine Products¹	33	28	11	5	*	*
Prescription Fentanyl Products²	23	22	11	3	*	*
Buprenorphine Products¹	20	19	7	12	*	*
Oxymorphone Products¹	13	10	8	4	*	*
Demerol^®1	9	7	*	3	*	*
Hydromorphone Products¹	4	12	2	1	*	*
Methadone¹	12	8	8	4	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.111D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	0.39	0.42	0.19	0.15	1.68	1.25
Hydrocodone Products¹	0.21	0.22	0.07	0.08	2.56	2.89
Oxycodone Products¹	0.17	0.22	0.08	0.09	3.43	3.24
OxyContin^®	0.11	0.12	0.05	0.06	*	*
Tramadol Products¹	0.15	0.15	0.02	0.06	2.00	4.36
Codeine Products¹	0.30	0.30	0.14	0.11	2.34	1.79
Morphine Products¹	0.13	0.11	0.04	0.02	*	*
Prescription Fentanyl Products²	0.09	0.09	0.04	0.01	*	*
Buprenorphine Products¹	0.08	0.07	0.03	0.05	*	*
Oxymorphone Products¹	0.05	0.04	0.03	0.01	*	*
Demerol^®1	0.03	0.03	*	0.01	*	*
Hydromorphone Products¹	0.01	0.05	0.01	<0.01	*	*
Methadone¹	0.05	0.03	0.03	0.01	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.111P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Prescription Opioid Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)
ANY PRESCRIPTION OPIOID	0.0364	0.0659	0.0065
Hydrocodone Products¹	0.3761	0.6015	0.7946
Oxycodone Products¹	0.1352	0.9411	0.5518
OxyContin^®	0.5447	0.9452	*
Tramadol Products¹	0.4079	0.0511	0.0564
Codeine Products¹	0.8070	0.3058	0.2236
Morphine Products¹	0.8210	0.1282	*
Prescription Fentanyl Products²	0.4452	0.0616	*
Buprenorphine Products¹	0.8757	0.5996	*
Oxymorphone Products¹	0.9104	0.2781	*
Demerol^®1	0.4030	*	*
Hydromorphone Products¹	0.0932	0.2258	*
Methadone¹	0.2567	0.3121	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.112C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	829	901	324	309	0.53	0.49
Hydrocodone Products¹	658	714	226	205	0.66	0.59
Oxycodone Products¹	553	591	184	180	0.84	0.83
OxyContin^®	343	392	125	146	1.54	1.61
Tramadol Products¹	478	488	151	120	0.97	0.79
Codeine Products¹	533	541	139	138	0.76	0.74
Morphine Products¹	299	283	47	52	1.01	0.93
Prescription Fentanyl Products²	182	219	67	67	2.51	2.22
Buprenorphine Products¹	201	227	94	97	2.87	2.51
Oxymorphone Products¹	89	132	33	19	4.28	2.22
Demerol^®1	82	151	40	11	*	1.23
Hydromorphone Products¹	170	149	76	22	4.45	1.35
Methadone¹	147	135	46	67	3.14	4.62
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.112D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	0.32	0.34	0.13	0.12	0.53	0.49
Hydrocodone Products¹	0.26	0.27	0.09	0.08	0.66	0.59
Oxycodone Products¹	0.22	0.23	0.07	0.07	0.84	0.83
OxyContin^®	0.13	0.15	0.05	0.06	1.54	1.61
Tramadol Products¹	0.19	0.19	0.06	0.05	0.97	0.79
Codeine Products¹	0.21	0.21	0.05	0.05	0.76	0.74
Morphine Products¹	0.12	0.11	0.02	0.02	1.01	0.93
Prescription Fentanyl Products²	0.07	0.08	0.03	0.03	2.51	2.22
Buprenorphine Products¹	0.08	0.09	0.04	0.04	2.87	2.51
Oxymorphone Products¹	0.03	0.05	0.01	0.01	4.28	2.22
Demerol^®1	0.03	0.06	0.02	<0.01	*	1.23
Hydromorphone Products¹	0.07	0.06	0.03	0.01	4.45	1.35
Methadone¹	0.06	0.05	0.02	0.03	3.14	4.62
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.112P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Prescription Opioid Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)
ANY PRESCRIPTION OPIOID	0.4234	0.1320	0.0622
Hydrocodone Products¹	0.8680	0.3319	0.2896
Oxycodone Products¹	0.5171	0.0351	0.0156
OxyContin^®	0.1628	0.4732	0.2148
Tramadol Products¹	0.8047	0.3206	0.3359
Codeine Products¹	0.7417	0.9400	0.9641
Morphine Products¹	0.0500	0.7124	0.8076
Prescription Fentanyl Products²	0.0969	0.4235	0.1013
Buprenorphine Products¹	0.1354	0.3486	0.7691
Oxymorphone Products¹	0.2886	0.1443	0.0512
Demerol^®1	0.0097	0.1722	*
Hydromorphone Products¹	0.6552	0.1151	0.0704
Methadone¹	0.5246	0.8684	0.6614
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.113C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	150	155	59	82	1.13	1.55
Hydrocodone Products¹	110	111	41	47	1.65	1.97
Oxycodone Products¹	99	86	40	42	1.96	2.41
OxyContin^®	58	54	25	24	3.21	3.59
Tramadol Products¹	72	68	27	36	2.92	3.95
Codeine Products¹	97	85	39	51	2.03	2.81
Morphine Products¹	52	56	7	7	1.37	1.34
Prescription Fentanyl Products²	35	33	15	15	5.04	5.51
Buprenorphine Products¹	30	24	12	13	5.72	*
Oxymorphone Products¹	20	20	13	7	*	*
Demerol^®1	6	8	*	3	*	*
Hydromorphone Products¹	16	20	7	3	*	*
Methadone¹	19	18	12	2	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.113D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	0.44	0.44	0.17	0.23	1.13	1.55
Hydrocodone Products¹	0.32	0.32	0.12	0.13	1.65	1.97
Oxycodone Products¹	0.29	0.25	0.12	0.12	1.96	2.41
OxyContin^®	0.17	0.16	0.07	0.07	3.21	3.59
Tramadol Products¹	0.21	0.19	0.08	0.10	2.92	3.95
Codeine Products¹	0.29	0.24	0.12	0.15	2.03	2.81
Morphine Products¹	0.15	0.16	0.02	0.02	1.37	1.34
Prescription Fentanyl Products²	0.10	0.09	0.05	0.04	5.04	5.51
Buprenorphine Products¹	0.09	0.07	0.04	0.04	5.72	*
Oxymorphone Products¹	0.06	0.06	0.04	0.02	*	*
Demerol^®1	0.02	0.02	*	0.01	*	*
Hydromorphone Products¹	0.05	0.06	0.02	0.01	*	*
Methadone¹	0.05	0.05	0.03	0.01	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.113P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Prescription Opioid Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)
ANY PRESCRIPTION OPIOID	0.1945	0.4572	0.1744
Hydrocodone Products¹	0.0468	0.8589	0.3256
Oxycodone Products¹	0.0419	0.7163	0.5031
OxyContin^®	0.2031	0.3088	0.6335
Tramadol Products¹	0.1200	0.7401	0.2975
Codeine Products¹	0.1508	0.5470	0.2017
Morphine Products¹	0.6163	0.7516	0.8767
Prescription Fentanyl Products²	0.3013	0.4897	0.8449
Buprenorphine Products¹	0.1377	0.6912	*
Oxymorphone Products¹	0.3680	0.1627	*
Demerol^®1	0.7273	*	*
Hydromorphone Products¹	0.5602	0.6418	*
Methadone¹	0.5365	0.1080	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.114C – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	817	877	314	295	0.56	0.51
Hydrocodone Products¹	652	698	222	202	0.70	0.62
Oxycodone Products¹	544	579	178	174	0.90	0.86
OxyContin^®	335	389	122	144	1.67	1.73
Tramadol Products¹	471	482	149	115	1.01	0.80
Codeine Products¹	527	538	135	126	0.81	0.75
Morphine Products¹	288	277	47	52	1.12	1.02
Prescription Fentanyl Products²	175	217	65	65	2.77	2.34
Buprenorphine Products¹	198	226	93	96	3.05	2.61
Oxymorphone Products¹	87	130	30	18	4.66	2.32
Demerol^®1	82	151	40	10	*	1.19
Hydromorphone Products¹	168	148	74	22	4.52	1.40
Methadone¹	146	134	44	67	3.23	4.87
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.114D – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Standard Errors of Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	0.37	0.39	0.14	0.13	0.56	0.51
Hydrocodone Products¹	0.29	0.31	0.10	0.09	0.70	0.62
Oxycodone Products¹	0.24	0.26	0.08	0.08	0.90	0.86
OxyContin^®	0.15	0.17	0.05	0.06	1.67	1.73
Tramadol Products¹	0.21	0.21	0.07	0.05	1.01	0.80
Codeine Products¹	0.24	0.24	0.06	0.06	0.81	0.75
Morphine Products¹	0.13	0.12	0.02	0.02	1.12	1.02
Prescription Fentanyl Products²	0.08	0.10	0.03	0.03	2.77	2.34
Buprenorphine Products¹	0.09	0.10	0.04	0.04	3.05	2.61
Oxymorphone Products¹	0.04	0.06	0.01	0.01	4.66	2.32
Demerol^®1	0.04	0.07	0.02	<0.01	*	1.19
Hydromorphone Products¹	0.08	0.07	0.03	0.01	4.52	1.40
Methadone¹	0.07	0.06	0.02	0.03	3.23	4.87
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.114P – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Prescription Opioid Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)
ANY PRESCRIPTION OPIOID	0.2749	0.0867	0.0306
Hydrocodone Products¹	0.5977	0.3112	0.2244
Oxycodone Products¹	0.3181	0.0370	0.0126
OxyContin^®	0.1055	0.5886	0.2809
Tramadol Products¹	0.9948	0.2742	0.2526
Codeine Products¹	0.9443	0.7642	0.7821
Morphine Products¹	0.0542	0.7426	0.7833
Prescription Fentanyl Products²	0.0638	0.5051	0.1156
Buprenorphine Products¹	0.0886	0.3179	0.7918
Oxymorphone Products¹	0.2116	0.3174	0.1346
Demerol^®1	0.0101	0.1432	*
Hydromorphone Products¹	0.6967	0.1154	0.0733
Methadone¹	0.5803	0.6787	0.5028
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.115C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	467	466	193	209	0.87	0.88
Amphetamines or Methylphenidate Products¹	404	406	189	185	1.02	0.97
Amphetamines¹	382	373	188	175	1.17	1.07
Methylphenidate Products¹	206	202	49	73	1.16	1.58
Anorectic (Weight-Loss) Stimulants¹	211	180	36	36	1.23	1.27
Provigil^®1	65	76	23	23	*	*
Any Other Prescription Stimulant^1,2	180	185	20	79	0.76	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.115D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	0.16	0.16	0.07	0.07	0.87	0.88
Amphetamines or Methylphenidate Products¹	0.14	0.14	0.07	0.06	1.02	0.97
Amphetamines¹	0.13	0.13	0.07	0.06	1.17	1.07
Methylphenidate Products¹	0.07	0.07	0.02	0.03	1.16	1.58
Anorectic (Weight-Loss) Stimulants¹	0.07	0.06	0.01	0.01	1.23	1.27
Provigil^®1	0.02	0.03	0.01	0.01	*	*
Any Other Prescription Stimulant^1,2	0.06	0.06	0.01	0.03	0.76	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.115P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Stimulant Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	0.5938	0.7588	0.5356
Amphetamines or Methylphenidate Products¹	0.4043	0.6332	0.2981
Amphetamines¹	0.6741	0.3125	0.1525
Methylphenidate Products¹	0.9704	0.0898	0.0767
Anorectic (Weight-Loss) Stimulants¹	0.5683	0.7895	0.9298
Provigil^®1	0.3737	0.6351	*
Any Other Prescription Stimulant^1,2	0.1647	0.4516	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.116C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	89	89	32	31	1.62	1.52
Amphetamines or Methylphenidate Products¹	83	85	26	31	1.50	1.68
Amphetamines¹	68	74	22	26	1.81	2.12
Methylphenidate Products¹	57	64	14	21	2.05	2.60
Anorectic (Weight-Loss) Stimulants¹	17	21	8	11	*	*
Provigil^®1	6	5	1	*	*	*
Any Other Prescription Stimulant^1,2	36	35	17	2	*	0.65
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.116D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	0.34	0.34	0.12	0.12	1.62	1.52
Amphetamines or Methylphenidate Products¹	0.32	0.33	0.10	0.12	1.50	1.68
Amphetamines¹	0.26	0.29	0.09	0.10	1.81	2.12
Methylphenidate Products¹	0.22	0.25	0.05	0.08	2.05	2.60
Anorectic (Weight-Loss) Stimulants¹	0.06	0.08	0.03	0.04	*	*
Provigil^®1	0.02	0.02	<0.01	*	*	*
Any Other Prescription Stimulant^1,2	0.14	0.14	0.07	0.01	*	0.65
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.116P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Stimulant Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	0.8733	0.5309	0.4624
Amphetamines or Methylphenidate Products¹	0.7872	0.7519	0.8201
Amphetamines¹	0.4934	0.9060	0.6696
Methylphenidate Products¹	0.3784	0.3513	0.4672
Anorectic (Weight-Loss) Stimulants¹	0.8979	0.8594	*
Provigil^®1	0.5123	*	*
Any Other Prescription Stimulant^1,2	0.9325	0.2065	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.117C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	453	455	190	206	0.96	0.94
Amphetamines or Methylphenidate Products¹	393	396	188	182	1.14	1.04
Amphetamines¹	372	362	188	173	1.28	1.15
Methylphenidate Products¹	192	193	46	69	1.29	1.80
Anorectic (Weight-Loss) Stimulants¹	208	176	35	35	1.23	1.25
Provigil^®1	65	76	23	23	*	*
Any Other Prescription Stimulant^1,2	178	180	11	79	0.47	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.117D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	0.18	0.17	0.07	0.08	0.96	0.94
Amphetamines or Methylphenidate Products¹	0.15	0.15	0.07	0.07	1.14	1.04
Amphetamines¹	0.14	0.14	0.07	0.07	1.28	1.15
Methylphenidate Products¹	0.07	0.07	0.02	0.03	1.29	1.80
Anorectic (Weight-Loss) Stimulants¹	0.08	0.07	0.01	0.01	1.23	1.25
Provigil^®1	0.03	0.03	0.01	0.01	*	*
Any Other Prescription Stimulant^1,2	0.07	0.07	<0.01	0.03	0.47	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.117P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Stimulant Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	0.6068	0.8241	0.6024
Amphetamines or Methylphenidate Products¹	0.4223	0.5896	0.2647
Amphetamines¹	0.5737	0.2963	0.1187
Methylphenidate Products¹	0.8117	0.1311	0.0892
Anorectic (Weight-Loss) Stimulants¹	0.5468	0.7441	0.8838
Provigil^®1	0.3486	0.6471	*
Any Other Prescription Stimulant^1,2	0.1619	0.2939	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.118C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	150	150	79	73	1.80	1.68
Amphetamines or Methylphenidate Products¹	144	143	78	72	1.94	1.80
Amphetamines¹	135	126	78	70	2.20	2.02
Methylphenidate Products¹	76	75	18	26	1.87	2.45
Anorectic (Weight-Loss) Stimulants¹	28	25	14	9	*	*
Provigil^®1	3	21	3	1	*	*
Any Other Prescription Stimulant^1,2	47	49	4	3	1.00	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.118D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	0.44	0.43	0.23	0.21	1.80	1.68
Amphetamines or Methylphenidate Products¹	0.42	0.41	0.23	0.21	1.94	1.80
Amphetamines¹	0.40	0.36	0.23	0.20	2.20	2.02
Methylphenidate Products¹	0.22	0.22	0.05	0.08	1.87	2.45
Anorectic (Weight-Loss) Stimulants¹	0.08	0.07	0.04	0.03	*	*
Provigil^®1	0.01	0.06	0.01	<0.01	*	*
Any Other Prescription Stimulant^1,2	0.14	0.14	0.01	0.01	1.00	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.118P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Stimulant Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	0.5848	0.2681	0.3331
Amphetamines or Methylphenidate Products¹	0.3568	0.3059	0.5564
Amphetamines¹	0.1214	0.2005	0.6766
Methylphenidate Products¹	0.6925	0.1805	0.2140
Anorectic (Weight-Loss) Stimulants¹	0.5106	0.5208	*
Provigil^®1	0.0120	0.5311	*
Any Other Prescription Stimulant^1,2	0.2814	0.4434	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.119C – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	416	438	170	193	1.08	1.11
Amphetamines or Methylphenidate Products¹	345	379	167	168	1.36	1.25
Amphetamines¹	330	349	165	159	1.50	1.36
Methylphenidate Products¹	178	168	42	63	1.62	2.32
Anorectic (Weight-Loss) Stimulants¹	206	175	32	34	1.22	1.29
Provigil^®1	65	73	23	23	*	*
Any Other Prescription Stimulant^1,2	172	174	10	79	0.52	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.119D – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Standard Errors of Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	0.19	0.19	0.08	0.08	1.08	1.11
Amphetamines or Methylphenidate Products¹	0.15	0.17	0.07	0.07	1.36	1.25
Amphetamines¹	0.15	0.15	0.07	0.07	1.50	1.36
Methylphenidate Products¹	0.08	0.07	0.02	0.03	1.62	2.32
Anorectic (Weight-Loss) Stimulants¹	0.09	0.08	0.01	0.01	1.22	1.29
Provigil^®1	0.03	0.03	0.01	0.01	*	*
Any Other Prescription Stimulant^1,2	0.08	0.08	<0.01	0.03	0.52	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.119P – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Stimulant Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)
ANY PRESCRIPTION STIMULANT	0.4718	0.8425	0.9024
Amphetamines or Methylphenidate Products¹	0.2229	0.8743	0.3709
Amphetamines¹	0.2264	0.5487	0.1562
Methylphenidate Products¹	0.6436	0.2773	0.1885
Anorectic (Weight-Loss) Stimulants¹	0.6085	0.9089	0.9813
Provigil^®1	0.6710	0.6952	*
Any Other Prescription Stimulant^1,2	0.2389	0.2698	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.120C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	652	630	225	221	0.66	0.67
Benzodiazepine Tranquilizers¹	549	563	209	204	0.84	0.84
Alprazolam Products¹	427	418	175	148	1.23	1.15
Lorazepam Products¹	264	315	76	73	1.15	1.10
Clonazepam Products¹	273	289	102	116	1.74	1.92
Diazepam Products¹	233	259	61	86	1.41	1.69
Muscle Relaxants¹	313	327	89	85	1.21	1.09
Cyclobenzaprine¹	300	306	68	84	1.02	1.17
Soma^®1	96	101	52	11	*	1.71
Any Other Prescription Tranquilizer^1,2	274	265	27	46	0.49	1.00
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.120D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	0.23	0.22	0.08	0.08	0.66	0.67
Benzodiazepine Tranquilizers¹	0.19	0.20	0.07	0.07	0.84	0.84
Alprazolam Products¹	0.15	0.15	0.06	0.05	1.23	1.15
Lorazepam Products¹	0.09	0.11	0.03	0.03	1.15	1.10
Clonazepam Products¹	0.10	0.10	0.04	0.04	1.74	1.92
Diazepam Products¹	0.08	0.09	0.02	0.03	1.41	1.69
Muscle Relaxants¹	0.11	0.11	0.03	0.03	1.21	1.09
Cyclobenzaprine¹	0.11	0.11	0.02	0.03	1.02	1.17
Soma^®1	0.03	0.04	0.02	<0.01	*	1.71
Any Other Prescription Tranquilizer^1,2	0.10	0.09	0.01	0.02	0.49	1.00
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.120P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Tranquilizer Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	0.6118	0.4557	0.5577
Benzodiazepine Tranquilizers¹	0.9182	0.2442	0.2321
Alprazolam Products¹	0.3529	0.0805	0.1490
Lorazepam Products¹	0.8664	0.4438	0.4658
Clonazepam Products¹	0.5971	0.8353	0.9964
Diazepam Products¹	0.1726	0.0603	0.1415
Muscle Relaxants¹	0.4799	0.5565	0.4022
Cyclobenzaprine¹	0.6005	0.8500	0.9709
Soma^®1	0.9173	0.0208	*
Any Other Prescription Tranquilizer^1,2	0.0059	0.5829	0.3473
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.121C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	62	46	18	23	2.53	3.71
Benzodiazepine Tranquilizers¹	37	39	18	20	4.18	4.81
Alprazolam Products¹	31	32	16	18	5.21	6.02
Lorazepam Products¹	17	20	11	13	*	*
Clonazepam Products¹	21	18	7	12	*	*
Diazepam Products¹	17	20	6	11	*	*
Muscle Relaxants¹	12	11	6	4	*	*
Cyclobenzaprine¹	10	10	6	4	*	*
Soma^®1	6	7	1	<1	*	*
Any Other Prescription Tranquilizer^1,2	49	25	6	2	*	1.31
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.121D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	0.24	0.18	0.07	0.09	2.53	3.71
Benzodiazepine Tranquilizers¹	0.14	0.15	0.07	0.08	4.18	4.81
Alprazolam Products¹	0.12	0.12	0.06	0.07	5.21	6.02
Lorazepam Products¹	0.07	0.08	0.04	0.05	*	*
Clonazepam Products¹	0.08	0.07	0.03	0.05	*	*
Diazepam Products¹	0.07	0.08	0.02	0.04	*	*
Muscle Relaxants¹	0.05	0.04	0.02	0.01	*	*
Cyclobenzaprine¹	0.04	0.04	0.02	0.01	*	*
Soma^®1	0.02	0.03	<0.01	<0.01	*	*
Any Other Prescription Tranquilizer^1,2	0.19	0.09	0.02	0.01	*	1.31
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.121P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Tranquilizer Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	0.0033	0.8285	0.0411
Benzodiazepine Tranquilizers¹	0.1734	0.5877	0.7357
Alprazolam Products¹	0.3397	0.5621	0.9523
Lorazepam Products¹	0.7472	0.9332	*
Clonazepam Products¹	0.4012	0.6712	*
Diazepam Products¹	0.5831	0.4194	*
Muscle Relaxants¹	0.7145	0.6513	*
Cyclobenzaprine¹	0.5350	0.6930	*
Soma^®1	0.7435	0.5454	*
Any Other Prescription Tranquilizer^1,2	0.0028	0.3935	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.122C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	645	628	225	219	0.68	0.68
Benzodiazepine Tranquilizers¹	549	561	210	202	0.86	0.84
Alprazolam Products¹	426	415	175	147	1.25	1.17
Lorazepam Products¹	264	312	75	72	1.15	1.10
Clonazepam Products¹	274	289	102	116	1.76	1.93
Diazepam Products¹	234	258	60	85	1.42	1.70
Muscle Relaxants¹	313	326	89	85	1.21	1.09
Cyclobenzaprine¹	300	305	68	84	1.02	1.18
Soma^®1	96	101	52	11	*	1.74
Any Other Prescription Tranquilizer^1,2	270	263	26	45	0.51	1.04
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.122D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	0.25	0.24	0.09	0.08	0.68	0.68
Benzodiazepine Tranquilizers¹	0.21	0.21	0.08	0.08	0.86	0.84
Alprazolam Products¹	0.17	0.16	0.07	0.06	1.25	1.17
Lorazepam Products¹	0.10	0.12	0.03	0.03	1.15	1.10
Clonazepam Products¹	0.11	0.11	0.04	0.04	1.76	1.93
Diazepam Products¹	0.09	0.10	0.02	0.03	1.42	1.70
Muscle Relaxants¹	0.12	0.12	0.03	0.03	1.21	1.09
Cyclobenzaprine¹	0.12	0.12	0.03	0.03	1.02	1.18
Soma^®1	0.04	0.04	0.02	<0.01	*	1.74
Any Other Prescription Tranquilizer^1,2	0.10	0.10	0.01	0.02	0.51	1.04
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.122P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Tranquilizer Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	0.7682	0.4346	0.4808
Benzodiazepine Tranquilizers¹	0.9628	0.2601	0.2379
Alprazolam Products¹	0.3750	0.0908	0.1575
Lorazepam Products¹	0.8648	0.4275	0.4489
Clonazepam Products¹	0.5695	0.8718	0.9417
Diazepam Products¹	0.1660	0.0751	0.1727
Muscle Relaxants¹	0.5023	0.5736	0.4259
Cyclobenzaprine¹	0.6301	0.8364	0.9435
Soma^®1	0.9395	0.0211	*
Any Other Prescription Tranquilizer^1,2	0.0198	0.5157	0.3318
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.123C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	98	95	45	53	1.81	2.23
Benzodiazepine Tranquilizers¹	85	90	41	50	2.17	2.59
Alprazolam Products¹	68	73	38	49	2.96	3.53
Lorazepam Products¹	52	44	19	12	3.55	2.93
Clonazepam Products¹	39	40	20	20	4.77	4.86
Diazepam Products¹	36	35	12	19	3.79	6.15
Muscle Relaxants¹	40	27	16	16	*	*
Cyclobenzaprine¹	38	26	13	16	*	*
Soma^®1	11	7	9	3	*	*
Any Other Prescription Tranquilizer^1,2	49	42	6	11	1.29	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.123D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	0.29	0.27	0.13	0.15	1.81	2.23
Benzodiazepine Tranquilizers¹	0.25	0.26	0.12	0.14	2.17	2.59
Alprazolam Products¹	0.20	0.21	0.11	0.14	2.96	3.53
Lorazepam Products¹	0.15	0.13	0.06	0.04	3.55	2.93
Clonazepam Products¹	0.11	0.11	0.06	0.06	4.77	4.86
Diazepam Products¹	0.11	0.10	0.03	0.05	3.79	6.15
Muscle Relaxants¹	0.12	0.08	0.05	0.05	*	*
Cyclobenzaprine¹	0.11	0.07	0.04	0.05	*	*
Soma^®1	0.03	0.02	0.03	0.01	*	*
Any Other Prescription Tranquilizer^1,2	0.14	0.12	0.02	0.03	1.29	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.123P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Tranquilizer Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	0.0110	0.8296	0.2232
Benzodiazepine Tranquilizers¹	0.1640	0.9585	0.3695
Alprazolam Products¹	0.2849	0.8223	0.2849
Lorazepam Products¹	0.0560	0.1757	0.5879
Clonazepam Products¹	0.8818	0.9793	0.9268
Diazepam Products¹	0.3708	0.3785	0.1604
Muscle Relaxants¹	0.0307	0.6942	*
Cyclobenzaprine¹	0.0428	0.3384	*
Soma^®1	0.5099	0.3657	*
Any Other Prescription Tranquilizer^1,2	0.2969	0.5827	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.124C – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	638	622	217	210	0.71	0.69
Benzodiazepine Tranquilizers¹	535	554	202	194	0.90	0.87
Alprazolam Products¹	416	411	170	139	1.32	1.19
Lorazepam Products¹	257	310	71	70	1.19	1.15
Clonazepam Products¹	270	286	100	114	1.84	2.03
Diazepam Products¹	232	256	59	82	1.51	1.75
Muscle Relaxants¹	310	325	87	83	1.25	1.11
Cyclobenzaprine¹	298	303	66	82	1.05	1.19
Soma^®1	95	101	51	11	*	1.71
Any Other Prescription Tranquilizer^1,2	270	259	26	44	0.54	1.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.124D – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Standard Errors of Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	0.29	0.27	0.10	0.09	0.71	0.69
Benzodiazepine Tranquilizers¹	0.24	0.24	0.09	0.09	0.90	0.87
Alprazolam Products¹	0.19	0.18	0.08	0.06	1.32	1.19
Lorazepam Products¹	0.12	0.14	0.03	0.03	1.19	1.15
Clonazepam Products¹	0.12	0.13	0.04	0.05	1.84	2.03
Diazepam Products¹	0.10	0.11	0.03	0.04	1.51	1.75
Muscle Relaxants¹	0.14	0.14	0.04	0.04	1.25	1.11
Cyclobenzaprine¹	0.13	0.13	0.03	0.04	1.05	1.19
Soma^®1	0.04	0.04	0.02	<0.01	*	1.71
Any Other Prescription Tranquilizer^1,2	0.12	0.11	0.01	0.02	0.54	1.10
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.124P – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Tranquilizer Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)
ANY PRESCRIPTION TRANQUILIZER	0.9160	0.4481	0.4074
Benzodiazepine Tranquilizers¹	0.8475	0.2384	0.1868
Alprazolam Products¹	0.4797	0.0711	0.0983
Lorazepam Products¹	0.8779	0.6028	0.5623
Clonazepam Products¹	0.5750	0.8654	0.9576
Diazepam Products¹	0.1258	0.1001	0.2407
Muscle Relaxants¹	0.3605	0.5184	0.3452
Cyclobenzaprine¹	0.4763	0.9791	0.8582
Soma^®1	0.8869	0.0293	*
Any Other Prescription Tranquilizer^1,2	0.0296	0.5918	0.4196
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.125C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	497	500	148	127	0.95	0.88
Zolpidem Products¹	355	338	107	109	1.46	1.69
Eszopiclone Products¹	99	121	17	16	1.85	1.56
Zaleplon Products¹	52	66	4	*	*	*
Benzodiazepine Sedatives¹	163	156	28	39	1.65	2.34
Flurazepam¹	47	15	1	3	*	*
Temazepam Products¹	108	114	24	37	2.72	*
Triazolam Products¹	115	107	7	12	0.96	1.62
Barbiturates¹	72	84	11	15	*	2.95
Any Other Prescription Sedative^1,2	291	321	99	33	1.48	0.53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.125D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	0.18	0.17	0.05	0.04	0.95	0.88
Zolpidem Products¹	0.13	0.12	0.04	0.04	1.46	1.69
Eszopiclone Products¹	0.04	0.04	0.01	0.01	1.85	1.56
Zaleplon Products¹	0.02	0.02	<0.01	*	*	*
Benzodiazepine Sedatives¹	0.06	0.05	0.01	0.01	1.65	2.34
Flurazepam¹	0.02	0.01	<0.01	<0.01	*	*
Temazepam Products¹	0.04	0.04	0.01	0.01	2.72	*
Triazolam Products¹	0.04	0.04	<0.01	<0.01	0.96	1.62
Barbiturates¹	0.03	0.03	<0.01	0.01	*	2.95
Any Other Prescription Sedative^1,2	0.10	0.11	0.03	0.01	1.48	0.53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.125P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Sedative Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	0.0931	0.3990	0.6585
Zolpidem Products¹	0.0617	0.5049	0.9278
Eszopiclone Products¹	0.5268	0.8991	0.7293
Zaleplon Products¹	0.3743	*	*
Benzodiazepine Sedatives¹	0.6557	0.3862	0.3178
Flurazepam¹	0.0613	0.5015	*
Temazepam Products¹	0.9720	0.6367	*
Triazolam Products¹	0.7046	0.3852	0.3447
Barbiturates¹	0.8813	0.4922	*
Any Other Prescription Sedative^1,2	0.4331	0.2018	0.2240
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.126C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	50	51	18	17	2.96	2.96
Zolpidem Products¹	21	21	15	12	*	*
Eszopiclone Products¹	4	6	*	5	*	*
Zaleplon Products¹	4	7	*	*	*	*
Benzodiazepine Sedatives¹	22	17	5	10	*	*
Flurazepam¹	9	6	1	1	*	*
Temazepam Products¹	11	8	5	1	*	*
Triazolam Products¹	17	14	*	10	*	*
Barbiturates¹	10	10	*	6	*	*
Any Other Prescription Sedative^1,2	41	49	7	13	1.68	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.126D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	0.19	0.20	0.07	0.07	2.96	2.96
Zolpidem Products¹	0.08	0.08	0.06	0.05	*	*
Eszopiclone Products¹	0.01	0.02	*	0.02	*	*
Zaleplon Products¹	0.02	0.03	*	*	*	*
Benzodiazepine Sedatives¹	0.09	0.07	0.02	0.04	*	*
Flurazepam¹	0.04	0.02	<0.01	<0.01	*	*
Temazepam Products¹	0.04	0.03	0.02	<0.01	*	*
Triazolam Products¹	0.06	0.06	*	0.04	*	*
Barbiturates¹	0.04	0.04	*	0.02	*	*
Any Other Prescription Sedative^1,2	0.16	0.19	0.03	0.05	1.68	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.126P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Sedative Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	0.6045	0.8652	0.9899
Zolpidem Products¹	0.7949	0.6990	*
Eszopiclone Products¹	0.2074	*	*
Zaleplon Products¹	0.5421	*	*
Benzodiazepine Sedatives¹	0.4710	0.4581	*
Flurazepam¹	0.3710	0.5672	*
Temazepam Products¹	0.3121	0.5199	*
Triazolam Products¹	0.9091	*	*
Barbiturates¹	0.6585	*	*
Any Other Prescription Sedative^1,2	0.8580	0.4605	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.127C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	493	496	147	125	0.99	0.91
Zolpidem Products¹	355	337	106	108	1.48	1.70
Eszopiclone Products¹	99	121	17	15	1.86	1.48
Zaleplon Products¹	52	66	4	*	*	*
Benzodiazepine Sedatives¹	161	154	28	37	1.71	2.34
Flurazepam¹	47	14	*	3	*	*
Temazepam Products¹	108	114	23	37	2.76	*
Triazolam Products¹	114	106	7	6	1.01	0.83
Barbiturates¹	71	84	11	14	*	*
Any Other Prescription Sedative^1,2	286	316	99	30	1.57	0.52
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.127D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	0.19	0.19	0.06	0.05	0.99	0.91
Zolpidem Products¹	0.14	0.13	0.04	0.04	1.48	1.70
Eszopiclone Products¹	0.04	0.05	0.01	0.01	1.86	1.48
Zaleplon Products¹	0.02	0.03	<0.01	*	*	*
Benzodiazepine Sedatives¹	0.06	0.06	0.01	0.01	1.71	2.34
Flurazepam¹	0.02	0.01	*	<0.01	*	*
Temazepam Products¹	0.04	0.04	0.01	0.01	2.76	*
Triazolam Products¹	0.04	0.04	<0.01	<0.01	1.01	0.83
Barbiturates¹	0.03	0.03	<0.01	0.01	*	*
Any Other Prescription Sedative^1,2	0.11	0.12	0.04	0.01	1.57	0.52
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.127P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Sedative Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	0.1000	0.4114	0.6578
Zolpidem Products¹	0.0571	0.5320	0.9590
Eszopiclone Products¹	0.5688	0.6127	0.4895
Zaleplon Products¹	0.4057	*	*
Benzodiazepine Sedatives¹	0.7137	0.4791	0.4197
Flurazepam¹	0.0856	*	*
Temazepam Products¹	0.9076	0.5799	*
Triazolam Products¹	0.6876	0.9433	0.9589
Barbiturates¹	0.8361	0.8579	*
Any Other Prescription Sedative^1,2	0.4070	0.1627	0.1778
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.128C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	62	65	19	19	2.11	2.20
Zolpidem Products¹	33	24	15	10	5.73	5.30
Eszopiclone Products¹	16	13	7	12	*	*
Zaleplon Products¹	7	19	*	*	*	*
Benzodiazepine Sedatives¹	26	22	6	6	*	*
Flurazepam¹	8	3	*	*	*	*
Temazepam Products¹	2	14	*	3	*	*
Triazolam Products¹	24	18	6	5	*	*
Barbiturates¹	14	11	6	2	*	*
Any Other Prescription Sedative^1,2	49	56	4	10	0.67	1.91
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.128D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	0.18	0.18	0.06	0.05	2.11	2.20
Zolpidem Products¹	0.10	0.07	0.04	0.03	5.73	5.30
Eszopiclone Products¹	0.05	0.04	0.02	0.03	*	*
Zaleplon Products¹	0.02	0.05	*	*	*	*
Benzodiazepine Sedatives¹	0.08	0.06	0.02	0.02	*	*
Flurazepam¹	0.02	0.01	*	*	*	*
Temazepam Products¹	0.01	0.04	*	0.01	*	*
Triazolam Products¹	0.07	0.05	0.02	0.01	*	*
Barbiturates¹	0.04	0.03	0.02	0.01	*	*
Any Other Prescription Sedative^1,2	0.15	0.16	0.01	0.03	0.67	1.91
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.128P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Sedative Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	0.4459	0.5379	0.6983
Zolpidem Products¹	0.1060	0.2283	0.5851
Eszopiclone Products¹	0.1652	0.7419	*
Zaleplon Products¹	0.3614	*	*
Benzodiazepine Sedatives¹	1.0000	0.6843	*
Flurazepam¹	0.0525	*	*
Temazepam Products¹	0.0029	*	*
Triazolam Products¹	0.5492	0.9760	*
Barbiturates¹	0.1658	0.6188	*
Any Other Prescription Sedative^1,2	0.5074	0.3904	0.3254
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.129C – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	488	495	146	124	1.05	0.95
Zolpidem Products¹	352	338	105	108	1.51	1.75
Eszopiclone Products¹	99	120	15	9	1.83	0.97
Zaleplon Products¹	52	63	4	*	*	*
Benzodiazepine Sedatives¹	160	152	23	37	1.53	2.50
Flurazepam¹	46	14	*	3	*	*
Temazepam Products¹	108	113	23	36	2.78	*
Triazolam Products¹	113	104	5	3	0.74	0.51
Barbiturates¹	71	83	9	14	*	*
Any Other Prescription Sedative^1,2	284	313	99	28	1.73	0.53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.129D – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Standard Errors of Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	0.22	0.22	0.07	0.05	1.05	0.95
Zolpidem Products¹	0.16	0.15	0.05	0.05	1.51	1.75
Eszopiclone Products¹	0.04	0.05	0.01	<0.01	1.83	0.97
Zaleplon Products¹	0.02	0.03	<0.01	*	*	*
Benzodiazepine Sedatives¹	0.07	0.07	0.01	0.02	1.53	2.50
Flurazepam¹	0.02	0.01	*	<0.01	*	*
Temazepam Products¹	0.05	0.05	0.01	0.02	2.78	*
Triazolam Products¹	0.05	0.05	<0.01	<0.01	0.74	0.51
Barbiturates¹	0.03	0.04	<0.01	0.01	*	*
Any Other Prescription Sedative^1,2	0.13	0.14	0.04	0.01	1.73	0.53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.129P – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Sedative Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)
ANY PRESCRIPTION SEDATIVE	0.1236	0.4661	0.6987
Zolpidem Products¹	0.0776	0.6323	0.9702
Eszopiclone Products¹	0.4440	0.3773	0.2808
Zaleplon Products¹	0.5203	*	*
Benzodiazepine Sedatives¹	0.7130	0.4946	0.4365
Flurazepam¹	0.1559	*	*
Temazepam Products¹	0.8880	0.6269	*
Triazolam Products¹	0.7760	0.8699	0.9307
Barbiturates¹	0.6643	0.7007	*
Any Other Prescription Sedative^1,2	0.4710	0.1351	0.1409
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.130C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	577	577	230	207	0.89	0.81
Benzodiazepine Tranquilizers¹	549	563	209	204	0.84	0.84
Alprazolam Products¹	427	418	175	148	1.23	1.15
Lorazepam Products¹	264	315	76	73	1.15	1.10
Clonazepam Products¹	273	289	102	116	1.74	1.92
Diazepam Products¹	233	259	61	86	1.41	1.69
Benzodiazepine Sedatives¹	163	156	28	39	1.65	2.34
Flurazepam¹	47	15	1	3	*	*
Temazepam Products¹	108	114	24	37	2.72	*
Triazolam Products¹	115	107	7	12	0.96	1.62
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	87	4	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.130D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	0.20	0.20	0.08	0.07	0.89	0.81
Benzodiazepine Tranquilizers¹	0.19	0.20	0.07	0.07	0.84	0.84
Alprazolam Products¹	0.15	0.15	0.06	0.05	1.23	1.15
Lorazepam Products¹	0.09	0.11	0.03	0.03	1.15	1.10
Clonazepam Products¹	0.10	0.10	0.04	0.04	1.74	1.92
Diazepam Products¹	0.08	0.09	0.02	0.03	1.41	1.69
Benzodiazepine Sedatives¹	0.06	0.05	0.01	0.01	1.65	2.34
Flurazepam¹	0.02	0.01	<0.01	<0.01	*	*
Temazepam Products¹	0.04	0.04	0.01	0.01	2.72	*
Triazolam Products¹	0.04	0.04	<0.01	<0.01	0.96	1.62
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.03	<0.01	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.130P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Benzodiazepine Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	0.9110	0.1913	0.1819
Benzodiazepine Tranquilizers¹	0.9182	0.2442	0.2321
Alprazolam Products¹	0.3529	0.0805	0.1490
Lorazepam Products¹	0.8664	0.4438	0.4658
Clonazepam Products¹	0.5971	0.8353	0.9964
Diazepam Products¹	0.1726	0.0603	0.1415
Benzodiazepine Sedatives¹	0.6557	0.3862	0.3178
Flurazepam¹	0.0613	0.5015	*
Temazepam Products¹	0.9720	0.6367	*
Triazolam Products¹	0.7046	0.3852	0.3447
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.1566	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.131C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	42	43	18	20	3.68	4.37
Benzodiazepine Tranquilizers¹	37	39	18	20	4.18	4.81
Alprazolam Products¹	31	32	16	18	5.21	6.02
Lorazepam Products¹	17	20	11	13	*	*
Clonazepam Products¹	21	18	7	12	*	*
Diazepam Products¹	17	20	6	11	*	*
Benzodiazepine Sedatives¹	22	17	5	10	*	*
Flurazepam¹	9	6	1	1	*	*
Temazepam Products¹	11	8	5	1	*	*
Triazolam Products¹	17	14	*	10	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.131D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	0.16	0.17	0.07	0.08	3.68	4.37
Benzodiazepine Tranquilizers¹	0.14	0.15	0.07	0.08	4.18	4.81
Alprazolam Products¹	0.12	0.12	0.06	0.07	5.21	6.02
Lorazepam Products¹	0.07	0.08	0.04	0.05	*	*
Clonazepam Products¹	0.08	0.07	0.03	0.05	*	*
Diazepam Products¹	0.07	0.08	0.02	0.04	*	*
Benzodiazepine Sedatives¹	0.09	0.07	0.02	0.04	*	*
Flurazepam¹	0.04	0.02	<0.01	<0.01	*	*
Temazepam Products¹	0.04	0.03	0.02	<0.01	*	*
Triazolam Products¹	0.06	0.06	*	0.04	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	<0.01	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.131P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Benzodiazepine Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	0.1585	0.8607	0.4473
Benzodiazepine Tranquilizers¹	0.1734	0.5877	0.7357
Alprazolam Products¹	0.3397	0.5621	0.9523
Lorazepam Products¹	0.7472	0.9332	*
Clonazepam Products¹	0.4012	0.6712	*
Diazepam Products¹	0.5831	0.4194	*
Benzodiazepine Sedatives¹	0.4710	0.4581	*
Flurazepam¹	0.3710	0.5672	*
Temazepam Products¹	0.3121	0.5199	*
Triazolam Products¹	0.9091	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	*	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.132C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	574	575	230	205	0.90	0.82
Benzodiazepine Tranquilizers¹	549	561	210	202	0.86	0.84
Alprazolam Products¹	426	415	175	147	1.25	1.17
Lorazepam Products¹	264	312	75	72	1.15	1.10
Clonazepam Products¹	274	289	102	116	1.76	1.93
Diazepam Products¹	234	258	60	85	1.42	1.70
Benzodiazepine Sedatives¹	161	154	28	37	1.71	2.34
Flurazepam¹	47	14	*	3	*	*
Temazepam Products¹	108	114	23	37	2.76	*
Triazolam Products¹	114	106	7	6	1.01	0.83
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	87	4	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.132D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	0.22	0.22	0.09	0.08	0.90	0.82
Benzodiazepine Tranquilizers¹	0.21	0.21	0.08	0.08	0.86	0.84
Alprazolam Products¹	0.17	0.16	0.07	0.06	1.25	1.17
Lorazepam Products¹	0.10	0.12	0.03	0.03	1.15	1.10
Clonazepam Products¹	0.11	0.11	0.04	0.04	1.76	1.93
Diazepam Products¹	0.09	0.10	0.02	0.03	1.42	1.70
Benzodiazepine Sedatives¹	0.06	0.06	0.01	0.01	1.71	2.34
Flurazepam¹	0.02	0.01	*	<0.01	*	*
Temazepam Products¹	0.04	0.04	0.01	0.01	2.76	*
Triazolam Products¹	0.04	0.04	<0.01	<0.01	1.01	0.83
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.03	<0.01	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.132P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Benzodiazepine Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	0.9663	0.1927	0.1733
Benzodiazepine Tranquilizers¹	0.9628	0.2601	0.2379
Alprazolam Products¹	0.3750	0.0908	0.1575
Lorazepam Products¹	0.8648	0.4275	0.4489
Clonazepam Products¹	0.5695	0.8718	0.9417
Diazepam Products¹	0.1660	0.0751	0.1727
Benzodiazepine Sedatives¹	0.7137	0.4791	0.4197
Flurazepam¹	0.0856	*	*
Temazepam Products¹	0.9076	0.5799	*
Triazolam Products¹	0.6876	0.9433	0.9589
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.1538	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.133C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	85	91	43	51	2.14	2.53
Benzodiazepine Tranquilizers¹	85	90	41	50	2.17	2.59
Alprazolam Products¹	68	73	38	49	2.96	3.53
Lorazepam Products¹	52	44	19	12	3.55	2.93
Clonazepam Products¹	39	40	20	20	4.77	4.86
Diazepam Products¹	36	35	12	19	3.79	6.15
Benzodiazepine Sedatives¹	26	22	6	6	*	*
Flurazepam¹	8	3	*	*	*	*
Temazepam Products¹	2	14	*	3	*	*
Triazolam Products¹	24	18	6	5	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	2	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.133D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	0.25	0.26	0.13	0.14	2.14	2.53
Benzodiazepine Tranquilizers¹	0.25	0.26	0.12	0.14	2.17	2.59
Alprazolam Products¹	0.20	0.21	0.11	0.14	2.96	3.53
Lorazepam Products¹	0.15	0.13	0.06	0.04	3.55	2.93
Clonazepam Products¹	0.11	0.11	0.06	0.06	4.77	4.86
Diazepam Products¹	0.11	0.10	0.03	0.05	3.79	6.15
Benzodiazepine Sedatives¹	0.08	0.06	0.02	0.02	*	*
Flurazepam¹	0.02	0.01	*	*	*	*
Temazepam Products¹	0.01	0.04	*	0.01	*	*
Triazolam Products¹	0.07	0.05	0.02	0.01	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	0.01	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.133P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Benzodiazepine Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	0.1977	0.9374	0.4791
Benzodiazepine Tranquilizers¹	0.1640	0.9585	0.3695
Alprazolam Products¹	0.2849	0.8223	0.2849
Lorazepam Products¹	0.0560	0.1757	0.5879
Clonazepam Products¹	0.8818	0.9793	0.9268
Diazepam Products¹	0.3708	0.3785	0.1604
Benzodiazepine Sedatives¹	1.0000	0.6843	*
Flurazepam¹	0.0525	*	*
Temazepam Products¹	0.0029	*	*
Triazolam Products¹	0.5492	0.9760	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	*	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.134C – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	560	568	223	197	0.95	0.85
Benzodiazepine Tranquilizers¹	535	554	202	194	0.90	0.87
Alprazolam Products¹	416	411	170	139	1.32	1.19
Lorazepam Products¹	257	310	71	70	1.19	1.15
Clonazepam Products¹	270	286	100	114	1.84	2.03
Diazepam Products¹	232	256	59	82	1.51	1.75
Benzodiazepine Sedatives¹	160	152	23	37	1.53	2.50
Flurazepam¹	46	14	*	3	*	*
Temazepam Products¹	108	113	23	36	2.78	*
Triazolam Products¹	113	104	5	3	0.74	0.51
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	87	3	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.134D – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Standard Errors of Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	0.25	0.25	0.10	0.09	0.95	0.85
Benzodiazepine Tranquilizers¹	0.24	0.24	0.09	0.09	0.90	0.87
Alprazolam Products¹	0.19	0.18	0.08	0.06	1.32	1.19
Lorazepam Products¹	0.12	0.14	0.03	0.03	1.19	1.15
Clonazepam Products¹	0.12	0.13	0.04	0.05	1.84	2.03
Diazepam Products¹	0.10	0.11	0.03	0.04	1.51	1.75
Benzodiazepine Sedatives¹	0.07	0.07	0.01	0.02	1.53	2.50
Flurazepam¹	0.02	0.01	*	<0.01	*	*
Temazepam Products¹	0.05	0.05	0.01	0.02	2.78	*
Triazolam Products¹	0.05	0.05	<0.01	<0.01	0.74	0.51
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.04	<0.01	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.134P – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2023
Benzodiazepine Subtype	Any Use in Past Year (2023)	Misuse in Past Year among Total Population (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)
ANY PRESCRIPTION BENZODIAZEPINE	0.8634	0.1861	0.1444
Benzodiazepine Tranquilizers¹	0.8475	0.2384	0.1868
Alprazolam Products¹	0.4797	0.0711	0.0983
Lorazepam Products¹	0.8779	0.6028	0.5623
Clonazepam Products¹	0.5750	0.8654	0.9576
Diazepam Products¹	0.1258	0.1001	0.2407
Benzodiazepine Sedatives¹	0.7130	0.4946	0.4365
Flurazepam¹	0.1559	*	*
Temazepam Products¹	0.8880	0.6269	*
Triazolam Products¹	0.7760	0.8699	0.9307
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	0.1464	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.